Checklists and illustrative financial statements : Life and Health insurance entities, September 2010 edition by American Institute of Certified Public Accountants (AICPA)
University of Mississippi 
eGrove 
Industry Guides (AAGs), Risk Alerts, and 
Checklists 
American Institute of Certified Public 
Accountants (AICPA) Historical Collection 
2010 
Checklists and illustrative financial statements : Life and Health 
insurance entities, September 2010 edition 
American Institute of Certified Public Accountants (AICPA) 
Follow this and additional works at: https://egrove.olemiss.edu/aicpa_indev 
 Part of the Accounting Commons, and the Taxation Commons 
aicpa.org  |  cpa2biz.com
0089510
Life and
 H
ealth Insurance E
ntities          Sep
tem
b
er 2010
September 2010
C h e C k l i s t s  &  i l l u s t r a t i v e  F i n a n C i a l  s t a t e m e n t s
Life and Health 
Insurance Entities
CHK-LHI_2010_cover.indd   1 2/3/2011   10:12:02 AM
10691-344
September 2010
C h e C k l i s t s  &  i l l u s t r a t i v e  F i n a n C i a l  s t a t e m e n t s
Life and Health 
Insurance Entities
Checklists and Illustrative Financial Statements for 
Life and Health Insurance Entities has not been 
approved, disapproved, or otherwise acted upon 
by any senior technical committees of the American 
Institute of Certified Public Accountants or the 
Financial Accounting Standards Board and has no 
official or authoritative status.
CHK-LHI_2010_titlepage.indd   1 1/12/2011   11:43:59 AM
Copyright © 2011 by 
American Institute of Certified Public Accountants, Inc. 
New York, NY 10036-8775
All rights reserved. Checklists and sample documents contained herein may be reproduced and distributed as part of  
professional services or within the context of professional practice, provided that reproduced materials are not in any  
way directly offered for sale or profit. For information about the procedure for requesting permission to make copies of 
any part of this work, please visit www.copyright.com or call (978) 750-8400.
1 2 3 4 5 6 7 8 9 0  AAP  1 9 8 7 6 5 4 3 2 1
ISBN 978-0-87051-940-6
CHK-LHI_2010_copyright.indd   1 1/13/2011   10:39:53 AM
iii
TABLE OF CONTENTS
PAGE
FSP 20,000—Checklists and Illustrative Financial Statements for Life and Health Insurance
Entities ................................................................................................................................... 1
Letter to Customers ............................................................................................................. 1
Introduction ....................................................................................................................... 2
General .............................................................................................................................. 2
Instructions ........................................................................................................................ 5
Recognition ........................................................................................................................ 6
FSP 20,100—Financial Statements and Notes Checklist .................................................................. 7
I. Presentation ..................................................................................................................... 10
II. Assets ............................................................................................................................. 38
III. Liabilities ....................................................................................................................... 64
IV. Equity ........................................................................................................................... 85
V. Revenue ......................................................................................................................... 90
VI. Expenses ....................................................................................................................... 95
VII. Broad Transactions ....................................................................................................... 125
FSP 20,200—Auditors’ Reports Checklist ...................................................................................... 211
FSP 20,300—Supplemental Information for Life Insurance Companies That Are Securities and
Exchange Commission Registrants ........................................................................................... 231
FSP 20,400—Illustrative Financial Statements ................................................................................ 233

1Checklists and Illustrative Financial Statements for Life and Health Insurance Entities
FSP §20,000
FSP Section 20,000
Checklists and Illustrative Financial
Statements for Life and Health Insurance
Entities
Letter to Customers
Dear Valued Customer,
The following checklists and illustrative materials have been developed by the AICPA Accounting and Au-
diting Publications Staff to serve as nonauthoritative practice aids for use by preparers of financial state-
ments and by practitioners who audit, review, or compile financial statements. The auditor’s and account-
ant’s report checklists address those requirements most likely to be encountered when reporting on financial
statements of a commercial corporation prepared in conformity with U.S. generally accepted accounting
principles.
Relevant financial statement reporting and disclosure guidance issued through September 30, 2010, has been
considered in the development of this edition of the checklist. The accounting guidance in this checklist has
been conformed to reflect reference to FASB Accounting Standards Codificatione as it existed on September
30, 2010.
Any guidance issued subsequent to September 30, 2010, has not been included in this checklist; therefore, if
your entity has a fiscal year-end after September 30, 2010, you need to consider the applicability of such
guidance. In determining the applicability of newly issued guidance, its effective date also should be consid-
ered.
Recognizing that many entities have December 31 year-ends and in an effort to assist those users, this check-
list includes guidance issued through September 30, 2010, which may become effective by December 31,
2010. This guidance is discussed in each section of the checklist when applicable. Additional questions ap-
pear and are indicated with an “A” or “B” reference. As determined by the effective date or early imple-
mentation decision
● entities for which this guidance has not been implemented should consider all questions with an
“A” reference (for example, question 1A, question 2A, and so on) and should place an “N/A” mark
by questions with a “B” reference.
● entities for which this guidance has been implemented should consider all questions with a “B”
reference (for example, question 1B, question 2B, and so on) and should place an “N/A” mark by
questions with an “A” reference.
Therefore, based upon the year-end of the entities and the decision to early implement (if allowed), the
appropriate additional questions should be answered when provided.
We hope you find this checklist helpful as you perform your audit and compilation and review engage-
ments. We would greatly appreciate your feedback on this checklist. You may e-mail these comments to
A&APublications@aicpa.org or write to
A&A Publications
AICPA
220 Leigh Farm Road
Durham, NC 27707-8110
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Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death
of the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance. Tradi-
tionally, life insurance entities provided life and health products to protect against the loss of financial sta-
bility resulting from premature death or illness and provided annuity products to protect against the risk of
outliving one’s financial resources. The primary emphasis was on meeting the customer’s insurance needs.
The provisions of AICPA Audit and Accounting Guide Life and Health Insurance Entities (2010) (product no.
0126310kk) apply to all life and health insurance entities including stock, mutual, fraternal, and assessment
entities.
.02 The National Association of Insurance Commissioners (NAIC) codified statutory accounting prac-
tices for certain insurance enterprises, resulting in a revised Accounting Practices and Procedures Manual. The
insurance laws and regulations of the states require insurance companies domiciled in the states to comply
with the guidance provided in the NAIC Accounting Practices and Procedures Manual except as prescribed or
permitted by state law.
.03 Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 944-505-50-3
requires insurance entities to disclose, at the date each balance sheet is presented, a description of the pre-
scribed or permitted statutory accounting practice and the related monetary effect on statutory surplus of
using an accounting practice that differs from either state prescribed statutory accounting practices or NAIC
statutory accounting practices.
.04 As discussed in FASB ASC 944-505-50-2, those disclosures should be made if (a) state prescribed
statutory accounting practices differ from NAIC statutory accounting practices or (b) permitted state statu-
tory accounting practices differ from either state prescribed statutory accounting practices or NAIC statutory
accounting practices, and the use of prescribed or permitted statutory accounting practices (individually or
in the aggregate) results in reported statutory surplus or risk-based capital that is significantly different from
the statutory surplus or risk-based capital that would have been reported had NAIC statutory accounting
practices been followed.
.05 According to paragraphs 4–6 of FASB ASC 944-505-50, those disclosures should be applied by a U.S.
insurance entity, a U.S. entity with a U.S. insurance subsidiary, or a foreign entity with a U.S. insurance
subsidiary if the entity prepares U.S. generally accepted accounting principles (GAAP) financial statements.
If a foreign insurance entity that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial
statements or is included in its parent’s consolidated U.S. GAAP financial statements, the notes to the finan-
cial statements should disclose permitted regulatory accounting practices that significantly differ from the
prescribed regulatory accounting practices of its respective regulatory authority and their monetary effects.
If an insurance entity’s risk-based capital would have triggered a regulatory event had it not used a permit-
ted practice, that fact should be disclosed in the financial statements.
General
.06 This publication includes the following information:
● Financial Statements and Notes Checklist (FSP section 20,100)—For use by preparers of finan-
cial statements and by auditors as they evaluate the adequacy of disclosures.
● Auditors’ Reports Checklist (FSP section 20,200)—For use by auditors in reporting on audited
financial statements.
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● Supplemental Information for Life Insurance Entities That are Securities and Exchange Com-
mission Registrants (FSP section 20,300)—For use by auditors of Securities and Exchange Com-
mission (SEC) registrants.
● Illustrative Financial Statements (FSP section 20,400).
.07 These checklists and illustrative materials are intended to be used in connection with engagements
of nonpublic entities and is not intended to be used in connection with audits of public entities that are
required to be audited under standards established by the Public Accounting Oversight Board (PCAOB).
.08 These checklists and illustrative materials have been developed by the AICPA Accounting and Au-
diting Publications Staff to serve as nonauthoritative practice aids for use by preparers of financial state-
ments and by practitioners who audit them. The auditor’s and accountant’s report checklists address those
requirements most likely to be encountered when reporting on financial statements of a life and health
insurance entity prepared in conformity with U.S. GAAP. They do not include reporting requirements relat-
ing to other matters such as internal control or agreed-upon procedures. The financial statement and notes
checklist includes disclosure considerations applicable to life and health insurance entities in preparing fi-
nancial statements in conformity with U.S. GAAP. It does not include disclosures prescribed by guidance
whose applicability to life and health insurance entities is considered to be remote.
.09 Users of the financial statements and notes checklist should remember that it is a disclosure checklist
only and not a comprehensive U.S. GAAP application or measurement checklist. Accordingly, application
and measurement issues related to preparing financial statements in conformity with U.S. GAAP are not
included in the checklist.
.10 The AICPA Accounting and Auditing Publications staff has included guidance from FASB ASC as
it existed at September 30, 2010. Questions are derived primarily from the content of the “Presentation” and
“Disclosure” sections of FASB ASC. The AICPA Accounting and Auditing Publications staff has included
presentation and disclosure items deemed most likely to be encountered when reporting on the financial
statements of a property and liability insurance entity prepared in conformity with U.S. GAAP. Thus, not
all paragraphs of the “Presentation” and “Disclosure” sections of FASB ASC have been included. Users
should evaluate whether circumstances exist for which the relevant presentation and disclosure guidance is
not provided in these checklists and illustrative materials and refer directly to FASB ASC as appropriate.
These checklists and illustrative materials note significant areas where “Presentation” and “Disclosure” par-
agraphs were deemed too specific for this general publication and, where noted, users are urged to consult
the FASB ASC as necessary.
.11 The checklists and illustrative financial statements should be used by, or under the supervision of,
persons having adequate technical training and proficiency in the application of U.S. GAAP, generally ac-
cepted auditing standards, and other relevant technical guidance.
.12 In some cases, this checklist uses the terms Additional Presentation Information or Additional Disclosure
Information to further illustrate an item. In such cases, the information contained under those headings con-
tinues to be authoritative guidance, and the heading is included to further clarify a presentation or disclo-
sure requirement or to add useful information.
.13 Relevant financial statement reporting and disclosure guidance issued through September 30, 2010,
has been considered in the development of this edition of the checklist. This includes relevant guidance
issued up to and including the following:
● FASB Accounting Standards Updates issued through September 30, 2010
● Statement on Auditing Standards No. 120, Required Supplementary Information (AICPA, Profes-
sional Standards, vol. 1, AU sec. 558)
● Interpretation No. 4, "Appropriateness of Identifying No Significant Deficiencies or No Material
Weaknesses in an Interim Communication," of AU section 325, Communicating Internal Control
Related Matters Identified in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 9325 par.
.11–.13)
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● Statement of Position 09-1, Performing Agreed-Upon Procedures Engagements That Address the Com-
pleteness, Accuracy, or Consistency of XBRL-Tagged Data (AICPA, Technical Practice Aids, AUD sec.
14,440)
● Statements on Standards for Attestation Engagements No. 16, Reporting on Controls at a Service
Organization (AICPA, Professional Standards, vol. 1, AT sec. 801)
● Interpretation No. 8, "Including a Description of Tests of Controls or Other Procedures, and the
Results Thereof, in an Examination Report," of AT section 101, Attest Engagements (AICPA, Pro-
fessional Standards, vol. 1, AT sec. 9101 par. .70–.72)
● Statements on Standards for Accounting and Review Services No. 19, Compilation and Review
Engagements (AICPA, Professional Standards, vol. 2)
● PCAOB Auditing Standard No. 7, Engagement Quality Review (AICPA, PCAOB Standards and
Related Rules, Standards, AU-P sec. 162)
.14 Any guidance issued subsequent to September 30, 2010, has not been included in this checklist;
therefore, if your entity has a fiscal year-end after September 30, 2010, you need to consider the applicability
of such guidance. In determining the applicability of newly issued guidance, its effective date should also
be considered.
.15 These checklists contain numerous references to accounting and auditing guidance. Abbreviations
and acronyms used in such references include the following:
FASB ASC5 Reference to a topic, subtopic, section, or paragraph in Financial Accounting
Standards Board Accounting Standards Codificatione
AAG-LHI5 Reference to AICPA Audit and Accounting Guide Life and Health Insurance
Entities (2010)
AU5 Reference to a section number in AICPA Professional Standards for U.S. Auditing
Standards that are applicable to nonissuers
AU-P5 Reference to a section number in AICPA PCAOB Standards and Related Rules for
standards of the PCAOB that are applicable to issuers
AUD5 Reference to a section number in AICPA Technical Practice Aids, Statements of
Position—Auditing and Attestation
SOP5 AICPA Statement of Position
.16 The accounting guidance in this checklist has been conformed to reflect reference to FASB ASC as it
existed on September 30, 2010.
.17 On June 30, 2009, FASB issued FASB Statement No. 168, The FASB Accounting Standards Codifica-
tione and the Hierarchy of Generally Accepted Accounting Principles—a replacement of FASB Statement No. 162,
which is codified at FASB ASC 105, Generally Accepted Accounting Principles. On the effective date of this
statement, FASB ASC is the authoritative source of U.S. accounting and reporting standards for nongovern-
mental entities, in addition to guidance issued by the SEC. At that time, FASB ASC supersedes all then-
existing, non-SEC accounting and reporting standards for nongovernmental entities. Once effective, all other
nongrandfathered, non-SEC accounting literature not included in FASB ASC is nonauthoritative. This state-
ment is effective for financial statements issued for interim and annual periods ending after September 15,
2009. See the FASB website at www.fasb.org for further information.
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Instructions
.18 Within these checklists are a number of questions or statements that are accompanied by references
to applicable authoritative guidance. The financial statements and notes checklist is organized into seven
discrete sections. Disclosures listed in the “Presentation,” “Assets,” “Liabilities,” “Equity,” “Revenue,” and
“Expenses” sections are common to most life and health insurance entities. Those listed in the “Broad Trans-
actions” sections are required when circumstances dictate.
.19 The checklists provide spaces for checking off or initialing each question or point to indicate that it
has been considered. Carefully review the topics listed and consider whether they represent potential disclo-
sure items for the reporting entity for which you are preparing or auditing financial statements. Users
should check or initial
● Yes—If the disclosure is required and has been made appropriately.
● No—If the disclosure is required but has not been made.
● N/A (Not Applicable)—If the disclosure is not applicable to the organization.
.20 It is important that the effect of any "No" response be considered on the auditor’s or accountant’s
report. For audited financial statements, a "No" response that is material to the financial statements may
warrant a departure from an unqualified opinion as discussed in paragraphs .20–.64 of AU section 508,
Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1). If a "No" response is indicated,
the Accounting and Auditing Publications staff recommend that a notation be made in the margin to explain
why the disclosure was not made (for example, because the item was not considered to be material to the
financial statements).
.21 Users may find it helpful to use the right margin for certain other remarks and comments as appro-
priate, including the following:
a. For each disclosure for which a "Yes" is indicated, a notation as to where the disclosure is located
in the financial statements and a cross-reference to applicable working papers where the support
to a disclosure may be found
b. For items marked as "N/A," the reasons for which they do not apply in the circumstances of the
particular report
c. For each disclosure for which a "No" response is indicated, a notation as to why the disclosure
was not made (for example, because the item was not considered to be material to the financial
statements)
.22 These checklists include guidance mandatorily effective for annual reporting periods ending on or
before September 30, 2010. Recognizing that many entities have December 31 year-ends, these checklists also
include guidance issued through September 30, 2010, that may become effective for annual reporting periods
ending on or before December 31, 2010, either because of the effective date or an entity’s decision to early
adopt (where permitted). Any guidance included herein that is not yet mandatorily effective for annual
reporting periods ending on or before September 30, 2010, is described in footnotes within each section of
the checklists where applicable.
.23 Where this aforementioned type of dual guidance is provided, the checklist questions are segregated
into those denoted with “A” references and those denoted with “B” references. Checklist questions pertain-
ing to guidance mandatorily effective for annual reporting periods ending on or before September 30, 2010,
absent an entity’s decision to early adopt any superseding guidance (where applicable and permissible), are
denoted with “A” references. Entities to which the “A” references apply should place an “N/A” mark by
the related checklist questions denoted with a “B” reference. Checklist questions pertaining to guidance
issued through September 30, 2010, that may become effective for entities with annual reporting periods
ending on or before December 31, 2010, either because of the effective date or an entity’s decision to early
adopt (where permitted), are denoted with a “B” reference. Entities to which the “B” references apply should
place an “N/A” mark by questions denoted with an “A” reference. Therefore, depending upon your entity’s
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(ies’) year-end(s) and decision(s) to early adopt (where permitted), the appropriate alternative questions
should be answered when provided.
.24 These checklists and illustrative materials have been prepared by the AICPA staff. They have not
been reviewed, approved, disapproved, or otherwise acted on by any senior technical committee of the
AICPA and do not represent official positions or pronouncements of the AICPA.
.25 The use of these or any other checklists requires the exercise of individual professional judgment.
These checklists are not substitutes for the original authoritative guidance. Users of these checklists and
illustrative materials should refer directly to applicable authoritative guidance when appropriate. The check-
lists and illustrative materials may not include all disclosures and presentation items promulgated, nor do
they represent minimum standards or requirements. Additionally, users of the checklists and illustrative
materials should tailor them as required to meet specific circumstances. As an additional resource, users
may call the AICPA Technical Hotline at (877) 242-7212.
.26 We hope you find this checklist helpful as you perform your audit engagement. We would greatly
appreciate your feedback on this checklist. You may e-mail these comments to A&APublications@aicpa.org.
Recognition
Anne Mundinger, CPA
Technical Manager,
Accounting and Auditing Publications
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FSP Section 20,100
Financial Statements and Notes Checklist
.01 Checklist Questionnaire. This financial statement disclosure checklist is organized into sections. Care-
fully review the topics listed and consider whether they represent potential disclosure items for the entity
for which you are preparing, compiling, reviewing, or auditing financial statements. Place a check mark by
the topics or sections that are applicable and complete those sections of the checklist. Other sections may be
marked “N/A” or left blank. For example, if the entity had a change in accounting principle, place a check
mark by the section “Accounting Changes” and complete that section of the checklist. On the other hand, if
the entity did not have a change in accounting principle, do not place a check mark by “Accounting
Changes” and skip that section when completing the checklist.
Place U by
Sections Applicable
I. Presentation
A. Presentation of Financial Statements (Financial Accounting
Standards Board [FASB] Accounting Standards Codification [ASC]
205-10)
B. Presentation of Discontinued Operations in the Financial
Statements (FASB ASC 205-20)
C. Presentation of the Balance Sheet (FASB ASC 210-10)
D. Presentation of Offsetting in the Balance Sheet (FASB ASC 210-20)
E. Presentation of Comprehensive Income (FASB ASC 220-10)
F. Presentation of the Income Statement (FASB ASC 225-10)
G. Presentation of Extraordinary and Unusual Items in the Income
Statement (FASB ASC 225-20)
H. Presentation of the Statement of Cash Flows (FASB ASC 230-10)
I. Presentation of the Notes to Financial Statements (FASB ASC 235-
10)
J. Presentation of Accounting Changes and Error Corrections (FASB
ASC 250-10)
K. Presentation of Changing Prices (FASB ASC 255-10)
L. Presentation of Earnings Per Share (FASB ASC 260-10)
M. Presentation Regarding Interim Reporting (FASB ASC 270-10)
N. Presentation Regarding Income Taxes for Interim Reporting (FASB
ASC 270-740)
O. Presentation of Risks and Uncertainties (FASB ASC 275-10)
P. Presentation Regarding Segment Reporting (FASB ASC 280-10)
II. Assets
A. Receivables (FASB ASC 310-10)
B. Nonrefundable Fees and Other Costs (FASB ASC 310-20)
C. Loans and Debt Securities Acquired With Deteriorated Credit
Quality (FASB ASC 310-30)
D. Troubled Debt Restructurings by Creditors (FASB ASC 310-40)
E. Investments—Debt and Equity Securities (FASB ASC 320-10)
F. Investments—Equity Method and Joint Ventures (FASB ASC 323-
10)
G. Cost Method Investments (FASB ASC 325-20)
H. Investments in Insurance Contracts (FASB ASC 325-30)
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Place U by
Sections Applicable
I. Inventory (FASB ASC 330-10)
J. Capitalized Advertising Costs (FASB ASC 340-20)
K. Insurance Contracts That Do Not Transfer Insurance Risks (FASB
ASC 340-30)
L. Goodwill (FASB ASC 350-20)
M. General Intangibles Other Than Goodwill (FASB ASC 350-30)
N. Property, Plant, and Equipment (FASB ASC 360-10)
III. Liabilities
A. Insurance-Related Assessment Liabilities (FASB ASC 405-30)
B. Asset Retirement and Environmental Obligations (FASB ASC 410-
20)
C. Asset Retirement and Environmental Obligations—Environmental
Obligations (FASB ASC 410-30)
D. Exit or Disposal Cost Obligations (FASB ASC 420-10)
E. Commitments (FASB ASC 440-10)
F. Loss Contingencies (FASB ASC 450-20)
G. Gain Contingencies (FASB ASC 450-30)
H. Guarantees (FASB ASC 460-10)
I. Debt—Overall (FASB ASC 470-10)
J. Debt—Debt With Conversion and Other Options (FASB ASC 470-
20)
K. Participating Mortgage Loans (FASB ASC 470-30)
L. Debt Modifications and Extinguishments (FASB ASC 470-50)
M. Troubled Debt Restructuring by Debtors (FASB ASC 470-60)
N. Distinguishing Liabilities From Equity (FASB ASC 480-10)
IV. Equity
A. Equity (FASB ASC 505-10)
B. Treasury Stock (FASB ASC 505-30)
C. Equity-Based Payments to Nonemployees (FASB ASC 505-50)
V. Revenue
A. Revenue Recognition—Products (FASB ASC 605-15)
B. Revenue Recognition—Services (FASB ASC 605-20)
C. Multiple Element Arrangements (FASB ASC 605-25)
D. Milestone Method Revenue Recognition (FASB ASC 605-28)
E. Gains and Losses—Revenue Recognition (FASB ASC 605-40)
F. Principal Agent Considerations—Revenue Recognition (FASB ASC
605-45)
G. Customer Payments and Incentives (FASB ASC 605-50)
VI. Expenses
A. Compensation (FASB ASC 710-10)
B. Nonretirement Postemployment Benefits (FASB ASC 712-10)
C. Defined Benefit Plans—Compensation (FASB ASC 715-20)
D. Defined Benefit Plans—Other Postretirement (FASB ASC 715-60)
E. Defined Contribution Plans (FASB ASC 715-70)
F. Multiemployer Plans (FASB ASC 715-80)
G. Stock Compensation (FASB ASC 718-10)
H. Employee Stock Ownership Plans (FASB ASC 718-40)
I. Stock Compensation—Income Taxes (FASB ASC 718-740)
J. Insurance Costs (FASB ASC 720-20)
K. Advertising Costs (FASB ASC 720-35)
L. Research and Development Expenses (FASB ASC 730-10)
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Place U by
Sections Applicable
M. Research and Development Arrangements (FASB ASC 730-20)
N. Income Taxes (FASB ASC 740-10)
O. Intraperiod Tax Allocations (FASB ASC 740-20)
P. Income Taxes—Other Considerations or Special Areas (FASB ASC
740-30)
Q. Income Taxes—Interim Reporting (FASB ASC 740-270)
VII. Broad Transactions
A. Business Combinations (FASB ASC 805-10)
B. Identifiable Assets and Liabilities, and Any Noncontrolling
Interest—Business Combinations (FASB ASC 805-20)
C. Goodwill or Gain From Bargain Purchase, Including Consideration
Transferred (FASB ASC 805-30)
D. Business Combinations—Related Issues (FASB ASC 805-50)
E. Collaborative Arrangements (FASB ASC 808-10)
F. Consolidation (FASB ASC 810-10)
G. Derivatives and Hedging (FASB ASC 815-10)
H. Embedded Derivatives (FASB ASC 815-15)
I. Fair Value Hedging (FASB ASC 815-25)
J. Cash Flow Hedges (FASB ASC 815-30)
K. Net Investment Hedges (FASB ASC 815-35)
L. Contracts in Entity’s Own Equity (FASB ASC 815-40)
M. Weather Derivatives (FASB ASC 815-45)
N. Fair Value Measurements and Disclosures (FASB ASC 820-10)
O. Financial Instruments (FASB ASC 825-10)
P. Financial Instruments—Registration Payment Arrangements (FASB
ASC 825-20)
Q. Foreign Currency Transactions (FASB ASC 830-20)
R. Foreign Currency Matters—Translation of Financial Statements
(FASB ASC 830-30)
S. Capitalization of Interest (FASB ASC 835-20)
T. Imputation of Interest (FASB ASC 835-30)
U. Leases—Overall (Lessees) (FASB ASC 840-10)
V. Operating Leases (Lessees) (FASB ASC 840-20)
W. Capital Leases (Lessees) (FASB ASC 840-30)
X. Sale-Leaseback Transactions (Lessees) (FASB ASC 840-40)
Y. Leases—Overall (Lessors) (FASB ASC 840-10)
Z. Operating Leases (Lessors) (FASB ASC 840-20)
AA. Capital Leases (Lessors) (FASB ASC 840-30)
BB. Nonmonetary Transactions (FASB ASC 845-10)
CC. Related Party Disclosures (FASB ASC 850-10)
DD. Reorganizations (FASB ASC 852-10 and FASB ASC 852-20)
EE. Subsequent Events (FASB ASC 855-10)
FF. Transfers and Servicing (FASB ASC 860-10)
GG. Sales of Financial Assets (FASB ASC 860-20)
HH. Secured Borrowing and Collateral (FASB ASC 860-30)
II. Servicing Assets and Liabilities (FASB ASC 860-50)
JJ. Financial Services—Insurance Activities (FASB ASC 944-20)
KK. Financial Services—Acquisition Costs (FASB ASC 944-30)
LL. Financial Services—Claims Cost and Liabilities for Future Policy
Benefits (FASB ASC 944-40)
MM. Financial Services—Policyholder Dividends (FASB ASC 944-50)
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Place U by
Sections Applicable
NN. Financial Services—Premium Deficiency and Loss Recognition
(FASB ASC 944-60)
OO. Financial Services—Separate Accounts (FASB ASC 944-80)
I. Presentation
Yes No N/A
A. Presentation of Financial Statements (FASB ASC 205-10)
Presentation
Comparative Financial Statements
1. Has the entity properly presented the statement of financial
position, the income statement, and the statement of changes
in equity for one or more preceding years, as well as for the
current year?
[FASB ASC 205-10-45-2]
2. Has the entity properly presented appropriate explanations
of changes related to any differences in the manner of or basis
for presenting corresponding items for two or more periods?
[FASB ASC 205-10-45-3]
3. Has the entity properly presented, or at least referred to, if
issuing comparative statements, notes and other disclosures
in the financial statements of the preceding year(s) in the cur-
rent year, to the extent that they continue to be of signifi-
cance?
[FASB ASC 205-10-45-4]
Disclosure
Changes Affecting Comparability
4. Has the entity properly disclosed information that will ex-
plain a change in the manner of or basis for presenting cor-
responding items for two or more periods (for example, any
change in practice that affects comparability of financial state-
ments must be disclosed), if changes have occurred?
[FASB ASC 205-10-50-1]
Other Guidance
5. Has the entity properly presented, for a full presentation in
conformity with accounting principles generally accepted in
the United States (U.S. GAAP), the following financial state-
ments:
a. Balance sheet?
b. Statement of income (operations)?
c. Statement of retained earnings or changes in sharehold-
ers’ equity?
d. Statement of cash flows?
e. Description of accounting policies?
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f. Notes to the financial statements?
[Common Practice]
6. Has the entity properly presented each financial statement
with a suitable title?
[Common Practice]
7. Has the entity properly presented a reference to the notes,
which are an integral part of the financial statements?
[Common Practice]
The following table summarizes the titles used to describe the statement of assets, liabilities, and equity
in the financial statements a sample of public entities surveyed by the AICPA. Reprinted from the
AICPA’s Accounting Trends & Techniques, 2010, 64th edition (product no. 0099010 [paperback] or WAT-
XX [online]).
BALANCE SHEET TITLE
2009 2008 2007 2006
Balance sheet 476 478 577 578
Statement of financial position 24 22 23 21
Statement of financial condition — — — 1
Total entities 500 500 600 600
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
B. Presentation of Discontinued Operations in the Financial State-
ments (FASB ASC 205-20)
Presentation
1. Has the entity properly presented, as discontinued opera-
tions, the results of operations of a component of an entity (as
that phrase is defined in FASB ASC glossary) that either has
been disposed of or is classified as held for sale under the
requirements of FASB ASC 360-10-45-9, in accordance with
FASB ASC 205-20-45-3 if both of the following conditions are
met:
a. The operations and cash flows of the component have
been (or will be) eliminated from the ongoing opera-
tions of the entity as a result of the disposal transac-
tion?
b. The entity will not have any significant continuing in-
volvement in the operations of the component after the
disposal transaction?
[FASB ASC 205-20-45-1]
2. Has the entity properly presented, in a period in which a
component of an entity either has been disposed of or is clas-
sified as held for sale, in the income statement for current and
prior periods, the results of operations of the component (in-
cluding any gain or loss recognized in accordance with FASB
ASC 360-10-35-40 and 360-10-40-5), in discontinued opera-
tions?
[FASB ASC 205-20-45-3]
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Yes No N/A
3. Has the entity properly presented the results of operations of
a component of an entity classified as held for sale in discon-
tinued operations in the period(s) in which they occur?
[FASB ASC 205-20-45-3]
4. Has the entity properly presented the results of discontinued
operations, less applicable income taxes (benefit), as a sepa-
rate component of income before extraordinary items?
[FASB ASC 205-20-45-3]
5. Has the entity properly presented the gain or loss recognized
on the disposal either on the face of the income statement or
in the notes to the financial statements?
[FASB ASC 205-20-45-3]
6. Has the entity properly presented adjustments to amounts
previously reported in discontinued operations that are di-
rectly related to the disposal of a component of an entity in a
prior period and classified them separately in the current pe-
riod in discontinued operations?
[FASB ASC 205-20-45-4]
Allocation of Interest to Discontinued Operations
7. Has the entity properly presented, as allocated to discontin-
ued operations, interest on debt that is to be assumed by the
buyer and interest on debt that is required to be repaid as a
result of a disposal transaction?
[FASB ASC 205-20-45-6]
Disposal Group Classified as Held for Sale
8. Has the entity properly presented the assets and liabilities of
a disposal group that is classified as held for sale separately
in the asset and liability sections, respectively, of the state-
ment of financial position? (Note: These assets and liabilities
should not be offset and presented as a single amount. Fur-
ther, major classes of assets and liabilities classified as held
for sale should be separately disclosed either on the face of
the statement of financial position or in the notes to the finan-
cial statements.)
[FASB ASC 205-20-45-10]
Disclosure
9. Has the entity properly disclosed the following information
in the notes to the financial statement that cover the period in
which a long-lived asset (disposal group) either has been sold
or is classified as held for sale under the requirements of
FASB ASC 360-10-45-9:
a. A description of the facts and circumstances leading to
the expected disposal, the expected manner and timing
of that disposal, and, if not separately presented on the
face of the statement, the carrying amount(s) of the ma-
jor classes of assets and liabilities included as part of a
disposal group?
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b. The gain or loss recognized in accordance with FASB
ASC 360-10-35-40 and FASB ASC 360-10-40-5 and if not
separately presented on the face of the income state-
ment, the caption in the income statement that includes
that gain or loss?
c. If applicable, amounts of revenue and pretax profit or
loss reported in discontinued operations?
d. If applicable, the segment in which the long-lived asset
(disposal group) is reported under FASB ASC 280?
[FASB ASC 205-20-50-1]
10. Has the entity properly disclosed the major classes of assets
and liabilities classified as held for sale either on the face of
the statement of financial position or in the notes to the finan-
cial statements?
[FASB ASC 205-20-50-2]
Change to a Plan of Sale
11. Has the entity properly disclosed, if the entity decides not to
sell a long-lived asset previously classified as held for sale,
and either FASB ASC 360-10-35-44 or FASB ASC 360-10-35-45
applies, is a description of the facts and circumstances lead-
ing to the decision to change the plan to sell the long-lived
asset (disposal group) and its effect on the results of opera-
tions for the period and any prior periods in the notes to the
financial statements that include the period of that decision?
[FASB ASC 205-20-50-3]
Continuing Cash Flows
12. Has the entity properly disclosed the following, for each dis-
continued operation that generates continuing cash flows:
a. The nature of the activities that give rise to continuing
cash flows?
b. The period of time continuing cash flows are expected
to be generated?
c. The principal factors used to conclude that the expected
continuing cash flows are not direct cash flows of the
disposed component?
d. Additionally, for each discontinued operation in which
the ongoing entity will engage in a “continuation of ac-
tivities” with the disposed component after its disposal
and for which the amounts presented in continuing op-
erations after the disposal transaction include a contin-
uation of revenues and expenses that were intra-entity
transactions before the disposal transaction, are those
intra-entity amounts before the disposal transaction
disclosed for all periods for comparability purposes?
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e. Are the types of continuing involvement, if any, that
the entity will have after the disposal transaction dis-
closed in the period in which the operations are ini-
tially classified as discontinued?
[FASB ASC 205-20-50-4 and FASB ASC 205-20-55 par.
9–12]
13. If the occurrence of a significant event or circumstance at any
time during the assessment period results in an expectation
that the criteria for reporting discontinued operations in
FASB ASC 205-20-45-1 will be met by the end of the assess-
ment period, is the component’s operations presented as dis-
continued operations?
[FASB ASC 205-20-55-22]
Adjustments to Previously Reported Amounts
14. Has the entity properly disclosed the nature and amount of
adjustments to amounts previously reported in discontinued
operations that are directly related to the disposal of a com-
ponent of an entity in a prior period?
[FASB ASC 205-20-50-5]
Continuing Involvement by Ongoing Entity
15. Has the entity properly disclosed, for each discontinued op-
eration in which the ongoing entity will engage in a continu-
ation of activities with the disposed component after its dis-
posal, and for which the amounts presented in continuing
operations after the disposal transaction include a continua-
tion of revenues and expenses that were intraentity transac-
tions (eliminated in consolidated financial statements) before
the disposal transaction, intraentity amounts before the dis-
posal transaction for all periods presented? Further, has the
entity properly disclosed the types of continuing involve-
ment, if any, that the entity will have after the disposal trans-
action? (That information should be disclosed in the period in
which operations are initially classified as discontinued.)
[FASB ASC 205-20-50-6]
C. Presentation of the Balance Sheet (FASB ASC 210-10)
Presentation
1. For classified balance sheets, are assets and liabilities segre-
gated into current and noncurrent classifications with totals
presented for current assets and current liabilities?
[FASB ASC 210-10-45-1]
2. Are significant categories of current liabilities, such as ac-
counts payable, accrued expenses, deferred revenue, interest
payable, and amounts due to officers and employees, segre-
gated and presented separately?
[Common Practice]
3. Are assets not expected to be realized during the current op-
erating cycle classified as noncurrent?
[FASB ASC 210-10-45 par. 3–4]
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4. Has the entity made disclosures related to any restrictions on
cash (common practice) and is any cash restricted regarding
withdrawal or use for other than current operations excluded
from current assets?
[FASB ASC 210-10-45-4]
5. If a classified balance sheet is presented, is a total for current
liabilities shown?
[FASB ASC 210-10-45-5]
6. Are bank overdrafts reclassified to and presented separately
in current liabilities?
[Common Practice]
7. Are held checks (those written before but not released until
after the balance sheet date) reclassified to accounts payable?
[Common Practice]
8. Are current portions of debt obligations presented as current
liabilities?
[FASB ASC 210-10-45-9]
Disclosure
9. Has the entity properly disclosed the amounts at which cur-
rent assets are stated, supplemented by information that re-
veals, for the various classifications of inventory items, the
basis upon which their amounts are stated, and where prac-
ticable, an indication of the method of determining the cost?
[FASB ASC 210-10-50-1]
D. Presentation of Offsetting in the Balance Sheet (FASB ASC 210-
10)
Presentation
Right of Setoff
1. Has the entity properly presented and exercised its option, if
it has a valid right of setoff, to offset the related asset and
liability and present the net amount?
[FASB ASC 210-20-45-2]
E. Presentation of Comprehensive Income (FASB ASC 220-10)
Presentation
Reporting Comprehensive Income
1. Has the entity properly presented a full set of financial state-
ments for the period which include (a) financial position at
the end of the period, (b) earnings (net income) for the period,
(c) comprehensive income (total nonowner changes in equity)
for the period, (d) cash flows during the period, and (e) in-
vestments by and distributions to owners during the period?
[FASB ASC 220-10-45-3]
2. Has the entity properly presented all components of compre-
hensive income in the financial statements in the period in
which they are recognized and presented them with the com-
ponents of other comprehensive income (OCI)?
[FASB ASC 220-10-45-5]
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Classifications Within Comprehensive Income
3. Has the entity properly presented an amount for net income,
even if the entity has no items of OCI and does not present
that fact?
[FASB ASC 220-10-45-6]
Alternative Formats for Reporting Comprehensive Income
4. Has the entity properly presented comprehensive income and
its components in a financial statement that is displayed with
the same prominence as other financial statements that con-
stitute a full set of financial statements?
[FASB ASC 220-10-45-8]
5. Has the entity properly presented the components of OCI and
total comprehensive income below the total for net income in
a statement that reports results of operations or in a separate
statement of comprehensive income that begins with net in-
come? (Note: This subtopic does not require a specific format,
but the above presentation is encouraged.)
[FASB ASC 220-10-45-9]
6. Has the entity properly presented the components of OCI ei-
ther net of related tax effects, or before related tax effects with
one amount shown for the aggregate tax effect related to the
total of OCI items?
[FASB ASC 220-10-45-11]
7. Has the entity properly presented the amount of income tax
expense or benefit allocated to each component of OCI (in-
cluding reclassification adjustments) on the face of the state-
ment in which those components are displayed or presented
in the notes to the financial statements?
[FASB ASC 220-10-45-12]
Reporting OCI in the Equity Section of a Statement of Financial Po-
sition
8. Has the entity properly presented the total of OCI for a pe-
riod, transferred to a component of equity, separately from
retained earnings and additional paid-in-capital in the bal-
ance sheet with a descriptive title such as “accumulated other
comprehensive income?”
[FASB ASC 220-10-45-14]
9. Has the entity properly presented accumulated balances for
each classification within accumulated OCI on the face of the
balance sheet, in the statement of changes in shareholders’ eq-
uity, or in the notes?
[FASB ASC 220-10-45-14]
10. Are items included in OCI classified separately based on their
nature, including the following:
a. Foreign currency translation adjustments?
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b. Gains and losses on foreign currency transactions that
are designated as, and are effective as, economic
hedges of a net investment in a foreign entity, com-
mencing as of the designation date (see FASB ASC 830-
20-35-3[a])?
c. Gains and losses on intraentity foreign currency trans-
actions that are of a long term investment nature (that
is, settlement is not planned or anticipated in the fore-
seeable future), when the entities to the transaction are
consolidated, combined, or accounted for by the equity
method in the reporting entity’s financial statements
(see FASB ASC 830-20-35-3[b])?
d. Gains and losses (effective portion) on derivative in-
struments that are designated as, and qualify as, cash
flow hedges (see FASB ASC 815-20-35-1[c])?
e. Unrealized holding gains and losses that result from a
debt security being transferred into the available-for-
sale category from the held-to-maturity category (see
FASB ASC 320-10-35-10[c])?
f. Subsequent decreases (if not an other-than-temporary
impairment) or increases in the fair value of available-
for-sale securities previously written down as impaired
(see FASB ASC 320-10-35-18)?
g. Gains or losses associated with pension or other postre-
tirement benefits (that are not recognized immediately
as a component of net periodic benefit cost) (see FASB
ASC 715-20-50-1[j])?
h. Prior service costs or credits associated with pension or
other postretirement benefits (see FASB ASC 715-20-50-
1[j])?
i. Transition assets or obligations associated with pension
or other postretirement benefits (that are not recog-
nized immediately as a component of net periodic ben-
efit cost) (see FASB ASC 715-20-50-1[j])?
[FASB ASC 220-10-45-13 and FASB ASC 220-10-55-2]
11. Are reclassification adjustments made to avoid double count-
ing in comprehensive income of items that are displayed as
part of net income for a period that also had been displayed
as part of OCI in that period or other periods presented on
the face of the financial statement in which comprehensive
income is reported or disclosed in the notes?
[FASB ASC 220-10-45-15]
Interim-Period Reporting
12. Has the entity properly presented a total for comprehensive
income in condensed financial statements of interim periods?
[FASB ASC 220-10-45-18]
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F. Presentation of the Income Statement (FASB ASC 225-10)
Presentation
1. Has the entity properly presented all items of profit and loss
recognized during the period, with the sole exception of error
corrections as addressed in FASB ASC 250, Accounting
Changes and Error Corrections, in order to present net income?
[FASB ASC 225-10-45-1]
Disclosure
2. Has the entity disclosed the following information in the
notes to the financial statements in the period(s) in which
business interruption insurance recoveries are recognized:
a. The nature of the event resulting in business interrup-
tion losses?
b. The aggregate amount of business interruption insur-
ance recoveries recognized during the period and the
line item(s) in the statement of operations in which
those recoveries are classified (including amounts re-
ported as an extraordinary item pursuant to FASB ASC
225-20)?
[FASB ASC 225-30-50-1]
G. Presentation of Extraordinary and Unusual Items in the Income
Statement (FASB ASC 225-20)
Presentation
Presentation of Extraordinary Items
1. Has the entity properly presented extraordinary items segre-
gated from the results of ordinary operations and shown sep-
arately in the income statement, with disclosure of the nature
and amounts thereof?
[FASB ASC 225-20-45-9]
2. Has the entity properly presented extraordinary items (in-
cluding applicable income taxes) segregated and following
income before extraordinary items and before net income?
[FASB ASC 225-20-45-10]
3. Has the entity properly presented the caption “extraordinary
items” to identify and present separately the effects of events
and transactions, other than disposals of components of an
entity, that meet the criteria for classification as extraordinary
as discussed in paragraphs 1–6 of FASB ASC 225-20-45?
(Note: The nature of an extraordinary event or transaction
and the principal items entering into the determination of an
extraordinary gain or loss should be described.)
[FASB ASC 225-20-45-11]
4. Has the entity properly presented earnings per share (EPS)
data for extraordinary items either on the face of the income
statement or in the related notes, as prescribed by FASB ASC
260-10-45?
[FASB ASC 225-20-45-12]
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Adjustment of Amounts Reported in Prior Periods
5. Has the entity properly presented any extraordinary items
that were reported in prior periods and that have been ad-
justed during the current period, including separate presen-
tation concerning year of origin, nature, and amount, and
have those items been classified separately in the current pe-
riod as an extraordinary item?
[FASB ASC 225-20-45-13]
Presentation of Unusual or Infrequently Occurring Items
6. Has the entity properly presented material events or transac-
tions that are either unusual in nature or of infrequent occur-
rence, but not both (and therefore not meeting the criteria for
extraordinary items), (a) as a separate component of income
from continuing operations and (b) accompanied by disclo-
sure of the nature and financial effects of each event?
[FASB ASC 225-20-45-16]
Disclosure
Unusual or Infrequently Occurring Items
7. Has the entity properly disclosed the nature and financial ef-
fects of each event or transaction that is unusual in nature or
occurs infrequently, but not both, on the face of the income
statement, or alternatively, in notes to the financial state-
ments?
[FASB ASC 225-20-50-3]
Interim Reporting
8. Has the entity properly disclosed extraordinary items sepa-
rately and included in the determination of net income for the
interim period or periods in which they occurred?
[FASB ASC 225-20-50-4]
H. Presentation of the Statement of Cash Flows (FASB ASC 230-10)
Presentation
Cash and Cash Equivalents
1. Has the entity properly presented the change during the pe-
riod in cash and cash equivalents and presented an explana-
tion for the change?
[FASB ASC 230-10-45-4]
Cash Flows From Investing Activities
2. Has the entity properly presented cash flows from purchases,
sales, and maturities of available-for-sale securities as cash
flows from investing activities and presented these amounts
as gross amounts in the statement of cash flows?
[FASB ASC 230-10-45-11]
Cash Flows From Operating Activities
3. Has the entity properly presented cash payments made to
settle an asset retirement obligation in the statement of cash
flows as an operating activity?
[FASB ASC 230-10-45-17(e)]
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Acquisitions and Sales of Certain Securities and Loans
4. Has the entity properly presented cash receipts and cash pay-
ments resulting from purchase and sales of securities classi-
fied as trading securities, as prescribed in FASB ASC 320, In-
vestments—Debt and Equity Securities, based on the nature and
purpose for which the securities were acquired?
[FASB ASC 230-10-45-19]
5. Has the entity properly presented cash receipts and cash pay-
ments resulting from the purchase or sale of securities and
other assets that were acquired for resale and that are being
carried at market value in a trading account as operating cash
flows?
[FASB ASC 230-10-45-20]
6. Has the entity properly presented cash receipts and cash pay-
ments resulting from the purchase or sale of loans that were
acquired for resale and that are being carried at market value
or at the lower of cost or market values as operating cash
flows?
[FASB ASC 230-10-45-21]
Reporting Operating, Investing, and Financing Activities
7. Has the entity properly presented, in the statement of cash
flows, net cash provided or used by the operating, investing,
and financing activities and the effect of those flows on cash
and cash equivalents during the period in a manner that rec-
onciles beginning and ending cash and cash equivalents?
(Note: Although not required, the entity may present sepa-
rate presentation of cash flows pertaining to extraordinary
items or discontinued operations in those categories provided
that the presentation is consistent for all periods effective.)
[FASB ASC 230-10-45-24]
8. Has the entity properly presented the following, if the direct
method of reporting net cash flow from operating activities,
as encouraged by FASB ASC 230-10-45-25, is used:
a. Cash received from customers?
b. Interest and dividends received?
c. Other operating cash receipts?
d. Cash paid to employees and suppliers?
e. Interest paid?
f. Income taxes paid and, separately, the cash that would
have been paid for income taxes if increases in the
value of equity instruments issued under share-based
payment arrangements that are not recognizable as a
cost of goods or services for accounting purposes also
had not been deductible in determining taxable income
(FASB ASC 230-10-45-14[e])?
g. Other operating cash payments (if any)?
[FASB ASC 230-10-45-25]
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9. If an other-than-insignificant financing element is present at
inception, other than a financing element inherently included
in an at-the-market derivative instrument with no prepay-
ments (that is, the forward points in an at-the-money forward
contract), does the borrower report all cash inflows and out-
flows associated with that derivative instrument as financing
activities?
[FASB ASC 230-10-45-27]
Reconciliation of Net Income and Net Cash Flow From Operating
Activities
10. Has the entity properly presented, if the direct method of re-
porting net cash flow from operating activities is not used,
the net cash flow from operating activities indirectly, by ad-
justing net income to reconcile it to net cash flow from oper-
ating activities?
[FASB ASC 230-10-45-28]
11. Has the entity properly presented a reconciliation of net in-
come to net cash flow from operating activities, including
separate reporting of all major classes of reconciling items?
[FASB ASC 230-10-45-29]
12. Has the entity properly presented, if the direct method is
used, a separate reconciling schedule to reconcile net income
to net cash flow from operating activities?
[FASB ASC 230-10-45-30]
13. Has the entity properly presented, if the indirect method is
used, a separate reconciling schedule to reconcile net income
to net cash flow from operating activities either within the
statement of cash flows or in a separate schedule, with the
statement of cash flows presenting only the net cash flow
from operating activities?
[FASB ASC 230-10-45-31]
The following table summarizes the methods used to report cash flows from operating
activities in the financial statements of a sample of public entities surveyed by the
AICPA. Reprinted from the AICPA’s Accounting Trends & Techniques, 2010, 64th edition
(product no. 0099010 [paperback] or WAT-XX [online]).
METHOD OF REPORTING CASH FLOWS FROM OPERATING ACTIVITIES
2009 2008 2007 2006
Indirect method 495 495 594 594
Direct method 5 5 6 6
Total entities 500 500 600 600
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
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Disclosure
Cash Equivalents Policy
14. Has the entity properly disclosed the accounting policy for
determining which items are treated as cash equivalents?
[FASB ASC 230-10-50-1]
Interest and Income Taxes Paid
15. Has the entity properly disclosed, if the indirect method of
reporting net cash flow from operating activities is used, the
amounts of interest paid (net of amounts capitalized) and in-
come taxes paid during the period in related disclosures?
[FASB ASC 230-10-50-2]
Noncash Investing and Financing Activities
16. Has the entity properly disclosed investing and financing ac-
tivities that affect recognized assets or liabilities, but that do
not result in cash receipts or cash payments in the period?
[FASB ASC 230-10-50-3]
17. Has the entity properly disclosed only the cash portion of any
transactions that are part cash and part noncash in the state-
ment of cash flows, or if there are a significant amount of
transactions, elsewhere in the financial statements with clear
reference to the statement of cash flows?
[FASB ASC 230-10-50 par. 5–6]
I. Presentation of the Notes to Financial Statements (FASB ASC 235-
10)
The following table lists accounting policies that were most frequently included in the summary of
accounting policies of a sample of public entities surveyed by the AICPA. Reprinted from the
AICPA’s Accounting Trends & Techniques, 2010, 64th edition (product no. 0099010 [paperback] or
WAT-XX [online]).
DISCLOSURE OF ACCOUNTING POLICIES
Number of Companies
2009 2008 2007 2006
Revenue recognition 485 486 587 590
Consolidation policy 477 481 561 570
Use of estimates 476 469 582 567
Property 475 453 570 572
Cash equivalents 474 475 551 546
Depreciation methods 456 469 513 514
Amortization of intangibles 456 451 548 540
Interperiod tax allocation 449 438 534 508
Impairment 436 415 517 546
Financial instruments 435 440 502 506
Inventory pricing 429 416 506 514
Stock-based compensation 414 408 493 507
Translation of foreign currency 383 376 445 428
(continued)
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Number of Companies
2009 2008 2007 2006
Nature of operations 365 363 376 286
Earnings per share calculation 297 300 351 368
Accounts receivable 349 333 381 386
Advertising costs 244 250 293 288
Employee benefits 229 195 217 185
Research and development costs 185 172 228 224
Credit risk concentrations 181 190 213 211
Fiscal years 150 145 165 168
Environmental costs 129 131 145 144
Capitalization of interest 98 86 102 92
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
Disclosure
What to Disclose
1. Do the disclosures for the entity properly identify and de-
scribe all significant accounting principles followed by the re-
porting entity and the methods of applying those principles
that materially affect the determination of financial position,
cash flows, and results of operations?
[FASB ASC 235-10-50-3]
2. Has the entity properly disclosed the following information,
when those principles and methods identified in FASB ASC
235-10-50-3 include all instances in which there
a. is a selection from existing acceptable alternatives?
b. are principles and methods peculiar to the industry in
which the reporting entity operates, even if such prin-
ciples and methods are predominantly followed in that
industry?
c. are unusual or innovative applications of U.S. GAAP?
[FASB ASC 235-10-50-3]
3. Do the notes to the accompanying insurance entity’s statutory
financial statements contain a summary of significant ac-
counting policies that discuss the following:
a. Statutory accounting practices?
b. Describe how this basis differs from GAAP?
[AAG-LHI 3.21]
4. For general-use statutory financial statements, are the effects
of the differences between statutory accounting practices and
GAAP, if quantified, disclosed?
[AAG-LHI 15.32–.33]
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Avoid Duplicate Details of Disclosures
5. Has the entity properly not disclosed duplicating details (for
example, composition of inventories or of plant assets) pre-
sented elsewhere as a part of the financial statements?
[FASB ASC 235-10-50-5]
Format
6. Has the entity properly disclosed a description of all signifi-
cant accounting policies of the reporting entity, presented as
either a separate summary preceding the notes to the finan-
cial statements or as the initial note under the same or similar
title?
[FASB ASC 235-10-50-6]
J. Presentation of Accounting Changes and Error Corrections (FASB
ASC 250-10)
The following table lists accounting changes that were most frequently reported in the financial
statements of a sample of public entities surveyed by the AICPA. Reprinted from the AICPA’s
Accounting Trends & Techniques, 2010, 64th edition (product no. 0099010 [paperback] or WAT-XX
[online]).
ACCOUNTING CHANGES
Number of Companies
2009 2008 2007 2006
Noncontrolling interests 96 * * *
Fair value measurements 51 175 2 —
Business combinations 46 * * *
Defined benefit pension and postretirement
plans 44 59 138 303
Financial instruments with debt and equity
characteristics 20 * * *
Derivatives and hedging activities 18 5 — —
Earnings per share 17 * * *
Income tax uncertainties 5 161 369 1
Inventories 4 4 3 8
Prior period financial statement misstatement 3 6 10 18
Consolidation of variable interest entities 3 — — —
Impairment or disposal of long-lived assets 2 1 — 2
Asset retirement obligation 2 — — 29
Servicing of financial assets 2 — — 4
Stock based compensation — — 42 437
* N/C 5 Not compiled. Line item was not included in table for year shown.
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
Presentation
Change in Reporting Entity
1. If a change in reporting entity results in financial statements
that are, in effect, the statements of a different reporting en-
tity, has the change been applied retrospectively to all per-
iods presented?
[FASB ASC 250-10-45-21]
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Disclosure
Changes in Accounting Principle
2. Has the entity properly disclosed the following in the fiscal,
and interim, if applicable, period in which a change in ac-
counting principle is made (not required for subsequent per-
iods): (Note: If a change accounting principle has no material
effect in the period of change but is reasonably certain to have
a material effect in later periods, the disclosures in item [a]
should be provided whenever the financial statements of the
period of change are presented)?
a. The nature of and reason for the change in accounting
principle, including an explanation of why the newly
adopted accounting principle is preferable?
b. The method of applying the change, including all of the
following:
i. A description of the prior-period information
that has been retrospectively adjusted, if any?
ii. The effect of the change on income from contin-
uing operations, net income (or other appropriate
captions of changes in the applicable net assets or
performance indicator), any other affected finan-
cial statement line item, and any affected per-
share amounts for the current period and any
prior periods retrospectively adjusted? Presenta-
tion of the effect on financial statement subtotals
and totals other than income from continuing op-
erations and net income (or other appropriate
captions of changes in the applicable net assets or
performance indicator) is not required.
iii. The cumulative effect of the change on retained
earnings or other components of equity or net as-
sets in the statement of financial position as of the
beginning of the earliest period presented?
iv. If retrospective application to all prior periods is
impracticable, disclosure of the reasons therefore,
and a description of the alternative method used
to report the change (see paragraphs 5–7 of FASB
ASC 250-10-45)?
c. If indirect effects of a change in accounting principle
are recognized,
i. a description of the indirect effects of a change in
accounting principle, including the amounts that
have been recognized in the current period, and
the related per-share amounts, if applicable?
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ii. unless impracticable, the amount of the total rec-
ognized indirect effects of the accounting change
and the related per-share amounts, if applicable,
that are attributable to each prior period pre-
sented?
[FASB ASC 250-10-50 par. 1–2]
3. Has the entity properly disclosed in the fiscal year in which a
new accounting principle is adopted, financial information
reported for interim periods after the date of adoption, which
includes disclosure of the effect of the change on income from
continuing operations, net income (or other appropriate cap-
tions of changes in the applicable net assets or performance
indicator), and related per-share amounts, if applicable, for
those postchange interim periods?
[FASB ASC 250-10-50-3]
4. If a public company that regularly reports interim informa-
tion makes an accounting change during the fourth quarter of
its fiscal year and does not report the data specified by FASB
ASC 270-10-50-1, in a separate fourth-quarter report or in its
annual report, does the entity include disclosure of the effects
of the accounting change on interim-period results, as re-
quired by FASB ASC 250-10-50-1, in a note to the annual fi-
nancial statements for the fiscal year in which the change is
made? (Note: A change in accounting principle made in an
interim period should be reported by retrospective applica-
tion in accordance with FASB ASC 250-10-45-5. However, the
impracticability exception in FASB ASC 250-10-45-9 may not
be applied to prechange interim periods of the fiscal year in
which the change is made. When retrospective application to
prechange interim periods is impracticable, the desired
change may only be made as of the beginning of a subsequent
fiscal year. [FASB ASC 250-10-45-14])
[FASB ASC 250-10-45-15]
Change in Accounting Estimate1
5. Has the entity properly disclosed the effect on income from
continuing operations, net income (or other appropriate cap-
tions of changes in the applicable net assets or performance
indicator), and any related per-share amounts of the current
period for a change in estimate that affects several future per-
iods, such as a change in service lives of depreciable assets?
(Note: Disclosure of those effects is not necessary for esti-
mates made each period in the ordinary course of accounting
for items such as uncollectible accounts or inventory obsoles-
cence unless the effect of a change in the estimate is material.)
[FASB ASC 250-10-50-4]
1 Per Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 250-10-50-5, the disclosure provisions for a
change in accounting estimate are not required for revisions resulting from a change in a valuation technique or its application.
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6. When the entity effects a change in estimate by changing an
accounting principle, are the disclosures required by ques-
tions 2–3 made?
[FASB ASC 250-10-50-4]
7. When the entity has a change in estimate that does not have
a material effect in the period of change but is reasonably cer-
tain to have a material effect in later periods, is a description
of that change in estimate disclosed whenever the financial
statements of the period of change are presented?
[FASB ASC 250-10-50-4]
Change in Reporting Entity
8. When there has been a change in the reporting entity, do the
financial statements of the period of the change, provide a
description of the nature of the change, and the reason for it?
[FASB ASC 250-10-50-6]
9. Is the effect of the change on income before extraordinary
items, net income (or other appropriate captions of changes
in the applicable net assets or performance indicator), OCI,
and any related per-share amounts disclosed for all periods
presented?
[FASB ASC 250-10-50-6]
10. If a change in reporting entity does not have a material effect
in the period of change but is reasonably certain to have a
material effect in later periods, the nature of and reason for
the change disclosed whenever the financial statements of the
period of change are presented?
[FASB ASC 250-10-50-6]
Correction of an Error in Previously Issued Financial Statements
11. When financial statements are restated to correct an error, has
the entity disclosed that its previously issued financial state-
ments have been restated, along with a description of the na-
ture of the error? Does the entity also properly disclose the
following:
a. The effect of the correction on each financial statement
line item and any per-share amounts affected for each
prior period presented?
b. The cumulative effect of the change on retained earn-
ings or other appropriate components of equity or net
assets in the statement of financial position, as of the
beginning of the earliest period presented?
[FASB ASC 250-10-50-7]
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12. Has the entity properly disclosed, if prior period adjustments
have been recorded, the resulting effects (both gross and net
of applicable income tax) on the net income of prior periods
in the annual report for the year in which the adjustments are
made and in interim reports, if applicable, issued during that
year subsequent to the date of recording the adjustments?
(Note: The entity should not repeat the disclosures in subse-
quent periods.)
[FASB ASC 250-10-50 par. 8 and 10]
13. Has the entity properly disclosed the following prior-period
adjustments and restatements (see also FASB ASC 205-10-45
and FASB ASC 205-10-50-1):
a. For single period financial statements, the effects (in-
cluding applicable income taxes) of such restatement
on the balance of retained earnings at the beginning of
the period and on the net income of the immediately
preceding period?
b. For multiple-period financial statements, the effects (in-
cluding applicable income taxes) for each of the periods
included in the statements, in total and by class, of the
correction on change in net assets for each of the per-
iods presented?
[FASB ASC 250-10-50-9]
Error Correction Related to Prior Interim Periods of the Current Fis-
cal Year
14. If the entity prepares interim reporting and an adjustment re-
lated to a prior period of the current fiscal year has been
made, has the entity properly disclosed both of the following:
a. The effect on income from continuing operations, net
income, and related per-share amounts for each prior
interim period of the current fiscal year?
b. Income from continuing operations, net income, and re-
lated per-share amounts for each prior interim period
restated in accordance with FASB ASC 250-10-45-26?
[FASB ASC 250-10-50-11]
K. Presentation of Changing Prices (FASB ASC 255-10)
Disclosure
1. Although not required, has the entity properly disclosed, as
encouraged, supplementary information on the effects of
changing prices?
[FASB ASC 255-10-50-1]
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L. Presentation of Earnings Per Share (FASB ASC 260-10)2
Presentation
Additional Presentation Information
For entities that have issued common stock or potential common stock, if those securities trade in a public
market either on a stock exchange or in the over-the-counter market, including securities quoted only locally
or regionally, as discussed in FASB ASC 260-10-15-2, see FASB ASC 260-10-45 for information on proper
presentation.
Disclosure
1. Has the entity properly disclosed the following for each pe-
riod for which an income statement is presented:
a. A reconciliation of the numerators and denominators of
the basic and diluted per share computations for in-
come from continuing operations?
b. The effect that has been given to preferred dividends in
arriving at income available to common shareholders’
in computing basic EPS?
c. Securities (including those issuable pursuant to contin-
gent stock agreements) that could potentially dilute ba-
sic EPS in the future that were not included in the com-
putation of diluted EPS because to do so would have
been antidilutive for the period(s) presented?
[FASB ASC 260-10-50-1]
2. Has the entity properly disclosed, for the latest period for
which an income statement is presented, a description of any
transaction that occurred after the end of the most recent pe-
riod but before the financial statements were issued or are
available to be issued (as discussed in FASB ASC 855-10-25)
that would have changed materially the number of common
shares or potential common shares outstanding at the end of
the period if the transaction had occurred before the end of
the period?
[FASB ASC 260-10-50-2]
2 Per FASB ASC 260-10-15-2, the guidance in FASB ASC 260, Earnings Per Share, requires presentation of earnings per share (EPS) by
all entities that have issued common stock or potential common stock (that is, securities such as options, warrants, convertible securities,
or contingent stock agreements) if those securities trade in a public market either on a stock exchange (domestic or foreign) or in the over-
the-counter market, including securities quoted only locally or regionally. FASB ASC 260 also requires presentation of EPS by an entity
that has made a filing or is in the process of filing with a regulatory agency in preparation for the sale of those securities in a public
market.
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M. Presentation Regarding Interim Reporting (FASB ASC 270-10)3
Disclosure
1. Has the public entity properly disclosed the following, at a
minimum, if the publicly traded entity reports summarized
financial information at interim dates (including reports on
the fourth quarter):
a. Sales or gross revenues, provision for income taxes, ex-
traordinary items (including related income tax effects),
net income, and comprehensive income?
b. Basic and diluted EPS data for each period presented,
determined in accordance with the provisions of FASB
ASC 260?
c. Seasonal revenue, costs, or expenses?
d. Significant changes in estimates or provisions for in-
come taxes?
e. Disposal of a component of an entity and extraordi-
nary, unusual or infrequently occurring items?
f. Contingent items?
g. Changes in accounting principles or estimates?
h. Significant changes in financial position?
i. All of the following information about reportable op-
erating segments determined according to the provi-
sions of FASB ASC 280, including provisions related to
restatement of segment information in previously is-
sued financial statements:
i. Revenues from external customers?
ii. Intersegment revenues?
iii. A measure of segment profit or loss?
iv. Total assets for which there has been a material
change from the amount disclosed in the last an-
nual report?
3 In July 2010, FASB issued Accounting Standards Update (ASU) No. 2010-20, Receivables (Topic 310): Disclosures about the Credit Quality
of Financing Receivables and the Allowance for Credit Losses. The effective dates are as follows:
a. For publicly traded companies:
i. The “Pending Content” for disclosures as of the end of a reporting period are effective for the first interim or annual
reporting period ending on or after December 15, 2010 (that is, December 31, 2010, for public entities with calendar year-
ends).
ii. The “Pending Content” for disclosures about activity that occurs during a reporting period is effective for the first interim
or annual reporting period beginning on or after December 15, 2010 (that is, January 1, 2011, for public entities with
calendar year-ends).
b. For nonpublic entities, the “Pending Content” is effective for the first annual reporting period ending on or after December 15,
2011 (that is, December 31, 2011, for entities with calendar year-ends).
This checklist has not been updated to include the presentation and disclosure requirements of ASU No. 2010-20.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 310-
10-65-2.
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v. A description of differences from the last annual
report in the basis of segmentation or in the
measurement of segment profit or loss?
vi. A reconciliation of the total of the reportable seg-
ments’ measures of profit or loss to the entity’s
consolidated income before income taxes, ex-
traordinary items, and discontinued operations?
j. All of the following information about defined benefit
pension plans and other defined benefit postretirement
benefit plans, disclosed for all periods presented pur-
suant to the provisions of FASB ASC 715-20:
i. The amount of net periodic benefit cost recog-
nized, for each period for which a statement of
income is presented, showing separately the ser-
vice cost component, the interest cost component,
the expected return on plan assets for the period,
the gain or loss component, the prior service cost
or credit component, the transition asset or obli-
gation component, and the gain or loss recog-
nized due to a settlement or curtailment?
ii. The total amount of the employer’s contributions
paid, and expected to be paid, during the current
fiscal year, if significantly different from amounts
previously disclosed pursuant to FASB ASC 715-
20-50-1. Estimated contributions may be pre-
sented in the aggregate combining all of the fol-
lowing: (1) contributions required by funding
regulations or laws, (2) discretionary contribu-
tions, and (3) noncash contributions?
k. The information about the use of fair value to measure
assets and liabilities recognized in the statement of fi-
nancial position pursuant to paragraphs 1–6 of FASB
ASC 820-10-50?
l. The information about derivative instruments as re-
quired by FASB ASC 815-10-50, 815-20-50, 815-25-50,
815-30-50, and 815-35-50?
m. The information about fair value of financial instru-
ments as required by FASB ASC 825-10-50?
n. The information about certain investments in debt and
equity securities as required by FASB ASC 320-10-50
and 942-320-50?
o. The information about other-than-temporary impair-
ments as required by FASB ASC 320-10-50, 325-20-50,
and 958-320-50?
[FASB ASC 270-10-50-1]
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2. Has the entity properly disclosed, if the reporting entity is a
publicly traded company and if interim financial data and
disclosures are not separately reported for the fourth quarter,
accounting changes made during the fourth quarter, dispos-
als of segments of a business, extraordinary, unusual, or in-
frequently occurring items recognized in the fourth quarter,
and the aggregate effect of year-end adjustments that are ma-
terial to the results of that quarter in a note to the financial
statements?
[FASB ASC 270-10-50-2]
3. Has the entity properly disclosed the impact of the financial
results for interim periods of the matters discussed in para-
graphs 12–16 of FASB ASC 270-10-45 and paragraphs 5–6 of
FASB ASC 270-10-50?
[FASB ASC 270-10-50-3]
4. Has the entity properly disclosed, as encouraged but not re-
quired, balance sheet and cash flow data been for the interim
periods?
[FASB ASC 270-10-50-4]
5. Has the entity properly disclosed extraordinary items sepa-
rately and included them in the determination of net income
for the period in which they occurred?
[FASB ASC 270-10-50-5]
6. Has the entity properly disclosed, in the same manner re-
quired for annual reports, contingencies and other uncertain-
ties that could be expected to affect the fairness of presenta-
tion of financial data at an interim date been?
[FASB ASC 270-10-50-6]
N. Presentation Regarding Income Taxes for Interim Reporting
(FASB ASC 270-740)
Additional Presentation and Disclosure Information
See the “Income Taxes” section of this checklist for information on the presentation and disclosure require-
ments under FASB ASC 270-740.
O. Presentation of Risks and Uncertainties (FASB ASC 275-10)
Disclosure
Nature of Operations
1. Has the entity properly disclosed a description of the major
products or services the entity sells or provides and it princi-
pal markets, including the locations of those markets?
[FASB ASC 275-10-50-2]
2. If the entity operates in more than one business, has the entity
properly disclosed information indicating the relative impor-
tance of its operations in each business and the basis for this
determination (assets, revenues, and earnings)?
[FASB ASC 275-10-50-2]
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Use of Estimates in the Preparation of Financial Statements
3. Has the entity properly disclosed in the financial statements
an explanation that the preparation of financial statements in
conformity with U.S. GAAP requires the use of manage-
ments’ estimates?
[FASB ASC 275-10-50-4]
Certain Significant Estimates
4. Has the entity properly disclosed if, based on known infor-
mation available to the entity before the issuance of the finan-
cial statements, it is reasonably possibly that estimates in the
financial statements will change in the near term (as defined
by the FASB ASC glossary as a period of time not to exceed
one year from the date of the financial statements) and the
effects will be material, discussion (including an estimate of
the effect of the change in condition, situation, or set of cir-
cumstances that existed at the date of the financial state-
ments) in the financial statements of these facts and circum-
stances?
[FASB ASC 275-10-50-6]
5. Has the entity properly disclosed, if the criteria in FASB ASC
275-10-50-8 are met, that it is at least reasonably possible that
a change in an entity’s estimate of its liability could occur in
the near term? (Note: If the estimate involves a loss contin-
gency under FASB ASC 450-20, the disclosure should also in-
clude an estimate of the possible loss or range of loss, or state
that such estimate cannot be made.)
[FASB ASC 275-10-50-9]
Current Vulnerability Due to Certain Concentrations
6. Has the entity properly disclosed, if the entity has concentra-
tions that exist at the date of the financial statements, that
those concentrations make the entity vulnerable to the risk of
a near term severe impact, and it is at least reasonably possi-
ble that the events that could cause the severe impact will
occur in the near term, further including information that is
adequate to inform users of the general nature of the risk as-
sociated with the concentration?
[FASB ASC 275-10-50-16]
7. For those concentrations of labor subject to collective bargain-
ing agreements and concentrations of operations located out-
side the reporting entity’s home country that (a) exist at the
date of the financial statements and (b) make the reporting
entity vulnerable to the risk of a near term severe impact,
where it is at least reasonably possible that the events that
could cause the severe impact will occur in the near term, are
the following disclosed:
a. The percentage of labor force covered by a collective
agreement and the percentage of the labor force cov-
ered by a collective bargaining agreement that will ex-
pire in one year?
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b. For operations located outside the reporting entity’s
home country, the carrying amounts of net assets and
the geographic areas in which they are located?
[FASB ASC 275-10-50-20]
P. Presentation Regarding Segment Reporting (FASB ASC 280-10)
Additional Disclosure Information
Per FASB ASC 280-10-15-2, the guidance in this topic applies to all public entities, with certain exceptions
outlined in FASB ASC 280-10-15-3; however, entities other than public entities are also encouraged to pro-
vide the disclosures described in this section.
Disclosure
Operating Segments—Disclosure Requirements—General Informa-
tion
1. Has the public entity properly disclosed the following for
each period for which an income statement is presented:
a. Factors used to identify the public entity’s reportable
segments, including the basis of organization (for ex-
ample, whether management has chosen to organize
the reporting entity around differences in products and
services, geographic areas, regulatory environments, or
a combination of factors and whether operating seg-
ments have been aggregated)?
b. Types of products and services from which each re-
portable segment derives its revenues?
[FASB ASC 280-10-50-21]
Operating Segments—Disclosure Requirements—Information
About Profit or Loss and Assets
2. Has the public entity properly disclosed a measure of profit
or loss and total assets for each reportable segment?
[FASB ASC 280-10-50-22]
3. Has the public entity properly disclosed the following for
each reportable segment, if the specified amounts are in-
cluded in the measure of segment profit or loss reviewed by
the chief operating decision maker or are otherwise regularly
provided to the chief operating decision maker:
a. Revenues from external customers?
b. Revenues from transactions with other operating seg-
ments of the reporting entity?
c. Interest revenue?
d. Interest expense?
e. Depreciation, depletion, and amortization expense?
f. Unusual items as described in FASB ASC 225-20-45-16?
g. Equity in the net income of investees accounted for by
the equity method?
h. Income tax expense or benefit?
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i. Extraordinary items?
j. Significant noncash items other than depreciation, de-
pletion, and amortization expense?
[FASB ASC 280-10-50-22]
4. Has the public entity properly disclosed, unless a segment
has no or immaterial financial operations, interest revenue
separately from interest expense for each reportable segment
(unless a majority of the segment’s revenues are from interest
and the chief operating decision maker relies primarily on net
interest revenue to assess the performance of the segment and
make decisions about resources to be allocated to the seg-
ment)? (In that situation, a public entity may report that seg-
ment’s interest revenue net of its interest expense and dis-
close that it has done so.)
[FASB ASC 280-10-50 par. 22–24]
5. Has the public entity properly disclosed the following speci-
fied amounts if (a) they included in the determination of seg-
ment assets reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating
decision maker, even if not included in that measure of seg-
ment assets, for each reportable segment:
i. The amount of investment in equity method investees?
ii. Total expenditures for additions to long-lived assets
other than any of the following: financial instruments,
long term customer relationships of a financial institu-
tion, mortgage and other servicing rights, deferred pol-
icy acquisition costs, or deferred tax assets?
[FASB ASC 280-10-50-25]
6. Has the public entity properly disclosed the fact that, and the
reason behind the fact, if it has no asset information to dis-
close for a reportable segment?
[FASB ASC 280-10-50-26]
Operating Segments—Disclosure Requirements—Information
About Profit or Loss and Assets—Measurement
7. Has the public entity properly provided an explanation of the
measurements of segment profit or loss and segment assets
for each reportable segment and disclosed all of the follow-
ing:
a. The basis of accounting for any transactions between
reportable segments?
b. The nature of any differences between the reporting en-
tity’s consolidated income before taxes, extraordinary
items, discontinued operations, and the cumulative ef-
fect of changes in accounting principle?
c. The nature of any differences between the measure-
ments of the reportable segments’ assets and the re-
porting entity’s consolidated assets?
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d. The nature of any changes from prior periods in the
measurement methods used to determine reported seg-
ment profit or loss and the effect, if any, of those
changes on the measure of segment profit or loss?
e. The nature and effect of any asymmetrical allocations
to segments?
[FASB ASC 280-10-50-29]
Operating Segments—Disclosure Requirements—Reconciliations
8. Has the public entity properly disclosed reconciliations of the
totals of the reportable segments’ revenues, measures of
profit or loss, assets, and every other significant item of infor-
mation disclosed to corresponding consolidated amounts
presented with all significant reconciling items separately
identified and described?
[FASB ASC 280-10-50 par. 30–31]
Operating Segments—Disclosure Requirements—Interim Period In-
formation
9. Has the public entity properly disclosed the following infor-
mation about each reportable segment in condensed financial
statements of interim periods for current quarter and year-to-
date amounts:
a. Revenues from external customers?
b. Intersegment revenues?
c. A measure of segment profit or loss?
d. Total assets for which there has been a material change
from the amount disclosed in the last annual report?
e. A description of differences from the last annual report
in the basis of segmentation or in the basis of measure-
ment of segment profit or loss?
f. A reconciliation of the total of the reportable segments’
measures of profit or loss to the public entity’s consoli-
dated income before income taxes, extraordinary items,
and discontinued operations? If a public entity allocates
items such as income taxes and extraordinary items to
segments, the public entity may choose to reconcile the
total of the segments’ measures of profit or loss to con-
solidated income after those items. Significant reconcil-
ing items should be separately identified and described
in that reconciliation.
[FASB ASC 280-10-50 par. 32–33]
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Operating Segments—Disclosure Requirements—Restatements of
Previously Reported Information
10. Has the public entity properly disclosed corresponding infor-
mation for prior periods restated and the fact that the corre-
sponding items of segment information for earlier periods
have been restated, if the reporting entity changes the struc-
ture of its internal organization in a manner that changes the
composition of its reportable segments?
[FASB ASC 280-10-50-34]
11. Has the public entity properly disclosed, in the year in which
a change in the structure of its internal organization in a man-
ner that changes the composition of its reportable segments
occurs and the corresponding information for prior periods is
not restated, segment information for the current period un-
der both the old basis and the new basis?
[FASB ASC 280-10-50-35]
Operating Segments—Disclosure Requirements—Information
About Products and Services
12. Has the public entity properly disclosed the revenues from
external customers for each product and service or each
group of similar products and services, unless it is impracti-
cable to do so? If impracticable, has that fact been disclosed?
[FASB ASC 280-10-50-40]
Operating Segments—Disclosure Requirements—Information
About Geographic Areas
13. Has the public entity properly disclosed the following infor-
mation about its geographical information, unless it is im-
practicable to do so? If impracticable, has that fact been dis-
closed?
a. Revenues from external customers (i) attributed to the
reporting entity’s country of domicile and (ii) attrib-
uted to all foreign countries in total from which the re-
porting entity derives revenue?
b. Revenues from external customers attributed to an in-
dividual foreign country, if material?
c. The basis for attributing revenues from external cus-
tomers to individual countries?
d. Long-lived assets other than financial instruments, long
term customer relationships of a financial institution,
mortgage and other servicing rights, deferred policy ac-
quisition costs, and deferred tax assets (i) located in the
reporting entity’s country of domicile and (ii) located in
all foreign countries in total in which the reporting en-
tity holds assets?
e. Long-lived assets as described above in an individual
foreign country, if material?
[FASB ASC 280-10-50-41]
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Operating Segments—Disclosure Requirements—Information
About Major Customers
14. Has the public entity properly disclosed information about
the extent of its reliance on its major customers (those
amounting to 10 percent or more of the entity’s revenue)?
[FASB ASC 280-10-50-42]
II. Assets
A. Receivables (FASB ASC 310-10)4, 5
Presentation
Loans or Trade Receivables
1. Has the entity properly presented receivables held for sale as
a separate balance sheet amount, which is not included with
other loans or trade receivables? (Note: Major categories of
loans or trade receivables should be presented separately ei-
ther in the balance sheet or in the notes to the financial state-
ments.)
[FASB ASC 310-10-45-2]
Foreclosed or Repossessed Assets
2. Has the entity properly presented foreclosed or repossessed
assets as a separate balance sheet amount or included in other
assets on the balance sheet with separate disclosures in the
notes to the financial statements? (Note: Certain returned or
repossessed assets, such as inventory, should not be classified
separately if the assets subsequently are to be utilized by the
entity in operations.)
[FASB ASC 310-10-45-3]
Allowances
3. Has the entity properly presented allowances for uncollecti-
ble receivables as deductions from the related receivables?
[FASB ASC 310-10-45-4]
4. Are changes in the allowance for uncollectible amounts relat-
ing to mortgage loans reported in income?
[FASB ASC 944-310-45-4]
4 In December 2009, FASB issued ASU No. 2009-16, Transfers and Servicing (Topic 860): Accounting for Transfers of Financial Assets (FASB
Statement No. 166, Accounting for Transfers of Financial Assets). This update is to incorporate FASB Statement No. 166, Accounting for
Transfers of Financial Assets—an amendment of FASB Statement No. 140, into the codification. ASU No. 2009-16 represents a revision to the
provisions of former FASB Statement No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities, and
requires more information about transfers of financial assets, including securitization transactions, and where entities have continuing
exposure to the risks related to transferred financial assets. It eliminates the concept of a “qualifying special-purpose entity,” changes the
requirements for derecognizing financial assets, and requires additional disclosures. This ASU should be applied as of the beginning of
each reporting entity’s first annual reporting period that begins after November 15, 2009 (that is, January 1, 2010, for entities with calendar
year-ends). Early adoption is not permitted.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2009-16.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 860-
10-65-3.
5 See footnote 3.
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Unearned Discounts
5. Has the entity properly presented unearned discounts (other
than cash or quantity discounts and similar items), finance
charges, and interest included in the face amounts of receiv-
ables as a deduction from the related receivables?
[FASB ASC 310-10-45-8]
Receivables from Officers, Employees, or Affiliates
6. Has the entity properly presented accounts and notes receiv-
able from officers, employees, and affiliated entities sepa-
rately (with appropriate disclosures), and not included under
a general heading such as “notes receivable” or “accounts re-
ceivable?”
[FASB ASC 310-10-45-13]
Reinsurance Receivables
7. Are estimated reinsurance receivables arising from ceding
transactions described in FASB ASC 944-310-25-2 reported
separately as assets?
[FASB ASC 944-310-45-5]
8. Are amounts receivable and payable between the ceding en-
tity and an individual reinsurer offset only when a right of
offset exists as defined in FASB ASC 210-20, even if the ced-
ing entity and reinsurer are affiliated entities?
[FASB ASC 944-310-45-7]
Disclosure
Loans or Trade Receivables
9. Has the entity properly disclosed the following in the ac-
counting policy note disclosure:
a. The basis of accounting for loans, trade receivables, and
lease financings, including those classified as held for
sale?
b. The method used in determining the lower of cost or
fair value of nonmortgage loans held for sale (that is
aggregate or individual asset basis)?
c. The classification and method of accounting for inter-
est-only strips, loans, other receivables, or retained in-
terests in securitizations that can be contractually pre-
paid or otherwise settled in a way that the holder
would not recover substantially all of its recorded in-
vestment?
d. The method for recognizing interest income on loan
and trade receivables, including a statement about the
entity’s policy for treatment of related fees and costs,
including the method of amortizing net deferred fees or
costs?
[FASB ASC 310-10-50-2]
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10. Has the entity properly disclosed the major categories of loan
or trade receivables separately in the balance sheet or in the
notes to the financial statements?
[FASB ASC 310-10-50-3]
11. Has the entity properly disclosed any allowance for credit
losses, allowance for doubtful accounts, and, as applicable,
any unearned income, any unamortized premiums and dis-
counts, and any net unamortized deferred fees and costs in
the financial statements?
[FASB ASC 310-10-50-4]
12. Is the carrying amount of loans, trade receivables, securities,
and financial instruments that serve as collateral for borrow-
ings disclosed pursuant to FASB ASC 860-30-50-1(b) for pub-
lic entities and pursuant to FASB ASC 860-30-50-4(b) for non-
public entities?
[FASB ASC 310-10-50-5]
Nonaccrual and Past Due Loans and Trade Receivables
13. Has the entity properly disclosed the following in the ac-
counting policy note disclosure:
a. The policy for placing loans and trade receivables, if
applicable, on nonaccrual status (or discontinuing ac-
crual of interest)?
b. The policy for recording payments received on nonac-
crual loans and trade receivables, if applicable?
c. The policy for resuming accrual of interest?
d. The policy for charging off uncollectible loans and
trade receivables?
e. The policy for determining past due or delinquency
status (that is, whether past due status is based on how
recently payments have been received or contractual
terms)?
[FASB ASC 310-10-50-6]
14. Has the entity properly disclosed the recorded investment in
loans (and trade receivables if applicable) on nonaccrual
status as of each balance sheet date in the notes to the finan-
cial statements?
[FASB ASC 310-10-50-7]
15. Has the entity properly disclosed the recorded investment in
loans, and trade receivables, if applicable, past due 90 days
or more and still accruing?
[FASB ASC 310-10-50-7]
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Accounting Policies for Credit Losses and Doubtful Accounts
16. Has the entity properly disclosed, in addition to the loss con-
tingencies disclosures required by FASB ASC 450-20, a de-
scription of the accounting policies and methodology the en-
tity used to estimate its allowance for loan losses, allowance
for doubtful accounts, and any liability for off-balance sheet
credit losses, and related charges for loan, trade receivable, or
other credit losses, including a description of the factors that
influenced management’s judgment? (Note: The entity may
also include a discussion of risk elements relevant to particu-
lar categories of financial instruments.)
[FASB ASC 310-10-50-9]
Allowance for Credit Losses Related to Loans
17. Has the entity properly disclosed, as applicable, the activity
in the total allowance for credit losses related to loans, includ-
ing the balance in the allowance at the beginning and end of
each period, additions charged to operations, direct write-
downs charged against the allowance, and recoveries of
amounts previously charged off?
[FASB ASC 310-10-50-12]
Impaired Loans
18. Has the entity properly disclosed, either in the body of the
financial statements or in the accompanying notes, the fol-
lowing information about loans that meet the definition of an
impaired loan in paragraphs 16 and 17 of FASB ASC 310-10-35:
a. As of the date of each statement of financial position
presented, the total recorded investment in the im-
paired loans at the end of each period and
i. the amount of that recorded investment for
which there is a related allowance for credit
losses determined in accordance with FASB ASC
310-10-35 and the amount of that allowance?
ii. the amount of that recorded investment for
which there is no related allowance for credit
losses determined in accordance with FASB ASC
310-10-35?
b. The creditor’s policy for recognizing interest income on
impaired loans, including how cash receipts are re-
corded?
c. For each period for which results of operations are pre-
sented, the average recorded investment in the im-
paired loans during each period, the related amount of
interest income recognized during the time within that
period that the loans were impaired, and, unless not
practicable, the amount of interest income recognized
using a cash-basis method of accounting during the
time within that period the loans were impaired?
[FASB ASC 310-10-50 par. 15–16]
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Loss Contingencies
19. Has the entity properly disclosed loss contingencies, as de-
scribed in FASB ASC 460-10-50-2 (see question 1 in “Guaran-
tees (FASB ASC 460-10)”), even though the possibility of loss
may be remote?
[FASB ASC 310-10-50-22]
Risks and Uncertainties
20. Has the entity properly disclosed concentrations that meet
the requirements of FASB ASC 275-10-50-16? (Note: Certain
loan products have contractual terms that expose entities to
risks and uncertainties that fall into one or more categories,
as discussed in FASB ASC 275-10-50-1.)
[FASB ASC 275-10-50-16; 310-10-50-25]
B. Nonrefundable Fees and Other Costs (FASB ASC 310-20)
Presentation
Balance Sheet Presentation
1. Has the entity properly presented the unamortized balance of
loan origination, commitment, and other fees and costs and
purchase premiums and discounts that are being recognized
as an adjustment of yield pursuant to FASB ASC 310-20 on
the balance sheet as a part of the loan balance to which it
relates?
[FASB ASC 310-20-45-1]
2. Has the entity properly presented commitment fees that meet
the criteria of FASB ASC 310-20-35-2 as deferred income in
the financial statements?
[FASB ASC 310-20-45-2]
Income Statement Clarification
3. Has the entity properly presented amounts of loan origina-
tion, commitment, and other fees and costs recognized as an
adjustment of yield as a part of interest income? (Note: Am-
ortization of other fees, such as commitment fees that are be-
ing amortized on a straight-line basis over the commitment
period or included in income when the commitment expires,
should be presented as service fee income.)
[FASB ASC 310-20-45-3]
Disclosure
Net Fees and Costs
4. Has the entity properly disclosed, in the summary of signifi-
cant accounting policies, a description of the method for rec-
ognizing interest income on loan and trade receivables, in-
cluding a statement about the entity’s policy for treatment of
related fees and costs, including the method of amortizing net
deferred fees or costs included in the notes to the financial
statements?
[FASB ASC 310-20-50-1]
43Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
5. If the entity anticipates prepayments in applying the interest
method, has the entity disclosed the policy and any signifi-
cant assumptions underlying the prepayment estimates?
[FASB ASC 310-20-50-2]
6. Has the entity properly disclosed the unamortized net fees
and costs as a part of each loan category? (Note: Additional
disclosures such as unamortized net fees and costs may be
included in the footnotes to the financial statements if the
lender believes that such information is useful to the users of
financial statements.)
[FASB ASC 310-20-50-3]
7. Has the entity properly disclosed, with respect to credit card
fees and costs, for both purchased and originated credit
cards, the net amount capitalized at the balance sheet date
and the amortization period(s)?
[FASB ASC 310-20-50-4]
C. Loans and Debt Securities Acquired With Deteriorated Credit
Quality (FASB ASC 310-30)
Presentation
Accretable Yield
1. Has the entity properly not presented in the balance sheet the
amount of the loan’s accretable yield or the loan’s contractu-
ally required payments receivable in excess of the amount of
its cash flows expected at acquisition?
[FASB ASC 310-30-45-1]
Disclosure
Footnote Disclosures for Loans
2. Has the entity properly disclosed in the notes to financial
statements how prepayments are considered in the determi-
nation of contractual cash flows and cash flows expected to
be collected?
[FASB ASC 310-30-50-1]
3. Has the entity properly disclosed, for each balance sheet pre-
sented, the following information about loans within the
scope of FASB ASC 310-30:
a. Separately for both those loans that are accounted for
as debt securities and those loans that are not ac-
counted for as debt securities,
i. the outstanding balance and related carrying
amount at the beginning and end of the period?
ii. the amount of accretable yield at the beginning
and end of the period, reconciled for additions,
accretion, disposals of loans, and reclassifications
to or from nonaccretable difference during the
period?
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iii. for loans acquired during the period, the contrac-
tually required payments receivable, cash flows
expected to be collected, and fair value at the ac-
quisition date?
iv. for those loans within the scope of FASB ASC
310-30 for which the income recognition model is
not applied in accordance with FASB ASC 310-
30-35-3, the carrying amount at the acquisition
date for loans acquired during the period and the
carrying amount of all loans at the end of the pe-
riod?
b. Further, for those loans that are not accounted for as
debt securities, has the entity disclosed
i. the amount of (1) any expense recognized pur-
suant to FASB ASC 310-30-35-10(a) and (2) any
reductions of the allowance recognized pursuant
to FASB ASC 310-30-35-10(b)(1) for each period
for which an income statement is presented?
ii. the amount of the allowance for uncollectible ac-
counts at the beginning and end of the period?
[FASB ASC 310-30-50-2]
D. Troubled Debt Restructurings by Creditors (FASB ASC 310-40)
Disclosure6
Creditor Disclosure of Troubled Debt Restructurings
1. Has the entity properly disclosed the amount of commit-
ments, if any, to lend additional funds to debtors owing re-
ceivables whose terms have been modified in troubled debt
restructurings either in the body of the financial statements
or in the notes thereto as of the date of each balance sheet
presented?
[FASB ASC 310-40-50-1]
2. Has the entity properly disclosed, or not disclosed, informa-
tion established by FASB ASC 310-10-50-15(a) and 310-10-50-
15(c) in the years after a loan restructuring (restructured in a
troubled debt restructuring involving a modification of
terms) if the restructuring agreement for the impaired loan (a)
specifies an interest rate equal to or greater than the rate that
the creditor was willing to accept at the time of restructuring
for a new loan with comparable risk, and (b) the loan is not
impaired based on the terms specified by the restructuring
agreement? (Note: This exception should be applied consis-
tently to all loans restructured in a troubled debt restructur-
ing that meet the criteria in this paragraph.)
[FASB ASC 310-40-50 par. 2–3]
6 See footnote 3.
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3. Has the amount of writedown and recorded investment of a
loan modified in a troubled debt restructuring been disclosed
in the year of writedown?
[FASB ASC 310-40-50-4]
Loan Restructured Into Two (or More) Loan Agreements
4. As related to a loan restructured in a troubled debt restruc-
turing into two (or more) loan agreements, has the entity sep-
arately considered the restructured loans in years after the re-
structuring when assessing the applicability of the disclosures
in FASB ASC 310-10-50-15(a) and FASB ASC 310-10-50-15(c)?
[FASB ASC 310-40-50-5]
E. Investments—Debt and Equity Securities (FASB ASC 320-10)
Presentation
Balance Sheet Classification
1. Are there separate captions for each of the following invest-
ment categories:
a. Trading securities?
b. Securities available for sale?
c. Securities held to maturity?
d. Mortgage loans on real estate?
e. Real estate?
[FASB ASC 320-10-45]
2. Has the entity properly presented any investments in avail-
able-for-sale securities and trading securities separately from
similar assets that are subsequently measured using another
measurement attribute on the face of the statement of finan-
cial position and, in doing so, does the entity
a. present the aggregate of those fair value and non-fair-
value amounts in the same line item and parentheti-
cally disclose the amount of fair value included in the
aggregate amount?
b. present two separate line items to display the fair value
and non-fair-value carrying amounts?
[FASB ASC 320-10-45-1]
3. If the entity presents a classified statement of financial posi-
tion, has the entity properly presented all individual held-to-
maturity securities, individual available-for-sale securities,
and individual trading securities as either current or noncur-
rent, as appropriate, under the current asset and current lia-
bility provisions of FASB ASC 210-10-45?
[FASB ASC 320-10-45-2]
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Income Statement Classification
4. Has the entity properly presented gains and losses that have
accumulated before the transfer consistently with realized
gains and losses for the category from which the security is
being transferred, and not the category into which the secu-
rity is being transferred?
[FASB ASC 320-10-45-7]
Other-Than-Temporary Impairment
5. Has the entity properly presented, in a period in which the
entity determines that a security’s decline in fair value below
its amortized cost basis is other than temporary, the total
other-than-temporary impairment in the statement of earn-
ings with an offset for the amount of the total other-than-tem-
porary impairment that is recognized in OCI, in accordance
with FASB ASC 320-10-35-34D?
[FASB ASC 320-10-45-8A]
Other Comprehensive Income
6. Has the entity properly presented subsequent increases in the
fair value of available-for-sale securities in OCI pursuant to
FASB ASC 320-10-35-1(b) and FASB ASC 320-10-45-8? (Note:
Subsequent decreases in fair value, if not an other-than-tem-
porary impairment, should also be included in OCI.)
[FASB ASC 320-10-45-9]
Other Than Temporary Impairment
7. Has the entity properly presented, in the financial statement
in which the components of accumulated OCI are reported,
amounts recognized therein related to held-to-maturity and
available-for-sale debt securities for which a portion of an
other-than-temporary impairment has been recognized in
earnings?
[FASB ASC 320-10-45-9A]
Cash Flow Presentation
8. Has the entity properly presented cash flows from purchases,
sales, and maturities of available-for-sale securities and held-
to-maturity securities as cash flows from investing activities
and presented them at gross for each security classification in
the statement of cash flows?
[FASB ASC 320-10-45-11]
9. Has the entity properly presented cash flows from purchases,
sales, and maturities of trading securities as cash flows based
on the nature and purpose for which the securities were ac-
quired (generally, operating activities) in the statement of
cash flows?
[FASB ASC 320-10-45-11]
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Disclosure
General
10. Has the entity properly disclosed the major security types,
based on the nature and risks of each security? (Note: In de-
termining whether disclosure for a particular security type is
necessary and whether it is necessary to further separate a
particular security type into greater detail, the entity should
consider all of the following: [a] [shared] activity or business
sector, [b] vintage, [c] geographic concentration, [d] credit
quality, and [e] economic characteristics.)
[FASB ASC 320-10-50-1B]
11. For cost-method investments, does the entity disclose all of
the following additional information, if applicable, as of each
date for which a statement of financial position is presented
in its annual financial statements:
a. The aggregate carrying amount of all cost-method in-
vestments?
b. The aggregate carrying amount of cost-method invest-
ments that the entity did not evaluate for impairment
(see FASB ASC 325-20-35)?
c. The fact that the fair value of a cost-method investment
is not estimated if there are no identified events or
changes in circumstances that may have a significant
adverse effect on the fair value of the investment, and
any one of the following:
i. The entity determined, in accordance with para-
graphs 16–19 of FASB ASC 825-10-50, that it is
not practicable to estimate the fair value of the
investment;
ii. The entity is exempt from estimating fair value
under FASB ASC 825, Financial Instruments; or
iii. The entity is exempt from estimating interim fair
values because it does not meet the FASB ASC
definition of a publicly traded company?
[FASB ASC 325-20-50-1]
12. Insurance subsidiaries may be required to deposit securities
with state regulatory authorities. If so, is the carrying amount
of securities deposited with state regulatory authorities dis-
closed?
[FASB ASC 944-320-50-1]
Securities Classified as Available for Sale
13. Has the entity properly disclosed, for securities classified as
available for sale, all of the following by major security type,
as of each date for which a statement of financial position is
presented: (Note: Investments in mutual funds that invest
only in U.S. government debt securities may be shown sepa-
rately rather than grouped with other equity securities.)
a. Amortized cost basis?
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b. Aggregate fair value?
c. Total other-than-temporary impairment recognized in
accumulated OCI?
d. Total gains for securities with net gains in accumulated
OCI?
e. Total losses for securities with net losses in accumu-
lated OCI?
f. Information about the contractual maturities of those
securities as of the date of the most recent statement of
financial position reported? (Note: Maturity informa-
tion may be combined in appropriate groupings. Fur-
ther, securities not due at a single maturity date, such
as mortgage backed securities, may be disclosed sepa-
rately rather than allocated over several maturity
groupings.)
[FASB ASC 320-10-50 par. 2–4]
14. Has the entity properly disclosed the following by major se-
curity type, for securities classified as held-to-maturity as of
each date for which a statement of financial position is pre-
sented:
a. Amortized cost basis?
b. Aggregate fair value?
c. Gross unrecognized holding gains?
d. Gross unrecognized holding losses?
e. Net carrying amount?
f. Total other-than-temporary impairment recognized in
accumulated OCI?
g. Gross gains and losses in accumulated OCI for any de-
rivatives that hedged the forecasted acquisition of the
held-to-maturity securities?
h. Information about the contractual maturities of those
securities as of the date of the most recent statement of
financial position presented?
[FASB ASC 320-10-50-5]
Impairment of Securities
15. Has the entity properly disclosed, for all investments in an
unrealized loss position, including those that fall within the
scope of FASB ASC 325-40, for which other-than-temporary
impairments have not been recognized in earnings (including
investments for which a portion of an other-than-temporary
impairment has been recognized in OCI), the following in its
interim and annual financial statements:
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a. As of each date for which a statement of financial po-
sition is presented, quantitative information, aggre-
gated by category of investment—each major security
type that the entity discloses in accordance with FASB
ASC 320-10 and cost-method investments—in tabular
form (Note: These disclosures should be segregated by
those investments that have been in a continuous un-
realized loss position7 for less than 12 months and those
that have been in a continuous unrealized loss position
for 12 months or longer.),
i. the aggregate related fair value of investments
with unrealized losses?
ii. the aggregate amount of unrealized losses (that
is, the amount by which cost basis exceeds fair
value)?
b. As of the date of the most recent statement of financial
position, additional information (in narrative form) that
provides sufficient information to allow financial state-
ment users to understand the quantitative disclosures
and the information that the entity considered (both
positive and negative) in reaching the conclusion that
the impairment or impairments are not other than tem-
porary? (Note: The disclosures may be aggregated by
investment categories, but individually significant un-
realized losses generally should not be aggregated.)
(See FASB ASC 320-10-50-6 for example disclosures.)
[FASB ASC 320-10-50 par. 6–7]
16. Has the entity properly disclosed, for interim and annual per-
iods in which an other-than-temporary impairment of a debt
security is recognized and only the amount related to a credit
loss was recognized in earnings, by major security type, the
methodology and significant inputs used to measure the
amount related to credit loss? (Examples of significant inputs
include default rates, delinquency rates, percentage of non-
performing assets, loan-to-collateral-value ratios, third-party
guarantees, current levels of subordination, vintage, geo-
graphic concentration and credit ratings.)
[FASB ASC 320-10-50-8A]
17. Has the entity properly disclosed, in tabular format, a rollfor-
ward of the amount related to credit losses recognized in
earnings in accordance with FASB ASC 320-10-35-34D, for in-
terim and annual periods, including, at a minimum,
7 Per FASB ASC 320-10-50-8, the reference point for determining how long an investment has been in a continuous unrealized loss
position is the balance sheet date of the reporting period in which the impairment is identified. The continuous unrealized loss position
ceases upon either of the following:
● The recognition of the total amount by which amortized cost basis exceeds fair value as an other-than-temporary impairment
in earnings
● The investor becoming aware of a recovery of fair value up to (or beyond) the cost of the investment during the period
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a. the beginning balance of the amount related to credit
losses on debt securities held by the entity at the begin-
ning of the period for which a portion of an other-than-
temporary impairment was recognized in OCI?
b. additions for the amount related to the credit loss for
which an other-than-temporary impairment was not
previously recognized?
c. reductions for securities sold during the period (real-
ized)?
d. reductions for securities for which the amount previ-
ously recognized in OCI was recognized in earnings
because the entity intends to sell the security or more
likely than not will be required to sell the security be-
fore recovery of its amortized cost basis?
e. if the entity does not intend to sell the security and it is
not more likely than not that the entity will be required
to sell the security before recovery of its amortized cost
basis, additional increases to the amount related to the
credit loss for which an other-than-temporary impair-
ment was previously recognized?
f. reductions for increases in cash flows expected to be
collected that are recognized over the remaining life of
the security?
g. the ending balance of the amount related to credit
losses on debt securities held by the entity at the end of
the period for which a portion of an other-than-tempo-
rary impairment was recognized in OCI?
[FASB ASC 320-10-50-8B]
Sales, Transfers, and Related Matters That Occurred During the Pe-
riod
18. Has the entity properly disclosed the following for each pe-
riod for which an income statement is presented:
a. The proceeds from sales of available-for-sale securities
and gross realized gains and losses that have been in-
cluded in earnings as a result of those sales?
b. The basis on which the cost of a security sold or the
amount reclassified out of accumulated OCI into earn-
ings was determined (that is, specific identification, av-
erage cost, or other method used)?
c. The gross gains and losses included in earnings from
transfers of securities from the available-for-sale cate-
gory to the trading category?
d. The amount of the net unrealized holding gain or loss
on available-for-sale securities for the period that has
been included in accumulated OCI and the amount of
gains and losses reclassified out of accumulated OCI
into earnings for the period?
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e. The portion of trading gains and losses for the period
that relates to trading securities still held at the report-
ing date?
[FASB ASC 320-10-50-9]
19. Has the entity properly disclosed the following for any sales
of or transfers from securities classified as held-to-maturity
for each period for which an income statement is presented:
(Note: FASB ASC 320-10-25-14 sets forth the conditions under
which sales of debt securities may be considered as maturities
for the purposes of these disclosures.)
a. Net carrying amount of the sold or transferred secu-
rity?
b. The net gain or loss in accumulated OCI for any deriv-
ative that hedged the forecasted acquisition of the held-
to-maturity security?
c. Related realized or unrealized gain or loss?
d. The circumstances leading to the decision to sell or
transfer the security?
[FASB ASC 320-10-50 par. 10–11]
F. Investments—Equity Method and Joint Ventures (FASB ASC 323-
10)
Presentation
1. For investments in common stock accounted for by the equity
method, is the investor’s share of earnings shown as a single
amount except for investee extraordinary items and prior-pe-
riod adjustments that are material to the investor?
[FASB ASC 323-10-45 par. 1–2]
Disclosure
General
2. Has the entity properly disclosed the following for invest-
ments in common stock accounted for by the equity method:
a. The name of each investee and their percentage of own-
ership of common stock? (Note: Disclosure should in-
clude the names of any significant investee entities in
which the investor holds 20 percent or more of the vot-
ing stock, but the common stock is not accounted for
on the equity method, together with the reasons why
the equity method is not considered appropriate, and
the names of any significant investee corporations in
which the investor holds less than 20 percent of the vot-
ing stock and the common stock is accounted for on the
equity method, together with the reasons why the eq-
uity method is considered appropriate.)
b. The accounting policies of the investor with respect to
investments in common stock?
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c. The difference between the amount at which an invest-
ment is carried and the amount of underlying equity in
net assets, and the accounting treatment of this differ-
ence?
d. For investments in common stock for which a quoted
market price is available, the aggregate value of each
identified investment based on the quoted market
price? (This is not required for investments in common
stock of subsidiaries.)
e. For investments in common stock of corporate joint
ventures or other investments accounted for under the
equity method which are in the aggregate material in
relation to the financial position or results of operations
of an investor, summarized information as to assets, li-
abilities, and results of operation of the investees as ap-
propriate?
f. Material effects of possible conversions of outstanding
convertible securities, exercises, or contingent issu-
ances?
[FASB ASC 323-10-50-3]
3. If the entity holds 20 percent or more of the voting stock of a
significant investee corporation but does not account for the
investment using the equity method, are the following dis-
closed:
a. The name of such investee?
b. The reasons why the equity method is not considered
appropriate?
[FASB ASC 323-10-50-3(a)(2)]
4. If the entity holds less than 20 percent of the voting stock of
a significant investee corporation and accounts for the invest-
ment using the equity method, are the following disclosed:
a. The name of such investee?
b. The reasons why the equity method is considered ap-
propriate?
[FASB ASC 323-10-50-3(a)(2)]
G. Cost Method Investments (FASB ASC 325-20)
Disclosure
1. Has the entity properly disclosed, for cost-method invest-
ments, the following additional information, if applicable, as
of each date for which a statement of financial position is pre-
sented in its annual financial statements:
a. The aggregate carrying amount of all cost-method in-
vestments?
b. The aggregate carrying amount of cost-method invest-
ments that the entity did not evaluate for impairment
(see FASB ASC 325-20-35)?
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c. The fact that the fair value of a cost-method investment
is not estimated if there are no identified events or
changes in circumstances that may have a significant
adverse effect on the fair value of the investment, and
any one of the following:
i. The entity determined, in accordance with para-
graphs 16–19 of FASB ASC 825-10-50, that it is
not practicable to estimate the fair value of the
investment?
ii. The entity is exempt from estimating fair value
under FASB ASC 825?
iii. the entity is exempt from estimating interim fair
values because it does not meet the FASB ASC
definition of a publicly traded company?
[FASB ASC 325-20-50-1]
H. Investments in Insurance Contracts (FASB ASC 325-30)
Presentation
Life Settlement Contract—Statement of Financial Position
1. Has the entity properly presented, to accomplish separate re-
porting, its investments that are remeasured at fair value on
the face of the statement of financial position separately from
those accounted for under the investment method by either
of the following:
a. Displaying separate line items on the statement of fi-
nancial position for the fair value method and invest-
ment method carrying amounts?
b. Presenting the aggregate of those fair value method
and investment method carrying amounts and paren-
thetically disclosing the amount of those investments
accounted for under the fair value method included in
the aggregate amount?
[FASB ASC 325-30-45-1]
Life Settlement Contract—Income Statement
2. Has the entity properly presented, to accomplish separate re-
porting, the investment income from its investments in life
settlement contracts that are remeasured at fair value on the
face of the income statement separately from the investment
income from those accounted for under the investment
method by either of the following:
a. Displaying separate line items on the income statement
for the investment income from the investments in life
settlement contracts that are accounted for under the
fair value method and investment method?
54 Life and Health Insurance Entities
FSP §20,100.01
Yes No N/A
b. Presenting the aggregate of the investment income in
life settlement contracts and parenthetically disclosing
the investment income from those investments ac-
counted for under the fair value method that are in-
cluded in the aggregate amount?
[FASB ASC 325-30-45-3]
3. Has the entity properly presented, if applying the fair value
method, premiums paid and life insurance proceeds received
on the same financial reporting line as the changes in fair
value?
[FASB ASC 325-30-45-4]
Life Settlement Contract—Statement of Cash Flows
4. Has the entity properly presented cash receipts and cash pay-
ments related to life settlement contracts pursuant to FASB
ASC 230, Statement of Cash Flows, based on the nature and
purpose for which the life settlements were acquired?
[FASB ASC 325-30-45-5]
Certain Equity Securities
5. Has the entity reported unrealized gains and losses of certain
equity securities subject to FASB ASC 944-325-35-1, net of ap-
plicable income taxes in OCI?
[FASB ASC 944-325-45-1]
6. Has the not-for-profit insurance entity recognized the change
in fair value of equity securities that are not within the scope
of FASB ASC 958-20 because they do not have readily deter-
minable fair values in its statement of activities?
[FASB ASC 944-325-45-2]
All Investments
7. Has the entity reported realized gains and losses on all in-
vestments in the statement of earnings as a component of
other income, on a pretax basis (except those that are ac-
counted for as either hedges of net investments in foreign op-
erations or cash flow hedges)?
[FASB ASC 944-325-45-3]
8. Has the entity presented all realized gains and losses as a sep-
arate item in the statement of earnings or disclosed in the
notes to the financial statements, except losses arising from
an other-than-temporary impairment which is presented in
accordance with FASB ASC 320-10?
[FASB ASC 944-325-45 par. 4–5]
Disclosure
General
9. Has the entity properly disclosed when contractual restric-
tions on the ability to surrender a policy exist?
[FASB ASC 325-30-50-1]
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Life Settlement Contract
10. Has the entity properly disclosed its accounting policy for life
settlement contracts including the classification of cash re-
ceipts and cash disbursements in the statement of cash flows?
(Note: The disclosure requirements in FASB ASC 325-30-50
do not eliminate disclosure requirements included in else-
where in FASB ASC, including other disclosure requirements
on the use of fair value.)
[FASB ASC 325-30-50 par. 2–3]
Life Settlement Contract—Investment Method
11. Has the entity properly disclosed the following for life settle-
ments contracts accounted for under the investment method
based on the remaining life expectancy for each of the first
five succeeding years from the date of the statement of finan-
cial position and thereafter, as well as in the aggregate:
a. The number of life settlement contracts?
b. The carrying value of the life settlement contracts?
c. The face value (death benefits) of the life insurance pol-
icies underlying the contracts?
[FASB ASC 325-30-50-4]
12. Has the entity properly disclosed the life insurance premiums
anticipated to be paid for each of the five succeeding fiscal
years to keep the life settlement contracts in force as of the
date of the most recent statement of financial position pre-
sented?
[FASB ASC 325-30-50-5]
13. Has the entity properly disclosed, if the entity becomes aware
of new or updated information that causes it to change its
expectations on the timing of the realization of proceeds from
the investments in life settlement contracts, the nature of the
information and the related effect on the timing of the reali-
zation of proceeds from the life settlement contracts, includ-
ing disclosing significant changes to the amounts disclosed in
accordance with FASB ASC 325-30-50-4? (Note: The investor
is not required to actively seek out new or updated informa-
tion to update the assumptions used in determining the re-
maining life expectancy of the life settlement contracts.)
[FASB ASC 325-30-50-6]
Life Settlement Contract—Fair Value Method
14. Has the entity properly disclosed the method(s) and signifi-
cant assumptions used to estimate the fair value of invest-
ments in life settlement contracts, including any mortality as-
sumptions?
[FASB ASC 325-30-50-7]
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15. Has the entity properly disclosed the following for life settle-
ment contracts accounted for under the fair value method
based on remaining life expectancy for each of the first five
succeeding years from the date of the statement of financial
position and thereafter, as well as in the aggregate:
a. The number of life settlement contracts?
b. The carrying value of the life settlement contracts?
c. The face value (death benefits) of the life insurance pol-
icies underlying the contracts?
[FASB ASC 325-30-50-8]
16. Has the entity properly disclosed the reasons for changes in
its expectation of the timing of the realization of the invest-
ments in life settlement contracts, including disclosing signif-
icant changes to the amounts disclosed in accordance with
FASB ASC 325-30-50-8?
[FASB ASC 325-30-50-9]
17. Has the investor (entity) properly disclosed the following for
each reporting period presented in the income statement:
a. The gains or losses recognized during the period on in-
vestments sold during the period?
b. The unrealized gains or losses recognized during the
period on investments that are still held at the date of
the statement of financial position?
[FASB ASC 325-30-50-10]
All Investments
18. If realized gains and losses are not presented as a separate
item in the statement of earnings, have they been disclosed in
the notes to the financial statements?
[FASB ASC 944-325-50-1]
I. Inventory (FASB ASC 330-10)
Disclosure
Basis for Stating Inventories
1. Has the entity properly disclosed the basis of stating inven-
tories and has that basis been consistently applied? Whenever
a significant change is made therein, has the entity disclosed
the nature of the change and, if material, the effect on in-
come?
[FASB ASC 330-10-50-1]
Losses From Application of Lower of Cost or Market
2. Has the entity properly disclosed information regarding sub-
stantial and unusual losses which have resulted from the ap-
plication of the rule of lower of costs or market (normally as
a charge separately identified from the consumed inventory
costs described as cost of goods sold)?
[FASB ASC 330-10-50-2]
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Goods Stated Above Cost
3. Has the entity properly disclosed if goods are stated above
cost?
[FASB ASC 330-10-50-3]
Stating Inventories at Sales Prices
4. Has the entity properly disclosed if goods are stated at sales
prices?
[FASB ASC 330-10-50-4]
Losses on Firm Purchase Commitments
5. Has the entity properly disclosed net losses on firm purchase
commitments for goods for inventory, separately in the in-
come statement?
[FASB ASC 330-10-50-5]
J. Capitalized Advertising Costs (FASB ASC 340-20)
Presentation
Presentation of Qualifying Direct-Response Advertising Assets
1. Has the entity properly presented direct-response advertising
costs as assets net of accumulated amortization, if those costs
meet the recognition criteria as capitalized assets of FASB
ASC 340-20-25-4?
[FASB ASC 340-20-45-1]
Disclosure
2. Has the entity properly disclosed the following related to ad-
vertising:
a. The accounting policy for reporting advertising, indi-
cating whether such costs are expensed as incurred or
expensed the first time the advertising takes place?
b. A description of direct-response-advertising reported
as assets (if any), the related accounting policy, and the
amortization method and period?
c. The amount charged to advertising expense for each
statement of income presented, with separate disclo-
sure of amounts, if any, representing a write-down of
capitalized advertising costs to net realizable value?
d. The amount of advertising reported as assets in each
balance sheet presented?
[FASB ASC 340-20-50-1]
K. Insurance Contracts That Do Not Transfer Insurance Risks (FASB
ASC 340-30)
Presentation
Deposit Asset and Liability
1. Has the entity properly presented deposit assets and liabili-
ties on the gross basis, unless the right of offset exists as de-
fined in FASB ASC 210-20?
[FASB ASC 340-30-45-1]
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Insurance and Reinsurance Contracts That Transfer Only Signifi-
cant Timing Risk and Insurance and Reinsurance Contracts That
Transfer Neither Timing nor Significant Underwriting Risk
2. Has the entity properly presented changes in the carrying
amount of the deposit as interest income or interest expense?
[FASB ASC 340-30-45-2]
Insurance and Reinsurance Contracts that Transfer Only Significant
Underwriting Risk
3. Has the entity properly presented the changes in the recorded
amount of the deposit, other than the unexpired portion of
the coverage provided, arising from an insurance or reinsur-
ance contract that transfers only significant underwriting risk
in an insured’s income statement as an offset against the loss
recorded by the insured that will be reimbursed under the
insurance or reinsurance contract and in an insurer’s income
statement as an incurred loss?
[FASB ASC 340-30-45-3]
4. Has the entity properly presented the reduction in the deposit
related to the unexpired portion of the coverage provided as
an adjustment to incurred loss?
[FASB ASC 340-30-45-4]
5. Has the entity (if not an insurance entity) properly presented
the reduction in the deposit related to the unexpired portion
of the coverage provided as an expense?
[FASB ASC 340-30-45-5]
Disclosure
Deposit Asset and Liability
6. Has the entity properly disclosed a description of the con-
tracts accounted for as deposits and the separate amounts of
total deposit assets and total deposit liabilities reported in the
statement of financial position?
[FASB ASC 340-30-50-1]
Insurance and Reinsurance Contracts That Transfer Only Under-
writing Risk
7. Has the entity properly disclosed the following regarding the
changes in the recorded amount of the deposit arising from
an insurance or reinsurance contract that transfers only sig-
nificant underwriting risk:
a. The present values of initial expected recoveries that
will be reimbursed under the insurance or reinsurance
contracts that have been recorded as an adjustment to
incurred losses?
b. Any adjustment of amounts initially recognized for ex-
pected recoveries and the individual components of the
adjustment (meaning, interest accrual, the present
value of additional expected recoveries, and the present
value of reductions in expected recoveries) disclosed
separately?
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c. The amortization expense attributable to the expiration
of coverage provided under the contract?
[FASB ASC 340-30-50-2]
L. Goodwill (FASB ASC 350-20)
Presentation
1. Has the entity properly presented the aggregate amount of
goodwill as a separate line item in the statement of financial
position?
[FASB ASC 350-20-45-1]
2. Has the entity properly presented the aggregate amount of
goodwill impairment losses as a separate line item in the in-
come statement before the subtotal “income from continuing
operations” (or similar caption) unless a goodwill impair-
ment loss is associated with a discontinued operation?
[FASB ASC 350-20-45-2]
3. Has the entity properly presented a goodwill impairment loss
associated with a discontinued operation (on a net-of-tax ba-
sis) within the results of discontinued operations?
[FASB ASC 350-20-45-3]
Disclosure
Information for Each Period for Which a Statement of Financial Po-
sition Is Presented
4. Has the entity properly disclosed any changes in the carrying
amount of goodwill during the period, including showing the
following separately, (see example 3 in FASC ASC 350-20-55-
24):8
a. The gross amount and accumulated impairment losses
at the beginning of the period?
b. Additional goodwill recognized during the period, ex-
cept goodwill included in a disposal group that, on ac-
quisition, meets the criteria to be classified as held for
sale in accordance with FASB ASC 360-10-45-9?
c. Adjustments resulting from the subsequent recognition
of deferred tax assets during the period in accordance
with paragraphs 2–4 of FASB ASC 805-740-25 and
FASB ASC 805-740-45-2?
d. Goodwill included in a disposal group classified as
held for sale in accordance with FASB ASC 360-10-45-9
and goodwill derecognized during the period without
having previously been reported in a disposal group
classified as held for sale?
e. Impairment losses recognized during the period in ac-
cordance with FASB ASC 350-10?
8 Entities that report segment information in accordance with FASB ASC 280, Segment Reporting, should provide this information about
goodwill in total and for each reportable segment and should disclose any significant changes in the allocation of goodwill by reportable
segment. If any portion of goodwill has not yet been allocated to a reporting unit at the date the financial statements are issued, that
unallocated amount and the reasons for not allocating that amount should be disclosed.
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f. Net exchange differences arising during the period in
accordance with FASB ASC 830, Foreign Currency Mat-
ters?
g. Any other changes in the carrying amounts during the
period?
h. The gross amount and accumulated impairment losses
at the end of the period?
[FASB ASC 350-20-50-1]
Goodwill Impairment Loss
5. Has the entity properly disclosed, for each goodwill impair-
ment loss recognized, the following information in the notes
to the financial statement that include the period in which the
impairment loss is recognized:
a. A description of the facts and circumstances leading to
the impairment?
b. The amount of the impairment loss and the method of
determining the fair value of the associated reporting
unit (whether based on quoted market prices, prices of
comparable businesses, a present value or other valua-
tion technique, or a combination thereof)?
c. If a recognized impairment loss is an estimate that has
not yet been finalized (refer to paragraphs 18–19 of
FASB ASC 350-20-35), that fact and the reasons there-
fore and, in subsequent periods, the nature and amount
of any significant adjustments made to the initial esti-
mate of the impairment loss?
[FASB ASC 350-20-50-2]
M. General Intangibles Other Than Goodwill (FASB ASC 350-30)
Presentation
1. At a minimum, are all intangible assets aggregated and pre-
sented as a separate line item in the statement of financial
position? (This requirement does not preclude presentation of
individual intangible assets or classes of intangible assets as
separate line items.)
[FASB ASC 350-30-45-1]
2. Are amortization expense and impairment losses for intangi-
ble assets presented in income statement line items within
continuing operations as deemed appropriate for each entity?
[FASB ASC 350-30-45-2]
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Disclosure
Disclosures in the Period of Acquisition
3. Has the entity properly disclosed, for intangible assets ac-
quired either individually or with a group of assets (in either
an asset acquisition or business combination), all of the fol-
lowing in the notes to financial statements in the period of
acquisition: (Note: The following information also should be
disclosed separately for each material business combination
or in the aggregate for individually immaterial business com-
binations that are material collectively, if the aggregate fair
values of intangible assets, other than goodwill, are signifi-
cant.)
a. For intangible assets subject to amortization, all of the
following:
i. The total amount assigned and the amount as-
signed to any major intangible asset class?
ii. The amount of any significant residual value, in
total and by major intangible asset class?
iii. The weighted-average amortization period, in to-
tal and by major intangible asset class?
b. For intangible assets not subject to amortization, the to-
tal amount assigned and the amount assigned for each
major intangible asset class?
c. The amount of research and development assets ac-
quired in a transaction other than a business combina-
tion and written off in the period and the line item in
the income statement in which the amounts written off
are aggregated?
d. For intangible assets with renewal or extension terms,
the weighted-average period before the next renewal or
extension (both explicit and implicit), by major asset
class?
[FASB ASC 350-30-50-1]
Disclosures for Each Period for Which a Statement of Financial Po-
sition is Presented
4. Has the entity properly disclosed the following information
in the financial statements or notes to the financial state-
ments, for each period for which a statement of financial po-
sition is presented:
a. For intangible assets subject to amortization, all of the
following:
i. The gross carrying amount and accumulated am-
ortization, in total and by major intangible asset
class?
ii. The aggregate amortization expense for the pe-
riod?
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iii. The estimated aggregate amortization expense
for each of the five succeeding fiscal years?
b. For intangible assets not subject to amortization, the to-
tal carrying amount and the carrying amount for each
major intangible asset class?
c. The entity’s accounting policy on the treatment of costs
incurred to renew or extend the term of a recognized
intangible asset?
d. For intangible assets that have been renewed or ex-
tended in the period for which a statement of financial
position is presented, both of the following:
i. For entities that capitalize renewal or extension
costs, the total amount of costs incurred in the
period to renew or extend the term of a recog-
nized intangible asset, by major intangible asset
class?
ii. The weighted-average period before the next re-
newal or extension (both explicit and implicit),
by major intangible asset class?
[FASB ASC 350-30-50-2]
Disclosures Relating to Impairment Loss
5. Has the entity properly disclosed, for each impairment loss
recognized related to an intangible asset, the following infor-
mation in the notes to the financial statements that include
the period in which the impairment loss is recognized:
a. A description of the impaired intangible asset and the
facts and circumstances leading to the impairment?
b. The amount of the impairment loss and the method for
determining fair value?
c. The caption in the income statement in which the im-
pairment loss is aggregated?
d. If applicable, the segment in which the impaired intan-
gible asset is reported under FASB ASC 280?
[FASB ASC 350-30-50-3]
Renewal or Extension of an Intangible Asset’s Legal or Contractual
Life
6. Has the entity properly disclosed, for recognized intangible
assets, information that enables users of financial statements
to assess the extent to which the expected future cash flows
associated with the asset are affected by the entity’s intent or
ability (or both intent and ability) to renew or extend the ar-
rangement?
[FASB ASC 350-30-50-4]
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N. Property, Plant, and Equipment (FASB ASC 360-10)
Presentation
Impairment of Long-Lived Assets—Impairment of Long-Lived As-
sets Classified as Held and Used—Presentation of Impairment Loss
for Long-Lived Assets to Be Held and Used
1. Is an impairment loss recognized for a long-lived asset (asset
group) to be held and used included in income from contin-
uing operations before income taxes in the income statement?
If a subtotal such as income from operations is presented,
does it include the amount of the loss?
[FASB ASC 360-10-45-4]
2. If a long-lived asset is to be disposed of other than by sale,
does it continue to be classified as held and used until it is
disposed of?
[FASB ASC 360-10-45-15]
3. Is a long-lived asset that is classified as held for sale pre-
sented separately in the statement of financial position?
[FASB ASC 360-10-45-14]
Impairment of Long-Lived Assets—Impairment of Long-Lived As-
sets Classified as Held and Used—Presentation of Disposal Gains
or Losses in Continuing Operations
4. Is a gain or loss that is recognized on the sale of a long-lived
asset (disposal group) that is not a component of an entity
included in income from continuing operations before in-
come taxes in the income statement? (Note: If a subtotal such
as “income from operations” is presented, it should include
the amounts of those gains or losses.)
[FASB ASC 360-10-45-5]
Change of Classification After Balance Sheet Date but Before Issu-
ance of Financial Statements
5. Has the entity properly presented, if the held for sale criteria
were met after the balance sheet date but before the financial
statements were issued or were available to be issued, the
long-lived asset as held and used in those financial state-
ments when issued or available to be issued?
[FASB ASC 360-10-45-13]
Real Estate Acquired in Settling Certain Claims
6. Has the entity reported real estate acquired in settling claims
separately in the balance sheet and not as an investment?
[FASB ASC 944-360-45-1]
7. Has the entity reported depreciation and other real estate op-
erating costs as investment expenses or operating expenses
consistent with the balance sheet classification of the related
asset?
[FASB ASC 944-360-45-2]
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Disclosure
8. Has the entity properly disclosed the following regarding the
depreciation method or methods used in the financial state-
ments or notes thereto:
a. Depreciation expense for the period?
b. Balances of major classes of depreciable assets, by na-
ture or function, at the balance sheet date?
c. Accumulated depreciation, either by major class of de-
preciable assets or in total, at the balance sheet date?
d. A general description of the method or methods used
in computing depreciation with respect to major classes
of depreciable assets?
[FASB ASC 360-10-50-1]
9. If realized gains and losses on the sale of property have not
been presented as a separate line item in the statement of
earnings, have they been disclosed in the notes to the finan-
cial statements?
[FASB ASC 944-360-50]
10. Is the following information disclosed in the notes to the fi-
nancial statements that include the period in which an im-
pairment loss is recognized:
a. A description of the impaired long-lived asset (asset
group) and the facts and circumstances leading to the
impairment?
b. If not separately presented on the face of the statement,
the amount of the impairment loss and the caption in
the income statement that includes the loss?
c. The method or methods for determining fair value
(whether based on a quoted market price, prices for
similar assets, or another valuation technique)?
d. If applicable, the segment in which the impaired long-
lived asset (asset group) is reported under FASB ASC
280?
[FASB ASC 360-10-50-2]
III. Liabilities
A. Insurance-Related Assessment Liabilities (FASB ASC 405-30)
Disclosure
1. Has the entity properly disclosed, for insurance-related as-
sessments,
a. if amounts relating to insurance-related assessments
have been discounted, has the entity disclosed in the
financial statements the undiscounted amounts of the
liability and any related asset for premium tax offsets
or policy surcharges as well as the discount rate used?
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b. if amounts have not been discounted, has the entity dis-
closed in the financial statements the amounts of the
liability, any related asset for premium tax offsets or
policy surcharges, the periods over which the assess-
ments are expected to be paid, and the period over
which the recorded premium tax offsets or policy sur-
charges are expected to be realized?
[FASB ASC 405-30-50-1]
B. Asset Retirement and Environmental Obligations (FASB ASC 410-
20)
Presentation
1. Has the entity properly presented accretion expense as an op-
erating item in the statement of income? (Note: The entity
may use any descriptor for accretion expense so long as it
conveys the underlying nature of the expense.)
[FASB ASC 410-20-45-1]
2. Is, on a pro forma basis, in the footnotes to the financial state-
ments, for the beginning of the earliest period presented and
at the end of all periods presented during the year of adop-
tion, the amount of liability for asset retirement obligations
presented, as if FASB ASC 410-20 had been applied during all
periods affected? (These pro forma amounts should be meas-
ured using the information, assumptions, and interest rates
used to measure the obligation recognized upon adoption of
the provisions of FASB ASC 410-20.)
[FASB ASC 410-20]
Disclosure
3. Has the entity properly disclosed the following information
about its asset retirement obligations:
a. A general description of the asset retirement obliga-
tions and the associated long-lived assets?
b. The fair value of assets that are legally restricted for
purposes of settling asset retirement obligations?
c. A reconciliation of the beginning and ending aggregate
carrying amount of asset retirement obligations show-
ing separately the changes attributable to (1) liabilities
incurred in the current period, (2) liabilities settled in
the current period, (3) accretion expense, and (4) revi-
sions in estimated cash flows, whenever there is a sig-
nificant change in one or more of those four compo-
nents during the reporting period?
[FASB ASC 410-20-50-1]
4. Has the entity properly disclosed, if the fair value of an asset
retirement obligation cannot be reasonably estimated, that
fact and the reasons therefore?
[FASB ASC 410-20-50-2]
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C. Asset Retirement and Environmental Obligations—
Environmental Obligations (FASB ASC 410-30)
Presentation
General
1. Has the entity properly not presented environmental remedi-
ation obligations as extraordinary? (Note: Environmental re-
mediation obligations are not events that are unusual in na-
ture.)
[FASB ASC 410-30-45-3]
2. Has the entity properly presented environmental remediation
costs as a charge against operations, rather than nonoperating
expenses?
[FASB ASC 410-30-45-4]
3. Has the entity properly presented any earnings on assets that
are reflected on the entity’s financial statements and are ear-
marked for funding environmental liabilities as investment
income?
[FASB ASC 410-30-45-4]
4. Has the entity properly presented environmental remediation
expenses and related recoveries attributable to discontinued
operations, accounted for in accordance with FASB ASC 205-
20, as discontinued operations?
[FASB ASC 410-30-45-5]
Disclosure
Disclosures That Are Required
5. Has the entity properly disclosed whether the accrual for en-
vironmental remediation liabilities is measured on a dis-
counted basis? (Note: If the entity utilizes present-value
measurement techniques, additional disclosures are appro-
priate. See FASB ASC 410-30-50-7.)
[FASB ASC 410-30-50-4]
6. Has the entity properly disclosed, with respect to recorded
accruals for environmental remediation loss contingencies
and assets for third-party recoveries related to environmental
remediation obligations, if any portion of the accrued obliga-
tion is discounted, the undiscounted amount of the obliga-
tion, and the discount rate used in the present-value deter-
minations?
[FASB ASC 410-30-50-7]
Disclosures That Are Encouraged But Not Required
7. Has the entity properly disclosed any events, situations, or
sets of circumstances that generally trigger recognition of loss
contingencies that have arisen out of the entity’s environmen-
tal remediation-related obligations, as well as the entity’s pol-
icy concerning the timing of recognition of recoveries?
[FASB ASC 410-30-50-8]
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8. Has the entity properly disclosed additional specific disclo-
sures, as necessary, with respect to environmental remedia-
tion loss contingencies that would be useful to further users’
understanding of the entity’s financial statements?
[FASB ASC 410-30-50-9]
9. Has the entity properly disclosed the following encouraged,
but not required, items:
a. The estimated time frame of disbursements for re-
corded amounts if expenditures are expected to con-
tinue over the long term?
b. The estimated time frame for realization of recognized
probable recoveries, if realization is not expected in the
near term?
c. If an estimate of the probable or reasonably possible
loss or range of loss cannot be made, the reasons why
it cannot be made?
d. If information about the reasonably possible loss or the
recognized and additional reasonably possible loss for
an environmental remediation obligation related to an
individual site is relevant to an understanding of the
financial position, cash flows, or results of operations
of the entity, the following with respect to the site:
i. The total amount accrued for the site?
ii. The nature of any reasonably possible loss con-
tingency or additional loss, and an estimate of
the possible loss or the fact that an estimate can-
not be made and the reasons why it cannot be
made?
iii. Whether other potentially responsible parties are
involved and the entity’s estimated share of the
obligation?
iv. The status of regulatory proceedings?
v. The estimated time frame for resolution of the
contingency?
[FASB ASC 410-30-50-10]
10. Has the entity properly disclosed the estimated time frame
for resolution of the uncertainty as to the amount of the loss?
[FASB ASC 410-30-50-11]
11. Has the entity properly disclosed the following encouraged,
but not required, items in the income statement:
a. The amount recognized for environmental remediation
loss contingencies in each period?
b. The amount of any recovery from third parties that is
credited to environmental remediation costs in each pe-
riod?
c. The income statement caption in which environmental
remediation costs and credits are included?
[FASB ASC 410-30-50-12]
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Disclosure Related to Loss Contingencies
12. Has the entity properly disclosed, in the financial statements,
a contingency conclusion that addresses the estimated total
unrecognized exposure to environmental remediation and
other loss contingencies?
[FASB ASC 410-30-50-14]
13. Has the entity properly disclosed a description of the general
applicability and impact of environmental laws and regula-
tions upon their business and how the existence of such laws
and regulations may give rise to loss contingencies for future
environmental remediation?
[FASB ASC 410-30-50-17]
D. Exit or Disposal Cost Obligations (FASB ASC 420-10)
Presentation
1. Has the entity properly presented the cumulative effect of a
change resulting from a revision to either the timing or the
amount of estimated cash flows in the same line item(s) in the
income statement used when the related costs were recog-
nized initially in the period of change?
[FASB ASC 420-10-45-1]
2. Has the entity properly presented costs associated with an
exit or disposal activity that involves a discontinued opera-
tion in the results of discontinued operations in accordance
with FASB ASC 205-20-45?
[FASB ASC 420-10-45-2]
3. Has the entity properly presented costs associated with an
exit or disposal activity that does not involve a discontinued
operation in income from continuing operations before in-
come taxes, for example, in a subtotal such as “income from
operations?”
[FASB ASC 420-10-45-3]
4. Has the entity properly presented accretion expense sepa-
rately from interest cost in the income statement?
[FASB ASC 420-10-45-5]
Disclosure
5. Has the entity properly disclosed the following information
in notes to the financial statements that include the period in
which an exit or disposal activity is initiated and any subse-
quent period until the activity is completed:
a. A description of the exit or disposal activity, including
the facts and circumstances leading to the expected ac-
tivity and the expected completion date?
b. For each major type of cost associated with the activity
(for example, one-time termination benefits, contract
termination costs, and other associated costs),
i. the total amount expected to be incurred in con-
nection with the activity, the amount incurred in
the period, and the cumulative amount incurred
to date?
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ii. a reconciliation of the beginning and ending lia-
bility balances showing separately the changes
during the period attributable to costs incurred
and charged to expense, costs paid or otherwise
settled, and any adjustments to the liability with
an explanation of the reason(s) therefore?
c. The line item(s) in the income statement in which the
costs in item (b) are aggregated?
d. For each reportable segment, as defined in FASB ASC
280-10-50-10,
i. the total amount of costs expected to be incurred
in connection with the activity?
ii. the amount incurred in the period?
iii. the cumulative amount incurred to date, net of
any adjustments to the liability with an explana-
tion of the reason(s) why?
e. If a liability for a cost associated with the activity is not
recognized because fair value cannot be reasonably es-
timated, that fact and the reasons why?
[FASB ASC 420-10-50-1]
E. Commitments (FASB ASC 440-10)
The following table lists the types of contingencies (loss and gain) and commitments that were most
commonly reported in the financial statements of a sample of public entities surveyed by the AICPA.
Reprinted from the AICPA’s Accounting Trends & Techniques, 2010, 64th edition (product no. 0099010
[paperback] or WAT-XX [online]).
CONTINGENCIES
Number of Companies
2009 2008 2007 2006
Loss Contingencies
Litigation 379 404 4489 476
Environmental 203 225 266 263
Possible tax assessments 145 166 185 117
Insurance 132 160 176 152
Government investigations 95 122 153 138
Other—described 63 66 45 70
Gain Contingencies
Operating loss carryforward 429 423 499 496
Tax credits and other tax credit
carryforwards 273 255 278 265
Capital loss carryforward 69 65 83 85
Plaintiff litigation 44 55 40 40
Alternative minimum tax carryforward 42 40 51 57
Investment credit carryforward 8 11 9 6
Asset sale receivable 7 8 10 11
(continued)
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Number of Companies
2009 2008 2007 2006
Charitable contribution carryforward 7 5 7 6
Potential tax refund 4 4 12 5
Other—described 6 3 6 5
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
Disclosure
1. Has the entity properly disclosed, notwithstanding more ex-
plicit disclosures required elsewhere in FASB ASC, all of the
following in the financial statements:
a. Unused letters of credit?
b. Long-term leases?
c. Assets pledged for security for loans?
d. Pension plans?
e. The existence of cumulative preferred stock dividends
in arrears?
f. Commitments, including the following:
i. A commitment for plant acquisition?
ii. An obligation to reduce debts?
iii. An obligation to maintain working capital?
iv. An obligation to restrict dividends?
[FASB ASC 440-10-50-1]
Unconditional Purchase Obligations
2. Has the entity properly disclosed any unconditional purchase
obligations, exhibiting all of the following characteristics, in
accordance with FASB ASC 440-10-50-4 (if not on the balance
sheet), or in accordance with FASB ASC 440-10-50-6 (if re-
corded on the balance sheet):
a. It is noncancelable, or cancelable only in any of the fol-
lowing circumstances:
i. Upon the occurrence of some remote contin-
gency?
ii. With the permission of the other party?
iii. If a replacement agreement is signed between the
same parties?
iv. Upon payment of a penalty in an amount such
that continuation of the agreement appears rea-
sonably assured?
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b. It was negotiated as part of arranging financing for the
facilities that will provide the contracted goods or ser-
vices or for costs related to those goods or services (for
example, carrying costs for contracted goods)? A pur-
chaser is not required to investigate whether a supplier
used an unconditional purchase obligation to help se-
cure financing, if the purchaser would otherwise be un-
aware of that fact.
c. It has a remaining term in excess of one year?
[FASB ASC 440-10-50-2]
Unconditional Purchase Obligations—Unrecognized Commitments
3. Has the entity properly disclosed the following for long term
unconditional purchase obligations that are not recorded in
the purchaser’s balance sheet: (Note: These disclosures may
be omitted only if the aggregate commitment for all such ob-
ligations not disclosed is immaterial.)
a. Nature and term of the obligations?
b. Amount of the fixed and determinable portion of the
obligations as of the date of the latest balance sheet pre-
sented in the aggregate and, if determinable, for each
of the next five years?
c. Nature of any variable components of the obligation?
d. Amounts of purchases under the obligations for each
year for which an income statement is presented?
[FASB ASC 440-10-50-4]
4. Has the entity properly disclosed, as encouraged, but not re-
quired, the amount of imputed interest necessary to reduce
the unconditional purchase obligation(s) to present value?
[FASB ASC 440-10-50-5]
Unconditional Purchase Obligations—Recognized Commitments
5. Has the entity properly disclosed, for unconditional purchase
obligations that meet the criteria of FASB ASC 440-10-50-2
and that have been recognized on the purchaser’s balance
sheet, for each of the 5 years following the date of the latest
balance sheet presented, the aggregate amount of payments?
[FASB ASC 440-10-50-6]
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F. Loss Contingencies (FASB ASC 450-20)9
Disclosure
Accruals for Loss Contingencies
1. Has the entity properly disclosed the nature, and in some cir-
cumstances, the amount accrued, if necessary for the financial
statements not to be misleading, for loss contingencies that
are probable and estimable? (Note: The terminology used
should be descriptive of the nature of the accrual, such as es-
timated liability or liability of an estimated amount. Further,
the term reserve should not be used and is limited to an
amount of unidentified or unsegregated assets held or re-
tained for a specific purpose.)
[FASB ASC 450-20-50-1]
2. Has the entity properly disclosed the following, if it is at least
reasonably possible that the loss estimate will change in the
near term and the change would be material to the financial
statements:
a. The nature of the uncertainty?
b. An indication that it is at least reasonably possible that
a change in the estimate will occur in the near term?
c. An estimate of the possible loss or range of loss, or a
statement that such an estimate cannot be made?
d. A disclosure of the facts that cause the estimate to be
sensitive to change? (Note: This disclosure is encour-
aged, but not required.)
[FASB ASC 450-20-50-2]
Unrecognized Contingencies
3. Has the entity properly disclosed the contingency if there is
at least a reasonable possibility that a loss or an additional
loss may have been incurred and either of the following con-
ditions exists:
a. An accrual is not made for a loss contingency because
any of the conditions in FASB ASC 450-20-25-2 are not
met?
b. An exposure to loss exists in excess of the amount ac-
crued pursuant to the provisions of FASB ASC 450-20-
30-1?
[FASB ASC 450-20-50-3]
4. Has the entity properly disclosed the following for unrecog-
nized loss contingencies when there is at least a reasonable
possibility that a loss or an additional loss has been incurred:
a. The nature of the contingency?
b. An estimate of the possible loss or range of loss, or a
statement that such an estimate cannot be made?
[FASB ASC 450-20-50-4]
9 See footnote 3.
73Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
5. Has the entity properly disclosed information for contingen-
cies for which there is a reasonable possibility that a loss may
have been incurred even though information may not indi-
cate that it is probable that an asset had been impaired or a
liability had been incurred at the date of the financial state-
ments?
[FASB ASC 450-20-50-5]
6. Has the entity properly disclosed a loss contingency involv-
ing any unasserted claim or assessment, if and only if, (a) it is
considered probable that a claim will be asserted and (b) there
is a reasonable possibility that the outcome will be unfavora-
ble? (Note: The disclosures in FASB ASC 450-20-50-4 should
be provided.)
[FASB ASC 450-20-50-6]
Note: The basis for conclusions of the original standard (FASB State-
ment No. 5, Accounting for Contingencies) indicated that disclosure was
not required because of the problems involved in developing opera-
tional criteria for disclosure of noninsured or underinsured risks.
Nonetheless, a 1987 AICPA report, Disclosure Concerning Insurance
Coverage, stated that disclosure of these risks should be encouraged
rather than simply not discouraged. Questions 8–9 that follow are
nonauthoritative suggestions from that report. The AICPA noted that
disclosure of this kind is experimental. Therefore, its location in a fi-
nancial report would depend on the judgment of preparers of the re-
port.
7. For publicly held entities and entities with public accounta-
bility, such as governments, are circumstances disclosed in
which
a. they are exposed to risks of future material loss related
to the following:
i. Torts?
ii. Theft of, damage to, expropriation of, or destruc-
tion of assets?
iii. Business interruption?
iv. Errors or omissions?
v. Injuries to employees?
b. those risks have not been transferred to unrelated third
parties through insurance? (Encouraged, but not re-
quired.)
8. In considering those matters to be disclosed that relate to cer-
tain uninsured risks of future material loss as described in
FASB ASC 720-20, has the entity considered the following:
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a. The actual and potential effects of losses from such
risks on the entity’s historical or planned operations,
including exposure to losses from claims, curtailment
of research and development or manufacturing, or con-
traction or cessation of other activities, such as discon-
tinuance of a product line?
b. Comparison of current insurance coverage by major
categories of risk to coverage in prior periods, without
necessarily quantifying such coverage or change in cov-
erage?
c. Recent claims experience?
d. A description of the reporting entity’s risk management
programs? (Encouraged, but not required.)
Losses Arising After the Date of the Financial Statements
9. Has the entity properly disclosed a loss or a loss contingency
arising after the date of the entity’s financial statements (but
before those financial statements are issued), if applicable. If
such a disclosure is required, have the following been pro-
vided:
a. The nature of the contingency?
b. An estimate of the possible loss or range of loss, or a
statement that such an estimate cannot be made?
[FASB ASC 450-20-50-9]
G. Gain Contingencies (FASB ASC 450-30)
Disclosure
1. Has the entity properly disclosed, with care to avoid any mis-
leading implications about likelihood of realization, any gain
contingencies?
[FASB ASC 450-30-50-1]
H. Guarantees (FASB ASC 460-10)
Presentation
1. Has an accrual for credit loss on a financial instrument with
off-balance sheet risk been recorded separately from a valua-
tion account related to a recognized financial instrument?
[FASB ASC 460-10-45-1]
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Disclosure10
Information About Each Guarantee or Group of Similar Guaran-
tees—Loss Contingencies
2. Has the entity properly disclosed the existence of a loss con-
tingency, even though the possibility of loss may be remote?
(Examples may include: guarantees of indebtedness of others,
including indirect guarantees of indebtedness of others, obli-
gations of commercial banks under standby letters of credit,
guarantees to repurchase receivables that have been sold or
otherwise assigned, and other agreements that in substance
have the same guarantee characteristic.)
[FASB ASC 460-10-50-2]
3. Has the entity properly disclosed the nature and amount of
the guarantee disclosed as a result of FASB ASC 460-10-50-2?
[FASB ASC 460-10-50-3]
Information About Each Guarantee or Group of Similar Guaran-
tees—Disclosures About a Guarantor’s Obligation
4. Has the entity properly disclosed the following information
about each guarantee, or each group of similar guarantees,
even if the likelihood of the guarantor’s having to make any
payments under the guarantee is remote:
a. The nature of the guarantee, including the following:
i. The approximate term of the guarantee?
ii. How the guarantee arose?
iii. The events or circumstances that would require
the guarantor to perform under the guarantee?
iv. The current status (that is, as of the date of the
statement of financial position) of the payment or
performance risk of the guarantee?
v. If the entity uses internal groupings for the pur-
poses of item (iv), how those groupings are deter-
mined and used for managing risk?
b. The maximum potential amount of future payments
(undiscounted) the guarantor could be required to
make under the guarantee?
c. If the terms of the guarantee provide for no limitation
to the maximum potential future payments under the
guarantee, is that fact disclosed?
10 Per FASB ASC 460-10-50-5, the disclosure requirements of this subsection of FASB ASC do not eliminate or affect the disclosure
requirements of the following:
● The requirements of the general subsection of FASB ASC 825-10-50
● The requirements of FASB ASC 450-20-50 par. 3–4 that an entity disclose a contingent loss that has a reasonable possibility of
occurring
● The requirements of the disclosure subsections of FASB ASC 815, Derivatives and Hedging
● The requirements of FASB ASC 275-10-50 that an entity disclose information about risks and uncertainties that could signifi-
cantly affect the amounts reported in the financial statements in the near term
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d. If the guarantor is unable to develop an estimate of the
maximum potential amount of future payments under
its guarantee, are the reasons why the maximum poten-
tial amount cannot be estimated disclosed?
e. The current carrying amount of the liability, if any, for
the guarantor’s obligations under the guarantee, in-
cluding the amount, if any, recognized under FASB
ASC 450-20-30, regardless of whether the guarantee is
freestanding or embedded in another contract?
f. The nature of
i. any recourse provisions that would enable the
guarantor to recover from third parties any of the
amounts paid under the guarantee?
ii. any assets held either as collateral or by third
parties that, upon the occurrence of any trigger-
ing event or condition under the guarantee, the
guarantor can obtain and liquidate to recover all
or a portion of the amounts paid under the guar-
antee?
g. If estimable, the approximate extent to which the pro-
ceeds from liquidation of those assets would be ex-
pected to cover the maximum potential amount of fu-
ture payments under the guarantee?
[FASB ASC 460-10-50-4]
Product Warranties
5. For product warranties and other guarantee contracts re-
quired to be disclosed by FASB ASC 460-10-15-9, is has the
entity properly disclosed the following information:
a. The information required to be disclosed by FASB ASC
460-10-50-4, except that a guarantor is not required to
disclose the maximum potential amount of future pay-
ments in FASB ASC 460-10-50-4(b)?
b. The guarantor’s accounting policy and methodology
used in determining its liability for product warranties
(including any liability associated with extended war-
ranties)?
c. A tabular reconciliation of the changes in the guaran-
tor’s aggregate product warranty liability for the re-
porting period?
d. Does the tabular reconciliation present
i. the beginning balance of the aggregate product
warranty liability?
ii. the aggregate reductions in that liability for pay-
ments made (in cash or in kind) under the war-
ranty?
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iii. the aggregate changes in the liability for accruals
related to product warranties issued during the
reporting period, and the aggregate changes in
the liability for accruals related to preexisting
warranties, including adjustments related to
changes in estimates?
iv. the ending balance of the aggregate product war-
ranty liability?
[FASB ASC 460-10-50-8]
I. Debt—Overall (FASB ASC 470-10)
Presentation
Additional Presentation Information
Due to the vast differences in debt presentation concerns, readers should see FASB ASC 470-10-45 for infor-
mation on the proper presentation of debt related items for their particular entity.
1. Are short term obligations expected to be refinanced reclas-
sified to long term liabilities?
[FASB ASC 470-10-45-13]
2. Are borrowings outstanding under revolving credit agree-
ments that include both a subjective acceleration clause and a
requirement to maintain a lock-box arrangement, whereby re-
mittances from the borrower’s customers reduce the debt out-
standing, classified as short term obligations?
[FASB ASC 470-10-45-5]
3. Has an entity classified long-term debt as noncurrent, unless
both of the following conditions exist:
a. A covenant violation that gives the lender the right to
call the debt has occurred at the balance sheet date, or
would have occurred absent a loan modification?
b. It is probable that the entity will not be able to cure the
default within the next 12 months?
[FASB ASC 470-10-45-1]
4. Are long term obligations that are or will be callable by the
creditor, either because the debtor’s violation of the debt
agreement at the balance-sheet date makes the obligation call-
able or because the violation, if not cured within a specified
grace period, will make the obligation callable, classified as
current unless either of the following conditions is met:
a. The creditor has waived or subsequently lost the right
to demand repayment for more than one year (or op-
erating cycle, if longer) from the balance-sheet date?
b. The obligation contains a grace period within which the
debtor may cure the violation, and it is probable that
the violation will be cured within that period, thus pre-
venting the violation from becoming callable?
[FASB ASC 470-10-45-11]
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Surplus Notes
5. Has the entity that issues surplus notes properly presented
the surplus notes as liabilities in the financial statements and
not as equity?
[FASB ASC 944-470-45-1]
Disclosure
Disclosure of Long-Term Obligations
6. Has the entity properly disclosed, for each of the five years
following the date of the latest balance sheet presented, the
combined aggregate amount of maturities and sinking fund
requirements for all long-term borrowings?
[FASB ASC 470-10-50-1]
7. Has the entity properly disclosed the circumstances related to
any callable debt, as defined in FASB ASC 470-10-45-11, that
is classified as a long-term liability (or, in the case of an un-
classified balance sheet, is included as a long-term liability in
the disclosure of debt maturities)?
[FASB ASC 470-10-50-2]
Subjective Acceleration Clauses
8. Has the entity properly disclosed any long term debt agree-
ments subject to a subjective acceleration clause unless the
likelihood of the acceleration of the due date is remote?
[FASB ASC 470-10-50-3]
Short-Term Obligations Expected to be Refinanced
9. Has the entity properly disclosed any short-term obligations
that are excluded from current liabilities and a general de-
scription of the financing agreement and the terms of any
new obligation incurred or expected to be incurred or equity
securities issued or expected to be issued as a result of a refi-
nancing?
[FASB ASC 470-10-50-4]
Summary Disclosure of Securities Outstanding
10. Are major categories of debt (notes payable to banks, mort-
gages payable, notes to related parties) identified on the bal-
ance sheet or in the notes to the financial statements?
[Common Practice]
11. Has the entity properly disclosed interest rates, maturities,
conversion features, and other significant terms (for example,
subordinated features) of long term debt, pursuant to FASB
ASC 505-10-50-3 (See question 3 in “Equity [FASB ASC 505-
10]”)?
[FASB ASC 470-10-50-5]
Surplus Notes
12. Has the state insurance commissioner’s role and ability to ap-
prove or disapprove any interest and principal payments
been appropriately disclosed?
[FASB ASC 944-470-50-1]
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J. Debt—Debt With Conversion and Other Options (FASB ASC 470-
20)11
Presentation
Income Statement Classification
1. Has the entity properly not presented any expense recog-
nized on the date of conversion of convertible debt related to
a beneficial conversion feature as extraordinary?
[FASB ASC 470-20-45-1]
2. Has the entity properly not presented any expense recognized
on the date of conversion of convertible debt related to an
inducement offer as extraordinary?
[FASB ASC 470-20-45-2]
Own-Share Lending Arrangements Issued in Contemplation of
Convertible Debt Issuance
3. (Accounting Standards Update [ASU] No. 2009-15) Has the
entity properly not presented loaned shares in the calculation
of basic and diluted EPS, unless default of the share-lending
arrangement occurs? (Note: If dividends on the loaned shares
are not reimbursed to the entity, any amounts, including con-
tractual [accumulated] dividends and participation rights in
undistributed earnings, attributable to the loaned shares
should be deducted in computing income available to com-
mon shareholders, in a manner consistent with the two-class
method in FASB ASC 260-10-45-60B.)
[“Pending Content” in FASB ASC 470-20-45-2A]
Disclosure
Own-Share Lending Arrangements Issued in Contemplation of
Convertible Debt Issuance
4. (ASU No. 2009-15) Has the entity properly disclosed the fol-
lowing when it has entered into a share-lending arrangement
on its own shares in contemplation of a convertible debt of-
fering or other financing:
a. A description of any outstanding share-lending ar-
rangements on the entity’s own stock?
11 In October 2010, FASB issued ASU No. 2009-15, Accounting for Own-Share Lending Arrangements in Contemplation of Convertible Debt
Issuance or Other Financing. This update is the result of the consensus of Emerging Issues Task Force Issue No. 09-1, “Accounting for Own-
Share Lending Arrangements in Contemplation of Convertible Debt Issuance,” which clarified how an entity should account for a share-
lending arrangement that is entered into in contemplation of a convertible debt offering and the effect the share-lending arrangement has
on the calculation of EPS. ASU No. 2009-15 is effective for financial statements issued for fiscal years beginning on or after December 15,
2009 (that is, January 1, 2010, for entities with calendar year-ends), and interim periods within those fiscal years for arrangements
outstanding as of the beginning of those fiscal years. Early adoption is not permitted.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2009-15.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 470-
20-65-3.
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b. All significant terms of the share-lending arrangement
including (i) the number of shares, (ii) the term, (iii) the
circumstances under which cash settlement would be
required, and (iv) any requirements for the counter-
party to provide collateral?
c. The entity’s reason for entering into the share-lending
arrangement?
d. The fair value of the outstanding loaned shares as of
the balance sheet date?
e. The treatment of the share-lending arrangement for the
purposes of calculating EPS?
f. The unamortized amount of the issuance costs associ-
ated with the share-lending arrangement at the balance
sheet date?
g. The classification of the issuance costs associated with
the share-lending arrangement at the balance sheet
date?
h. The amount of interest cost recognized relating to the
amortization of the issuance cost associated with the
share-lending arrangement for the reporting period?
i. Any amounts of dividends paid related to the loaned
shares that will not be reimbursed?
[“Pending Content” in FASB ASC 470-20-50-2A]
5. (ASU No. 2009-15) If the entity has entered into a share-lend-
ing arrangement on its own shares in contemplation of a con-
vertible debt offering or other financing has it properly dis-
closed the items required by FASB ASC 505, Equity?
[“Pending Content” in FASB ASC 470-20-50-2B]
6. (ASU No. 2009-15) Has the entity properly disclosed, in the
period in which it concludes that it is probable that the coun-
terparty to its share-lending arrangement will default, the
amount of expense reported in the statement of earnings re-
lated to the default? (Note: The entity should disclose, in any
subsequent period, any material changes in the amount of ex-
pense as a result of changes in the fair value of the entity’s
shares or the probable recoveries. Further, it default is prob-
able, but has not yet occurred, the entity should disclose the
number of shares related to the share-lending arrangement
that will be reflected in basic and diluted EPS when the coun-
terparty defaults.)
[“Pending Content” in FASB ASC 470-20-50-2C]
Cash Conversion Options12
7. Has the entity properly disclosed, as of each date for which a
statement of financial position is presented, the following:
12 Per FASB ASC 470-20-50-3, the entity should provide the incremental disclosures required by the guidance in FASB ASC 470-20 in
annual financial statements for convertible debt instruments that are within the scope of the cash conversions subsections of FASB ASC
470-20 that were outstanding during any of the periods presented.
81Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
a. The carrying amount of the equity component?
b. The principal amount, unamortized discount, and net
carrying amount for the liability component?
[FASB ASC 470-20-50-4]
8. Has the entity properly disclosed, as of the date of the most
recent statement of financial position that is presented, the
following:
a. The remaining period over which any discount on the
liability component with be amortized?
b. The conversion price and the number of shares on
which the aggregate consideration to be delivered upon
conversion is determined?
c. All of the following information about derivative trans-
actions entered into (in connection with the issuance of
instruments within the scope of the cash conversions
subsections of FASB ASC 470-20-50, regardless of
whether such derivative transactions are accounted for
as assets, liabilities, or equity instruments):
i. The terms of those derivative transactions?
ii. How those derivative transactions relate to the
instruments (within the scope of the cash conver-
sions subsections of FASB ASC 470-20-50)?
iii. The number of shares underlying the derivative
transactions?
iv. The reasons for entering into those derivative
transactions?
[FASB ASC 470-20-50-5]
9. Has the entity properly disclosed, as of each date for which a
statement of financial position is presented, the following:
a. The effective interest rate on the liability component for
the period?
b. The amount of interest cost recognized for the period
relating to both the contractual interest coupon and am-
ortization of the discount on the liability component?
[FASB ASC 470-20-50-6]
K. Participating Mortgage Loans (FASB ASC 470-30)
Presentation
1. Has the entity properly included the amortization of the debt
discount relating to the participation liability in interest ex-
pense?
[FASB ASC 470-30-45-1]
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2. Has the entity properly presented the debt extinguishment
gain or loss from the extinguishment of a participating mort-
gage loan as required by FASB ASC 470-50-40-2? (Note: This
subtopic does not preclude these gains or losses that meet the
criteria of FASB ASC 225, Income Statement, from being clas-
sified as extraordinary.)
[FASB ASC 470-30-45 par. 2–3]
Disclosure
3. If the entity has borrowed funds in the form of participating
mortgage loans, has it properly disclosed the following in the
financial statements:
a. The aggregate amount of participating mortgage obli-
gations at the balance-sheet date, with separate disclo-
sure of the aggregate participation liabilities and re-
lated debt discounts?
b. Terms of the participations by the lender in either the
appreciation in the market value of the mortgaged real
estate project or the results of operations of the mort-
gaged real estate project, or both?
[FASB ASC 470-30-50-1]
L. Debt Modifications and Extinguishments (FASB ASC 470-50)13, 14
Disclosure
1A. Has the entity properly disclosed if debt was considered to be
extinguished by in-substance defeasance under the provi-
sions of FASB Statement No. 76, Extinguishment of Debt, prior
to the effective date of FASB Statement No. 125, Accounting
for Transfers and Servicing of Financial Assets and Extinguish-
ments of Liabilities, a general description of the transaction and
the amount of debt that is considered extinguished at the end
of the period so long as that debt remains outstanding?
[FASB ASC 470-50-50-1]
1B. (ASU No. 2009-16, Transfers and Servicing (Topic 860): Ac-
counting for Transfers of Financial Assets (FASB Statement
No. 166, Accounting for Transfers of Financial Assets)) Has
the entity properly disclosed, if debt was considered to be ex-
tinguished by in-substance defeasance under the provisions
of FASB Statement No. 76 prior to the effective date of FASB
Statement No. 125, a general description of the transaction
and the amount of debt that is considered extinguished at the
end of each period that debt remains outstanding?
[“Pending Content” in FASB ASC 470-50-50-1]
13 Per FASB ASC 470-50-45 paragraphs 2–3, gains and losses from extinguishment of debt that meet the criteria in FASB ASC 225-20
are not precluded from being classified as extraordinary items. However, any charges to earnings resulting from application of FASB
ASC 470-50-40-21(c) should not be classified as extraordinary.
14 See footnote 4.
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M. Troubled Debt Restructuring by Debtors (FASB ASC 470-60)
Disclosure
1. Has the entity properly disclosed the following, related to a
troubled debt restructuring occurring during the current pe-
riod:
a. A description of the principal changes in terms, the ma-
jor features of settlement, or both? (Note: Separate res-
tructurings within a fiscal period for the same category
of payables may be grouped for disclosure purposes.)
b. Aggregate gain on restructuring of payables?
c. Aggregate net gain or loss on transfers of assets recog-
nized during the period?
d. Per-share amount of the aggregate gain on restructur-
ing of payables?
[FASB ASC 470-60-50-1]
2. Has the entity properly disclosed the following, related to
periods after a troubled debt restructuring:
a. The extent to which amounts contingently payable are
included in the carrying amount of restructured paya-
bles pursuant to the provisions of FASB ASC 470-60-35-
7?
b. If required by paragraphs 1–6 and 9–10 of FASB ASC
450-20-50, total amounts contingently payable on re-
structured payables and conditions under which those
amounts would become payable or forgiven?
[FASB ASC 470-60-50-2]
N. Distinguishing Liabilities From Equity (FASB ASC 480-10)15
Presentation
Additional Presentation Information
For those entities for which FASB Statement No. 150, Accounting for Certain Financial Instruments with Char-
acteristics of Both Liabilities and Equity, applies, please reference FASB ASC at www.fasb.org for the presen-
tation items relevant to your entity.
15 In November 2003, FASB issued FASB Staff Position (FSP) FAS 150-3, Effective Date, Disclosures, and Transition for Mandatorily
Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests under FASB State-
ment No. 150, to clarify and defer specific implementation of the provisions of FASB Statement No. 150, Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity.
FASB Statement No. 150 as issued is effective for mandatorily redeemable financial instruments of nonpublic entities for the first
fiscal period beginning after December 15, 2003. For mandatorily redeemable instruments of other entities, FASB Statement No. 150 as
issued is effective for financial instruments entered into or modified after May 31, 2003, and for all other instruments for interim periods
beginning after June 15, 2003.
FSP FAS 150-3 deferred the effective date for mandatorily redeemable financial instruments issued by nonpublic entities that are
not Securities and Exchange Commission (SEC) registrants, as follows:
a. For instruments that are mandatorily redeemable on fixed dates for amounts that either are fixed or are determined by reference
to an interest rate index, currency index, or another external index, the classification, measurement, and the disclosure provi-
sions of FASB ASC 480-10-50 and the presentation provisions of FASB ASC 480-10-45 were effective for fiscal periods beginning
after December 15, 2004.
(continued)
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Disclosure
Additional Disclosure Information
For those entities for which FASB Statement No. 150 applies, please reference FASB ASC at www.fasb.org
for the disclosure items relevant to your entity.
1. Has the entity properly disclosed the following (if it issues
financial instruments within the scope of FASB ASC 480-10-
25):
a. The nature and terms of the financial instruments?
b. The rights and obligations embodied in those instru-
ments, including both:
i. settlement alternatives, if any, in the contract,
and
ii. the entity that controls the settlement alterna-
tives?
[FASB ASC 480-10-50-1]
2. Has the entity properly disclosed the following for all out-
standing financial instruments (within the scope of FASB
ASC 480-10) and for each settlement alternative:
a. The amount that would be paid, or the number of
shares that would be issued and their fair value, deter-
mined under the conditions specified in the contract if
the settlement were to occur at the reporting date?
b. How changes in the fair value of the issuer’s equity
shares would affect those settlement amounts (for ex-
ample, “the issuer is obligated to issue an additional x
shares or pay an additional y dollars in cash for each
$1 decrease in the fair value of one share”)?
c. The maximum amount that the issuer could be re-
quired to pay to redeem the instrument by physical set-
tlement, if applicable?
d. The maximum number of shares that could be required
to be issued, if applicable?
e. That a contract does not limit the amount that the is-
suer could be required to pay or the number of shares
that the issuer could be required to issue, if applicable?
b. For all other financial instruments that are mandatorily redeemable, the classification, measurement, and disclosure provisions
of FASB ASC 480-10-50 and the presentation provisions of FASB ASC 480-10-45 are deferred indefinitely pending further FASB
action.
Readers should review this FSP or the relevant transition guidance to understand the various effective dates of FASB Statement No. 150,
as discussed in FASB ASC 480-10-65-1.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 150-3.
Readers can refer to the full text of the statement on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 480-
10-65-1.
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f. For a forward contract or an option indexed to the is-
suer’s equity shares, the forward price or option strike
price, the number of issuer’s shares to which the con-
tract is indexed, and the settlement date or dates of the
contract, as applicable?
[FASB ASC 480-10-50-2]
IV. Equity
A. Equity (FASB ASC 505-10)
The following table summarizes the titles used to describe the equity section in the financial statements
of a sample of public entities surveyed by the AICPA. Reprinted from the AICPA’s Accounting Trends
& Techniques, 2010, 64th edition (product no. 0099010 [paperback] or WAT-XX [online]).
TITLE OF STOCKHOLDERS’ EQUITY SECTION
2009 2008 2007 2006
Stockholders’ equity 256 258 307 299
Shareholders’ equity 179 181 225 233
Shareowners’ equity 16 17 17 16
Common stockholders’ equity 5 5 6 6
Common shareholders’ equity 5 1 4 4
Term deficit or deficiency in title 1 18 24 27
Other or no title 22 13 10 7
Total entities 16 500 600 600
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
General
Disclosure
1. Is the following information relating to stockholders’ equity,
statutory capital, and surplus, and the effects of statutory ac-
counting practices on the ability to pay dividends to stock-
holders, disclosed:
a. The amount of statutory capital and surplus?
b. The amount of statutory capital surplus necessary to
satisfy regulatory requirements (based on the entity’s
current operations) if significant in relation to the en-
tity’s statutory capital and surplus?
c. The nature of statutory restrictions on the payment of
dividends and the amount of retained earnings that is
not available for the payment of dividends to stock-
holders?
[FASB ASC 944-505-50-1]
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2. If either the state-prescribed statutory accounting practices
differ from National Association of Insurance Commis-
sioner’s (NAIC) statutory accounting practices or permitted
state statutory accounting practices differ from either state-
prescribed statutory accounting practices or NAIC’s statutory
accounting practices, the use of prescribed or permitted stat-
utory accounting practices (individually or in the aggregate)
results in reported statutory surplus or risk-based capital that
is significantly different from the statutory surplus or risk-
based capital that would have been reported had NAIC’s
statutory accounting practices been followed, has the entity
disclosed the items in the following paragraph?
[FASB ASC 944-505-50-2]
3. If the entity is a U.S. insurance entity or a U.S. or foreign en-
tity with a U.S insurance subsidiary and prepares U.S. GAAP
financial statements and the criteria in the preceding question
has been met, have both of the following been disclosed:
a. A description of the prescribed or permitted statutory
accounting practice?
b. The related monetary effect on statutory surplus of us-
ing an accounting practice that differs from either state-
prescribed statutory accounting practices or NAIC’s
statutory accounting practices?
[FASB ASC 944-505-50 par. 3–4]
4. If the entity is a foreign insurance entity that does not have a
U.S. insurance subsidiary and prepares U.S. GAAP financial
statements or is included in a parent’s consolidated U.S.
GAAP financial statements, have the notes to financial state-
ments disclosed permitted regulatory accounting practices
that significantly differ from the prescribed regulatory ac-
counting practices of its respective regulatory authority and
their monetary effects?
[FASB ASC 944-505-50-5]
5. Has disclosure of the fact that an entity’s risk-based capital
would have triggered a regulatory event if it had not used a
permitted practice been made?
[FASB ASC 944-505-50-6]
Presentation
Receivables for Issuance of Equity
6. Has the entity properly presented a note received as a contri-
bution to equity as an offset against stock in the equity sec-
tion? (Note: Such notes may be recorded as an asset if col-
lected in cash before the financial statements are issued or are
available to be issued.)
[FASB ASC 505-10-45-2]
Appropriations of Retained Earnings
7. Are appropriations of retained earnings for loss contingencies
clearly identified and included in shareholders’ equity?
[FASB ASC 505-10-45-3]
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Disclosure
8. Has the entity properly disclosed changes in the separate ac-
count comprising shareholders’ equity (in addition to re-
tained earnings) and changes in the number of shares of eq-
uity securities during at least the most recent annual fiscal
period and any subsequent interim period presented? (Note:
This disclosure may take the form of separate statements or
may be made in the basic financial statements or in the notes.)
[FASB ASC 505-10-50-2]
9. Has the entity properly disclosed information about the per-
tinent rights and privileges of the various securities outstand-
ing, including mandatory redemption requirements, in sum-
mary form? (Note: Examples of information to be included
are dividend and liquidation preferences, participation rights,
call prices and dates, and conversion or exercise prices or
rates and pertinent date. See FASB ASC 505-10-50-3 for more
examples of disclosures.)
[FASB ASC 505-10-50-3]
Securities With Preferences
10. Has the entity properly disclosed, for preferred stock that has
a preference in involuntary liquidation considerably in excess
of par or stated value of the shares, the liquidation preference
in the equity section of the balance sheet in the aggregate,
either parenthetically or “in short,” rather than on a per share
basis or in the notes to the financial statements?
[FASB ASC 505-10-50-4]
11. Has the entity properly disclosed the following on the face of
the balance sheet or in the notes to the financial statements:
a. The aggregate or per-share amounts at which preferred
stock may be called or are subject to redemption
through sinking-fund operations or otherwise?
b. The aggregate and per-share amounts of arrearages in
cumulative preferred dividends?
[FASB ASC 505-10-50-5]
Convertible Securities
12. Has the entity properly disclosed, for contingently converti-
ble securities that disclose the significant quantitative and
qualitative terms of the conversion features to enable users of
the financial statements to understand the circumstances of
the contingency and the potential impact of conversion, in-
cluding:
a. events or changes in circumstances that would cause
the contingency to be met and any significant features
necessary to understand the conversion rights and the
timing of those rights (for example, the periods in
which [i] the contingency might be met and [ii] the se-
curities may be converted if the contingency is met)?
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b. the conversion price and the number of shares into
which the security is potentially convertible?
c. events or changes in circumstances, if any, that could
adjust or change the contingency, conversion price, or
number of shares, including significant terms of those
changes?
d. the manner of settlement upon conversion and any al-
ternative settlement methods (for example, cash,
shares, or a combination)?
[FASB ASC 505-10-50-6]
13. Has the entity properly disclosed, in order to meet the re-
quirements of FASB ASC 505-10-50-6, the possible conversion
prices and dates as well as other significant terms for each
convertible instrument?
[FASB ASC 505-10-50-7]
14. Has the entity properly disclosed, in the footnotes to the fi-
nancial statements, the terms of the transaction (as referred to
in FASB ASC 505-10-50-6), including the excess of the aggre-
gate fair value of the instruments that the holder would re-
ceive at conversion over the proceeds received and the period
over which the discount is amortized?
[FASB ASC 505-10-50-8]
15. Has the entity properly disclosed whether the shares that
would be issued if the contingently convertible securities
were converted are included in the calculation of diluted EPS,
and the reasons why or why not?
[FASB ASC 505-10-50-9]
16. Although not required, has the entity disclosed information
about derivative instruments entered into in connection with
the issuance of the contingently convertible securities that
may be useful in terms of fully explaining the potential im-
pact of the contingently convertible securities? (Note: Infor-
mation might include the terms of those derivative instru-
ments, including the terms of settlement, how those
instruments relate to the contingently convertible securities,
and the number of shares underlying the derivative instru-
ments.)
[FASB ASC 505-10-50-10]
17. For debt with conversion and other options, has the entity
considered incremental disclosures in accordance with FASB
ASC 470-20-10-2 and paragraphs 2–6 of FASB ASC 470-20-50?
[FASB ASC 505-10-50-10A]
18. Has the entity properly disclosed, for redeemable stock, the
amount of redemption requirements, separately by issue or
combined, for all issues of capital stock that are redeemable
at fixed or determinable prices on fixed or redeemable dates
in each of the five years following the date of the latest bal-
ance sheet?
[FASB ASC 505-10-50-11]
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B. Treasury Stock (FASB ASC 505-30)
The following table summarizes the presentations of treasury stock in the balance sheets of a sample
of public entities surveyed by the AICPA. Reprinted from the AICPA’s Accounting Trends & Techniques,
2010, 64th edition (product no. 0099010 [paperback] or WAT-XX [online]).
TREASURY STOCK—BALANCE SHEET PRESENTATION
2009 2008 2007 2006
Common Stock
Cost of treasury stock shown as stockholders’
equity deduction 316 318 371 381
Cost of treasury stock deducted from stock of
the same class 5 10 6 8
Par or stated value of treasury stock deducted
from issued stock of the same class 19 20 20 14
Other — 2 1 2
Total presentations 340 350 398 405
Preferred Stock
Cost of treasury stock shown as stockholders’
equity deduction — — — 3
Other — — 1 2
Total presentations — — 1 5
Number of Entities
Disclosing treasury stock 340 350 398 408
Not disclosing treasury stock 160 150 202 192
Total entities 500 500 600 600
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
Presentation
1. Has the entity properly presented, if the entity purchased
stock for purposes other than retirement or if ultimate dispo-
sition has not yet been decided, the cost separately as a de-
duction from the total of capital stock, additional paid-in cap-
ital, and retained earnings, or has it been presented in
accordance with paragraphs 7–10 of FASB ASC 505-30-30?
[FASB ASC 505-30-45-1]
Disclosure
Disclosures Relating to State Laws
2. Has the entity made appropriate disclosures regarding state
laws that may affect or restrict the entity’s ability to repur-
chase its own outstanding common stock?
[FASB ASC 505-30-50-2]
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Disclosures Relating to Allocation of Repurchase Price
3. Has the entity made proper disclosures if treasury shares are
purchased at a stated price significantly in excess of the cur-
rent market price of the shares, including the allocation of the
amounts paid and the accounting treatment for such
amounts?
[FASB ASC 505-30-50 par. 3–4]
C. Equity-Based Payments to Nonemployees (FASB ASC 505-50)
Presentation
1. Has the entity properly not presented an asset, other than a
note or receivable, received in return for fully vested, nonfor-
feitable equity instruments, that are issued at the date of an
agreement for goods or services, as a contra-equity of the eq-
uity instrument?
[FASB ASC 505-50-45-1]
Disclosure
Grantor Disclosures
2. Has the entity properly disclosed, to the extent that the dis-
closures are important to an understanding of the effects of
the transactions on the financial statements, information
about goods or services, other than employee services, ac-
quired in a share-based payment transaction?
[FASB ASC 505-50-50-1]
Grantee Disclosures
3. Has the entity properly disclosed, in accordance with para-
graphs 1–2 of FASB ASC 845-10-50, in each period’s financial
statements, the amount of gross operating revenue recog-
nized as a result of nonmonetary transactions addressed by
the guidance of FASB ASC 505-50?
[FASB ASC 505-50-50-2]
V. Revenue
The following table summarizes the titles used to describe the income statement in the financial
statements of a sample of public entities surveyed by the AICPA. Reprinted from the AICPA’s
Accounting Trends & Techniques, 2010, 64th edition (product no. 0099010 [paperback] or WAT-XX
[online]).
INCOME STATEMENT TITLE
2009 2008 2007 2006
Income 242 227 264 252
Operations 181 195 244 260
Earnings 70 74 89 87
Other 7 4 3 1
Total entities 500 500 600 600
2008–2009 based on 500 entities surveyed; 2006–2007 based on 600 entities surveyed.
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A. Revenue Recognition—Products (FASB ASC 605-15)
Presentation
General
1. Has the entity properly presented revenue and cost of sales,
reduced for any estimated returns, for sales made with a right
of return which meet the criteria in FASB ASC 605-15-25-1?
[FASB ASC 605-15-45-1]
2. Are the important components of income, such as sales or
other sources of revenue, cost of sales, selling and administra-
tive expenses, interest expense, and income taxes, separately
disclosed on the face of the income statement?
[Common Practice]
Disclosure
3. To meet the disclosure objective in FASB ASC 944-20-50-7,
has the entity disclosed all of the following:
a. The amount and reasons for acceleration for premium
revenue recognition that has been accelerated?
b. A schedule of the future expected premium revenue as
of the latest date of the statement of financial position
which details both (i) the four quarters of the subse-
quent annual period and each of the next four annual
periods, and (ii) the remaining periods aggregated in
five year increments?
[FASB ASC 944-605-50-4]
Reinsurance Contracts
Presentation
4. Are the amounts of earned premiums ceded and recoveries
recognized under reinsurance contracts reported in the state-
ment of earnings as separate line items or disclosed in the
notes?
[FASB ASC 944-605-45-1]
Disclosure
5. Are the following disclosed for short-duration reinsurance
contracts on both a written and an earned basis:
a. Premiums from direct business?
b. Reinsurance assumed?
c. Reinsurance ceded?
[FASB ASC 944-605-50-1(b)]
6. Are the following disclosed for long-duration reinsurance
contracts:
a. Premiums and amounts assessed against policyholders
from direct business?
b. Reinsurance assumed?
c. Reinsurance ceded?
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d. Premiums and amounts earned?
[FASB ASC 944-605-50-1(c)]
7. Are the methods used for income recognition on reinsurance
contracts disclosed?
[FASB ASC 944-605-50-1(a)]
8. For foreign reinsurance accounted for by the open year
method, are the following disclosures made for each period
for which an income statement is presented:
a. The amounts of premiums, claims, and expenses rec-
ognized as income on closing underwriting balances?
b. The additions to underwriting balances for the year for
reported premiums, claims, and expenses?
[FASB ASC 944-605-50-1(d)]
9. Are the amounts of premiums, claims, and expenses in the
underwriting account disclosed for every balance sheet pre-
sented?
[FASB ASC 944-605-50-1(e)]
10. Has the entity identified both (a) the extent to which reinsur-
ance contracts indemnify the ceding entity against loss or li-
ability relating to insurance risk and (b) the indemnification
policies as part of the required disclosures about the nature
and effect of reinsurance transactions? (Encouraged, but not re-
quired.)
[FASB ASC 944-605-50-2]
11. Has the entity included a description of the methods used to
account for foreign reinsurance in its accounting policies dis-
closure?
[FASB ASC 944-605-50-3]
B. Revenue Recognition—Services (FASB ASC 605-20)
Disclosure
Receivables for Issuance of Equity
1. Has the entity properly disclosed the amount of revenue and
expense recognized from advertising barter transactions for
each income statement period presented?
[FASB ASC 605-20-50-1]
C. Multiple Element Arrangements (FASB ASC 605-25)
Disclosure16
1. Has the entity properly disclosed the following in regard to
revenue arrangements with multiple deliverables:
16 In October 2009, FASB issued ASU No. 2009-13, Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements. This
update amends FASB ASC 605-25 to separate consideration in multiple-deliverable arrangements; establish a selling-price hierarchy for
determining the selling price of a deliverable; replace the term fair value in the revenue allocation guidance with selling price; eliminate
the residual method of allocation, and require that a vendor determine its best estimate of selling price in a manner that is consistent with
that used to determine the price to sell the deliverable on a standalone basis. This ASU should be applied on a prospective basis for
(continued)
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a. Its accounting policy for recognition of revenue from
multiple-deliverable arrangements (for example,
whether deliverables are separable into units of ac-
counting)?
b. The description and nature of such arrangements, in-
cluding performance, cancellation, termination, or re-
fund-type provisions?
[FASB ASC 605-25-50-1]
D. Milestone Method Revenue Recognition (FASB ASC 605-28)
Disclosure17
Additional Disclosure Information
If the entity has elected to early adopt ASU No. 2010-17, Revenue Recognition (Topic 605): Milestone Method of
Revenue Recognition— a consensus of the FASB Emerging Issues Task Force, see FASB ASC 605-28-50 for required
disclosures.
E. Gains and Losses—Revenue Recognition (FASB ASC 605-40)
Presentation
1. Has the entity properly presented any gain or loss resulting
from an involuntary conversion of a nonmonetary asset in ac-
cordance with the provisions of FASB ASC 225-20?
[FASB ASC 605-40-45-1]
revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (that is, January 1, 2011, for
entities with calendar year-ends), unless the entity elects to adopt this ASU on a retroactive basis in accordance with FASB ASC 605-25-
65-1(e). Early application is permitted.
This checklist has not been updated to include the presentation and disclosure requirements of ASU No. 2009-13.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 605-
25-65-1.
17 In April 2010, FASB issued ASU No. 2010-17, Revenue Recognition (Topic 605): Milestone Method of Revenue Recognition—a consensus of
the FASB Emerging Issues Task Force. ASU No. 2010-17 provides guidance on applying the milestone method to milestone payments for
achieving specified performance measures when those payments are related to uncertain future events. The scope of this ASU is limited
to transactions involving research or development if the milestone payment is to be recognized in its entirety in the period the milestone
is achieved. Entities can make an accounting policy election to recognize arrangement consideration received for achieving specified
performance measures during the period in which the milestones are achieved, provided certain criteria are met. Although the milestone
method is an accounting policy election, other methods that would result in recognizing a milestone in its entirety during the period in
was achieved would not be acceptable for milestones if the criteria are not met. This ASU should be applied on a prospective basis for
milestones achieved fiscal years beginning on or after June 15, 2010 (that is, January 1, 2011, for entities with calendar year-ends), unless
the entity elects to adopt this ASU on a retroactive basis in accordance with FASB ASC 250, Accounting Changes and Error Corrections.
Early application is permitted.
This checklist has not been updated to include the presentation and disclosure requirements of ASU No. 2010-17.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 605-
28-65-1.
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F. Principal Agent Considerations—Revenue Recognition (FASB
ASC 605-45)
Presentation
Overall Considerations of Reporting Revenue Gross as a Principal
Versus Net as an Agent
1. Has the entity used sound judgment in determining whether
to report revenue on either (a) the gross amount billed to a
customer because it has earned revenue (as a principal) from
the dale of the goods or services, or (b) the net amount re-
tained because it has earned a commission or fee as an agent?
(See FASB ASC 605-45-45 paragraphs 3 and 15 for indicators
of gross and net reporting, respectively.)
[FASB ASC 605-45-45-1]
Shipping and Handling Fees and Costs
2. Has the entity properly not presented shipping and handling
costs as a deduction from revenues?
[FASB ASC 605-45-45-21]
Reimbursements Received for Out-of-Pocket Expenses Incurred
3. Has the entity properly presented reimbursements received
for out-of-pocket expenses incurred as revenue in the income
statement?
[FASB ASC 605-45-45-23]
Disclosure
Gross Transaction Volumes
4. Although not required, has the entity properly disclosed
gross transaction volume for those revenues reported as net?
(Note: Such disclosure can be made parenthetically in the in-
come statement or in the notes to the financial statements, but
they should not be characterized as revenues, nor should they
be reported in a column that sums to net income or loss.)
[FASB ASC 605-45-50-1]
Shipping and Handling Fees and Costs
5. In addition to disclosing the accounting policy decision re-
garding the classification of shipping and handling costs, has
the entity properly disclosed both the amounts if significant
and if not included in the cost of sales, and the line item(s) on
the income statement where included?
[FASB ASC 605-45-50-2]
Taxes Collected From Customers and Remitted to Governmental
Authorities
6. Has the entity properly disclosed the accounting policy deci-
sion regarding the presentation of taxes within the scope of
FASB ASC 605-45-15-2(e), either on a gross basis (included in
revenues and costs) or a net basis (excluded from revenues),
disclosed pursuant to FASB ASC 235-10?
[FASB ASC 605-45-50-3]
95Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
7. Has the entity properly disclosed the amount of taxes that are
reported on a gross basis in interim and annual financial
statements for each period for which an income statement is
presented, if significant? (Note: The disclosure of these taxes
may be done on an aggregate basis.)
[FASB ASC 605-45-50-4]
G. Customer Payments and Incentives (FASB ASC 605-50)
Presentation
Additional Presentation Information
For entities involved in providing customers sales incentives or other consideration, see FASB ASC 605-50-
45 for further presentation information, including circumstances under which that consideration is either
● an adjustment of the selling prices of the vendor’s product or services and therefore characterized
as a reduction of revenue when recognized in the vendor’s income statement, or
● a cost incurred by the vendor for assets or services received from the customer and therefore char-
acterized as a cost or expense when recognized in the vendor’s income statement.
Disclosure
Service Provider’s Accounting for Consideration Given to a Manu-
facturer or Reseller of Equipment
1. Has the entity properly disclosed, if the entity is a service
provider and provides incentives to a third-party manufac-
turer or reseller that ultimately benefits the service provider’s
customer, this fact?
[FASB ASC 605-50-50-1]
VI. Expenses
A. Compensation (FASB ASC 710-10)
Presentation
Additional Presentation Information
For entities with rabbi trusts, as discussed in FASB ASC 710-10-25-15, see FASB ASC 710-10-45 for informa-
tion on proper presentation.
Disclosure
Compensated Absences
1. Has the entity properly disclosed, if the entity meets the con-
ditions for recognizing a liability for compensated absences
in subparagraphs 1(a)–1(c) of FASB ASC 710-10-2518 and does
not accrue a liability because the amount cannot be reasona-
bly estimated, that fact?
[FASB ASC 710-10-50-1]
18 FASB ASC 710-10-25 paragraph 1(a)–1(c) reads:
An employer shall accrue a liability for employees’ compensation for future absences if all of the following conditions are met:
(continued)
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B. Nonretirement Postemployment Benefits (FASB ASC 712-10)
Disclosure
Other Postemployment Benefits
1. If the entity does not accrue an obligation for other postem-
ployment benefits in accordance with FASB ASC 450-20-25-2
or FASB ASC 710-10-25-1 because the amount cannot be rea-
sonably estimated, has the entity properly disclosed that fact?
[FASB ASC 712-10-50-2]
C. Defined Benefit Plans—Compensation (FASB ASC 715-20)19, 20
Presentation
1. If the entity sponsors one or more defined benefit pension
plans or one or more defined benefit other postretirement
plans, has the entity separately presented, for pension plans
and other postretirement benefit plans, the funded status of
the plans and the amounts recognized in the statement of fi-
nancial position, showing separately the assets and current
and noncurrent liabilities recognized?
[FASB ASC 715-20-45-2]
2. If the entity presents a classified statement of financial posi-
tion, has the entity properly presented the liability for an un-
derfunded plan as a current liability, a noncurrent liability, or
a combination of both? (Note: The current portion is the
amount by which the actuarial present value of benefits in-
cluded in the benefit obligation payable in the next 12
months, or operating cycle, if longer, exceeds the fair value of
plan assets and that the amount classified as a current liabil-
ity is limited to the amount of the plan’s unfunded status rec-
ognized in the employer’s statement of financial position.)
[FASB ASC 715-20-45-3]
a. The employer’s obligation relating to employees’ rights to receive compensation for future absences is attributable to
employees’ services already rendered.
b. The obligation relates to rights that vest or accumulate. Vested rights are those for which the employer has an obligation
to make payment even if an employee terminates; thus, they are not contingent on an employee’s future service. Accu-
mulate means that earned but unused rights to compensated absences may be carried forward to one or more periods
subsequent to that in which they are earned, even though there may be a limit to the amount that can be carried forward.
c. Payment of the compensation is probable.
19 Paragraphs 1–2 of FASB ASC 715-30-50, regarding defined benefit plans, refer to FASB ASC 715-20-50 for the disclosure requirements
applicable to FASB ASC 715-30-50.
20 In January 2010, FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair
Value Measurements. This ASU establishes new disclosure requirements regarding transfers in and out of levels 1 and 2 of the fair value
hierarchy and activity in level 3 fair value measurements. It also clarifies certain existing disclosures within FASB ASC 820-10-50
regarding level of disaggregation and inputs and valuation techniques. The amendments in this ASU will be effective for interim and
annual reporting periods beginning after December 15, 2009 (that is, January 1, 2010, for entities with calendar year-ends), except for the
disclosures in the level 3 fair value measurement roll forward. Those disclosures are effective for fiscal years beginning after December
15, 2010 (that is, January 1, 2011, for entities with calendar year-ends), and for interim periods within those fiscal years.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2010-06.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 605-
28-65-1.
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3. If the entity presents a classified statement of financial posi-
tion, has the entity properly presented the asset for an over-
funded plan as a noncurrent asset?
[FASB ASC 715-20-45-3]
Disclosure
Additional Disclosure Information
FASB ASC 715-20-50 contains disclosures for both nonpublic and public companies. See the following “Pub-
lic Entity Disclosures” section for required disclosures specific to public entities.
Disclosures by Nonpublic Entities
4A. Has the entity properly disclosed separately for pension
plans and other postretirement benefit plans, if the entity
sponsors one or more defined benefit pension plans or one or
more other defined benefit postretirement plans:
a. The benefit obligation, fair value of plan assets, and
funded status of the plan?
b. Employer contributions, participant contributions, and
benefits paid?
Additional Disclosure Information
The objectives of the disclosures about postretirement benefit plan assets are to provide users of financial
statements with an understanding of the following:
● How investment allocation decisions are made, including the factors that are pertinent to an under-
standing of investment policies and strategies
● The major category of plan assets
● The inputs and valuation techniques used to measure the fair value of plan assets
● The effect of fair value measurements using significant unobservable inputs (level 3) on changes in
the plan assets for the period
● Significant concentrations of risk within plan assets
c. Considering the items in the preceding “Additional
Disclosure Information,” has the entity provided:
i. A narrative description of investment policies
and strategies, including target allocation per-
centages or range of percentages considering the
major categories of plan assets disclosed pursu-
ant to item (ii), as of the latest statement of finan-
cial position presented (on a weighted-average
basis for employers with more than one plan),
and other factors that are pertinent to an under-
standing of those policies and strategies such as
investment goals, risk management practices,
permitted and prohibited investments including
the use of derivatives, diversification, and the re-
lationship between plan assets and benefit obli-
gations?
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ii. The fair value of each major category of plan as-
sets as of each date for which a statement of fi-
nancial position is presented? (Note: Asset cate-
gories are based on the nature and risks of assets
in the entity’s plan[s].)
iii. A narrative description of the basis used to deter-
mine the overall expected long-term rate-of-re-
turn-on-assets assumption, such as the general
approach used, the extent to which the overall
rate-of-return-on-assets assumption was based
on historical returns, the extent to which adjust-
ments were made to those historical returns in
order to reflect expectations of future returns,
and how those adjustments were determined?
iv. Information that enables users of financial state-
ments to assess the inputs and valuation tech-
niques used to develop fair value measurements
of plan assets at the reporting date? To meet this
objective, has the entity properly disclosed the
following:
(1) The level within the fair value hierarchy in
which the fair value measurements in their
entirety fall, segregating fair value meas-
urements using quoted prices in active
markets for identical assets or liabilities
(level 1), significant other observable in-
puts (level 2), and significant unobservable
inputs (level 3)?
(2) For fair value measurements of plan assets
using significant unobservable inputs
(level 3), a reconciliation of the beginning
and ending balances, separately presenting
changes during the period attributable to
the following:
(a) Actual return on plan assets?
(b) Purchases, sales, and settlements,
net?
(c) Transfers in or out, or both, of level
3?
(3) Information about the valuation tech-
nique(s) and inputs used to measure fair
value and a discussion of changes in valu-
ation techniques and inputs, if any, during
the period?
d. For defined benefit pension plans, the accumulated
benefit obligation?
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e. The benefits (as of the date of the latest statement of
financial position presented) expected to be paid in
each of the next five fiscal years, and in the aggregate
for the five fiscal years thereafter? The expected bene-
fits should be estimated based on the same assump-
tions used to measure the entities benefit obligation at
the end of the year and should include benefits attrib-
utable to estimated future employee service.
f. The employer’s best estimate, as soon as it can reason-
ably be determined, of contributions expected to be
paid to the plan during the next fiscal year beginning
after the date of the latest statement of financial posi-
tion presented? Estimated contributions may be pre-
sented in the aggregate combining any of the following:
(i) contributions required by funding regulations or
laws, (ii) discretionary contributions, and (iii) noncash
contributions.
g. The amounts recognized in the statements of financial
position, showing separately the postretirement benefit
assets and current and noncurrent postretirement ben-
efit liabilities?
h. Separately, the net gain or loss and net prior service
cost or credit recognized in OCI for the period pursuant
to FASB ASC 715-30-35 paragraphs 11 and 21 and
FASB ASC 715-60-35 paragraphs 16 and 25 and reclas-
sification adjustments of OCI for the period, as those
amounts, including amortization of the net transition
asset or obligation, are recognized as components of net
periodic benefit cost?
i. The amounts in accumulated OCI that have not yet
been recognized as components of net periodic benefit
cost, showing separately the net gain or loss, net prior
service cost or credit, and net transition asset or obli-
gation?
j. On a weighted-average basis, all of the following as-
sumptions used in the accounting for the plans, speci-
fying in a tabular format, the assumptions used to de-
termine the benefit obligation and the assumptions
used to determine net benefit cost:
i. Assumed discount rates (refer to FASB ASC 715-
30-35-45 for a discussion of representationally
faithful disclosure)?
ii. Rates of compensation increase (for pay-related
plans)?
iii. Expected long term rates of return on plan as-
sets?
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k. The assumed health care cost trend rate(s) for the next
year used to measure the expected cost of benefits cov-
ered by the plan (gross eligible charges), and a general
description of the direction and pattern of change in the
assumed trend rates thereafter, together with the ulti-
mate trend rate(s) and when that rate is expected to be
achieved?
l. If applicable, the amounts and types of securities of the
employer and related parties included in plan assets,
the approximate amount of future annual benefits of
plan participants covered by insurance contracts, in-
cluding annuity contracts, issued by the employer or
related parties, and any significant transactions be-
tween the employer or related parties and the plan dur-
ing the period?
m. The nature and effect of significant nonroutine events,
such as amendments, combinations, divestitures, cur-
tailments, and settlements?
n. The amounts in accumulated OCI expected to be rec-
ognized as components of net periodic benefit cost over
the fiscal year that follows the most recent annual state-
ment of financial position presented, showing sepa-
rately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?
o. The amount and timing of any plan assets expected to
be returned to the employer during the 12 month pe-
riod, or operating cycle if longer, that follows the most
recent annual statement of financial position pre-
sented?
p. The amount of net periodic benefit cost recognized?
[FASB ASC 715-20-50-5]
Note (ASU No. 2010-06): ASU No. 2010-06 affects FASB ASC
715-20-50-5, question 4A, preceding, in the following manner:
Throughout the paragraph, the term major category was re-
placed with the term class. As such, entities that have adopted
the provisions of ASU No. 2010-06 should consider the disclo-
sure requirements contained in question 4A with this change
in mind.
[“Pending Content” in FASB ASC 715-20-50-5]
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Interim Disclosure Requirements for Nonpublic Entities
5. Has the entity properly disclosed, in interim periods for
which a complete set of financial statement is presented, the
total amount of the employer’s contributions paid, and ex-
pected to be paid, during the current fiscal year, if signifi-
cantly different than amounts previously disclosed pursuant
to FASB ASC 715-20-50-5(f)?21 (Note: Estimated contributions
may be presented in the aggregate by combining [a] contri-
butions required by regulations or laws, [b] discretionary con-
tributions, and [c] noncash contributions.)
[FASB ASC 715-20-50-7]
Disclosures Related to Expected Rate of Return on Plan Assets
6. If the entity has changed the previously disclosed weighted-
average expected long-term rate of return for plan assets,
based on a subsequent interim measurement of both pension
or other postretirement plan assets and obligations, has the
entity disclosed the beginning and more recently assumed
rate, or a properly weighted combination of the two?
[FASB ASC 715-20-50-8]
Disclosures Related to Japanese Governmental Settlement Transac-
tions
Additional Disclosure Information
For entities with activities regarding accounting for Japanese governmental settlement transactions, see par-
agraphs 9–10 of FASB ASC 715-20-50 for disclosure requirements.
Public Entity Disclosure
Disclosures by Public Entities
7A. Has the public entity properly disclosed the following items,
separately for pension plans and other postretirement bene-
fits, if the entity is a sponsor of one or more defined benefit
pension plans or one or more defined benefit other postreti-
rement plans: (Note: Amounts related to the entity’s results
of operations should be disclosed for each period for which a
statement of income is presented and amounts related to the
entity’s statement of financial position for each statement of
financial position presented.)
a. A reconciliation of beginning and ending balances of
the benefit obligation, showing separately, if applica-
ble, the effects during the period attributable to each of
the following: (Note: For defined benefit pension plans,
the benefit obligation is the projected benefit obligation
and for defined other postretirement plans, the benefit
obligation is the accumulated postretirement benefit
obligation.)
i. Service cost?
ii. Interest cost?
21 See question 4A(f) in the “VI.C. Defined Benefit Plans—Compensation (FASB ASC 715-20)” section.
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iii. Contribution by plan participants?
iv. Actuarial gains and losses?
v. Foreign currency exchange rates? (Note: The ef-
fects of foreign currency exchange rate changes
that are to be disclosed are those applicable to
plans of a foreign operation whose functional
currency is not the reporting currency pursuant
to FASB ASC 830-10-45.)
vi. Benefits paid?
vii. Plan amendments?
viii. Business combinations?
ix. Divestitures?
x. Curtailments, settlements, and special and con-
tractual termination benefits?
b. A reconciliation of the beginning and ending balances
of the fair value of plan assets showing separately, if
applicable, the effects during the period attributable to
each of the following:
i. Actual return on plan assets?
ii. Foreign currency exchange rates?
iii. Contribution by the employer?
iv. Contributions by plan participants?
v. Benefits paid?
vi. Business combinations?
vii. Divestitures?
viii. Settlements?
c. The funded status of the plans and the amounts recog-
nized in the statement of financial position, showing
separately the assets and current and noncurrent liabil-
ities?
Additional Disclosure Information
The objectives of the disclosures about postretirement benefit plan assets are to provide users of financial
statements with an understanding of the following:
● How investment allocation decisions are made, including the factors that are pertinent to an under-
standing of investment policies and strategies
● The major category of plan assets
● The inputs and valuation techniques used to measure the fair value of plan assets
● The effect of fair value measurements using significant unobservable inputs (level 3) on changes in
the plan assets for the period
● Significant concentrations of risk within plan assets
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d. Considering the items in the preceding “Additional
Disclosure Information,” has the entity provided the
following:
i. A narrative description of investment policies
and strategies, including target allocation per-
centages or range of percentages considering the
major categories of plan assets disclosed pursu-
ant to item (ii), as of the latest statement of finan-
cial position presented (on a weighted-average
basis for employers with more than one plan),
and other factors that are pertinent to an under-
standing of those policies and strategies such as
investment goals, risk management practices,
permitted and prohibited investments including
the use of derivatives, diversification, and the re-
lationship between plan assets and benefit obli-
gations?
ii. The fair value of each major category of plan as-
sets as of each date for which a statement of fi-
nancial position is presented? (Note: Asset cate-
gories are based on the nature and risks of assets
in the entity’s plan[s].)
iii. A narrative description of the basis used to deter-
mine the overall expected long-term rate-of-re-
turn-on-assets assumption, such as the general
approach used, the extent to which the overall
rate-of-return-on-assets assumption was based
on historical returns, the extent to which adjust-
ments were made to those historical returns in
order to reflect expectations of future returns,
and how those adjustments were determined?
iv. Information that enables users of financial state-
ments to assess the inputs and valuation tech-
niques used to develop fair value measurements
of plan assets at the reporting date? To meet this
objective, has the entity properly disclosed the
following:
(1) The level within the fair value hierarchy in
which the fair value measurements in their
entirety fall, segregating fair value meas-
urements using quoted prices in active
markets for identical assets or liabilities
(level 1), significant other observable in-
puts (level 2), and significant unobservable
inputs (level 3)?
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(2) For fair value measurements of plan assets
using significant unobservable inputs
(level 3), a reconciliation of the beginning
and ending balances, separately presenting
changes during the period attributable to
the following:
(a) Actual return on plan assets?
(b) Purchases, sales, and settlements,
net?
(c) Transfers in, out, or both of level 3?
(3) Information about the valuation tech-
nique(s) and inputs used to measure fair
value and a discussion of changes in valu-
ation techniques and inputs, if any, during
the period?
e. The accumulated benefit obligation? (For defined ben-
efit pension plans)
f. The benefits expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years
thereafter? (Note: The expected benefits should be esti-
mated based on the same assumptions used to measure
the entity’s benefit obligation at the end of the year and
should include benefits attributable to estimated future
employee service.)
g. The entity’s best estimate, as soon as it can reasonably
be determined, of contributions expected to be paid to
the plan during the next fiscal year beginning after the
date of the latest statement of financial position pre-
sented. (Note: Estimated contributions may be pre-
sented in the aggregate combining [i] contributions re-
quired by funding regulations or laws, [ii] discretionary
contributions, and [iii] noncash contributions.)
h. The amount of net benefit cost recognized, showing
separately all of the following:
i. The service cost component?
ii. The interest cost component?
iii. The expected return on plan assets for the pe-
riod?
iv. The gain or loss component?
v. The prior service cost or credit component?
vi. The transition asset or obligation component?
vii. The gain or loss recognized due to settlements or
curtailments?
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i. Separately the net gain or loss and net prior service cost
or credit recognized in OCI for the period pursuant to
FASB ASC 715-30-35 paragraphs 11 and 21 and FASB
ASC 715-60-35 paragraphs 16 and 25 and reclassifica-
tion adjustments of OCI for the period, as those
amounts, including amortization of the net transition
asset or obligation, are recognized as components of net
periodic benefit cost?
j. The amounts in accumulated OCI that have not yet
been recognized as components of net periodic benefit
cost, showing separately the net gain or loss, net prior
service cost or credit, and net transition asset or obli-
gation?
k. On a weighted-average basis, the assumptions used in
the accounting for the plans, specifying in a tabular for-
mat, the assumptions used to determine the benefit ob-
ligation and the assumptions used to determine net
benefit cost including (i) assumed discount rates, (ii)
rates of compensation increase (for pay-related plans),
and (iii) expected long-term rates of return on plan as-
sets?
l. The assumed health care cost trend rate(s) for the next
year used to measure the expected cost of benefits cov-
ered by the plan (gross eligible charges), and a general
description of the direction and pattern of change in the
assumed trend rates thereafter, together with the ulti-
mate trend rate(s) and when that rate is expected to be
achieved?
m. The effect of a one-percentage-point increase and the
effect of a one-percentage-point decrease in the as-
sumed health care cost trend rates on the aggregate of
the service and interest cost components of net periodic
postretirement health care benefit costs and the accu-
mulated postretirement benefit obligation for health
care benefits?
n. If applicable, the amounts and types of securities of the
employer and related parties included in plan assets,
the approximate amount of future annual benefits of
plan participants covered by insurance contracts, in-
cluding annuity contracts issued by the employer or re-
lated parties, and any significant transactions between
the employer or related parties and the plan during the
period?
o. If applicable, any alternative method used to amortize
prior service amounts or net gains and losses pursuant
to FASB ASC 715-30-35-13 and 715-30-35-25 or FASB
ASC 715-60-35-18 and 715-60-35-31?
p. If applicable, any substantive commitment, such as past
practice or a history of regular benefit increases, used
as the basis for accounting for the benefit obligation?
106 Life and Health Insurance Entities
FSP §20,100.01
(continued)
Yes No N/A
q. If applicable, the cost of providing special or contrac-
tual termination benefits recognized during the period
and a description of the nature of the event?
r. An explanation of any significant change in the benefit
obligation or plan assets not otherwise apparent in the
other disclosures required by FASB ASC 715-20-50?
s. The amounts in accumulated OCI expected to be rec-
ognized as components of net periodic benefit cost over
the fiscal year that follows the most recent annual state-
ment of financial position presented, showing sepa-
rately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?
t. The amount and timing of any plan assets expected to
be returned to the employer during the 12-month pe-
riod, or operating cycle if longer, that follows the most
recent annual statement of financial position pre-
sented?
[FASB ASC 715-20-50-1]
Note (ASU No. 2010-06): ASU No. 2010-06 affects FASB ASC
715-20-50-1, question 7A, in the following manner: (a)
throughout the paragraph, the term major category was re-
placed with the term class and (b) the following statement was
added to item 7A(d)(ii): “For additional guidance on deter-
mining appropriate classes of plan assets, see FASB ASC 820-
10-50-2A.” As such, public entities that have adopted the pro-
visions of ASU No. 2010-06 should consider the disclosure
requirements contained in question 7A with these changes in
mind.
[“Pending Content” in FASB ASC 715-20-50-1]
8. Has the public entity properly aggregated the disclosures, as
required by FASB ASC 715-20-50, for the entity’s entire de-
fined benefit pension plans and for all of the entity’s other
defined benefit postretirement plans, unless disaggregating in
groups is considered to provide useful information or is oth-
erwise required by paragraphs 3–4 of FASB ASC 715-20-50
(discussed subsequently)?
[FASB ASC 715-20-50-2]
Additional Disclosure Information
Disclosures about pension plans with assets in excess of the accumulated benefit obligation generally may
be aggregated with disclosures about pension plans with accumulated benefit obligations in excess of assets.
The same aggregation is permitted for other postretirement benefit plans. If aggregate disclosures are pre-
sented, an employer should disclose both of the following:
● The aggregate benefit obligation and aggregate fair value of plan assets for plans with benefit obli-
gations in excess of plan assets as of the measurement date of each statement of financial position
presented, and
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● The aggregate pension accumulated benefit obligation and aggregate fair value of plan assets for
pension plans with accumulated benefit obligations in excess of plan assets
[FASB ASC 715-20-50-3]
U.S. reporting entities may combine disclosures about pension plans or other postretirement benefit plans
outside the United States with those for U.S. plans unless the benefit obligations of the plans outside the
United States are significant relative to the total benefit obligation and those plans use significantly different
assumptions. A foreign reporting entity that prepares financial statements in conformity with U.S. GAAP
should apply the preceding guidance to its domestic and foreign plans.
[FASB ASC 715-20-50-4]
Interim Disclosure Requirements for Publicly Traded Entities
9. Has the public entity properly disclosed the following infor-
mation for its interim financial statements that include a
statement of income:
a. The amount of net benefit cost recognized, for each pe-
riod for which a statement of income is presented,
showing separately each of the following:
i. The service cost component?
ii. The interest cost component?
iii. The expected return on plan assets for the pe-
riod?
iv. The gain or loss component?
v. The prior service cost or credit component?
vi. The transition asset or obligation component?
vii. The gain or loss recognized due to a settlement
or curtailment?
b. The total amount of the employer’s contributions paid,
and expected to be paid, during the current fiscal year,
if significantly different from amounts previously dis-
closed pursuant to FASB ASC 715-20-50-1(g)?22 Esti-
mated contributions may be presented in the aggregate
combining all of the following: (i) contributions re-
quired by funding regulations or laws, (ii) discretionary
contributions, and (iii) noncash contributions.
[FASB ASC 715-20-50-6]
D. Defined Benefit Plans—Other Postretirement (FASB ASC 715-60)
Disclosure
Medicare Prescription Drug, Improvement, and Modernization Act
1. Has the entity properly disclosed the following, if the entity
is including for the first time, in interim or annual financial
statements, the effects of the Medicare subsidy in measuring
the accumulated postretirement benefit obligation and in
measuring net periodic postretirement benefit cost:
22 See question 7A(g) in the “VI.C. Defined Benefit Plans—Compensation (FASB ASC 715-20)” section.
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a. The reduction in the accumulated postretirement bene-
fit obligation for the subsidy related to benefits attrib-
uted to past service?
b. The effect of the subsidy on the measurement of net pe-
riodic postretirement benefit cost for the current pe-
riod? (Note: That effect includes any amortization of
the actuarial gain, noted in question 1[a], as a compo-
nent of the net amortization called for by paragraphs
29–30 of FASB ASC 715-60-35, the reduction in current
period service cost due to the subsidy, and the resulting
reduction in interest cost on the accumulated postreti-
rement benefit obligation as a result of the subsidy.)
c. Any other disclosures required by FASB ASC 715-20-
50-1(r)?
[FASB ASC 715-60-50-3]
2. Has the entity properly disclosed, for purposes of the disclo-
sures required by paragraphs 1(a) and 1(f) of FASB ASC 715-
20-50, gross benefit payments (paid and expected, respec-
tively), including prescription drug benefits, and separately
the gross amount of the Medicare subsidy receipts (received
and expected, respectively)?
[FASB ASC 715-60-50-4]
3. Until the entity is able to determine whether benefits pro-
vided by its plan are actuarially equivalent (as defined in the
act), has the entity properly disclosed the following in the fi-
nancial statements for interim or annual periods:
a. The existence of the Medicare Prescription Drug, Im-
provement, and Modernization Act?
b. That measures of the accumulated postretirement ben-
efit obligation or net periodic postretirement benefit
cost do not reflect any amount associated with the sub-
sidy because the employer is unable to conclude
whether the benefits provided by the plan are actuari-
ally equivalent to Medicare Part D under the act?
[FASB ASC 715-60-50-6]
E. Defined Contribution Plans (FASB ASC 715-70)
Disclosure
1. Has the entity properly disclosed the amount of cost recog-
nized for defined contribution pension plans and for other
defined contribution postretirement benefit plans for all per-
iods presented separately from the amount of cost recognized
for defined benefit plans? (Note: The disclosures should in-
clude a description of the nature and effect of any significant
changes during the period affecting comparability, such as a
change in the rate of employer contributions, a business com-
bination, or a divestiture.)
[FASB ASC 715-70-50-1]
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F. Multiemployer Plans (FASB ASC 715-80)
Disclosure
1. Has the entity properly disclosed the amount of contributions
to multiemployer plans for each annual period for which a
statement of income is presented? (Note: An entity may dis-
close total contributions to multiemployer plans without dis-
aggregating the amounts attributable to pension plans and
other postretirement benefit plans. The disclosures should in-
clude a description of the nature and effect of any changes
affecting comparability, such as a change in the rate of em-
ployer contributions, a business combination, or a divesti-
ture.)
[FASB ASC 715-80-50-1]
2. Has the entity properly disclosed if it is either probable or
reasonably possible that (a) an employer would withdraw
from the plan under circumstances that would give rise to an
obligation, or (b) an entity’s contribution to the fund would
be increased during the remainder of the contract period to
make up a shortfall in the funds necessary to maintain the
negotiated level of benefit coverage (a “maintenance of bene-
fits” clause), the provisions of FASB ASC 450, Contingencies?
[FASB ASC 715-80-50-2]
G. Stock Compensation (FASB ASC 718-10)
Disclosure
1. Has the entity properly disclosed, if the entity has one or
more share-based payment arrangements, information that
enables users of the financial statements to understand (Note:
This information is not required for interim disclosure.)
a. the nature and terms of such arrangements that existed
during the period and the potential effects of those ar-
rangements on shareholders?
b. the effect of compensation cost arising from share-
based payment arrangements on the income statement?
c. the method of estimating the fair value of the goods or
services received, or the fair value of the equity instru-
ments granted (or offered to grant), during the period?
d. the cash flow effects resulting from share-based pay-
ment arrangements?
[FASB ASC 718-10-50-1]
2. Has the entity properly disclosed the following, at a mini-
mum, with regards to stock-based compensation: (Note: In
some circumstances, an entity may need to disclose informa-
tion beyond the following to achieve the disclosure objec-
tives.)
a. A description of the share-based payment arrange-
ment(s), including the general terms of awards under
the arrangement(s), such as
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i. the requisite service period(s) and any other sub-
stantive conditions (including those related to
vesting)?
ii. the maximum contractual term of equity (or lia-
bility) share options or similar instruments?
iii. the number of shares authorized for awards of
equity share options or other equity instruments?
b. The method it uses for measuring compensation cost
from share-based payment arrangements with employ-
ees?
c. For the most recent year for which an income statement
is provided, both of the following:
i. The number and weighted-average exercise
prices (or conversion ratios) for (1) shares out-
standing at the beginning of the year, (2) shares
outstanding at the end of the year, (3) shares ex-
ercisable or convertible at the end of the year,
and (4) those during the year that were granted,
exercised or converted, forfeited or expired?
ii. The number and weighted-average grant-date
fair value (or calculated value for a nonpublic en-
tity that uses that method or intrinsic value for
awards measured pursuant to FASB ASC 718-10-
30-21) of equity instruments not specified in item
(c)(i), for those (1) nonvested at the beginning of
the year, (2) nonvested at the end of the year, and
(3) those during the year that were granted,
vested or forfeited?
d. For each year for which an income statement is pro-
vided
i. the weighted average grant-date fair values (or
calculated value for a nonpublic entity that uses
that method or intrinsic value for awards meas-
ured at that value pursuant to paragraphs 21–22
of FASB ASC 718-10-30) of equity options or
other equity instruments granted during the
year?
ii. the total intrinsic value of options exercised (or
share units converted), share-based liabilities
paid, and the total fair value of shares vested
during the year?
e. For fully vested share options (or share units) and share
options expected to vest at the date of the latest state-
ment of financial position
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i. the number, weighted-average exercise price (or
conversion ratio), aggregate intrinsic value (ex-
cept for nonpublic entities), and weighted-aver-
age remaining contractual term of options (or
share units) outstanding?
ii. the number, weighted-average exercise price (or
conversion ratio), aggregate intrinsic value (ex-
cept for nonpublic entities), and weighted-aver-
age remaining contractual term of options (or
share units) currently exercisable (or converti-
ble)?
f. For each year for which an income statement is pre-
sented, both of the following (an entity that uses the
intrinsic value method pursuant to paragraphs 21–22 of
FASB ASC 718-10-30 is not required to disclose the fol-
lowing information for awards accounted for under
that method):
i. A description of the method used during the year
to estimate the fair value (or calculated value) of
awards under share-based payment arrange-
ments?
ii. A description of the significant assumptions used
during the year to estimate the fair value (or cal-
culated value) of share-based compensation
awards, including (if applicable)
(1) expected term of share options and similar
instruments, including a discussion of the
method used to incorporate the contractual
term of the instruments and employees’ ex-
pected exercise and postvesting employ-
ment termination behavior into the fair
value (or calculated value) of the instru-
ment?
(2) expected volatility of the entity’s shares
and the method used to estimate it? (An
entity that uses a method that employs dif-
ferent volatilities during the contractual
term should disclose the range of expected
volatilities used and the weighted-average
expected volatility. A nonpublic entity that
uses the calculated value method should
disclose the reasons why it is not practica-
ble for it to estimate the expected volatility
of its share price, the appropriate industry
sector index that it has selected, the reasons
for selecting that particular index, and how
it has calculated historical volatility using
that index.)
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(3) expected dividends? (An entity that uses a
method that employs different dividend
rates during the contractual term should
disclose the range of expected dividends
used and the weighted-average expected
dividends.)
(4) risk-free rate(s)? (An entity that uses a
method that employs different risk-free
rates should disclose the range of risk-free
rates used.)
(5) discount for post-vesting restrictions and
the method for estimating it?
g. Has the entity, if the entity grants equity or liability in-
struments under multiple share-based payment ar-
rangements with employees, provided the information
specified in items (a)–(f) of this question separately for
different types of awards to the extent that the differ-
ences in the characteristics of the awards make separate
disclosure important to an understanding of the en-
tity’s use of share-based compensation?
h. For each year for which an income statement is pre-
sented, both of the following:
i. Total compensation cost for share-based payment
arrangements (including recognized in income as
well as the total recognized tax benefit related
thereto and capitalized as part of the cost of an
asset)?
ii. A description of the significant modifications, in-
cluding the terms of the modifications, the num-
ber of employees affected, and the total incre-
mental compensation cost resulting from the
modifications?
i. As of the latest balance sheet date presented, the total
compensation cost related to nonvested awards not yet
recognized and the weighted-average period over
which it is expected to be recognized?
j. If not separately disclosed elsewhere, the amount of
cash received from exercise of share options and simi-
lar instruments granted under share-based payment ar-
rangements and the tax benefit realized from stock op-
tions exercised during the annual period?
k. If not separately disclosed elsewhere, the amount of
cash used to settle equity instruments granted under
share-based payment arrangements?
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l. Description of the entity’s policy, if any, for issuing
shares upon share option exercise (or share unit con-
version), including the source of those shares (that is,
new shares or treasury shares). If as a result of its pol-
icy, an entity expects to repurchase shares in the fol-
lowing annual period, the entity should disclose an es-
timate of the amount (or a range, if more appropriate)
of shares to be repurchased during that period?
[FASB ASC 718-10-50-2]
Additional Disclosure Information
In addition to the information required by FASB ASC 718-10-50, the entity may disclose supplemental infor-
mation that it believes would be useful to investors and creditors, such as a range of values calculated on
the basis of different assumptions, provided that the supplemental information is reasonable and does not
lessen the prominence and credibility of the information required by FASB ASC 718-10-50. The alternative
assumptions should be described to enable users of the financial statements to understand the basis for the
supplemental information.
[FASB ASC 718-10-50-4]
H. Employee Stock Ownership Plans (FASB ASC 718-40)
Presentation
Earnings Per Share
1. Has the entity properly presented dividends on preferred
stock held by an employee stock ownership plan as a deduc-
tion from net income net of any applicable tax benefit when
computing both basic and diluted EPS (if that preferred stock
is considered outstanding)?
[FASB ASC 718-40-45-1]
Issuance of Shares or the Sale of Shares to an Employee Stock Own-
ership Plan
2. Has the entity properly presented, as a separate balance sheet
item, the issuance of shares or the sale of treasury shares to
an employee stock ownership plan when the issuance or sale
occurred and presented a corresponding charge to unearned
employee stock ownership plan shares?
[FASB ASC 718-40-45-2]
Disclosure
3. Has an entity that sponsors an employee stock ownership
plan properly disclosed the following information about the
plan:
a. A description of the plan, the basis for determining
contributions, including the employee groups covered,
and the nature and effect of significant matters affect-
ing comparability of information for all periods pre-
sented? (Note: For leveraged employee stock owner-
ship plans and pension reversion employee stock
ownership plans, the description should include the ba-
sis for releasing shares and how dividends on allocated
and unallocated shares are used.)
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b. A description of the accounting policies followed for
employee stock ownership plan transactions, including
the method of measuring compensation, the classifica-
tion of dividends on employee stock ownership plan
shares, and the treatment of employee stock ownership
plan shares for EPS computations? (Note: If the entity
has both old employee stock ownership plan shares for
which it does not adopt the guidance in FASB ASC 718-
40 and new employee stock ownership plan shares for
which the guidance in FASB ASC 718-40 is required,
the accounting policies for both blocks of shares shall
be described.)
c. The amount of compensation cost recognized during
the period?
d. The number of allocated shares, committed-to-be-re-
leased shares, and suspense shares held by the em-
ployee stock ownership plan at the balance sheet date?
(Note: If the disclosure should be made separately for
shares accounted for under FASB ASC 718-40 and for
grandfathered employee stock ownership plan shares.)
e. The fair value of unearned employee stock ownership
plan shares at the balance sheet date for shares ac-
counted for under FASB ASC 718-40? (Note: This dis-
closure does not apply to old employee stock owner-
ship plan shares that are not accounted for under FASB
ASC 718-40.)
f. The existence and nature of any repurchase obligation,
including disclosure of the fair value of the shares al-
located as of the balance sheet date which are subject to
the repurchase obligation?
g. The amount and treatment in the EPS computation of
the tax benefit related to dividends paid to any em-
ployee stock ownership plan, if material?
[FASB ASC 718-40-50-1]
I. Stock Compensation—Income Taxes (FASB ASC 718-740)
Presentation
Excess Tax Benefit
1. Has the entity recognized an excess tax benefit pursuant to
FASB ASC 718-740-35-3 as additional paid-in capital, unless
the excess of a tax benefit for an award over the deferred tax
asset for that award is recognized in the income statement for
an excess, which stems from a reason other than changes in
the fair value of the entity’s shares between the measurement
date for accounting purposes and a later measurement date
for tax purposes?
[FASB ASC 718-740-45-2]
115Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
Tax Deficiency
2. Has the entity properly offset the write-off of a deferred tax
deficiency, pursuant to the guidance in paragraphs 5–8 of
FASB ASC 718-840-35, against additional paid-in capital, with
the remaining balance of the write-off of a deferred tax asset
related to a tax deficiency recognized in the income state-
ment?
[FASB ASC 718-740-45-4]
Employee Stock Ownership Plans
3. Pursuant to the requirements of FASB ASC 740-20-45-11(d), if
the cost of shares committed to be released in an employee
stock ownership plan is greater than their fair value has the
entity credited to shareholders equity the tax effect of the
amount by which the deductible expense exceeds the book
expense?
[FASB ASC 718-740-45-5]
4. If the cost of shares committed to be released in an employee
stock ownership plan is less than their fair value, has the en-
tity charged shareholders’ equity the tax effect of the amount
by which the book expense exceeds the deductible expense,
to the extent of previous credits to shareholders’ equity re-
lated to cost exceeding fair value of the shares committed to
be released in previous periods?
[FASB ASC 718-740-45-6]
Tax Benefits of Dividends on Share-Based Payment Awards to Em-
ployees
5. Has the entity properly recognized a realized income tax ben-
efit as an increase to additional paid-in capital from divi-
dends that are charged to retained earnings and paid to em-
ployees for nonvested equity shares, nonvested equity share
units or outstanding share options, and included the amount
in the pool of excess tax benefits available to absorb tax defi-
ciencies on share-based payment awards?
[FASB ASC 718-740-45-8]
6. Has the entity excluded the unrealized income tax benefits
from dividends on equity-classified employee share-based
payment awards from the pool of excess tax benefits available
to absorb potential future tax deficiencies on share-based
payment awards?
[FASB ASC 718-740-45-10]
7. If the entity estimates an increase in forfeitures, has the tax
benefits from dividends that are reclassified from additional
paid-in capital to the income statement been limited to the
entity’s pool of excess tax benefits available to absorb tax de-
ficiencies on the date of the reclassification?
[FASB ASC 718-740-45-12]
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J. Insurance Costs (FASB ASC 720-20)
Disclosure
Claims-Made Contracts
1. Has the entity properly disclosed, when it changes from oc-
currence-based insurance claims-made insurance or elects to
significantly reduce or eliminate its insurance coverage, the
items required by paragraphs 3–6 of FASB ASC 450-20-50,23 if
it is at least reasonably possible that a loss has been incurred?
[FASB ASC 720-20-50-1]
Other
2. For publicly held entities and entities with public accounta-
bility, such as governments, are circumstances disclosed in
which
a. they are exposed to risks of future material loss related
to
i. torts?
ii. theft of, damage to, expropriation of, or destruc-
tion of assets?
iii. business interruption?
iv. errors or omissions?
v. injuries to employees?
vi. acts of God?
b. those risks have not been transferred to unrelated third
parties through insurance? (Encouraged, but not re-
quired.)
3. In considering those matters to be disclosed that relate to cer-
tain uninsured risks of future material loss as described in
FASB ASC 720-20, has the entity considered the following:
a. The actual and potential effects of losses from such
risks on the entity’s historical or planned operations,
including exposure to losses from claims, curtailment
of research and development or manufacturing, or con-
traction or cessation of other activities, such as discon-
tinuance of a product line?
b. Comparison of current insurance coverage by major
categories of risk to coverage in prior periods, without
necessarily quantifying such coverage or change in cov-
erage?
c. Recent claims experience?
d. A description of the reporting entity’s risk management
programs? (Encouraged, but not required.)
23 See questions 3–6 of the “III.F. Loss Contingencies (FASB ASC 450-20)” section.
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K. Advertising Costs (FASB ASC 720-35)
Disclosure
1. Has the entity properly disclosed the following related to ad-
vertising costs:
a. The accounting policy for reporting whether such costs
are expensed as incurred or the first time the advertis-
ing takes place?
b. The total amount charged to advertising expense for
each income statement presented?
[FASB ASC 720-35-50-1]
L. Research and Development Expenses (FASB ASC 730-10)
Disclosure
1. Has the entity properly disclosed the total research and de-
velopment costs charged to expense in each period for which
an income statement is presented? (Note: This disclosure
should include research and development costs incurred for
a computer software product to be sold, leased, or otherwise
marketed.)
[FASB ASC 730-10-50-1]
M. Research and Development Arrangements (FASB ASC 730-20)
Disclosure
1. Has the entity properly disclosed the following, for research
and development arrangements to perform research and de-
velopment for others which are accounted for under FASB
ASC 730-20:
a. The terms of significant agreements under the research
and development arrangement (including royalty ar-
rangements, purchase provisions, license agreements,
and commitments to provide additional funding) as of
the date of each balance sheet presented?
b. The amount of compensation earned and costs incurred
under such contracts for each period for which an in-
come statement is presented?
[FASB ASC 730-20-50-1]
2. Has the entity properly disclosed each research and develop-
ment arrangement separately, if such separate disclosure is
necessary to understand the effects on the financial state-
ments? (Note: Aggregation of similar arrangements, by type,
may be appropriate.)
[FASB ASC 730-20-50-3]
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N. Income Taxes (FASB ASC 740-10)
Presentation
Deferred Tax Assets
1. Has the entity properly presented separately, in a classified
statement of financial position, the deferred tax assets and li-
abilities into a current amount and a noncurrent amount?
(Note: Deferred tax assets and liabilities should be classified
as current or noncurrent based on the classification of the re-
lated asset or liability for financial reporting.)
[FASB ASC 740-10-45-4]
2. Has the entity properly allocated the valuation allowance for
a particular tax jurisdiction, properly allocated between cur-
rent and noncurrent deferred tax assets for that tax jurisdic-
tion on a pro rata basis?
[FASB ASC 740-10-45-5]
3. Has the entity properly presented, for a particular tax-paying
component of the entity and within a particular tax jurisdic-
tion, all current deferred tax assets and liabilities offset and
as a single amount and all noncurrent tax assets and liabilities
in the same manner? (Note: The entity should not offset de-
ferred tax liabilities and assets attributable to different tax-
paying components of the entity or to different tax jurisdic-
tions.)
[FASB ASC 740-10-45-6]
4. If the entity is an S corporation, partnership, or proprietor-
ship, is the reason that no income tax expense is recorded dis-
closed?
[Common Practice]
Deferred Tax Accounts Not Related to an Asset or Liability
5. Has the entity properly presented and classified deferred tax
assets not related to an asset or liability for financial reporting
(see paragraphs 25–26 of FASB ASC 740-10-25), including
those related to carryforwards, according to the expected re-
versal date of the temporary difference?
[FASB ASC 740-10-45-9]
Tax Accounts, Other Than Deferred—Unrecognized Tax Benefits
6. If the entity presents a classified statement of financial posi-
tion, has the entity properly classified a liability associated
with an unrecognized tax benefit as a current liability (or the
amount of a net operating loss carryforward or amount re-
fundable is reduced) to the extent the entity anticipates pay-
ment (or receipt) of cash within one year or the operating cy-
cle, if longer? (Note: The liability for unrecognized tax
benefits (or reduction in amounts refundable) should not
been combined with deferred tax liabilities or assets.)
[FASB ASC 740-10-45-11]
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7. Has the entity properly not presented and classified a liability
recognized for an unrecognized tax benefit as a deferred tax
liability, unless it arose from a taxable temporary difference?
[FASB ASC 740-10-45-12]
8. Has the entity properly not presented, as offset, cash or other
assets against a tax liability or other amount owing to govern-
mental bodies, except as noted in FASB ASC 210-20-45-6?24
[FASB ASC 740-10-45-13]
Income Statement Presentation of Certain Measurement Changes to
Income Tax Accounts—Changes in Tax Laws or Rates
9. Has the entity properly presented changes to deferred tax ac-
counts, as required by FASB ASC 740-10-35-4, for the effect of
a change in tax laws or rates in income from continuing op-
erations for the period that includes the enactment date?
[FASB ASC 740-10-45-15]
Income Statement Presentation of Certain Measurement Changes to
Income Tax Accounts—Changes in the Tax Status of an Entity
10. Has the entity properly presented changes as a result of rec-
ognition or derecognition of a deferred tax account, as re-
quired by FASB ASC 740-10-25-32 and FASB ASC 740-10-40-
6, due to a change in tax status, included in income from
continuing operations?
[FASB ASC 740-10-45-19]
Disclosure
Additional Disclosure Information
FASB ASC 740-10-50 contains disclosures for both nonpublic and public companies. See the following “Pub-
lic Entity Disclosures” section of this checklist for required disclosures specific to public entities.
Statement of Financial Position Related Disclosures
11. Has the entity properly disclosed the components of the net
deferred tax asset or liability recognized in the statement of
financial position, as follows:
a. The total of all deferred tax liabilities (measured as de-
scribed in FASB ASC 740-10-30-5[b])?
b. The total of all deferred tax assets (measured as de-
scribed in [c] and [d] of FASB ASC 740-10-30-5)?
c. The total valuation allowance recognized for deferred
tax assets (measured as described in FASB ASC 740-10-
30-5[e])?
[FASB ASC 740-10-50-2]
24 The offset of cash or other assets against the tax liability or other amounts owing to governmental bodies should not be acceptable
except in the following circumstance.
Most securities issued by governments are not by their terms designed specifically for the payment of taxes and, accordingly, should
not be deducted from taxes payable on the balance sheet. The only exception to this general principle occurs when it is clear that a
purchase of securities is in substance an advance payment of taxes that will be payable in the relatively near future, so that in the special
circumstances the purchase is tantamount to the prepayment of taxes.
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12. Has the entity properly disclosed the net change in the total
valuation allowance during the year?
[FASB ASC 740-10-50-2]
13. Has the entity properly disclosed the following:
a. The amounts and expiration dates of operating loss and
tax credit carryforwards for tax purposes?
b. Any portion of the valuation allowance for deferred tax
assets for which subsequently recognized tax benefits
will be credited directly to contributed capital?
[FASB ASC 740-10-50-3]
14. Has the entity properly disclosed the change in the entity’s
tax status for year 2 and the effects of that change, if material,
if a change in the entity’s tax status becomes effective after
year-end in year 2 but before the financial statements for year
1 are issued or are available to be issued?
[FASB ASC 740-10-50-4]
Statement of Financial Position Related Disclosures—Nonpublic
Entities
15. Has the entity properly disclosed the types of significant tem-
porary differences and carryforwards? (Note: The entity may
omit disclosures of the tax effects of each type.)
[FASB ASC 740-10-50-8]
Income Statement Related Disclosures
16. Has the entity properly disclosed the following significant
components of income tax expense attributable to continuing
operations for each year presented: (Note: The components
that follow are not exhaustive.)
a. Current tax expense (or benefit)?
b. Deferred tax expense (or benefit) (exclusive of the ef-
fects of other components in this list)?
c. Investment tax credits?
d. Government grants (to the extent recognized as a re-
duction of income tax expense)?
e. The benefits of operating loss carryforwards?
f. Tax expense that results from allocating certain tax ben-
efits directly to contributed capital?
g. Adjustments of a deferred tax liability or asset for en-
acted changes in tax laws or rates or a change in the tax
status of the reporting entity?
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h. Adjustments of the beginning-of-the-year balance of a
valuation allowance because of a change in circum-
stances that causes a change in judgment about the re-
alizability of the related deferred tax asset in future
years (for example, any acquisition-date income tax
benefits or expenses recognized from changes in the ac-
quirer’s valuation allowance for its previously existing
deferred tax assets as a result of a business combination
[see FASB ASC 805-740-30-3])?
[FASB ASC 740-10-50-9]
17. Has the entity properly disclosed the amount of income tax
expense or benefit allocated to continuing operations and the
amounts separately allocated to other items (in accordance
with the intraperiod tax allocation provisions of paragraphs
2–14 of FASB ASC 740-20-45 and FASB ASC 852-740-45-3) for
each year for which those items are presented?
[FASB ASC 740-10-50-10]
Income Tax Expense Compared to Statutory Expectations—
Nonpublic Entities
18. Has the entity properly disclosed the nature of significant
items required to reconcile the reported amount of income tax
expense attributable to continuing operations for the year to
the amount of income tax expense that would result from ap-
plying domestic federal statutory tax rates to pretax income
from continuing operations? (Note: A numerical reconcilia-
tion is not required.)
[FASB ASC 740-10-50-13]
Income Tax Expense Compared to Statutory Expectations—All En-
tities
19. If not otherwise evident, has the entity properly disclosed the
nature and effect of any other significant matter affecting
comparability of information for all periods presented?
[FASB ASC 740-10-50-14]
Unrecognized Tax Benefit Related Disclosures
20. Has the entity properly disclosed the following at the end of
each annual reporting period presented:
a. The total amounts of interest and penalties recognized
in the statement of operations and the total amounts of
interest and penalties recognized in the statement of fi-
nancial position?
b. For positions for which it is reasonably possible that the
total amounts of unrecognized tax benefits will signifi-
cantly increase or decrease within 12 months of the re-
porting date,
i. the nature of the uncertainty?
ii. the nature of the event that could occur in the
next 12 months that would cause the change?
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iii. an estimate of the range of the reasonably possi-
ble change or a statement that an estimate of the
range cannot be made?
c. A description of tax years that remain subject to exam-
ination by major tax jurisdictions?
[FASB ASC 740-10-50-15]
Entities With Separately Issued Financial Statements That Are
Members of a Consolidated Tax Return
21. If the entity is a member of a group that files a consolidated
tax return, has the entity properly disclosed the following
items in its separately issued financial statements:
a. The aggregate amount of current and deferred tax ex-
pense for each income statement presented and the
amount of any tax-related balances due to or from affil-
iates as of the date of each balance sheet presented?
b. The principal provisions of the method by which the
consolidated amount of current and deferred tax ex-
pense is allocated to members of the group and the na-
ture and effect of any changes in that method (and in
determining related balances to or from affiliates) dur-
ing the years for which the disclosures in item (a) are
presented?
[FASB ASC 740-10-50-17]
Policy-Related Disclosures—Interest and Penalty Recognition Poli-
cies
22. Has the entity properly disclosed its policy on classification
of interest and penalties in accordance with FASB ASC 740-
10-45-25 in the footnotes to the financial statements? (Note:
Interest may be classified as either income taxes or interest
expense and penalties may be classified as income taxes or
another expense. These determinations are based on the pol-
icy election of the entity.)
[FASB ASC 740-10-50-19]
Policy-Related Disclosures—Investment Tax Credit Recognition
Policy
23. Has the entity properly disclosed its policy on accounting for
investment tax credits and amounts involved, if material?
(Note: FASB ASC 740-10-25-46 identifies the deferral method
and the flow-through method as acceptable methods of ac-
counting for investment tax credits.)
[FASB ASC 740-10-50-20]
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Public Entity Disclosures
Statement of Financial Position Related to Disclosures
24. Has the public entity properly disclosed the approximate tax
effect of each type of temporary difference and carryforward
that gives rise to a significant portion of deferred tax liabili-
ties and deferred tax assets (before allocation of valuation al-
lowances)?
[FASB ASC 740-10-50-6]
Income Tax Expense Compared to Statutory Expectations
25. Has the public entity properly disclosed a reconciliation us-
ing percentages or dollar amounts of the reported amount of
income tax expense attributable to continuing operations for
the year to the amount of income tax expense that would re-
sult from applying domestic federal statutory tax rates to pre-
tax income from continuing operations? (Note: The statutory
tax rates should be the regular tax rates if there are alternative
tax systems. Further the estimated amount and nature of each
significant reconciling item should be disclosed.)
[FASB ASC 740-10-50-12]
Unrecognized Tax Benefit Related Disclosures
26. Has the entity properly disclosed the following at the end of
each annual reporting period presented:
a. A tabular reconciliation of the total amount of unrecog-
nized tax benefits at the beginning and the end of the
period that includes, at a minimum, the following:
i. The gross amounts of the increases and decreases
in unrecognized tax benefits as a result of tax po-
sitions taken during the prior period?
ii. The gross amounts of increases and decreases in
unrecognized tax benefits as a result of tax posi-
tions taken during the current period?
iii. The amounts of decreases in the unrecognized
tax benefits relating to settlements with taxing
authorities?
iv. Reductions to unrecognized tax benefits as a re-
sult of a lapse of the applicable statute of limita-
tions?
b. The total amount of unrecognized tax benefits that, if
recognized, would affect the effective tax rate?
[FASB ASC 740-10-50-15A]
Public Entities Not Subject to Income Tax
27. Has the public entity properly disclosed the fact, if applicable,
that it is not subject to income taxes because its income is
taxed directly to its owners, as well as the net difference be-
tween the tax bases and the reported amounts of the entity’s
assets and liabilities?
[FASB ASC 740-10-50-16]
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Insurance Entity
28. Has the following information been disclosed if a deferred tax
liability is not recognized because of the exceptions to com-
prehensive recognition of deferred taxes for any of the areas
addressed by FASB ASC 740-10-25:
a. A description of the types of temporary differences for
which a deferred tax liability has not been recognized
and the types of events that would cause those tempo-
rary differences to become taxable?
b. The cumulative amount of each type of temporary dif-
ference?
c. The amount of the deferred tax liability for temporary
differences other than the policyholders’ surplus of a
life insurance entity that is not recognized in accor-
dance with the provisions of FASB ASC 740-10-25-3?
[FASB ASC 944-740-50-1]
O. Intraperiod Tax Allocations (FASB ASC 740-20)
Presentation
1. Has the entity properly presented the income tax expense or
benefit for the year, allocated among the following:
a. Continuing operations?
b. Discontinued operations?
c. Extraordinary items?
d. OCI?
e. Items charged or credited directly to shareholders’ eq-
uity?
[FASB ASC 740-20-45-2]
P. Income Taxes—Other Considerations or Special Areas (FASB ASC
740-30)
Undistributed Earnings of Subsidiaries and Corporate Joint Ven-
tures
1. Has the entity properly disclosed the following whenever a
deferred tax liability is not recognized because of the excep-
tions to comprehensive recognition of deferred taxes related
to subsidiaries and corporate joint ventures:
a. A description of the types of temporary differences for
which a deferred tax liability has not been recognized
and the types of events that would cause those tempo-
rary differences to become taxable?
b. The cumulative amount of each type of temporary dif-
ference?
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c. The amount of the unrecognized deferred tax liability
for temporary differences related to investments in for-
eign subsidiaries and foreign corporate joint ventures
that are essentially permanent in duration if determi-
nation of that liability is practicable or a statement that
determination is not practicable? (Note: Whereas FASB
ASC 740-30-25-14 prohibits recognition of a tax benefit
for tax deductions or favorable tax rates attributable to
future dividends of undistributed earnings for which a
deferred tax liability has not been recognized, favorable
tax treatment would be reflected in measuring that un-
recognized deferred tax liability for disclosure pur-
poses.)
d. The amount of the deferred tax liability for temporary
differences other than those in question 1(c) (that is, un-
distributed domestic earnings) that is not recognized in
accordance with the provisions of FASB ASC 740-30-25-
18?
[FASB ASC 740-30-50-2]
Q. Income Taxes—Interim Reporting (FASB ASC 740-270)
Disclosure
1. Has the entity properly disclosed the reasons for significant
variations in the customary relationship between income tax
expense and pretax accounting income in the interim period
financial statements if they are not otherwise apparent from
the financial statements or from the nature of the entity’s
business?
[FASB ASC 740-270-50-1]
VII. Broad Transactions
A. Business Combinations (FASB ASC 805-10)25
Presentation
Demutualizations
1. Has the entity displayed closed block assets, liabilities, reve-
nues, and expenses together with all other assets, liabilities,
revenues, and expenses of the entity based on the nature of
the particular item, with appropriate disclosures relating to
the closed block?
[FASB ASC 944-805-45-1]
25 In January 2010, FASB issued ASU No. 2010-02, Consolidation (Topic 810): Accounting and Reporting for Decreases in Ownership of a
Subsidiary—a Scope Clarification. The amendments in this ASU clarify that the scope of the decrease in ownership provisions of FASB ASC
810-10 and related guidance applies to all of the following:
● A subsidiary or group of assets that is a business or nonprofit activity
● A subsidiary that is a business or nonprofit activity that is transferred to an equity method investee or joint venture
● An exchange of a group of assets that constitutes a business or nonprofit activity for a noncontrolling interest in an entity
(including an equity method investee or joint venture)
(continued)
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2. Has the entity presented unrealized investment gains and
losses, other items of accumulated OCI, and the amount of
offsetting policyholder dividend obligation separately in the
presentation of OCI?
[FASB ASC 944-805-45-2]
3. Has the entity classified direct and incremental costs incurred
in demutualization or in the formation of a mutual insurance
holding entity as a single line item within income from con-
tinuing operations and not as an extraordinary item?
[FASB ASC 944-805-45-3]
4. Has the entity that demutualizes in a distribution form de-
mutualization reclassified all of its retained earnings as of the
date of the demutualization to capital stock and additional
paid-in capital accounts?
[FASB ASC 944-805-45-4]
5. Has the entity recorded the distribution of cash or policy
credits to policyholders in lieu of capital stock, as part of the
demutualization, as a direct reduction to the appropriate cap-
ital accounts?
[FASB ASC 944-805-45-4]
6. Has the entity left the amounts in accumulated OCI unchan-
ged as a result of the demutualization or formation of a mu-
tual insurance holding entity?
[FASB ASC 944-805-45-5]
The amendments in the ASU also clarify that the decrease in ownership guidance in FASB ASC 810-10 does not apply to: (a) sales of in
substance real estate and (b) conveyances of oil and gas mineral rights, even if these transfers involve businesses.
The amendments in ASU No. 2010-02 expand the disclosure requirements about deconsolidation of a subsidiary or derecognition of
a group of assets to include all of the the following:
● The valuation techniques used to measure the fair value of any retained investment
● The nature of any continuing involvement with the subsidiary or entity acquiring the group of assets
● Whether the transaction that resulted in the deconsolidation or derecognition was with a related party or whether the former
subsidiary or entity acquiring the assets will become a related party after the transaction
The amendments are effective beginning in the period that an entity adopts FASB Statement No. 160, Noncontrolling Interests in Consoli-
dated Financial Statements—an amendment of ARB 51 (now included in FASB ASC 810-10). If an entity has previously adopted FASB
Statement No. 160, the amendments are effective beginning in the first interim or annual reporting period ending on or after December
15, 2009 (that is, January 1, 2009, for entities with calendar year-ends). The amendments in ASU 2010-02 should be applied retrospectively
to the first period that an entity adopts FASB Statement 160.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2010-02.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 810-
10-65-3.
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Disclosure
Business Combinations Occurring During a Current Reporting Pe-
riod or After the Reporting Date but Before the Financial Statements
Are Issued
7. As the acquirer in a business combination, the entity must
properly disclose information that enables users of its finan-
cial statements to evaluate the nature and financial effect of a
business combination that occurred either in the current re-
porting period or after the reporting period but before the fi-
nancial statements are issued or are available to be issued. To
meet these objectives, has the entity properly disclosed the
following:
a. The name and a description of the acquiree?
b. The acquisition date?
c. The percentage of voting equity interests acquired?
d. The primary reasons for the business combination and
a description of how the acquirer obtained control of
the acquiree?
e. For transactions that are recognized separately from the
acquisition of assets and assumptions of liabilities in
the business combination (see FASB ASC 805-10-25-20),
all of the following:
i. A description of each transaction?
ii. How the acquirer accounted for each transaction?
iii The amounts recognized for each transaction and
the line item in the financial statements in which
each amount is recognized?
iv. If the transaction is the effective settlement of a
preexisting relationship, the method used to de-
termine the settlement amount?
f. For separately recognized transactions required in item
(e) all of the following:
i. The amount of acquisition-related costs, the
amount recognized as an expense, and the line
item or items in the income statement in which
those expenses are recognized?
ii. The amount of any issuance costs not recognized
as an expense and how they were recognized?
g. In a business combination achieved in stages, both of
the following:
i. The acquisition-date fair value of the equity inter-
est in the acquiree held by the acquirer immedi-
ately before the acquisition date?
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ii. The amount of any gain or loss recognized as a
result of remeasuring to fair value the equity in-
terest in the acquiree held by the acquirer before
the business combination (see FASB ASC 805-10-
25-10) and the line item in the income statement
in which that gain or loss is recognized?
h. If the acquirer is a public business entity, are all of the
following disclosed:
i. The amounts of revenue and earnings of the ac-
quiree since the acquisition date included in the
consolidated income statement for the reporting
period?
ii. The revenue and earnings of the combined entity
for the current reporting period as though the ac-
quisition date for all business combinations that
occurred during the year had been as of the be-
ginning of the annual reporting period (supple-
mental pro forma information)?
iii. If comparative financial statements are pre-
sented, the revenue and earnings of the com-
bined entity for the comparable prior reporting
period as though the acquisition date for all busi-
ness combinations that occurred during the cur-
rent year had occurred as of the beginning of the
comparable prior annual reporting period (sup-
plemental pro forma information)?
[FASB ASC 805-10-50-1; “Pending Content” in
FASB ASC 805-10-50-2]
8. Has the entity properly disclosed, for individually immaterial
business combinations occurring during the reporting period
that are material collectively, the information required by
“Pending Content” in FASB ASC 805-10-50-2(e)–(h), in the
aggregate?
[FASB ASC 805-10-50-3]
9. Has the entity properly disclosed, if the acquisition date of a
business combination is after the reporting date but before
the financial statements are issued or available to be issued,
has the entity, as the acquirer, the information required by
FASB ASC 805-10-50-2, unless the initial accounting for the
business combination is incomplete at the time the financial
statements are issued or available to be issued? (Note: If the
initial accounting is incomplete, the entity, as the acquirer,
should describe which disclosures could not be made and the
reasons why they could not be made.)
[FASB ASC 805-10-50-4]
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The Financial Effects of Adjustments That Relate to Business Com-
binations That Occurred in the Current or Previous Reporting Per-
iods26
10. Has the entity properly disclosed, if the initial accounting for
a business combination is incomplete (see paragraphs 13–14
of FASB ASC 805-10-25) and the amounts recognized in the
financial statements have been determined only provision-
ally, the following information for each material business
combination (or, in the aggregate for individually immaterial
business combinations that are material collectively):
a. The reasons why the initial accounting is incomplete?
b. The assets, liabilities, equity interests, or items of con-
sideration for which the initial accounting is incom-
plete?
c. The nature and amount of any measurement period ad-
justments recognized during the reporting period in ac-
cordance with FASB ASC 805-10-25-17?
[FASB ASC 805-10-50-6]
Other Disclosures
11. Has the entity properly disclosed, if the specific disclosures
required by FASB ASC 805-10-50 (this subtopic) and other
U.S. GAAP do not meet the objectives set out in paragraphs
1 and 5 of FASB ASC 805-10-50, whatever additional infor-
mation is necessary to meet those objectives?
[FASB ASC 805-10-50-7]
Demutualization
Disclosures
12. Has the entity disclosed the following:
a. The nature and terms of demutualization or formation
of a mutual insurance holding company?
b. The basis of presentation and terms of operation of the
closed block?
c. A general description of all of the following:
i. The method of emergence of earnings from the
closed block?
ii. Presentation of assets and liabilities of the closed
block?
iii. The policyholder dividend obligation?
[FASB ASC 944-805-50-2]
13. If the entity has formed a closed block, do the disclosures in-
clude the following:
26 FASB ASC 805-10-50-5 states that an acquirer should disclose information that enables users of its financial statements to evaluate
the financial effects of adjustments recognized in the current reporting period that relate to business combinations that occurred in the
current or previous reporting periods.
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a. A general description of the closed block that includes
the purpose of the closed block and the types of insur-
ance policies included?
b. The nature of the cash flows that increase and decrease
the amount of closed block assets and liabilities?
c. An indication of the continuing responsibility of the en-
tity to support the payment of contractual benefits?
d. The nature of expenses charged to the closed block op-
erations?
e. Summarized financial data as of, or for the periods
ending on the date of, the financial statements pre-
sented, including, at a minimum, all of the following:
i. The carrying amounts for the major types of in-
vested assets of the closed block?
ii. Future policy benefits and policyholders’ account
balances?
iii. Policyholder dividend obligation?
iv. Premiums?
v. Net investment income?
vi. Realized investment gains and losses?
vii. Policyholder benefits?
viii. Policyholder dividends?
ix. The amount of maximum future earnings re-
maining to inure to the benefit of stockholders
from the assets and liabilities of the closed block?
x. An analysis of the changes in the policyholder
dividend obligation?
[FASB ASC 944-805-50-3]
14. If the relative maturities of the closed block fixed maturities
differ from those of the reporting entity, has the reporting en-
tity properly made separate disclosures?
[FASB ASC 944-805-50-4]
B. Identifiable Assets and Liabilities, and Any Noncontrolling Inter-
est—Business Combinations (FASB ASC 805-20)
Disclosure
Business Combinations Occurring During a Current Reporting Pe-
riod or After the Reporting Date but Before the Financial Statements
Are Issued
1. Has the entity properly disclosed, in order to meet the objec-
tive of FASB ASC 805-10-50-1, the following information for
each business combination that occurred during the period:
a. For indemnification assets, all of the following:
i. The amount recognized as of the acquisition
date?
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ii. A description of the arrangement and the basis
for determining the amount of the payment?
iii. An estimate of the range of outcomes (undis-
counted) or, if a range cannot be estimated, that
fact and the reasons why a range cannot be esti-
mated? (If the maximum amount of the payment
is unlimited, the entity should disclose that fact.)
b. For acquired receivables not subject to the requirements
of FASB ASC 310-30, all of the following (by major class
of receivable, such as loans, direct financing leases in
accordance with FASB ASC 840-30, and any other class
of receivables):
i. The fair value of the receivables?
ii. The gross contractual amounts receivable?
iii. The best estimate at the acquisition date of the
contractual cash flows not expected to be col-
lected?
c. The amounts recognized as of the acquisition date for
each major class of assets acquired and liabilities as-
sumed (see example 5 in FASB ASC 805-10-55-37)?
d. For contingencies (included in the footnote that de-
scribes the business combination),
i. for assets and liabilities arising from contingen-
cies recognized at the acquisition date (which
may be aggregated for assets or liabilities arising
from contingencies that are similar in nature), (1)
the amounts recognized at the acquisition date
and the measurement basis applied (that is, at
fair value or at an amount recognized in accor-
dance with FASB ASC 450, Contingencies, and
FASB ASC 450-20-25), and (2) the nature of the
contingencies?
ii. for contingencies that are not recognized at the
acquisition date, the disclosures required by
FASB ASC 450 if the criteria for disclosures
therein are met (which may be aggregated for as-
sets and liabilities arising from contingencies that
are similar in nature)?
e. For each business combination in which the entity
holds less than 100 percent of the equity interests in the
acquiree at the acquisition date,
i. the fair value of the noncontrolling interest in the
acquiree at the acquisition date?
ii. the valuation technique(s) and significant inputs
used to measure the fair value of the noncontroll-
ing interest?
[FASB ASC 805-20-50-1]
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2. Has the entity properly disclosed, for individually immaterial
business combinations occurring during the reporting period
that are material collectively, the information required FASB
ASC 805-20-50-1, in the aggregate?
[FASB ASC 805-20-50-2]
3. Has the entity properly disclosed, if the acquisition date of a
business combination is after the reporting date but before
the financial statements are issued or available to be issued,
the information required by FASB ASC 805-20-50-1, unless
the initial accounting for the business combination is incom-
plete at the time the financial statements are issued or avail-
able to be issued? (Note: If the initial accounting is incom-
plete, the entity, as the acquirer, should describe which
disclosures could not be made and the reasons why they
could not be made.)
[FASB ASC 805-20-50-3]
C. Goodwill or Gain From Bargain Purchase, Including Considera-
tion Transferred (FASB ASC 805-30)
Disclosure
Business Combinations Occurring During a Current Reporting Pe-
riod or After the Reporting Date but Before the Financial Statements
Are Issued
1. Has the entity properly disclosed, in order to meet the objec-
tive of FASB ASC 805-10-50-1, the following information for
each business combination that occurred during the reporting
period:
a. A qualitative description of the factors that make up
the goodwill recognized, such as expected synergies
from combining operations of the acquiree and the ac-
quirer, intangible assets that do not qualify for separate
recognition, or other factors?
b. The acquisition-date fair value of the total considera-
tion transferred and the acquisition-date fair value of
each major class of consideration, such as the following:
i. Cash?
ii. Other tangible or intangible assets, including a
business or subsidiary of the acquirer?
iii. Liabilities incurred, for example, a liability for
contingent consideration?
iv. Equity interests of the acquirer, including the
number of instruments or interests issued or is-
suable and the method of determining the fair
value of those instruments or interests?
c. For contingent consideration arrangements, all of the
following:
i. The amount recognized as of the acquisition
date?
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ii. A description of the arrangement and the basis
for determining the amount of the payment?
iii. An estimate of the range of outcomes (undis-
counted) or, if a range cannot be estimated, that
fact and the reasons why a range cannot be esti-
mated? If the maximum amount of the payment
is unlimited, the acquirer should disclose that
fact.
d. The total amount of goodwill that is expected to be de-
ductible for tax purposes?
e. If the acquirer is required to disclose segment informa-
tion in accordance with FASB ASC 280-10, the amount
of goodwill by reportable segment? (If the assignment
of goodwill to reporting units required by paragraphs
41–44 of FASB ASC 350-20-35 has not been completed
as of the date the financial statements are issued or are
available to be issued, the acquirer should disclose that
fact.)
f. In a bargain purchase (see paragraphs 2–4 of FASB
ASC 805-30-25), both of the following:
i. The amount of any gain recognized in accor-
dance with FASB ASC 805-30-25-2 and the line
item in the income statement in which the gain is
recognized?
ii. A description of the reasons why the transaction
resulted in a gain?
[FASB ASC 805-30-50-1]
2. Has the entity properly disclosed, for individually immaterial
business combinations occurring during the reporting period
that are material collectively, the information required FASB
ASC 805-30-50-1, in the aggregate?
[FASB ASC 805-30-50-2]
3. Has the entity properly disclosed, if the acquisition date of a
business combination is after the reporting date but before
the financial statements are issued or available to be issued,
the information required by FASB ASC 805-30-50-1, unless
the initial accounting for the business combination is incom-
plete at the time the financial statements are issued or avail-
able to be issued? (Note: If the initial accounting is incom-
plete, the entity, as the acquirer, should describe which
disclosures could not be made and the reasons why they
could not be made.)
[FASB ASC 805-30-50-3]
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The Financial Effects of Adjustments That Relate to Business Com-
binations That Occurred in the Current or Previous Reporting Per-
iods
4. Has the entity properly disclosed, in order to meet the objec-
tive of FASB ASC 805-10-50-5, the following information for
each material business combination, or in the aggregate for
individually immaterial business combinations that are ma-
terial collectively, that occurred during the period:
a. For each reporting period after the acquisition date un-
til the entity collects, sells, or otherwise loses the right
to a contingent consideration asset, or until the entity
settles a contingent consideration liability or the liabil-
ity is cancelled or expires, all of the following:
i. Any changes in the recognized amounts, includ-
ing any differences arising upon settlement?
ii. Any changes in the range of outcomes (undis-
counted) and the reasons for those changes?
iii. The fair value disclosures required by para-
graphs 1–3 of FASB ASC 820-10-50?
b. A reconciliation of the carrying amount of goodwill at
the beginning and end of the reporting period as re-
quired by FASB ASC 350-20-50-1?
[FASB ASC 805-30-50-4]
D. Business Combinations—Related Issues (FASB ASC 805-50)
Presentation
Transactions Between Entities Under Common Control—Financial
Statement Presentation in Period of Transfer
1. For assets and liabilities transferred between entities under
common control, has the receiving entity properly presented
the results of operations for the period in which the transfer
occurs as though the transfer of net assets or exchange of eq-
uity interest had occurred at the beginning of the period?
[FASB ASC 805-50-45-2]
2. Has the receiving entity properly presented the statement of
financial position and other financial information as of the be-
ginning of the period as though the assets and liabilities had
been transferred at that date?
[FASB ASC 805-50-45-4]
Transactions Between Entities Under Common Control—
Comparative Financial Statement Presentation in Prior Years
3. Has the entity properly presented prior years’ financial state-
ments and financial information retrospectively adjusted to
furnish comparative information, only adjusting periods dur-
ing which the entities were under common control? (Note:
All adjusted financial statements and financial summaries
should clearly indicate that financial data of previously sep-
arate entities are combined.)
[FASB ASC 805-50-45-5]
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Disclosure
Transactions Between Entities Under Common Control27
4. Has the entity properly disclosed the nature of and effects on
EPS of nonrecurring intra-entity transactions involving long-
term assets and liabilities? (Note: Under the guidance of
FASB ASC 805-50-45-3 the effects of these transaction is not
required to be eliminated.)
[FASB ASC 805-50-50-2]
5. Has the entity properly disclosed, in the notes to the financial
statements, the following, for the period in which the transfer
of assets and liabilities or exchange of equity interests oc-
curred:
a. The name and brief description of the entity included
in the reporting entity as a result of the net asset trans-
fer or exchange of equity interests?
b. The method of accounting for the transfer of net assets
or exchange of equity interests?
[FASB ASC 805-50-50-3]
E. Collaborative Arrangements (FASB ASC 808-10)
Disclosure
1. Has the entity properly disclosed the following, if a partici-
pant in a collaborative arrangement, in the period in which
the collaborative arrangement has been entered into and all
annual periods thereafter: (Note: Information related to indi-
vidually significant collaborative arrangements should be
disclosed separately.)
a. Information about the nature and purpose of its collab-
orative arrangements?
b. Its rights and obligations under the collaborative ar-
rangements?
c. The accounting policy for collaborative arrangements
in accordance with FASB ASC 235, Notes to Financial
Statements?
d. The income statement classification and amounts attrib-
utable to transactions arising from the collaborative ar-
rangement between participants for each period an in-
come statement is presented?
[FASB ASC 808-10-50-1]
27 Per FASB ASC 805-50-50-4, the entity should also consider whether additional disclosures are required in accordance with FASB
ASC 850-10-50, which provides guidance on related party transactions and certain common control relationships.
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F. Consolidation (FASB ASC 810-10)28
Presentation
Procedures
1. Has the parent properly presented its consolidated financial
statements with intra-entity balances and transactions elimi-
nated?
[FASB ASC 810-10-45-1]
2. Has the parent properly presented its consolidated financial
statements without retained earnings or deficit of a subsidiary
at the date of acquisition included in consolidated retained
earnings?
[FASB ASC 810-10-45-2]
3. Has the parent properly presented in its consolidated finan-
cial statements a subsidiary’s revenues, expenses, gains, and
losses only from the date the subsidiary was initially consoli-
dated?
[FASB ASC 810-10-45-4]
4. Has the entity properly not presented shares of the parent,
held by the subsidiary as outstanding shares in the consoli-
dated statement of financial position? (These shares are not
considered outstanding shares and should be eliminated and
reflected as treasury shares.)
[FASB ASC 810-10-45-5]
Combined Financial Statements
5. Has the entity properly presented its combined financial
statements, prepared for a group of related entities, with in-
tra-entity transactions and profits or losses eliminated, and
noncontrolling interests, foreign operations, different fiscal
periods, or income taxes treated and presented in the same
manner as in consolidated financial statements?
[FASB ASC 810-10-45-10]
28 In December 2009, FASB issued ASU No. 2009-17, Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved
with Variable Interest Entities. This update is to incorporate FASB Statement No. 167, Amendments to FASB Interpretation No. 46(R), into the
codification. ASU No. 2009-17 represents a revision to former FSP FIN 46(R), Consolidation of Variable Interest Entities, and changes how a
reporting entity determines when an entity that is insufficiently capitalized or is not controlled through voting (or similar rights) should
be consolidated. The determination of whether a reporting entity is required to consolidate another entity is based on, among other
things, the other entity’s purpose and design and the reporting entity’s ability to direct the activities of the other entity that most
significantly impact the other entity’s economic performance. The amendments in this ASU will be effective for interim and annual
reporting periods beginning after November 15, 2009, and interim periods within those fiscal years (that is, January 1, 2010, for entities
with calendar year-ends). Early adoption is not permitted.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2009-17.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 810-
10-65-2.
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Parent-Entity Financial Statements
6. Has the entity properly presented parent-entity financial
statements, in addition to consolidated financial statements,
if necessary, to adequately indicate the position of bondhold-
ers and other creditors or preferred shareholders of the par-
ent?
[FASB ASC 810-10-45-11]
Differing Fiscal Year-Ends Between Parent and Subsidiary
7. Has the entity properly presented information regarding in-
tervening events that materially affect the financial position
or results of operations if the financial reporting periods of
any subsidiaries are different from that of the parent?
[FASB ASC 810-10-45-12]
A Change in the Fiscal Year-End Lag Between Subsidiary and Par-
ent
8. Has the parent or investor properly presented information re-
garding a change to (or the elimination of) a previously exist-
ing difference between the parent’s reporting period and the
reporting period of a consolidated entity or between the re-
porting period of an investor and the reporting period of an
equity method investee in the parent’s or investor’s consoli-
dated financial statements, in accordance with FASB ASC
250, Accounting Changes and Error Corrections, as described in
FASB ASC 810-10-45-13?
[FASB ASC 810-10-45-13]
Noncontrolling Interest in a Subsidiary—Nature and Classification
of the Noncontrolling Interest in the Consolidated Statement of Fi-
nancial Position
9. Has the entity properly presented, clearly identified and la-
beled, a noncontrolling interest in the entity (net assets) sec-
tion of the consolidated statement of position, separately
from the entity’s equity (net assets)? (Note: An entity with
noncontrolling interests in more than one subsidiary may
present those interests in aggregate.)
[FASB ASC 810-10-45-16]29
Attributing Net Income and Comprehensive Income to the Parent
and the Noncontrolling Interest
10. Has the entity properly presented, in the consolidated finan-
cial statements, revenues, expenses, gains, losses, net income
or loss, and OCI at the consolidated amounts, which include
amounts attributable to the owners of the parent and the non-
controlling interest?
[FASB ASC 810-10-45-19]
29 The “Pending Content” in FASB ASC 810-10-45-16 includes a parenthetical reference to “net assets” when discussing the entity’s
equity. Entities subject to FASB Statement No. 164, Not-for-Profit Entities: Mergers and Acquisitions, should refer to the transition and open
effective date information in FASB ASC 810-10-65-1 for more information.
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Disclosure
Additional Disclosure Information
FASB ASC 810-10-50 contains disclosures for both nonpublic and public companies. Further, “Pending Con-
tent” related to ASU No. 2009-17, Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises
Involved with Variable Interest Entities, contains guidance that is applicable to all entities. As such, this portion
of the checklist has been divided into three distinct sections.
For entities that have not adopted the guidance of ASU No. 2009-17, the following sections are applicable:
● Disclosures for all entities, and
● Disclosures for nonpublic entities, or
● Disclosures for public entities.
For entities for which the guidance of ASU No. 2009-17 is mandatorily effective (early adoption is not per-
mitted), the following sections are applicable:
● Disclosures for all entities, and
● Disclosures for all entities (subject to ASU No. 2009-17)
Disclosure for All Entities
Consolidation Policy
11. Has the entity properly disclosed the consolidation policy
that is being followed? (Note: In most cases this can be made
apparent by the headings or other information in the financial
statements.)
[FASB ASC 810-10-50-1]
Parent With a Less-Than-Wholly-Owned Subsidiary
12. Has the parent properly disclosed all the following regarding
one or more less-than-wholly-owned subsidiaries for each re-
porting period:
a. Separately, on the face of the consolidated financial
statements, both of the following:
i. The amounts of consolidated net income and
consolidated comprehensive income?
ii. The related amounts on each attributable to the
parent and the noncontrolling interest?
b. Either in the notes or on the face of the consolidated
income statement, amounts attributable to the parent
for any of the following, if reported in the consolidated
financial statements:
i. Income from continuing operations?
ii. Discontinued operations?
iii. Extraordinary items?
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c. Either in the consolidated statement of changes in eq-
uity, if presented, or in the notes to consolidated finan-
cial statements, a reconciliation at the beginning and
the end of the period of the carrying amount of total
equity (net assets), equity (net assets) attributable to the
parent, and equity (net assets) attributable to the non-
controlling interest? (Note: This reconciliation should
separately disclose [i] net income, [ii] transactions with
owners acting in their capacity as owners, showing sep-
arately contributions from and distributions to owners,
and [iii] each component of OCI.)
d. In notes to the consolidated financial statements, a sep-
arate schedule that shows the effects of any changes in
a parent’s ownership interest in a subsidiary on the eq-
uity attributable to the parent?
[FASB ASC 810-10-50-1A]
Deconsolidation of a Subsidiary
13. Has the entity properly disclosed the following, as a parent
entity, if a subsidiary has been deconsolidated:
a. The amount of any gain or loss recognized in accor-
dance with FASB ASC 810-10-40-5?
b. The portion of any gain or loss related to the remeasu-
rement of any retained investment in the former sub-
sidiary of group of assets to its fair value?
c. The caption in the income statement in which the gain
or loss is recognized unless separately presented on the
face of the income statement?
d. A description of the valuation technique(s) used to
measure the fair value of any direct or indirect retained
investment in the former subsidiary or group of assets?
e. Information that enables users of the parent’s financial
statements to assess the inputs used to develop the fair
value in item (d)?
f. The nature of continuing involvement with the subsid-
iary or entity acquiring the group of assets after it has
been deconsolidated or derecognized?
g. Whether the transaction that resulted in the deconsoli-
dation or derecognition was with a related party?
h. Whether the former subsidiary or entity acquiring a
group of assets will be a related party after deconsoli-
dation?
[“Pending Content” in FASB ASC 810-10-50-1B]
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A Change in the Difference Between Parent and Subsidiary Fiscal
Year-Ends
14. Has the entity properly disclosed, pursuant to FASB ASC 250,
regarding a change in (or elimination of) a previously exist-
ing difference between the fiscal year-ends of a parent entity
and subsidiary or an investor and an equity method investee?
[FASB ASC 810-10-50-2]
Disclosure for Nonpublic Entities
Variable Interest Entities—Nonpublic Entities—Primary Beneficiary
15. If the entity is a primary beneficiary of a variable interest en-
tity (VIE), has the entity disclosed all of the following (unless
the primary beneficiary also holds a majority voting interest):
a. The nature, purpose, size, and activities of the VIE?
b. The carrying amount and classification of consolidated
assets that are collateral for the VIE’s obligations?
c. Lack of recourse if creditors (or beneficial interest hold-
ers) of a consolidated VIE have no recourse to the gen-
eral credit of the primary beneficiary?
[FASB ASC 810-10-50-3]
Variable Interest Entities—Nonpublic Entities—Holder of Signifi-
cant Variable Interest in a Variable Interest Entity
16. Has the entity properly disclosed all of the following, if it
holds a significant interest in a VIE, but is not the VIE’s pri-
mary beneficiary:
a. The nature of its involvement with the VIE and when
that involvement began?
b. The nature, purpose, size, and activities of the VIE?
c. The reporting entity’s maximum exposure to loss as a
result of its involvement with the VIE?
[FASB ASC 810-10-50-4]
Variable Interest Entities—Nonpublic Entities—Relation to FASB
ASC 860, Transfers and Servicing, Disclosures
17. Has the entity properly disclosed information required by
FASB ASC 860 regarding VIEs in the same note as the disclo-
sures required by this subtopic? (Note: Information about
VIEs may be reported in the aggregate for similar entities if
separate reporting would not add material information.)
[FASB ASC 810-10-50-5]
Variable Interest Entities—Nonpublic Entities—Scope–Related, Dis-
closures
18. Has the reporting entity properly disclosed the following in-
formation if the entity does not apply the guidance in the
“Variable Interest Entities” subsections of FASB ASC 810,
Consolidation, to one or more VIEs or potential VIEs because
of the condition described in FASB ASC 810-10-15-17(c):
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a. The number of legal entities to which this guidance is
not being applied and the reason why the information
required to apply this guidance is not available?
b. The nature, purpose, size (if available), and activities of
the legal entity or entities and the nature of the report-
ing entity’s involvement with the legal entity or enti-
ties?
c. The reporting entity’s maximum exposure to loss be-
cause of its involvement with the legal entity or enti-
ties?
d. The amount of income, expense, purchases, sales, or
other measure of activity between the reporting entity
and the legal entity or entities for all periods presented?
[FASB ASC 810-10-50-6]
Disclosure for Public Entities
Aggregation of Certain Disclosures
19. Has the public entity made disclosures that provide financial
statement users with information regarding all of the follow-
ing:
a. The significant judgments and assumptions made by a
reporting entity in determining whether it must do any
of the following:
i. Consolidate a VIE?
ii. Disclose information about its involvement with
a VIE?
b. The nature of restrictions on a consolidated VIE’s assets
reported by a reporting entity in its statement of finan-
cial position, including the carrying amounts of such
assets?
c. The nature of, and changes in, the risks associated with
a reporting entity’s involvement with the VIE?
d. How a reporting entity’s involvement with the VIE af-
fects the entity’s financial position, financial perfor-
mance, and cash flows?
[FASB ASC 810-10-50-8]
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20. Has the public entity properly disclosed, if providing disclo-
sures about VIEs, and if providing separate reporting would
not provide more useful information to financial statement
users, how similar entities are aggregated? The reporting en-
tity should distinguish between (a) VIEs that are consolidated
and (b) those that are not consolidated because the reporting
entity is not the primary beneficiary, but has a significant var-
iable interest or is the sponsor that holds the variable interest?
(Note: The entity should consider quantitative and qualitative
information about different risk and reward characteristics of
each VIE and the significance of each VIE to the entity. Fur-
ther, disclosures should be presented in a manner that clearly
and fully explains to the financial statement users the nature
and extent of an entity’s involvement with VIEs.)
[FASB ASC 810-10-50-9]
Aggregation of Certain Disclosures—Public Entity That Is a Pri-
mary Beneficiary, Holds a Significant Variable Interest, or Is a Spon-
sor
21. Has the public entity properly disclosed the following infor-
mation if the entity is a primary beneficiary of a VIE, holds a
significant variable interest in a VIE, or is a sponsor that
holds a variable interest in a VIE:
a. Its methodology for determining whether the reporting
entity is (or is not) the primary beneficiary of a VIE,
including, but not limited to, significant judgments and
assumptions made?
b. If the conclusion to consolidate a VIE has changed in
the most recent financial statements the primary factors
that caused the change and the effect on the entity’s fi-
nancial statements?
c. Whether the reporting entity has provided financial or
other support during the periods presented to the VIE
that it was not previously contractually required to
provide, including both of the following:
i. The type and amount of support?
ii. The primary reasons for providing the support?
d. Qualitative and quantitative information about the re-
porting entity’s involvement with the VIE, including
but not limited to the nature, purpose, size, and activi-
ties of the VIE, including how the VIE is financed?
[FASB ASC 810-10-50-12]
Aggregation of Certain Disclosures—The Primary Beneficiary of a
VIE
22. Has the public entity properly disclosed the following, if the
entity is the primary beneficiary of a VIE:
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a. The carrying amount and classification of the VIE’s as-
sets and liabilities in the statement of financial position
that are consolidated in accordance with the guidance
in the “Variable Interest Entities” subsections of FASB
ASC 810-10, including qualitative information about
the relationship(s) between those assets and associated
liabilities?
b. Lack of recourse if creditors (or beneficial interest hold-
ers) of a consolidated VIE have no recourse to the gen-
eral credit of the primary beneficiary?
c. Terms of arrangements, giving consideration to both
explicit arrangements and implicit variable interests,
that could require the reporting entity to provide finan-
cial support to the VIE, including events or circum-
stances that could expose the reporting entity to a loss?
[FASB ASC 810-10-50-14]
Aggregation of Certain Disclosures—Public Entity That Holds a
Significant Variable Interest or Is a Sponsor but Is Not the Primary
Beneficiary
23. Has the public entity properly disclosed the following, if it
holds a significant variable interest or is a sponsor that holds
a variable interest in a VIE, but is not the VIE’s primary ben-
eficiary: (Note: A public entity meeting items [a]–[c], which
follow, are encouraged to disclose information about any li-
quidity arrangements, guarantees, or other commitments by
third parties that may affect the fair value or risk of the re-
porting entity’s variable interest in the VIE.)
a. The carrying amount and classification of the assets
and liabilities in the reporting entity’s statement of fi-
nancial position that relate to the reporting entity’s var-
iable interest in the VIE?
b. The reporting entity’s maximum exposure to loss as a
result of its involvement with the VIE, including the
following:
i. How the maximum exposure is determined?
ii. The significant sources of the reporting entity’s
exposure to the VIE?
iii. If a maximum exposure cannot be identified, has
that fact been disclosed?
c. A tabular comparison of the carrying amount of the li-
ability (as required by item [a]) and the reporting en-
tity’s maximum exposure to loss (as required by item
[b]).
[FASB ASC 810-10-50-15]
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Aggregation of Certain Disclosures—Scope-Related Disclosures
24. Has the entity properly disclosed the following if it has not
applied the guidance in the “Variable Interest Entities” sub-
sections of FASB ASC 810-10-50 to one or more VIEs or po-
tential VIEs because of the condition described in FASB ASC
810-10-15-17(c):
a. The number of legal entities to which that guidance is
not being applied?
b. The reason why the information required to apply that
guidance is not available?
c. The nature, purpose, size (if available), and activities of
the legal entities?
d. The nature of the reporting entity’s involvement with
the legal entities?
e. The reporting entity’s maximum exposure to loss be-
cause of its involvement with the legal entities?
f. The amount of income, expense, purchases, sales, or
other measure of activity between the reporting entity
and the legal entities for all periods presented?
[FASB ASC 810-10-50-16]
Aggregation of Certain Disclosures—Nontransferor Sponsor or
Nontransferor Servicer of a Qualifying Special-Purpose Entity
25. Has the public entity properly disclosed the following infor-
mation that provides financial statement users with an under-
standing of its involvement with the qualifying special-pur-
pose entity (QSPE) if the public entity is either a
nontransferor sponsor or a nontransferor servicer?
[FASB ASC 810-10-50-17]
26. Has the public entity properly disclosed the following infor-
mation that provides financial statement users with an under-
standing of its involvement with the QSPE if the public entity
is either a nontransferor sponsor or a nontransferor servicer?
a. The nature, purpose, size, and activities of the QSPE,
including how the entity is financed?
b. The carrying amount and classification of the assets
and liabilities recognized in the statement of financial
position related to the reporting entity’s involvement
with the QSPE?
c. Terms of arrangements that could require the reporting
entity to provide financial support to the QSPE, includ-
ing events or circumstances that could expose the entity
to loss? (All available evidence should be considered.
See FASB ASC 810-10-50-19[c] for specific examples of
evidence to consider).
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d. The reporting entity’s maximum exposure to loss as a
result of its involvement with the QSPE, including how
the maximum exposure is determined and the signifi-
cant sources of the reporting entity’s exposure to the
QSPE? (If the entity’s maximum exposure to loss as a
result of its involvement with the QSPE cannot be
quantified, that fact should be disclosed.)
e. Whether the entity has provided financial or other sup-
port during the periods presented to the QSPE that it
was not previously contractually required to provide,
including both of the following:
i. The type and amount of support?
ii. The primary reasons for providing the support?
[FASB ASC 810-10-50-19]
Disclosure for All Entities (subject to the guidance of ASU No. 2009-17)
27. (Public and nonpublic entities that have applied ASU No.
2009-17) Has the entity properly included disclosures, in or-
der to provide financial statement users with an understand-
ing of the following: (The entity may need to supplement the
disclosures required by this subsection to achieve the objec-
tives below. Further, these disclosures may be made in more
than one note, provided there is a cross-reference provided.)
a. The significant judgments and assumptions made by
the entity in determining whether it must (i) consoli-
date a VIE, and (ii) disclose information about its in-
volvement in a VIE?
b. The nature of restrictions on the consolidated VIE’s as-
sets and on the settlement of its liabilities reported by
the entity in its statement of financial position, includ-
ing the carrying amounts of such assets and liabilities?
c. The nature of, and changes in, the risks associated with
the reporting entity’s involvement with the VIE?
d. How the entity’s involvement with the VIE affects the
reporting entity’s financial position, financial perfor-
mance, and cash flows?
[“Pending Content” in FASB ASC 810-10-50-2AA]
Variable Interest Entities—Primary Beneficiary of a Variable Inter-
est Entity
28. (Public and nonpublic entities that have applied ASU No.
2009-17) Has the entity properly disclosed, if it is the primary
beneficiary of a VIE, all of the following: (Note: A VIE may
issue voting equity interests, and the entity that holds a ma-
jority voting interest may also be the primary beneficiary of
the VIE. If so, and if the VIE meets the definition of a business
and the VIE’s assets can be used for purposes other than the
settlement of the VIE’s obligations, the disclosures that follow
are not required.)
146 Life and Health Insurance Entities
FSP §20,100.01
Yes No N/A
a. The carrying amounts and classification of the VIE’s as-
sets and liabilities in the statement of financial position
that are consolidated in accordance with the “Variable
Interest Entities” subsections of FASB ASC 810-10, in-
cluding qualitative information about the relation-
ship(s) between those assets and liabilities?
b. Lack of recourse if creditors (or beneficial interest hold-
ers) of a consolidated VIE have no recourse to the gen-
eral credit of the primary beneficiary?
c. Terms of arrangements, giving consideration to both
explicit arrangements and implicit variable interests
that could require the reporting entity to provide finan-
cial support to the VIE, including events or circum-
stances that could expose the reporting entity to a loss?
[“Pending Content” in FASB ASC 810-10-50-3]
Variable Interest Entities—Nonprimary Beneficiary of a Variable In-
terest Entity
29. (Public and nonpublic entities that have applied ASU No.
2009-17) Has the entity properly disclosed the following, if it
holds an interest in a VIE, but is not the VIE’s primary bene-
ficiary:
a. The carrying amounts and classification of the assets
and liabilities in the reporting entity’s statement of fi-
nancial position that relate to the reporting entity’s var-
iable interest in the VIE?
b. The reporting entity’s maximum exposure to loss as a
result of its involvement with the VIE, including how
the maximum exposure is determined and the signifi-
cant sources of the reporting entity’s exposure to the
VIE?
c. A tabular comparison of the carrying amounts of the
assets and liabilities, as required by item (a), preceding,
and the reporting entity’s maximum exposure to loss,
as required by item (b), preceding? (Note: The reporting
entity should provide qualitative and quantitative in-
formation to allow financial statement users to under-
stand the differences between the two amounts. That
discussion should include, but is not limited to, the
terms of arrangements, giving consideration to both ex-
plicit arrangements and implicit variable interests, that
could require the reporting entity to provide financial
support to the VIE, including events or circumstances
that could expose the reporting entity to a loss.)
d. Encouraged, although not required, information about
any liquidity arrangements, guarantees, or other com-
mitments by third parties that may affect the fair value
or risk of the reporting entity’s variable interest in
theVIE?
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e. If applicable, significant factors considered and judg-
ments made in determining that the power to direct the
activities of a VIE that most significantly impact the
VIE’s economic performance is shared in accordance
with the guidance in FASB ASC 810-10-25-38D?
[“Pending Content” in FASB ASC 810-10-50-4]
Variable Interest Entities—Primary Beneficiaries or Other Holders
of Interests in Variable Interest Entities
30. (Public and nonpublic entities that have applied ASU No.
2009-17) Has the reporting entity properly disclosed the fol-
lowing, if it is a primary beneficiary of a VIE or if it holds a
variable interest in a VIE but is not the entity’s primary ben-
eficiary: (Note: A VIE may issue voting equity interests, and
the entity that holds a majority voting interest may also be
the primary beneficiary of the VIE. If so, and if the VIE meets
the definition of a business and the VIE’s assets can be used
for purposes other than the settlement of the VIE’s obligation,
the disclosures that follow are not required.)
a. Its methodology for determining whether the reporting
entity is the primary beneficiary of a VIE, including,
but not limited to, significant judgments and assump-
tions made. (The entity may meet this disclosure re-
quirement by providing information about the types of
involvements a reporting entity considers significant,
supplemented with information about how the signifi-
cant involvements were considered in determining
whether the reporting entity is the primary benefici-
ary.)
b. If facts and circumstances change such that the conclu-
sion to consolidate a VIE has changed in the most re-
cent financial statements (for example, the VIE was pre-
viously consolidated and is not currently consolidated),
the primary factors that caused the change and the ef-
fect on the reporting entity’s financial statements?
c. Whether the reporting entity has provided financial or
other support (explicitly or implicitly) during the per-
iods presented to the VIE that it was not previously
contractually required to provide or whether the re-
porting entity intends to provide that support, includ-
ing both of the following:
i. The type and amount of support, including situ-
ations in which the reporting entity assisted the
VIE in obtaining another type of support?
ii. The primary reason for providing the support?
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d. Qualitative and quantitative information about the re-
porting entity’s involvement (giving consideration to
both explicit arrangements and implicit variable inter-
ests) with the VIE, including, but not limited to, the na-
ture, purpose, size, and activities of the VIE, including
how the VIE is financed?
[“Pending Content” in FASB ASC 810-10-50-5A]
31. (Public and nonpublic entities that have applied ASU No.
2009-17) Has the entity properly disclosed, if providing dis-
closures about VIEs, and if providing separate reporting
would not provide more useful information to financial state-
ment users, how similar entities are aggregated? The report-
ing entity should distinguish between (a) VIEs that are con-
solidated and (b) those that are not consolidated because the
reporting entity is not the primary beneficiary, but has a sig-
nificant variable interest. (Note: The entity should consider
quantitative and qualitative information about different risk
and reward characteristics of each VIE and the significance of
each VIE to the entity. Further, disclosures should be pre-
sented in a manner that clearly explains to the financial state-
ment users the nature and extent of an entity’s involvement
with VIEs.)
[“Pending Content” in FASB ASC 810-10-50-9]
G. Derivatives and Hedging (FASB ASC 815-10)30
Presentation
Balance Sheet—Netting
1. Has the entity properly not presented a hedging derivative’s
asset (or liability) position against the hedged liability (or as-
set) position in the balance sheet?
[FASB ASC 815-10-45-2]
30 In March 2010, FASB issued ASU No. 2010-11, Derivatives and Hedging (Topic 815): Scope Exception Related to Embedded Credit Deriva-
tives. The amendments in this ASU, among others, clarify the scope exception under paragraphs 8–9 of FASB ASC 815-15-25 for embedded
credit derivative features related to the transfer of credit risk in the form of subordination of one financial instrument to another. Further,
the amendments address how to determine which embedded credit derivatives, including those in collateralized debt obligations and
synthetic collateralized debt obligations, are considered to be embedded derivatives that should not be analyzed under FASB ASC 815-
15-25 for potential bifurcation and separate accounting. The amendments in this ASU are effective at the beginning of the entity’s first
fiscal quarter beginning after June 15, 2010. Early adoption is permitted at the beginning of each entity’s first fiscal quarter beginning
after issuance of this ASU.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2010-11.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 815-
10-65-5.
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Income Statement Classification—Derivative Instruments Held for
Trading Purposes
2. Has the entity properly presented gains and losses (realized
and unrealized) on all derivative instruments within the
scope of FASB ASC 815, Derivatives and Hedging, as net when
recognized in the income statement, whether or not settled
physically, if the derivative instruments are held for trading
purposes?
[FASB ASC 815-10-45-9]
Cash Flow Statement Classification—Derivative Instruments With a
Financing Element
3. If an other-than-insignificant financing element is present at
inception—other than a financing element inherently in-
cluded in an at-the-market derivative instrument with no pre-
payments—has the entity properly presented all cash inflows
and outflows associated with that derivative instrument, in a
manner consistent with financing activities as described in
paragraphs 14–15 of FASB ASC 230-10-45?
[FASB ASC 815-10-45-12]
Disclosure
4. Has the entity properly disclosed information, in order for
the users of the financial statements to understand the follow-
ing, if the entity has derivative instruments (or nonderivative
instruments that are designated and qualify as hedging in-
struments pursuant to FASB ASC 815-20-25-58 and 815-20-25-
66):
a. How and why an entity uses derivative instruments (or
such nonderivative instruments)?
b. How derivative instruments (or such nonderivative in-
struments) and related hedged items are accounted for
under FASB ASC 815?
c. How derivative instruments (or such nonderivative in-
struments) and related hedged items affect the entity’s
financial position, performance and cash flows?
[FASB ASC 815-10-50-1]
5. Has the entity properly disclosed the following for each an-
nual and interim reporting period for which a statement of
financial position and statement of financial performance are
presented, if the entity has derivative instruments (or nonder-
ivative instruments that are designated and qualify as hedg-
ing instruments pursuant to FASB ASC 815-20-25-58 and 815-
20-25-66):
a. Its objectives for holding or issuing those instruments?
b. The context needed to understand those objectives?
c. Its strategies for achieving those objectives?
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d. Information that would enable users of its financial
statements to understand the volume of its activity in
those instruments? (An entity should select the format
and the specifics of disclosures relating to its volume of
such activity that are most relevant and practicable for
its individual facts and circumstances.)
[FASB ASC 815-10-50-1A]
6. Has the entity properly disclosed information, regarding the
derivative instruments in question 5(d), in the preceding
question, in such a format and in enough specifics relating to
the volume of such activity such that the disclosures are most
relevant and practicable for the individual facts and circum-
stances? For items in question 5(a)–(c) in the preceding ques-
tion, has information been disclosed in the context of each
instrument’s primary underlying risk exposure and have
such items been distinguished between those used for risk
management purposes and those used for other purposes?
[FASB ASC 815-10-50-1B]
7. Has the entity properly disclosed the following to distinguish
between the instruments with disclosures required by ques-
tion 5(a)–(c):
a. Derivative instruments (and nonderivative instru-
ments) used for risk management purposes, distin-
guished between each of the following:
i. Derivative instruments (and nonderivative in-
struments) designated as hedging instruments,
distinguished between each of the following: (1)
fair value hedging instruments, (2) cash flow
hedging instruments, and (3) hedges of foreign
currency exposure of net investments in foreign
operations?
ii. Derivative instruments used as economic hedges
and for other purposes related to the entity’s risk
exposure?
b. Derivative instruments used for other purposes?
[FASB ASC 815-10-50-2]
8. Has the entity properly disclosed the purpose of any deriva-
tive instruments not designated as hedging instruments un-
der FASB ASC 815-20?
[FASB ASC 815-10-50-4]
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Overall Quantitative Disclosures
9. Has the entity properly disclosed in tabular format, for every
annual and interim reporting period for which a statement of
financial position and statement of financial performance are
presented, the location and fair value amounts of derivative
instruments reported in the statement of financial position
and the location and amount of the gains and losses on deriv-
ative instruments (or nonderivative instruments it holds or
issues that are designated and qualify as hedging instruments
pursuant to FASB ASC 815-20-25 paragraphs 58 and 66) re-
ported in the statement of financial performance (or when ap-
plicable, the statement of financial position) (for example,
gains and losses initially recognized in OCI)?
[FASB ASC 815-10-50-4A]
10. Has the entity properly formatted the disclosures, with re-
spect to the disclosures required by FASB ASC 815-10-50-
A(a), to conform to the following: (Note: Amounts to be re-
ported for nonderivative instruments pursuant to paragraphs
58 and 66 of FASB ASC 815-20-25 should be the carrying
value of the nonderivative hedging instrument, rather than
the following.)
a. The fair value of derivative instruments have been dis-
closed on a gross basis (even if the derivative instru-
ments are subject to master netting agreements and
qualify for net presentation in the statement of financial
position in accordance with FASB ASC 210-20 [general
hedging activities])?
b. Cash collateral payables and receivables associated
with those instruments have not been added to or net-
ted against fair value amounts?
c. Fair value amounts have been presented as separate as-
set and liability values segregated between each of the
following:
i. Those instruments designated and qualifying as
hedging instruments under FASB ASC 815-20,
presented separately by type of contract?
ii. Those instruments not designated as hedging in-
struments, presented separately by type of con-
tract?
d. The disclosure has identified the line item(s) in the
statement of financial position in which the fair value
amounts for these categories of derivative instruments
are included?
[FASB ASC 815-10-50-4B]
11. Has the entity properly disclosed in tabular format (with the
exception of item [a], which follows) the gains and losses dis-
closed pursuant to FASB ASC 815-10-50-4A(b) separately for
all of the following by type of contract:
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a. Derivative instruments designated and qualifying as
hedging instruments in fair value hedges and related
hedged items designated and qualifying in fair value
hedges?
b. The effective portion of gains and losses on derivative
instruments designated and qualifying in cash flow
hedges and net investment hedges that was recognized
in OCI during the current period?
c. The effective portion of gains and losses on derivative
instruments designated and qualifying in cash flow
hedges and net investment hedges recorded in accu-
mulated OCI during the term of the hedging relation-
ship and reclassified into earnings during the current
period?
d. The portion of gains and losses on derivative instru-
ments designated and qualifying in cash flow hedges
and net investment hedges representing (i) the amount
of the hedges’ ineffectiveness and (ii) the amount, if
any, excluded from the assessment of hedge effective-
ness?
e. Derivative instruments not designated or qualifying as
hedging instruments under FASB ASC 815-20?
[FASB ASC 815-10-50-4C]
12. Has the entity properly disclosed separately, pursuant to
question 11, information by type of derivative contract (for
example, interest rate contracts, foreign exchange contracts,
equity contracts, commodity contracts, credit contracts, and
so forth) as well as identify the line item(s) in the statement
of financial performance in which the gains and losses for the
categories of derivative instruments are included?
[FASB ASC 815-10-50-4D]
Trading Derivatives
13. If the entity’s policy is to include derivative instruments that
are not designated or qualified as hedging instruments under
FASB ASC 815-20 in its trading activities, and the entity elects
not to separately disclose gain and losses as required by
FASB ASC 815-10-50-4C(e), has the entity properly disclosed
the following: (Note: If the disclosure option in this para-
graph is elected, the entity should include a footnote in the
required tables referencing the use of this alternative disclo-
sure for trading activities.)
a. The gains and losses on its trading activities (including
both derivative and nonderivative instruments) recog-
nized in the statement of financial performance, sepa-
rately by major types of items (such as fixed income/
interest rates, foreign exchange, equity, commodity,
and credit)?
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b. The line items in the statement of financial performance
in which trading activities gains and losses are in-
cluded?
c. A description of the nature of its trading activities and
related risks, and how the entity manages those risks?
[FASB ASC 815-10-50-4F]
Credit-Risk-Related Contingent Features
14. Has the entity properly disclosed, for every annual and in-
terim reporting period for which a statement of financial po-
sition and statement of financial performance are presented,
the following information about derivative instruments it
holds or issues (or nonderivative instruments it holds or is-
sues that are designated and qualify as hedging instruments
pursuant to FASB ASC 815-20-25-58 and FASB ASC 815-20-
25-66) that have credit-risk-related contingent features and
that are in a net liability position at the end of the reporting
period: (Note: Amounts to be reported for nonderivative in-
struments pursuant to paragraphs 58 and 66 of FASB ASC
815-20-25 should be the carrying value of the nonderivative
hedging instrument, rather than the following.)
a. The existence and nature of credit-risk-related contin-
gent features and the circumstances in which the fea-
tures could be triggered in derivative instruments that
are in a net liability position at the end of the reporting
period?
b. The aggregate fair value amounts of derivative instru-
ments that contain credit-risk-related contingent fea-
tures that are in a net liability position at the end of the
reporting period?
c. The aggregate fair value of assets that are already
posted as collateral at the end of the reporting period
and (i) the aggregate fair value of additional assets that
would be required to be posted as collateral and (ii) the
aggregate fair value of assets needed to settle the in-
strument immediately, if the credit-risk-related contin-
gent features were triggered at the end of the reporting
period?
[FASB ASC 815-10-50-4H]
Information in More Than One Footnote
15. Has the entity properly included cross-references to other
notes in which derivative-related information is disclosed, if
the disclosures related to derivative instruments (or nonderi-
vative instruments that are designated and qualify as hedg-
ing instruments pursuant to paragraphs 58 and 66 of FASB
ASC 815-20-25) are disclosed in more than a single footnote?
[FASB ASC 815-10-50-4I]
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Credit Derivatives
16A. Has the entity properly disclosed the following, as a seller of
credit derivative (as defined in FASB ASC 815-10-50-4J as a
guarantor in a guarantee type contract or any party that pro-
vides the credit protection in an option type contract, a credit
default swap, or any other credit derivative), even if the like-
lihood of the seller’s having to make any payments under the
credit derivative is remote:
a. The nature of the credit derivative, including all of the
following:
i. The approximate term of the credit derivative?
ii. The reasons for entering into the credit deriva-
tive?
iii. The events or circumstances that would require
the seller to perform under the credit derivative?
iv. The current status (that is, as of the date of the
statement of financial position) of the payment/
performance risk of the credit derivative?
v. If the entity uses internal groupings for the pur-
poses of item (iv), how those groupings are deter-
mined and used for managing risk?
b. The maximum potential amount of future payments
(undiscounted) that the seller could be required to
make under the credit derivative, which should not be
reduced by the effect of any amounts that may possibly
be recovered under recourse or collateralization provi-
sions in the credit derivative?
c. If the terms of the credit derivative provide for no lim-
itation to the maximum potential future payments un-
der the credit derivative, is that fact disclosed?
d. If the seller is unable to develop an estimate of the max-
imum potential amount of future payments under the
credit derivative, the reasons why the maximum poten-
tial amount cannot be estimated?
e. The fair value of the credit derivative as of the date of
the statement of financial position?
f. The nature of
i. any recourse provisions that would enable the
seller to recover from third parties any of the
amounts paid under the guarantee?
ii. any assets held either as collateral or by third
parties that, upon the occurrence of any trigger-
ing event or condition under the guarantee, the
guarantor can obtain and liquidate to recover all
or a portion of the amounts paid under the guar-
antee?
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g. If estimable, the approximate extent to which the pro-
ceeds from liquidation of those assets would be ex-
pected to cover the maximum potential amount of fu-
ture payments under the guarantee? (Note: For hybrid
instruments that have embedded credit derivatives, the
seller of the embedded credit derivative should disclose
the information required for the entire hybrid instru-
ment, not just the embedded credit derivatives. [FASB
ASC 815-10-50-4L])
[FASB ASC 815-10-50-4K]
Note (ASU No. 2010-11, Derivatives and Hedging (Topic
815): Scope Exception Related to Embedded Credit Deriva-
tives): ASU No. 2010-11 affects FASB ASC 815-10-50-4K,
question 16A, preceding, in the following manner:
● The “Pending Content” included in FASB ASC 815-
10-50-4K includes minor wording changes which do
not significantly impact the disclosure requirements;
and
● The “Pending Content” included in FASB ASC 815-
10-50-4K includes the following additional passage,
“The disclosures required by this paragraph (FASB
ASC 815-10-50-4K) do not apply to the embedded de-
rivative feature discussed in FASB ASC 815-15-15-9.”
As such, entities that have adopted the provisions of ASU No.
2010-11 should consider the disclosure requirements con-
tained in question 16A, preceding, with these changes in
mind.
Qualitative Disclosures
17. Although encouraged, but not required, has the entity prop-
erly included additional qualitative disclosures for every an-
nual and interim reporting period for which a statement of
financial position and statement of financial performance are
presented related to qualitative items about the entity’s objec-
tives and strategies for using derivative instruments? (Note:
These disclosures may relate to interest rate risk, foreign cur-
rency exchange rate risk, commodity price risk, credit risk,
and equity price risk.)
[FASB ASC 815-10-50-5]
Unconditional Purchase Obligations
18. Has the entity properly disclosed the information required by
FASB ASC 440, Commitments, and FASB ASC 815 if the entity
has unconditional purchase obligations which are subject to
the requirements of those topics?
[FASB ASC 815-10-50-6]
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Balance Sheet Offering
19. Has the entity properly disclosed its policy for offsetting or
not offsetting in accordance with FASB ASC 815-10-45-6?
[FASB ASC 815-10-50-7]
20. Has the entity properly disclosed the amounts recognized at
the end of each reporting period for the right to reclaim cash
collateral or the obligation to return cash collateral as follows:
a. If the entity has made an accounting policy decision to
offset fair value amounts, has it separately disclosed
amounts recognized for the right to reclaim cash collat-
eral or the obligation to return cash collateral that have
been offset against net derivative positions in accor-
dance with FASB ASC 815-10-45-5?
b. Has the entity separately disclosed amounts recognized
for the right to reclaim cash collateral or the obligation
to return cash collateral under master netting arrange-
ments that have not been offset against net derivative
instrument positions?
c. If the entity has made an accounting policy decision to
not offset fair value amounts, has it separately dis-
closed the amounts recognized for the right to reclaim
cash collateral or the obligation to return cash collateral
under master netting arrangements?
[FASB ASC 815-10-50-8]
Certain Contracts on Debt and Equity Securities
21. Has the entity properly disclosed its accounting policy for the
premium paid (time value) to acquire an option that is clas-
sified as held to maturity or available for sale, if applicable?
[FASB ASC 815-10-50-9]
H. Embedded Derivatives (FASB ASC 815-15)
Presentation
1. Has the entity properly presented hybrid financial instru-
ments measured at fair value under the election and practi-
cability exception in FASB ASC 815-15-30-1 by either (a) dis-
playing separate line items for the fair value and
non-fair-value carrying amounts or (b) presenting the aggre-
gate of the fair value and non-fair-value amounts and paren-
thetically disclosing the amount of fair value included in the
aggregate amount?
[FASB ASC 815-15-45-1]
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Disclosure
Hybrid Instruments That Are Not Separated
2. Has the entity properly disclosed, for those hybrid financial
instruments measured at fair value under the election and
under the practicability exception in FASB ASC 815-15-30-1
on earnings (or other performance indicators for entities that
do not report earnings), the information in paragraphs 28–32
of FASB ASC 825-10-50?
[FASB ASC 815-15-50-1]
3. Has the entity properly disclosed information that will allow
users to understand the effect of changes in the fair value of
hybrid financial instruments measured at fair value under the
election and under the practicability exception in FASB ASC
815-15-30-1 on earnings (or other performance indicators for
entities that do not report earnings)?
[FASB ASC 815-15-50-2]
Embedded Conversion Option That Is No Longer Bifurcated
4. Has the entity properly disclosed, for those embedded con-
version options previously accounted for as a derivative in-
strument under FASB ASC 815-15 (embedded derivatives)
that no longer meet the separation criteria, a description of
the principal changes causing the embedded conversion op-
tion to no longer require bifurcation and the amount of the
liability for the conversion option which has been reclassified
to stockholders’ equity?
[FASB ASC 815-15-50-3]
I. Fair Value Hedging (FASB ASC 815-25)
Disclosure
1. Has the entity properly disclosed, for every annual and in-
terim reporting period for which a statement of financial po-
sition and statement of financial performance are presented,
the following for derivative instruments, as well as nonderi-
vative instruments that may give rise to foreign currency
transaction gains or losses under FASB ASC 830-20, that have
been designated and have qualified as fair value hedging in-
struments and for the related hedged items:
a. The net gain or loss recognized in earnings during the
reporting period representing (i) the amount of the
hedges’ ineffectiveness and (ii) the component of the
derivative instruments’ gain or loss, if any, excluded
from the assessment of hedge effectiveness?
b. The amount of net gain or loss recognized in earnings
when a hedged firm commitment no longer qualifies as
a fair value hedge?
[FASB ASC 815-25-50-1]
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J. Cash Flow Hedges (FASB ASC 815-30)
Presentation
Other Comprehensive Income
1. Has the entity properly presented, as a separate classification
within OCI, the net gain or loss on any derivative instru-
ments designated and qualifying as cash flow hedging instru-
ments that are reported in comprehensive income pursuant
to FASB ASC 815-20-25-65 and FASB ASC 815-30-35-3?
[FASB ASC 815-30-45-1]
Disclosure
2. Has the entity properly disclosed, for every annual and in-
terim reporting period for which a statement of financial po-
sition and statement of financial performance are presented,
the following for derivative instruments that have been des-
ignated and have qualified as cash flow hedging instruments
and for the related hedged transactions:
a. A description of the transactions or other events that
will result in the reclassification into earnings of gains
and losses that are reported in accumulated OCI, and
the estimated net amount of the existing gains or losses
at the reporting date that is expected to be reclassified
into earnings within the next 12 months?
b. The estimated net amount of the existing gains or losses
that are reported in accumulated OCI at the reporting
date that is expected to be reclassified into earnings in
the next 12 months?
c. The maximum length of time over which the entity is
hedging its exposure to the variability in future cash
flows for forecasted transactions excluding those fore-
casted transactions related to the payment of variable
interest on existing financial instruments?
d. The amount of gains and losses reclassified into earn-
ings as a result of the discontinuance of cash flow
hedges because it is probable that the original fore-
casted transactions will not occur by the end of the
originally specified time period or within the addi-
tional period of time discussed in paragraphs 4–5 of
FASB ASC 815-30-40?
[FASB ASC 815-30-50-1]
3. Has the entity properly disclosed, as a separate component of
OCI, the beginning and ending accumulated derivative in-
strument gain or loss, the related net change associated with
current period hedging transactions, and the net amount of
any reclassification into earnings?
[FASB ASC 815-30-50-2]
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K. Net Investment Hedges (FASB ASC 815-35)
Disclosure
1. Although encouraged, but not required, has the entity prop-
erly included additional qualitative disclosures to present a
more complete picture of its activities about derivative instru-
ments by presenting information that may be more useful,
and less likely to be perceived to be out of context or other-
wise misunderstood, if similar information is disclosed about
other financial instruments or nonfinancial assets and liabili-
ties to which the derivative instruments are related by activ-
ity?
[FASB ASC 815-35-50-2]
L. Contracts in Entity’s Own Equity (FASB ASC 815-40)
Disclosure
1. Has the entity properly disclosed, in the financial statements,
changes in fair value for all contracts within the scope of
FASB 815-40 classified as assets or liabilities as long as the
contracts remain classified as assets or liabilities?
[FASB ASC 815-40-50-1]
2. Has the entity properly disclosed the related disclosures re-
quired by FASB ASC 815-10-50; FASB ASC 815-25-50; FASB
ASC 815-30-50; and FASB ASC 815-35-50, if a contract within
the scope of FASB ASC 815-40 meets the definition of a deriv-
ative instrument?
[FASB ASC 815-40-50-2]
Reclassifications and Related Accounting Policy Disclosures
3. Has the entity properly disclosed the contract reclassification,
the reason for the reclassification and the effect on the entity’s
financial statements, if contracts within the scope of FASB
ASC 815-40 are reclassified into (or out of) equity during the
life of the instrument (in whole or in part) pursuant to the
provisions of paragraphs 8–13 of FASB ASC 815-40-35?
[FASB ASC 815-40-50-3]
4. Has the entity properly disclosed the accounting policy deci-
sion pursuant to FASB ASC 235, if the entity partially reclas-
sifies a contract(s) subject to FASB ASC 815-40?
[FASB ASC 815-40-50-4]
Interaction With Disclosures About Capital Structure
5. Has the entity properly disclosed the following, pursuant to
FASB ASC 505-10-50, if the entity has contracts related to
their capital structure of the following nature:
a. If the entity has an option or forward contract, has rel-
evant information including (i) the forward rate, (ii) the
option strike price, (iii) the number of shares to which
the contract is indexed, (iv) the settlement date(s), and
(v) the issuers accounting for the contract (asset, liabil-
ity, or equity) been disclosed?
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b. If the entity’s contract(s) provide settlement alterna-
tives, has the relevant information including (i) who
controls the settlement alternatives and (ii) the maxi-
mum number of shares that could be required to be is-
sued to net share settle the contract been disclosed?
c. If the entity’s contract(s) does not have a fixed or deter-
minable maximum number of shares that may be re-
quired to be issued, is the fact that an infinite number
may be required to settle the contract(s) disclosed?
d. For each of the entity’s contract(s) has disclosure been
made of the current fair value for each settlement alter-
native and how changes in the price of the issuer’s eq-
uity instruments affect those settlement amounts? (For
some issuers, a tabular format may provide the most
concise and informative presentation of these data.)
e. If the entity has temporary equity (for example redeem-
able stock issued by nonpublic entities) have the disclo-
sures required by FASB ASC 505-10-50-11 been made?
[FASB ASC 815-40-50-5]
M. Weather Derivatives (FASB ASC 815-45)
Disclosure
1. Has the entity properly disclosed information for financial in-
struments, such as those required in FASB ASC 825-10-50, for
weather derivative contracts, which are financial instruments
within the scope of FASB ASC 815-45?
[FASB ASC 815-45-50-1]
N. Fair Value Measurements and Disclosures (FASB ASC 820-10)31
Disclosure
Additional Disclosure Information
The quantitative disclosures required by FASB ASC 820-10-50 should be presented using a tabular format.
[FASB ASC 820-10-50-8]
31 In January 2010, FASB issued ASU No. 2010-06. This ASU requires some new disclosures and clarifies some existing disclosure
requirements about fair value measurement in FASB ASC 820-10. FASB’s objective is to improve these disclosures and, thus, increase the
transparency in financial reporting. Specifically, ASU No. 2010-06 amends FASB ASC 820-10 to now require the following:
● A reporting entity should disclose separately the amounts of significant transfers in and out of level 1 and level 2 fair value
measurements and describe the reasons for the transfers; and
● In the reconciliation for fair value measurements using significant unobservable inputs, a reporting entity should present
separately information about purchases, sales, issuances, and settlements.
In addition, ASU No. 2010-06 clarifies the requirements of the following existing disclosures:
● For purposes of reporting fair value measurement for each class of assets and liabilities, a reporting entity needs to use
judgment in determining the appropriate classes of assets and liabilities; and
● A reporting entity should provide disclosures about the valuation techniques and inputs used to measure fair value for both
recurring and nonrecurring fair value measurements.
The amendments in this ASU are effective for interim and annual reporting periods beginning after December 15, 2009 (that is, January
1, 2010, for entities with calendar year-ends), except for the disclosures about purchases, sales, issuances, and settlements in the roll
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161Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
1A. Has the entity properly disclosed information that enables us-
ers of its financial statements to assess both of the following:
a. For assets and liabilities that are measured at fair value
on a recurring basis in the periods subsequent to initial
recognition, the inputs used to develop those measure-
ments?
b. For recurring fair value measurements using significant
unobservable inputs (level 3), the effect of the measure-
ments on earnings (or changes in net assets) for the pe-
riod?
[FASB ASC 820-10-50-1]
1B. (ASU No. 2010-06, Fair Value Measurements and Disclo-
sures (Topic 820): Improving Disclosures about Fair Value
Measurements) Has the entity properly disclosed informa-
tion that enables users of its financial statements to assess
both of the following:
a. For assets and liabilities that are measured at fair value
on a recurring basis in the periods subsequent to initial
recognition, the valuation techniques and inputs used
to develop those measurements?
b. For recurring fair value measurements using significant
unobservable inputs (level 3), the effect of the measure-
ments on earnings (or changes in net assets) for the pe-
riod?
[“Pending Content” in FASB ASC 820-10-50-1]
2A. Has the entity properly disclosed the following information,
for each interim and annual period separately for each major
category of assets and liabilities: (Note: For equity and debt
securities, major category should be defined as major security
type as described in FASB ASC 320-10-50-1B, even if the eq-
uity or debt securities are not within the scope of FASB ASC
320-10.)
a. The fair value measurements at the reporting date?
b. The level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregat-
ing (i) fair value measurements using quoted prices in
active markets for identical assets or liabilities (level 1),
(ii) significant other observable inputs (level 2), and (iii)
significant unobservable inputs (level 3)?
forward of activity in level 3 fair value measurements, see FASB ASC 820-10-50-2(c)(2). Those disclosures are effective for fiscal years
beginning after December 15, 2010 (that is, January 1, 2011, for entities with calendar year-ends), and for interim periods within those
fiscal years. Early adoption is permitted.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2010-06.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and open effective date information discussed in FASB ASC 820-
10-65-7.
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c. For fair value measurements using significant unob-
servable inputs (level 3), a reconciliation of the begin-
ning and ending balances, separately presenting
changes during the period attributable to any of the fol-
lowing (may be presented net):
i. Total gains or losses for the period (realized and
unrealized), segregating those gains or losses in-
cluded in earnings (or changes in net assets), and
a description of where those gains or losses in-
cluded in earnings (or changes in net assets) are
reported in the statement of income (or activi-
ties)?
ii. Purchases, sales, issuances, and settlements (net)?
iii. Transfers in and out, or both, of level 3 (for ex-
ample, transfers due to changes in the observa-
bility of significant inputs)?
d. The amount of the total gains or losses for the period
in FASB ASC 820-10-50-1(c)(1) included in earnings (or
changes in net assets) that are attributable to the change
in unrealized gains or losses relating to those assets and
liabilities still held at the reporting date and a descrip-
tion of where those unrealized gains or losses are re-
ported in the statement of income?
e. The inputs and valuation technique(s) used to measure
fair value and a discussion of changes in valuation
techniques and related inputs, if any, during the pe-
riod?
[FASB ASC 820-10-50-2]
2B. (ASU No. 2010-06) Has the entity properly disclosed the fol-
lowing information, to meet the objectives of FASB ASC 820-
10-50-1, for each interim and annual period separately for
each class of assets and liabilities: (Note: The reporting entity
should determine appropriate classes of assets and liabilities
on the basis of guidance in “Pending Content” in FASB ASC
820-10-50-2. It should provide sufficient information to per-
mit reconciliation of the fair value measurement disclosures
for the various classes of assets and liabilities to the line items
in the statement of financial position.)
a. The fair value measurement at the reporting date?
b. The level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregat-
ing (i) fair value measurements using quoted prices in
active markets for identical assets or liabilities (level 1),
(ii) significant other observable inputs (level 2), and (iii)
significant unobservable inputs (level 3)?
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c. The amounts of significant transfers between level 1
and level 2 of the fair value hierarchy and the reasons
for the transfers? (Significant transfers into each level
should be disclosed separately from transfers out of
each level. The reporting entity should disclose and
consistently follow its policy for determining when
transfers between levels are recognized. The policy
about the timing of recognizing transfers should be the
same for transfers into the levels as that for transfers
out of the levels. Examples of policies for when to rec-
ognize the transfer include [i] the actual date of the
event or change in circumstances that caused the trans-
fer, [ii] the beginning of the reporting period, and [iii]
the end of the reporting period.)
d. For fair value measurements using significant unob-
servable inputs (level 3), a reconciliation of the begin-
ning and ending balances, separately presenting
changes during the period attributable to any of the fol-
lowing:
i. Total gains or losses for the period (realized and
unrealized), separately presenting gains or losses
included in earnings (or changes in net assets),
and gains or losses recognized in OCI, and a de-
scription of where those gains or losses included
in earnings (or changes in net assets) are reported
in the statement of income (or activities) or in
OCI?
ii. Purchases, sales, issuances, and settlements (each
type disclosed separately)?
iii. Transfers in and out, or both, of level 3 and the
reasons for those transfers? (Significant transfers
into level 3 should be disclosed separately from
significant transfers out of level 3. Examples in-
clude [1] the actual date of the event or change in
circumstances that caused the transfer and [2] the
beginning and [3] the end of the reporting pe-
riod.)
e. The amount of the total gains or losses for the period
in FASB ASC 820-10-50-1(c)(1) included in earnings (or
changes in net assets) that are attributable to the change
in unrealized gains or losses relating to those assets and
liabilities still held at the reporting date and a descrip-
tion of where those unrealized gains or losses are re-
ported in the statement of income (or activities)?
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f. For fair value measurements using significant other ob-
servable inputs (level 2) and significant unobservable
inputs (level 3), a description of the valuation technique
(or multiple valuation techniques) used, such as the
market approach, income approach, or the cost ap-
proach, and the inputs used in determining the fair val-
ues of each class of assets or liabilities? (Note: If there
has been a change in the valuation technique[s], the re-
porting entity should disclose that change and the rea-
son for making it.)
[“Pending Content” in FASB ASC 820-10-50-2]
3B. (ASU No. 2010-06) Has the entity properly disclosed both of
the following:
a. The fair value disclosures required by FASB ASC 820-
10-50-2(a) on a gross basis?
b. The reconciliation disclosure required by FASB ASC
820-10-50-2(c)–(d) either gross or net?
[“Pending Content” in FASB ASC 820-10-50-3]
Liability Issued With an Inseparable Third-Party Credit Enhance-
ment
4. Has the entity properly disclosed, for a liability issued with
an inseparable third-party credit enhancement that is meas-
ured or disclosed at fair value on a recurring basis (and is not
subject to the listed exceptions in FASB ASC 820-10-50-4A),
the existence of a third-party credit enhancement on its is-
sued liability, if such an enhancement exists?
[FASB ASC 820-10-50-4A]
Nonrecurring Measurements
5A. Has the entity properly disclosed the following information
regarding assets and liabilities that are measured at fair value
on a nonrecurring basis in periods subsequent to initial rec-
ognition, for each interim and annual period separately for
each major category of assets and liabilities: (Note: For equity
and debt securities, major category should be defined as ma-
jor security type as described in FASB ASC 320-10-50-1B,
even if the equity or debt securities are not within the scope
of FASB ASC 320-10.)
a. The fair value measurements recorded during the pe-
riod and the reasons for the measurements?
b. The level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregat-
ing (i) fair value measurements using quoted prices in
active markets for identical assets or liabilities (level 1),
(ii) significant other observable inputs (level 2), and (iii)
significant unobservable inputs (level 3)?
c. For fair value measurements using significant unob-
servable inputs (level 3), a description of the inputs and
the information used to develop the inputs?
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d. The inputs and valuation technique(s) used to measure
fair value and a discussion of changes, if any, in the
valuation technique(s) used to measure similar assets
or liabilities or both in prior periods?
[FASB ASC 820-10-50-5]
5B. (ASU No. 2010-06) Has the entity properly disclosed the fol-
lowing information regarding assets and liabilities that are
measured at fair value on a nonrecurring basis in periods
subsequent to initial recognition, for each interim and annual
period separately for each class of assets and liabilities: (Note:
The reporting entity should determine appropriate classes of
assets and liabilities on the basis of guidance in “Pending
Content” in FASB ASC 820-10-50-2A.)
a. The fair value measurement recorded during the pe-
riod and the reasons for the measurement?
b. The level within the fair value hierarchy in which the
fair value measurement in its entirety fall, segregating
the fair value measurement using quoted prices in ac-
tive markets for identical assets or liabilities (level 1),
significant other observable inputs (level 2), and signif-
icant unobservable inputs (level 3)?
c. For fair value measurements using significant other ob-
servable inputs (level 2) and significant unobservable
inputs (level 3), the disclosure required by FASB ASC
820-10-50-2(e)?
[“Pending Content” in FASB ASC 820-10-50-5]
Fair Value Measurements of Investments in Certain Entities That
Calculate Net Asset Value Per Share (or Its Equivalent)
6A. Has the entity properly disclosed the following information,
for each interim and annual period, separately, regarding
each major category of investment that are within the scope
of FASB ASC 820-10-15-4 and FASB ASC 820-10-15-5 and that
are measured at fair value on a recurring or nonrecurring ba-
sis during the period, information that enables users of its fi-
nancial statements to understand the nature and risks of the
investment and whether the investment are probably of being
sold at amounts different from net asset value per share (or
its equivalent):
a. The fair value of the investments in the major category,
and a description of the significant investment strate-
gies of the investee(s) in the major category?
b. For each major category of investment that includes in-
vestments that can never be redeemed with the inves-
tees, but the reporting entity receives distributions
through the liquidation of the underlying assets of the
investees, the reporting entity’s estimate of the period
of time over which the underlying assets are expected
to be liquidated by the investees?
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c. The amount of the reporting entity’s unfunded com-
mitments related to investments in the major category?
d. A general description of the terms and conditions upon
which the investor may redeem investments in the ma-
jor category?
e. The circumstances in which an otherwise redeemable
investment in the major category (or a portion thereof)
might not be redeemable. (Note: For those otherwise re-
deemable investments that are restricted from redemp-
tion as of the reporting entity’s measurement date, the
reporting entity should disclose its estimate of when
the restriction from redemption might lapse. If an esti-
mate cannot be made, the reporting entity should dis-
close that fact and how long the restriction has been in
effect.)
f. Any other significant restriction on the ability to sell in-
vestments in the major category at the measurement
date?
g. If the reporting entity determines that it is probable
that it will sell an investment(s) for an amount different
from net asset value per share (or its equivalent) as de-
scribed in FASB ASC 820-10-35-62, the reporting entity
should disclose the total fair value of all investments
that meet that criteria and any remaining actions re-
quired to complete the sale?
h. If a group of investments would otherwise meet the cri-
teria in FASB ASC 820-10-35-62 but the individual in-
vestments to be sold have not been identified, so the
investments continue to qualify for the practical expe-
dient in FASB ASC 820-10-35-59, the reporting entity
should disclose its plans to sell and any remaining ac-
tions required to complete the sale(s)?
[FASB ASC 820-10-50-6A]
6B. (ASU No. 2010-06) Has the entity properly disclosed the fol-
lowing information, for each interim and annual period, sep-
arately, regarding each class of investment that are within the
scope of paragraphs 4–5 of FASB ASC 820-10-15 and that are
measured at fair value, information that enables users of its
financial statements to understand the nature and risks of the
investment and whether the investment are probably of being
sold at amounts different from net asset value per share (or
its equivalent):
a. The fair value of the investments in the class, and a de-
scription of the significant investment strategies of the
investee(s) in the class?
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b. For each class of investment that includes investments
that can never be redeemed with the investees, but the
reporting entity receives distributions through the liq-
uidation of the underlying assets of the investees, the
reporting entity’s estimate of the period of time over
which the underlying assets are expected to be liqui-
dated by the investees?
c. The amount of the reporting entity’s unfunded com-
mitments related to investments in the class?
d. A general description of the terms and conditions upon
which the investor may redeem investments in the
class?
e. The circumstances in which an otherwise redeemable
investment in the class (or a portion thereof) might not
be redeemable? (Note: For those otherwise redeemable
investments that are restricted from redemption as of
the reporting entity’s measurement date, the reporting
entity should disclose its estimate of when the restric-
tion from redemption might lapse. If an estimate can-
not be made, the reporting entity should disclose that
fact and how long the restriction has been in effect.)
f. Any other significant restriction on the ability to sell in-
vestments in the class at the measurement date?
g. If the reporting entity determines that it is probable
that it will sell an investment(s) for an amount different
from net asset value per share (or its equivalent) as de-
scribed in FASB ASC 820-10-35-62, the reporting entity
should disclose the total fair value of all investments
that meet that criteria and any remaining actions re-
quired to complete the sale?
h. If a group of investments would otherwise meet the cri-
teria in FASB ASC 820-10-35-62 but the individual in-
vestments to be sold have not been identified, so the
investments continue to qualify for the practical expe-
dient in FASB ASC 820-10-35-59, the reporting entity
should disclose its plans to sell and any remaining ac-
tions required to complete the sale(s)?
[“Pending Content” in FASB ASC 820-10-50-6A]
Relation to Other Disclosure Requirements
7. Although encouraged but not required, has the entity
a. combined the fair value information disclosed under
FASB ASC 820-10-50 with the fair value information
disclosed under other FASB ASC subtopics (for exam-
ple, FASB ASC 825-10-50) in the periods in which those
disclosures are required, if practicable?
b. disclosed information about other similar measure-
ments (for example, inventories measured at market
value under FASB ASC 330, Inventory), if practicable?
[FASB ASC 820-10-50-9]
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8. Plan assets of a defined pension or other postretirement plan
that are accounted for under FASB ASC 715, Compensa-
tion—Retirement Benefits, are not subject to the disclosure re-
quirements in paragraphs 1–9 of FASB ASC 820-10-50 but are
subject to disclosure requirements under FASB ASC 715-20-
50-1(d)(iv) and FASB ASC 715-20-50-5(c)(iv). Have the proper
disclosures been made under the listed paragraphs of FASB
ASC 715?
[FASB ASC 820-10-50-10]
O. Financial Instruments (FASB ASC 825-10)
Presentation
Fair Value Option—Statement of Financial Position
1. Has the entity properly presented information that separates
the reported assets and liabilities that are measured at fair
value, pursuant to the fair value option in FASB ASC 825,
from the carrying amounts of similar assets measured using
another measurement attribute by either
a. presenting the aggregate of fair value and non-fair-
value amounts in the same line item in the statement of
financial position and parenthetically disclosing the
amount measured at fair value included in the aggre-
gate amount, or
b. presenting two separate line items to display the fair
value and non-fair-value carrying amounts?
[FASB ASC 825-10-45 par. 1–2]
2. Have deferred acquisition costs related to investment con-
tracts been reported as an asset consistent with FASB ASC
944-30-45-2?
[FASB ASC 944-825-45-1]
Fair Value Option—Statement of Cash Flows
3. Has the entity properly presented cash receipts and cash pay-
ments related to items measured at fair value according to
their nature and purpose as required by FASB ASC 230?
[FASB ASC 825-10-45-3]
Disclosure
Applicability of This Subsection—Entities
Additional Disclosure Information
The disclosure about fair values of financial instruments is optional (for annual reporting periods) for re-
porting entities that meet all of the following criteria:
● Are nonpublic entities as defined in the FASB ASC glossary,
● Have total assets of less than $100 million on the date of the financial statements, and
● Have no instrument that, in whole or in part, is accounted for as a derivative instrument under
FASB ASC 815, other than commitments related to the origination of mortgage loans to be held for
sale during the reporting period.
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This criterion should be applied to the most recent year presented in comparative financial statements to
determine the applicability of FASB ASC 825-10-50.
The following table clarifies the requirements for disclosures if prior periods are presented in comparative
financial statements.
If Disclosures for the Current
Period Are:
And Disclosures for Prior
Periods Were:
Then Disclosures for Prior
Periods Presented in
Comparative Statements Are:
Optional Optional Optional
Optional Required Optional
Required Optional Optional
Required Required Required
[FASB ASC 825-10-50 par. 3–7]
Transactions
4. Has the entity properly not made disclosure if the require-
ments of FASB ASC 825-10-50 paragraphs 10–16 for the fol-
lowing items:
a. Employers’ and plans’ obligations for pension benefits,
other postretirement benefits including health care and
life insurance benefits, postemployment benefits, em-
ployee stock option and stock purchase plans, and
other forms of deferred compensation agreements?
b. Substantively extinguished debt subject to the disclo-
sure requirements of FASB ASC 405-20?
c. Insurance contracts, other than financial guarantees
and investment contracts, as discussed in FASB ASC
944-20?
d. Lease contracts as defined in FASB ASC 840, Leases?
e. Warranty obligations?
f. Unconditional purchase obligations as defined in FASB
ASC 440-10-50-2?
g. Investments accounted for under the equity method in
accordance with the requirements of FASB ASC 323, In-
vestments—Equity Method and Joint Ventures?
h. Noncontrolling interests and equity investments in con-
solidated subsidiaries?
i. Equity instruments issued by the entity and classified
in stockholders’ equity in the statement of financial po-
sition?
[FASB ASC 825-10-50-8]
Fair Value of Financial Instruments
5. Has the entity properly made the following disclosures:
a. Either in the body of the financial statements or in the
accompanying notes, the fair value of financial instru-
ments for which it is practicable to estimate the value?
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b. The method or methods and significant assumptions
used to estimate the fair value of financial instruments?
c. A description of the changes in the method or methods
and significant assumptions used to estimate the fair
value of financial instruments, if any, during the pe-
riod?
[FASB ASC 825-10-50-10]
6. Has the entity properly disclosed fair value in the notes to-
gether with the related carrying amount in a form that clari-
fies both (a) whether the fair value and carrying amount rep-
resent assets or liabilities and (b) how the carrying amounts
relate to what is reported in the statement of financial posi-
tion?
[FASB ASC 825-10-50-11]
7. Has the entity properly disclosed, if fair value information is
disclosed in more than a single note, a summary table of the
fair value and related carrying amounts in one note, and does
the note cross-reference to the location(s) of the remaining re-
quired disclosures?
[FASB ASC 825-10-50-12]
8. Has the entity properly not disclosed a net presentation of the
fair value of financial instruments with the fair value of other
financial instruments, even if those financial instruments are
of the same class or are otherwise considered to be related,
except to the extent that the offsetting of carrying amounts in
the statement of financial position is permitted under the gen-
eral principle in FASB ASC 210-20-45-1, or the exceptions for
master netting arrangements in FASB ASC 815-10-45-5 and
for amounts related to certain repurchase and reverse repur-
chase agreements in paragraphs 11–17 of FASB ASC 210-20-
45?
[FASB ASC 825-10-50-15]
9. Has the entity properly made both of the following disclo-
sures if it is not practicable (see FASB ASC 825-10-50 para-
graphs 17–19 for a definition of practicable in this context) to
estimate the fair value of a financial instrument or a class of
financial instruments:
a. Information pertinent to estimating the fair value of
that financial instrument or class of financial instru-
ments, such as the carrying amount, effective interest
rate, and maturity?
b. The reasons why it is not practicable to estimate fair
value?
[FASB ASC 825-10-50-16]
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Concentration of Credit Risk
10. Has the entity properly disclosed, except as indicated in
FASB ASC 825-10-50-22, all significant concentrations of
credit risk arising from all financial instruments, whether
from an individual counterparty or groups of counterparties?
(Note: Group concentrations of credit risk exist if a number
of counterparties are engaged in similar activities and have
similar economic characteristics that would cause their ability
to meet contractual obligations to be similarly affected by
changes in economic or other conditions.) (Note: This disclo-
sure applies to derivatives.)
[FASB ASC 825-10-50-20]
11. Has the entity properly disclosed the following about each
significant concentration: (Note: These disclosure require-
ments do not apply to financial instruments described in
FASB ASC 825-10-50-8[a], [c], [e], or [f], except for reinsurance
receivables and prepaid reinsurance premiums or financial
instruments of a pension plan, including plan assets, if subject
to the accounting and reporting requirements of FASB ASC
715.) See the preceding, with regard to derivatives.
a. Information about the (shared) activity, region, or eco-
nomic characteristic that identifies the concentration?
b. The maximum amount of loss due to credit risk that,
based on the gross fair value of the financial instru-
ment, the entity would incur if parties to the financial
instruments that make up the concentration failed com-
pletely to perform according to the terms of the con-
tracts and the collateral or other security, if any, for the
amount due proved to be of no value to the entity?
c. The entity’s policy of requiring collateral or other se-
curity to support financial instruments subject to credit
risk, information about the entity’s access to that collat-
eral or other security, and the nature and a brief de-
scription of the collateral or other security supporting
those financial instruments?
d. The entity’s policy of entering into master netting ar-
rangements to mitigate the credit risk of financial in-
struments, information about the arrangements for
which the entity is a party, and a brief description of
the terms of those arrangements, including the extent
to which they would reduce the entity’s maximum
amount of loss due to credit risk?
[FASB ASC 825-10-50-21]
12. Are concentrations of credit risk associated with reinsurance
receivables and prepaid reinsurance premiums disclosed for
a ceding entity under the provisions of FASB ASC 825-10-50?
[FASB ASC 944-825-55-1]
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13. Has a ceding entity disclosed concentrations of credit risk un-
der FASB ASC 825-10-50 if it is aware that reinsured risks
have been retroceded to a diverse group of retrocessionaires
because the assuming entity’s rights under retrocessions are
generally not available to the ceding entity to mitigate its
credit risk?
[FASB ASC 944-825-55-3]
Market Risk of All Financial Instruments
14. Although encouraged but not required, has the entity prop-
erly disclosed quantitative information about the market risks
of financial instruments that is consistent with the way it
manages or adjusts those risks? Although appropriate ways
of reporting that quantitative information will differ, possibil-
ities include the following: (Note: The following is not an ex-
haustive list and the entity is encouraged to develop other
ways of reporting quantitative information.)
a. More details about current positions and perhaps activ-
ity during the period?
b. The hypothetical effects on comprehensive income (or
net assets), or annual income, of several possible
changes in market prices?
c. A gap analysis of interest rate repricing or maturity
dates?
d. The duration of the financial instruments?
e. The entity’s value at risk from derivatives and from
other positions at the end of the reporting period and
the average value at risk during the year?
[FASB ASC 825-10-50-23]
Fair Value Option—Required Disclosures as of Each Date for Which
an Interim or Annual Statement of Financial Position Is Presented
15. Has the entity properly disclosed, as of each date for which a
statement of financial position is presented, the following in-
formation about items measured at fair value under the op-
tion in FASB ASC 825:
a. Management’s reasons for electing a fair value option
for each eligible item or group of similar eligible items?
b. The following information of the fair value option is
elected for some but not all eligible items within a
group of similar eligible items:
i. A description of those similar items and the rea-
sons for partial election?
ii. Information to enable users to understand how
the group of similar items relates to individual
line items on the statement of financial position?
c. The following information for each line item in the
statement of financial position that includes an item or
items for which the fair value option has been elected:
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i. Information to enable users to understand how
each line item in the statement of financial posi-
tion relates to major categories of assets and lia-
bilities presented in accordance with the fair
value disclosure requirements in FASB ASC 820,
Fair Value Measurements and Disclosures?
ii. The aggregate carrying amount of items included
in each line item in the statement of financial po-
sition that are not eligible for the fair value op-
tion, if any?
d. The difference between the aggregate fair value and the
aggregate unpaid principal balance of the following:
i. Loans and long term receivables (other than se-
curities subject to FASB ASC 320, Invest-
ments—Debt and Equity Securities) that have con-
tractual principal amounts and for which the fair
value option has been elected?
ii. Long term debt instruments that have contrac-
tual principal amounts and for which the fair
value option has been elected?
e. For loans held as assets for which the fair value option
has been elected,
i. the aggregate fair value of loans that are 90 days
or more past due?
ii. if the entity’s policy is to recognize interest in-
come separately from other changes in fair value,
the aggregate fair value of loans in nonaccrual
status?
iii. the difference between the aggregate fair value
and the aggregate unpaid principal balance for
loans that are 90 days or more past due, in non-
accrual status, or both?
f. The information required by FASB ASC 323-10-50-3
(equity method and joint venture investments) for in-
vestments that would have been accounted for under
the equity method if the entity had not chosen to apply
the fair value option? (Note: This disclosure applies to
investments in common stock, in-substance common
stock, and other investments that both [i] would other-
wise be required to be accounted for under the equity
method and [ii] would be required to satisfy the re-
quirements of FASB ASC 323-10-50-3. When applying
this item, the entity should apply the guidance of FASB
ASC 323-10-50-2 and FASB ASC 323-10-50-3[a] and [c].)
[FASB ASC 825-10-50-28]
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Fair Value Option—Required Disclosures for Each Period for
Which an Interim or Annual Income Statement Is Presented
16. Has the entity properly disclosed, for each period for which
an interim or annual income statement is presented, the fol-
lowing information about items measured at fair value under
the option in FASB ASC 825:
a. For each line item in the statement of financial position,
the amounts of gains and losses from fair value
changes included in earnings during the period and in
which line in the income statement those gains and
losses are reported? (An entity may meet this require-
ment by disclosing amounts of gains and losses that in-
clude amounts of gains and losses for other items meas-
ured at fair value, such as items required to be
measured at fair value.)
b. A description of how interest and dividends are meas-
ured and where they are reported in the income state-
ment?
c. For loans and other receivables held as assets, (i) the
estimated amount of gains or losses included in earn-
ings during the period attributable to changes in instru-
ment-specific credit risk and (ii) how the gains or losses
attributable to changes in instrument-specific credit risk
were determined?
d. For liabilities with fair values that have been signifi-
cantly affected during the reporting period by changes
in the instrument-specific credit risk, (i) the estimated
amount of gains and losses from fair value changes in-
cluded in earnings that are attributable to changes in
the instrument-specific credit risk, (ii) qualitative infor-
mation about the reasons for those changes, and (iii)
how the gains and losses attributable to changes in in-
strument-specific credit risk were determined?
[FASB ASC 825-10-50-30]
Fair Value Option—Other Required Disclosures
17. Has the entity properly disclosed, for its annual period only,
the methods and significant assumptions used to estimate the
fair value of items for which the fair value option has been
elected?
[FASB ASC 825-10-50-31]
18. Has the entity properly disclosed the following information
in the financial statements for the period of the election, if it
had elected the fair value option at the time one of the events
in FASB ASC 825-10-25-4(d)–(e) occurred:
a. Qualitative information about the nature of the event?
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b. Quantitative information by line item in the statement
of financial position indicating which line items in the
income statement include the effect of initially electing
the fair value option for an item?
[FASB ASC 825-10-50-32]
P. Financial Instruments—Registration Payment Arrangements
(FASB ASC 825-20)
Disclosure
1. Has the entity properly disclosed the following information,
if it is the issuer of a registration payment arrangement, about
each registration payment arrangement or each group of sim-
ilar arrangements: (Note: These disclosures are incremental to
the disclosures that may be required under other applicable
GAAP and are required even if the likelihood of the issuer
having to make any payments under the arrangement is re-
mote.)
a. The nature of the registration payment, including all of
the following:
i. The approximate term of the arrangement?
ii. The financial instrument(s) subject to the ar-
rangement?
iii. The events or circumstances that would require
the issuer to transfer consideration under the ar-
rangement?
b. Any settlement alternatives contained in the terms of
the registration payment arrangement, including the
party that controls the settlement alternatives?
c. The maximum potential amount of consideration, un-
discounted, that the issuer could be required to transfer
under the registration payment arrangement (including
the maximum number of shares that may be required
to be issued)?
d. If the terms of the arrangement provide for no limita-
tion to the maximum potential consideration (including
shares) to be transferred, that fact should be disclosed?
e. The current carrying amount of the liability represent-
ing the issuer’s obligations under the registration pay-
ment arrangement?
f. The income statement classification of any gains or
losses resulting from changes in the carrying amount of
the liability representing the issuer’s obligations under
the registration payment arrangement?
[FASB ASC 825-20-50 par. 1–2]
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Q. Foreign Currency Transactions (FASB ASC 830-20)
Presentation
1. Has the entity properly presented the aggregate transaction
gain or loss included in determining net income for the pe-
riod in the financial statement or the notes thereto?
[FASB ASC 830-20-45-1]
Disclosure
2. Has the entity properly disclosed, in the notes to the financial
statements (if not disclosed in the financial statements, as dis-
cussed in FASB ASC 830-20-45-2), the aggregate transaction
gain or loss included in determining net income for the pe-
riod?
[FASB ASC 830-20-50-1]
Subsequent Rate Changes
3. Has the entity properly disclosed significant rate changes that
have occurred after the date of the financial statements and
the effects on unsettled balances related to foreign currency
transactions? (Note: The disclosure should include consider-
ation of changes in unsettled transactions from the date of the
financial statements to the date that the rate changed. Fur-
ther, in some cases it is not practicable to determine these
changes, if so, the entity should disclose that fact.)
[FASB ASC 830-20-50-2]
Effects of Rate Changes on Results of Operations
4. Although encouraged but not required, has the entity supple-
mented the disclosures required by FASB ASC 830-20-50 with
an analysis and discussion of the effects of rate changes on
the reported results of operations? (Note: This type of disclo-
sure might include the mathematical effects of translating
revenue and expenses at rates that are different from those
used in a preceding period as well as the economic effects of
rate changes, such as the effects on selling prices, sales vol-
ume, and cost structures. The purpose is to assist financial
report users in understanding the broader economic implica-
tions of rate changes and to compare recent results with those
of prior periods.)
[FASB ASC 830-20-50-3]
R. Foreign Currency Matters—Translation of Financial Statements
(FASB ASC 830-30)
Disclosure
Analysis of Changes in Cumulative Translation Adjustment
1. Has the entity properly disclosed an analysis of the changes
during the period in the accumulated amount of translation
adjustments reported in equity, either in a separate financial
statement, as a part of the statement of changes in equity or
in the notes to the financial statements? (See FASB ASC 830-
30-45-20 for minimum disclosure requirements.)
[FASB ASC 830-30-50-1]
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Subsequent Rate Change
2. Has the entity properly disclosed, if significant rate changes
have occurred after the date of the financial statements, the
rate change and its effects on unsettled balances related to
foreign currency transactions, if significant?
[FASB ASC 830-30-50-2]
S. Capitalization of Interest (FASB ASC 835-20)
Disclosure
1. Has the entity properly disclosed the following information
regarding interest cost, in the financial statement or related
notes:
a. For accounting periods in which no interest is capital-
ized, the amount of interest cost incurred and charged
to expense during the period?
b. For an accounting period in which some interest cost is
capitalized, the total amount of interest cost incurred
during the period and the amount thereof that has been
capitalized?
[FASB ASC 835-20-50-1]
T. Imputation of Interest (FASB ASC 835-30)
1. If a note is noninterest bearing or has an inappropriate stated
interest rate
a. is the discount or premium presented as a deduction
from or addition to the face amount of the note?
b. does the disclosure include the effective interest rate
and face amount of the note? (Note: See FASB ASC 835-
30-55-8 for an illustration of balance sheet presentation
of a discount on a note.)
c. is amortization of discount or premium reported as in-
terest in the income statement?
d. are issue costs reported on the balance sheet as deferred
charges?
[FASB ASC 835-30-45 par. 1–4]
U. Leases—Overall (Lessees) (FASB ASC 840-10)
Presentation
1. Has the entity properly presented the accounts of any subsid-
iaries whose principal business activity is leasing property or
facilities to the parent or other affiliated entities on a consoli-
dated basis? (Note: The equity method is not adequate for fair
presentation of those subsidiaries.)
[FASB ASC 840-10-45-1]
Disclosure
2. Has the entity properly disclosed the nature and extent of
leasing transactions with related parties?
[FASB ASC 840-10-50-1]
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3. Has the entity, as a lessee, properly disclosed, in its financial
statements or notes thereto, a general description of its leas-
ing arrangements, including, but not limited to:
a. The basis on which contingent rental payments are de-
termined?
b. The existence and terms of renewal or purchase options
and escalation clauses?
c. Restrictions imposed by lease agreements, such as
those concerning dividends, additional debt, and fur-
ther leasing?
[FASB ASC 840-10-50-2]
4. If leasing, exclusive of leveraged leasing, is a significant part
of the lessor’s business activities in terms of revenue, net in-
come, or assets, is a general description of the lessor’s leasing
arrangements disclosed?
[FASB ASC 840-10-50-4]
V. Operating Leases (Lessees) (FASB ASC 840-20)
Presentation
1. Has the entity properly presented rental costs in the lessee’s
income from continuing operations?
[FASB ASC 840-20-45-1]
Disclosure
2. Has the entity properly disclosed, for all operating leases, the
rental expense for each period for which an income statement
is presented, with separate amounts for minimum rentals,
contingent rentals, and sublease rentals? (Note: Rental pay-
ments under leases with terms of a month or less that were
not renewed need not be included.)
[FASB ASC 840-20-50-1]
3. Has the entity properly disclosed, for all operating leases
having initial or remaining noncancelable lease terms in ex-
cess of one year (a) the future minimum rental payments re-
quired as of the date of the latest balance sheet presented, in
aggregate and for each of the five succeeding fiscal years, and
(b) the total of minimal rentals to be received in the future
under noncancelable subleases as of the date of the latest bal-
ance sheet presented?
[FASB ASC 840-20-50-2]
4. If there is a modification of lease terms and the increase in
lease payments is a termination penalty, is the accounting
policy disclosed in accordance with FASB ASC 235, Notes to
Financial Statements?
[FASB ASC 840-20-55-6]
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W. Capital Leases (Lessees) (FASB ASC 840-30)
Presentation
1. Has the entity properly presented assets recorded under cap-
ital leases and the accumulated amortization thereon sepa-
rately in the lessee’s balance sheet or notes thereto?
[FASB ASC 840-30-45-1]
2. Has the entity properly presented obligations under capital
leases and separately identified them as such in the lessee’s
balance sheet and have they been properly classified using
the same consideration as other obligations in classifying
them with current and noncurrent liabilities in classified bal-
ance sheets?
[FASB ASC 840-30-45-2]
3. Has the entity properly presented interest expense or amor-
tization of leased assets with depreciation expense and prop-
erly disclosed that fact, or properly presented the amortiza-
tion charge as a separate disclosure in the financial
statements or notes thereto?
[FASB ASC 840-30-45-3]
Disclosure
4. Has the entity properly disclosed the following information,
in the financial statements or notes thereto, about capital
leases:
a. The gross amounts of assets recorded under capital
leases as of each balance-sheet date presented by major
classes according to nature or function? (Note: This in-
formation may be combined with comparable informa-
tion for owned assets.)
b. The future minimum lease payments as of the latest
balance sheet presented in the aggregate and for each
of the five succeeding fiscal years with separate deduc-
tions from the total for the amount representing execu-
tory costs, including any profit thereon, included in the
minimum lease payments and for the amount of im-
puted interest necessary to reduce net minimum lease
payments to present value?
c. The total of future minimum sublease rentals to be re-
ceived in the future under noncancelable subleases as
of the latest balance-sheet date?
d. The total contingent rentals actually incurred for each
period for which an income statement is presented?
[FASB ASC 840-30-50-1]
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X. Sale-Leaseback Transactions (Lessees) (FASB ASC 840-40)
Disclosure
1. Has the entity properly disclosed in the financial statements,
as a seller-lessee, a description of the terms of the sale-lease-
back transaction including future commitments, obligations,
provisions, or circumstances that require or result in the
seller-lessee’s continuing involvement?
[FASB ASC 840-40-50-1]
Real Estate—Transactions That Do Not Qualify for Sale-Leaseback
Accounting
2. Has the entity properly disclosed in the financial statements,
as a seller-lessee that has accounted for a sale-leaseback trans-
action by the deposit method or as a financing according to
the guidance of FASB ASC 840-40, both of the following:
a. The obligation for future minimum lease payments as
of the date of the latest balance sheet presented in the
aggregate and for each of the five succeeding fiscal
years?
b. The total of minimum sublease rentals, if any, to be re-
ceived in the future under noncancelable subleases in
the aggregate and for each of the five succeeding fiscal
years?
[FASB ASC 840-40-50-2]
Y. Leases—Overall (Lessors) (FASB ASC 840-10)
Disclosure
1. Has the entity properly disclosed the nature and extent of
leasing transactions with related parties?
[FASB ASC 840-10-50-1]
2. Has the entity properly disclosed, in the financial statements
or footnotes thereto, a general description of the leasing ar-
rangements if a significant part of the entity’s business activ-
ities is leasing activity?
[FASB ASC 840-10-50-4]
3. Has the entity properly disclosed (a) its accounting policy for
contingent rental income, and (b) if a lessor accrues contin-
gent rental income before the lessee’s achievement of the
specified target (provided the achievement of that target is
considered probable), disclosure of the impact on rental in-
come presented as if the lessor’s accounting policy was to
defer contingent rental income until the specified target is
met?
[FASB ASC 840-10-50-5]
Z. Operating Leases (Lessors) (FASB ASC 840-20)
Presentation
1. Has the entity properly presented leased property with or
near property, plant, and equipment in the balance sheet?
[FASB ASC 840-20-45-2]
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2. Has the entity properly presented accumulated depreciation
as a deduction in the investment in the leased property in the
balance sheet?
[FASB ASC 840-20-45-3]
Disclosure
3. Has the entity properly disclosed, in the financial statements
or footnotes thereto, the following, if a significant part of the
entity’s business activities are the result of leasing activity:
a. The cost and carrying amount (if different) of property
on lease or held for leasing by major classes of property
according to nature and function, and the amount of
accumulated depreciation in total as of the latest bal-
ance-sheet date?
b. The minimum future rentals on noncancelable leases as
of the latest balance-sheet date presented, in the aggre-
gate and for each of the five succeeding fiscal years?
c. The total contingent rentals included in income for each
period for which an income statement is presented?
[FASB ASC 840-20-50-4]
AA. Capital Leases (Lessors) (FASB ASC 840-30)
Presentation
Sales-Type Leases and Direct Financing Leases
1. Has the entity properly presented the net investment in a
sales-type or direct financing lease(s) using the same consid-
erations as other assets in classification as current or noncur-
rent assets in a classified balance sheet?
[FASB ASC 840-30-45-4]
Leveraged Leases
2. Has the entity properly presented, for the purposes of pre-
senting the investment in a leveraged lease, the amount of
related deferred taxes separately from the remainder of the
net investment, in the balance sheet, and the amount of pre-
tax income, the tax effect of pretax income, and the amount
of investment tax credit recognized, separately, in the income
statement or notes thereto?
[FASB ASC 840-30-45-5]
Disclosure
Sales-Type Leases and Direct Financing Leases
3. Has the entity properly disclosed, in the financial statements
or footnotes thereto, the following, if a significant part of the
entity’s business activities are the result of sales-type and di-
rect financing leasing activity:
a. The components of the net investment in sales-type and
direct financing leases as of each balance-sheet date:
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i. Future minimum lease payments to be received,
with separate deductions for (1) amounts repre-
senting executory costs, including any profit
thereon, included in minimum lease payments
and (2) the accumulated allowances for uncollec-
tible minimum lease payments receivable?
ii. The unguaranteed residual values accruing to the
benefit of the lessor?
iii. For direct financing leases only, initial direct
costs?
iv. Unearned income?
b. The future minimum lease payments to be received for
each of the five succeeding fiscal years as of the latest
balance sheet presented?
c. The total contingent rentals included in income for each
period for which an income statement is presented?
[FASB ASC 840-30-50-4]
Leveraged Leases
4. Has the entity properly disclosed, in the notes to the financial
statements, the following, as set forth in FASB ASC 840-30-
25-8, if a significant part of the entity’s business activities are
the result of leveraged leasing activity:
a. Rentals receivable?
b. Investment-tax-credit receivable?
c. Estimated residual value of the leased asset?
d. Unearned and deferred income?
[FASB ASC 840-30-50-5]
5. Has the entity properly disclosed, if accounting for the effect
on leveraged leases of the change in tax rates results in a sig-
nificant variation from the customary relationship between
income tax expense and pretax accounting income and the
reason for that variation is not otherwise apparent, the reason
for that variation?
[FASB ASC 840-30-50-6]
BB. Nonmonetary Transactions (FASB ASC 845-10)
Disclosure
1. Has the entity properly disclosed the following, related to
nonmonetary transactions during the period:
a. The nature of the transactions?
b. The basis of accounting for the assets transferred?
c. Any gains or losses recognized on the transfers?
[FASB ASC 845-10-50-1]
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2. Has the entity properly disclosed, in each period’s financial
statements, the amount of gross operating revenue recog-
nized as a result of nonmonetary transactions (see FASB ASC
505-50)?
[FASB ASC 845-10-50-2]
Purchase and Sale of Inventory
3. Has the entity properly disclosed the amount of revenue and
costs (or gains and losses) associated with inventory ex-
changes recognized at fair value?
[FASB ASC 845-10-50-3]
CC. Related Party Disclosures (FASB ASC 850-10)
Disclosure
1. Has the entity properly disclosed the following for material
related party transactions, other than compensation arrange-
ments, expense allowances, and other similar items in the or-
dinary course of business (excluding any that are eliminated
in the preparation of consolidated or combined financial
statements):
a. The nature of the relationship(s) involved?
b. A description of the transactions, including transac-
tions to which no amounts or nominal amounts were
ascribed, for each of the periods for which income
statements are presented, and such other information
deemed necessary to an understanding of the effects of
the transactions on the financial statements?
c. The dollar amounts of transactions for each of the per-
iods for which income statements are presented and the
effect of any change in the method of establishing the
terms from that used in the preceding period?
d. Amounts due from or to related parties as of the date
of each balance sheet presented and, if not otherwise
apparent, the terms and manner of settlement?
e. If the entity issues separate financial statements and is
a member of a group that files a consolidate tax return,
i. the aggregate amount of current and deferred tax
expense for each statement of earnings presented
and the amount of any tax-related balances due
to or from affiliates as of the date of each state-
ment of financial position presented?
ii. the principal provisions of the method by which
the consolidated amount of current and deferred
tax expense is allocated to members of the group
and the nature and effect of any changes in that
method (and in determining related balances to
or from affiliates) during the years for which the
preceding disclosures are presented?
[FASB ASC 850-10-50-1]
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2. Has the entity shown separately notes or accounts receivable
from officers, employees, or affiliated entities and not in-
cluded them under a general heading (such as notes receiva-
ble or accounts receivable)?
[FASB ASC 850-10-50-2]
3. Has the entity properly disclosed, if necessary to understand
the relationship, the name of the related party?
[FASB ASC 850-10-50-3]
4. Has the entity properly not disclosed duplicate disclosures in a
separate set of financial statements that are presented in the fi-
nancial report of another entity (the primary entity) if those sep-
arate financial statements are also consolidated or combined in
a complete set of financial statements and both sets of financial
statements are presented in the same financial report?
[FASB ASC 850-10-50-4]
Purchase and Sales of Inventory
5. Has the entity properly disclosed representations about trans-
actions with related parties in such a manner that they avoid
the implication that the related party transactions were con-
summated at arm’s length, or if such implications are made,
can they be substantiated?
[FASB ASC 850-10-50-5]
Control Relationships
6. If the reporting entity and one or more other entities are under
common ownership or common control and the existence of
that control could result in operating results or financial posi-
tion of the reporting entity being significantly different from
those that would have been obtained if the entities were auton-
omous, has the entity properly disclosed the nature of a control
relationship, even if there are no transactions between the en-
tities?
[FASB ASC 850-10-50-6]
DD. Reorganizations (FASB ASC 852-10 and FASB ASC 852-20)
Additional Presentation and Disclosure Information
For entities involved in reorganizations, see FASB ASC 852-10 for presentation and disclosure information.
For entities involved in quasi-reorganizations, see FASB ASC 852-20 for presentation and disclosure infor-
mation.
EE. Subsequent Events (FASB ASC 855-10)32
Disclosure
Dates Through Which Subsequent Events Have Been Evaluated
1. Has the entity properly disclosed the following regarding sub-
sequent events:
32 In February 2010, FASB issued ASU No. 2010-09, Subsequent Events (Topic 855): Amendments to Certain Recognition and Disclosure
Requirements. This ASU amends the guidance to require entities (except Securities and Exchange Commission [SEC] filers and conduit
(continued)
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a. The date through which subsequent events have been
evaluated?
b. Whether the date disclosed in item (a) is the date the
financial statements were issued, or the date the financial
statements were available to be issued?
[FASB ASC 855-10-50-1]
Nonrecognized Subsequent Events
2. Has the entity properly disclosed the following regarding non-
recognized subsequent events such that the financial state-
ments are kept from being misleading:
a. The nature of the event?
b. An estimate of its financial effect, or a statement that such
an estimate cannot be made?
[FASB ASC 855-10-50-2]
3. Has the entity considered disclosing, regarding significant non-
recognized subsequent events, historical financial statements
with pro forma financial data, including the presentation of pro
forma statements (usually a balance sheet only, in columnar
form on the face of the historical statements)?
[FASB ASC 855-10-50-3]
Reissuance of Financial Statements
4. Has the entity properly disclosed in revised financial state-
ments the dates through which subsequent events have been
evaluated in both the issued or available to be issued financial
statements and in the revised financial statements?
[FASB ASC 855-10-50-4]
FF. Transfers and Servicing (FASB ASC 860-10)33
Disclosure
Additional Disclosure Information
FASB ASC 860-10-50 contains disclosures for both nonpublic and public companies. See the following “Public
Entity Disclosures” section for required disclosures specific to public entities.
1A. If it is not practicable to estimate the fair value of certain assets
obtained or liabilities incurred in transfers of financial assets
during the period, has the entity disclosed a description of those
items and the reasons why it is not practicable to estimate their
fair value?
[FASB ASC 860-10-50-1]
debt obligors [CDOs]) to evaluate subsequent events through the date that the financial statements are available to be issued. SEC filers
and CDOs should evaluate subsequent events through the date the financial statements are issued. Entities other than SEC filers should
disclose both the date through which subsequent events have been evaluated and whether that date is the "issued" date or "available to
be issued" date.
The amendments in this ASU were effective immediately upon issuance, except for CDOs. The amendments in this ASU are effective
for CDOs for interim and annual periods ending after June 15, 2010 (that is, December 31, 2010, for entities with calendar year-ends).
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2010-09.
Readers can refer to the full text of the ASU on the FASB website at www.fasb.org.
33 See footnote 4.
186 Life and Health Insurance Entities
FSP §20,100.01
Yes No N/A
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-10-50-1]
Public Entity Disclosures
Public Entities—Disclosure Objectives
2A. Has the public entity properly disclosed the following:
a. A transferor’s continuing involvement with financial as-
sets that it has transferred in a securitization or asset-
backed financing arrangement?
b. The nature of any restrictions on assets reported by an
entity in its statement of financial position that related to
a transferred financial asset, including the carrying
amounts of such assets?
c. How servicing assets and servicing liabilities are re-
ported under FASB ASC 860-50?
d. For securitization or asset-backed financing arrange-
ments accounted for as sales if a transferor has continu-
ing involvement with the transferred financial assets and
transfers of financial assets accounted for as secured bor-
rowings, how the transfer of financial assets affects an
entity’s financial position, financial performance, and
cash flows?
[FASB ASC 860-10-50-3]
2B. (ASU No. 2009-16) Has the public entity properly disclosed, in
order to meet the objectives of the public entity disclosure re-
quirements of FASB ASC 860, the following in order to provide
the financial statement users an understanding of the follow-
ing:
a. A transferor’s continuing involvement, if any, with trans-
ferred financial assets?
b. The nature of any restrictions on assets reported by an
entity in its statement of financial position that related to
a transferred financial asset, including the carrying
amounts of such assets?
c. How servicing assets and servicing liabilities are re-
ported under FASB ASC 860-50?
d. For both of the following, how the transfer of financial
assets affects an entity’s financial position, financial per-
formance, and cash flows:
i. Transfers accounted for as sales, if a transferor has
continuing involvement with the transferred fi-
nancial assets?
ii. Transfers of financial assets accounted for as se-
cured borrowing?
[“Pending Content” in FASB ASC 860-10-50-3]
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3A. Has the public entity properly disclosed the items in FASB ASC
860-10-50-3 in a manner that clearly and fully explains to the
financial statements users the risks related to the transferred
financial assets and any restrictions on the assets of the entity?
(Note: The entity may need to supplement the required public-
entity disclosures of FASB ASC 860 depending on the facts and
circumstances of a transfer and the entity’s continuing involve-
ment with the transferred financial assets.)
[FASB ASC 860-10-50-4]
3B. (ASU No. 2009-16) Has the public entity achieved the objectives
in FASB ASC 860-10-50-3 through their disclosures, regardless
of whether any of the specific disclosures of FASB ASC 860,
including any possible supplemental disclosures depending on
the following apply (disclosures required for a particular form
of continuing involvement should be considered when deter-
mining whether the disclosure objectives of FASB ASC 860
have been met):
a. The facts and circumstances of the transfer?
b. The nature of an entity’s continuing involvement with
the transferred financial assets?
c. The effect of an entity’s continuing involvement on the
transferor’s financial position, financial performance,
and cash flows?
[“Pending Content” in FASB ASC 860-10-50-4]
Public Entities—Aggregation of Certain Disclosures
4. (ASU No. 2009-16) Has the public entity properly disclosed the
following, if it aggregates disclosures for similar transfers (and
separate reporting would not provide more information):
a. How similar transfers are aggregated?
b. A distinguishment between transfers that are accounted
for as secured borrowings and transfers that are ac-
counted for as sales?
[“Pending Content” in FASB ASC 860-10-50-4A]
5A. Has the public entity properly disclosed the following, if it
aggregates disclosures for similar transfers (and separate re-
porting would not provide more information): (Note: Quanti-
tative and qualitative information about the characteristics of
the transferred financial assets should be considered when de-
termining whether to aggregate disclosures for multiple trans-
fers. Consideration should be given to, at a minimum, [a] the
nature of the transferor’s continuing involvement, [b] the types
of financial assets transferred, [c] risks related to the transferred
financial assets to which the transferor continues to be exposed
after the transfer and the change in the transferor’s risk profile
as a result of the transfer, and [d] the guidance of FASB ASC
310-10-50-25 and FASB ASC 825-10-55 paragraphs 1–2.)
a. A distinguishment between transfers that are accounted
for as secured borrowings and transfers that are ac-
counted for as sales?
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b. A distinguishment between transfers to qualifying spe-
cial-purpose entities accounted for as sales and all other
transactions accounted for as sales?
[FASB ASC 860-10-50-5]34
GG. Sales of Financial Assets (FASB ASC 860-20)35
Disclosure
Additional Disclosure Information
FASB ASC 860-20-50 contains disclosures for both nonpublic and public companies. See the following “Public
Entity Disclosures” section for required disclosures specific to public entities.
Nonpublic Entities—Financial Assets Securitized36
1A. Has the entity properly disclosed the following, for each major
asset type, if it has securitized financial assets during any pe-
riod presented and accounts for that transfer as a sale:
a. Its accounting policies for initially measuring the inter-
ests that continue to be held by the transferor, if any, and
servicing assets or servicing liabilities, if any, including
the methodology (whether quoted market price, prices
based on sales of similar assets and liabilities, or prices
based on valuation techniques) used in determining their
fair value?
b. The characteristics of securitizations (a description of the
transferor’s continuing involvement with the transferred
assets, including, but not limited to, servicing, recourse,
and restrictions on interests that continue to be held by
the transferor) and the gain or loss from sale of financial
assets in securitizations?
c. The key assumptions used in measuring the fair value of
interests that continue to be held by the transferor and
servicing assets or servicing liabilities, if any, at the time
of securitization (including, at a minimum, quantitative
information about discount rates, expected prepayments
including the expected weighted-average life of prepay-
able financial assets, and anticipated credit losses, if ap-
plicable)? (If any entity has made multiple securitizations
of the same major asset type during a period, it may
disclose the range of assumptions.)
34 “Pending Content” in FASB ASC 860-10-50-5 removes the requirements from FASB ASC 860-10-50-5 regarding a distinguishment
between transfers that are accounted for as secured borrowings and transfers that are accounted for as sales and a distinguishment
between transfers to qualifying special-purpose entities accounted for as sales and all other transactions accounted for as sales. Entities
subject to FASB ASU No. 2009-16 should refer to “Pending Content” in FASB ASC 860-10-50-5 for more information.
35 See footnote 4.
36 At the effective date of ASU No. 2009-16, the title of this section will change to Nonpublic Entities—Disclosures for Each Income Statement
Presented.
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d. Cash flows between the securitization special purpose
entity and the transferor, unless reported separately else-
where in the financial statements or notes (including pro-
ceeds from new securitizations, proceeds from collec-
tions reinvested in revolving-period securitizations,
purchases of delinquent or foreclosed loans, servicing
fees, and cash flows received on interests that continue
to be held by the transferor)?
[FASB ASC 860-20-50-3]
1B. (ASU No. 2009-16) Has the entity properly disclosed the follow-
ing, for each income statement period presented, the following:
a. The characteristics of the transfer, including (i) a descrip-
tion of the transferor’s continuing involvement with the
transferred financial assets, (ii) the nature and fair value
of the assets obtained as proceeds and the liabilities in-
curred in the transfer, and (iii) the gain or loss from the
sale of transferred financial assets?
b. For the initial fair value measurements in item (a), the
level within the fair value hierarchy, as described in
FASB ASC 820, in which fair value measurements fall,
segregating fair value measurements into each “level?”
c. For the initial fair value measurements in item (a), the
key inputs and assumptions used in measuring the fair
value of assets obtained and liabilities incurred as a result
of the sale that relate to the transferor’s continuing in-
volvement, including quantitative information about all
of the following:
i. Discount rates?
ii. Expected prepayments including the expected
weighted-average life of prepayable financial as-
sets?
iii. Anticipated credit losses, including expected static
pool losses?
d. For the initial fair value measurements in item (a), the
valuation technique(s) used to measure fair value?
e. Cash flows between a transferor and transferee, includ-
ing (i) proceeds from new transfers, (ii) proceeds from
collections reinvested in revolving-period transfers, (iii)
purchases of previously transferred financial assets, (iv)
servicing fees, and (v) cash flows received from a trans-
feror’s interests?
[“Pending Content” in FASB ASC 860-20-50-3]
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Nonpublic Entities—Interests That Continue to Be Held37
2A. Has the entity properly disclosed the following, if the entity
has interests that continue to be held by a transferor in financial
assets that is has securitized or servicing assets or servicing
liabilities relating to assets that it has securitized, at the date of
the latest statement of financial position presented, for each
major asset type:
a. Its accounting policies for subsequently measuring those
interest, including the methodology used in determining
their fair value?
b. The key assumptions used in subsequently measuring
the fair value of those interests including, at a minimum,
quantitative information about (i) discount rates, (ii) ex-
pected prepayments including the expected weighted-
average life of prepayable financial assets, and (iii) antic-
ipated credit losses, if applicable?
c. A sensitivity analysis or stress test showing the hypo-
thetical effect on the fair value of those interests (includ-
ing any servicing assets or servicing liabilities) of two or
more unfavorable variations from the expected levels for
each key assumption that is reported under item (b) in-
dependently from any change in another key assump-
tion?
d. A description of the objectives, methodology, and limi-
tations of the sensitivity analysis or stress test?
e. For the securitized assets and any other financial assets
that it manages together with them,
i. the total principal amount outstanding, the por-
tion that has been derecognized, and the portion
that continues to be recognized in each category
reported in the statement of financial position, at
the end of the period?
ii. delinquencies at the end of the period?
iii. credit losses, net of recoveries, during the period?
[FASB ASC 860-20-50-4]
2B. (ASU No. 2009-16) Has the entity properly disclosed the follow-
ing, for each statement of financial presented, regardless of
when the transfer occurred, the following:
37 See footnote 36.
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a. Qualitative and quantitative information about the trans-
feror’s continuing involvement with transferred finan-
cial assets that provides financial statement users with
sufficient information to assess the reasons for the con-
tinuing involvement and the risks related to the trans-
ferred financial assets to which the transferor continues
to be exposed after the transfer and the extent that the
transferor’s risk profile has changed as a result of the
transfer, including the following:
i. The total principal amount outstanding?
ii. The amount that has been derecognized?
iii. The amount that continues to be recognized in the
statement of financial position?
iv. The terms of any arrangements that could require
the transferor to provide financial support to the
transferee or its beneficial interest holders, includ-
ing (1) a description of any events or circumstances
that could expose the transferor to loss and (2) the
amount of the maximum exposure to loss?
v. Whether the transformer has provided financial or
other support during the periods presented that it
was not previously contractually required to pro-
vide to the transferee or its beneficial interest hold-
ers, including (1) the type and amount of support
and (2) the primary reason for providing the sup-
port?
vi. Although encouraged, but not required, informa-
tion about any liquidity arrangements, guarantees,
or other commitments by third parties related to
the transferred financial assets that may affect the
fair value or risk of the related transferor’s interest?
b. The entity’s accounting policies for subsequently meas-
uring assets or liabilities that relate to the continuing
involvement with the transferred financial assets?
c. The key inputs and assumptions used in measuring the
fair value of those interests including, at a minimum,
quantitative information about (i) discount rates, (ii) ex-
pected prepayments including the expected weighted-
average life of prepayable financial assets, and (iii) antic-
ipated credit losses, if applicable? (Note: If the entity has
aggregated transfers during a period in accordance with
FASB ASC 860-10-50-5, it may disclose the range of as-
sumptions.)
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d. A sensitivity analysis or stress test showing the hypo-
thetical effect on the fair value of those interests (includ-
ing any servicing assets or servicing liabilities) of two or
more unfavorable variations from the expected levels for
each key assumption that is reported under item (b) in-
dependently from any change in another key assump-
tion?
e. A description of the objectives, methodology, and limi-
tations of the sensitivity analysis or stress test?
f. Information about the asset quality of transferred finan-
cial assets and any other financial assets that it manages
together with them? (Note: This information should be
separated between assets that have been derecognized
and assets that continue to be recognized in the statement
of financial position. This information is intended to pro-
vide financial statement users with an understanding of
the risks inherent in the transferred financial assets as
well as in other financial assets and liabilities that it man-
ages together with transferred financial assets.)
[“Pending Content” in FASB ASC 860-20-50-4]
All Entities Within the Scope of Subtopic—Sales of Loans and Trade
Receivables
3. Has the entity properly disclosed the aggregate amount of
gains or losses on sales of loans or trade receivables (including
adjustments to record loans held for sale at the lower of cost or
fair value) separately in the financial statements or in the notes
to the financial statements?
[FASB ASC 860-20-50-5]38
Public Entity Disclosures
Public Entities
4A. If specific disclosures are required elsewhere in FASB ASC for
a particular form of the transferor’s continuing involvement,
has the public entity properly disclosed the information re-
quired in paragraphs 8(b) and 9(a) of FASB ASC 860-20-50 with
a cross reference between the separate notes to the financial
statements so that a user can understand the risks retained in
the transfer, if, other specific disclosures required by FASB ASC
are made elsewhere? (Note: The entity is not required to pro-
vide each specific disclosure in FASB ASC 860-20-50-8(a), 860-
20-50-8(c), 860-20-50-9(a)(1)–(4), and 860-20-50-9(b)–(e) if the
disclosure is not required by other U.S. GAAP and if it is not
meaningful to financial statement users.)
[FASB ASC 860-20-50-7]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-20-50-7]
38 “Pending Content” in FASB ASC 860-20-50-5 will not change the disclosure requirements on FASB ASC 860-20-50-5 and has not
been included in this checklist.
193Financial Statements and Notes Checklist
FSP §20,100.01
Yes No N/A
Public Entities—Disclosures for Each Income Statement Presented
Presentation
5A. Has the public entity properly disclosed, for each income state-
ment presented, the following related to securitization or asset-
backed financing arrangements accounted for as sales if the
transferor has continuing involvement:
a. Its accounting policies for initially measuring the inter-
ests that continue to be held by the transferor, if any, and
servicing assets or servicing liabilities, if any?
b. The characteristics of the transfer including a description
of the transferor’s continuing involvement with the
transferred financial assets and the gain or loss from the
sale of transferred assets?
c. Cash flows between a transferee and the transferor, in-
cluding proceeds from new transfers, proceeds from col-
lections reinvested in revolving-period transfers, pur-
chases of previously transferred financial assets (or its
underlying collateral), servicing fees, and cash flows re-
ceived on the interests that continue to be held by the
transferor?
[FASB ASC 860-20-50-8]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-20-50-8]
Public Entities—Disclosures for Each Statement of Financial Position
Presented
6A. Has the public entity properly disclosed, for each statement of
financial position presented, the following related to securiti-
zation or asset-backed financing arrangements accounted for
as sales if the transferor has continuing involvement:
a. Qualitative and quantitative information about the trans-
feror’s continuing involvement with transferred finan-
cial assets that provides financial statement users with
sufficient information to assess the reasons for the con-
tinuing involvement and the risks related to the trans-
ferred financial assets to which the transferor continues
to be exposed after the transfer and the extent that the
transferor’s risk profile has changed as a result of the
transfer (including, but not limited to, credit risk, interest
rate risk, and other risks), including all of the following:
i. The nature, purpose, size, and activities of special-
purpose entities used to facilitate a transfer of fi-
nancial assets, if applicable, including how the spe-
cial-purpose entities are financed?
ii. The total principal amount outstanding, the por-
tion that has been derecognized, and the amount
that continues to be recognized in each category
reported in the statement of financial position?
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iii. The terms of any arrangements that could require
the transferor to provide financial support (for ex-
ample, liquidity arrangements and obligations to
purchase assets) to the transferee or its beneficial
interest holders, including a description of any
events or circumstances that could expose the
transferor to loss. All available evidence should be
considered, including, but not limited to all of the
following: (1) explicit written arrangements, (2)
communications between the transferor and the
transferee or its beneficial interest holders, and (3)
unwritten arrangements customary to similar
transfers?
iv. Whether the transferor has provided financial or
other support during the periods presented that it
was not previously contractually required to pro-
vide to the transferee or its beneficial interest hold-
ers, including—when the transferor assisted the
transferee or its beneficial interest holders in ob-
taining support—both the type and amount of
support and the primary reasons for the support?
v. Although encouraged, but not required, informa-
tion about any liquidity arrangements, guarantees,
or other commitments by third parties related to
the transferred financial assets that may affect the
fair value or risk of the interest that continues to
be held by the transferor?
b. The accounting policies for subsequently measuring as-
sets or liabilities that relate to the continuing involvement
with the transferred financial assets?
c. The key inputs and assumptions used in measuring the
fair value of assets or liabilities that relate to the trans-
feror’s continuing involvement including, at a minimum,
quantitative information about (i) discount rates, (ii) ex-
pected prepayments, including the expected weighted-
average life of prepayable financial assets, and (iii) antic-
ipated credit losses, including expected static pool
losses?
d. For interests that continue to be held by the transferor in
financial assets, both of the following:
i. A sensitivity analysis or stress test showing the
hypothetical effect on the fair value of those inter-
ests, including any servicing assets or servicing
liabilities, of two or more unfavorable variations
from the expected levels for each key assumption
that is reported under item (c), independently from
any change in another key assumption?
ii. A description of the objectives, methodology, and
limitations of the sensitivity analysis or stress test?
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e. Information about the asset quality of transferred finan-
cial assets and any other financial assets that it manages
together with them?
[FASB ASC 860-20-50-9]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-20-50-9]
HH. Secured Borrowing and Collateral (FASB ASC 860-30)39
Presentation
1. Has the entity properly presented a collateral asset, which the
secured party has the right by contract or custom to sell or
repledge, separately from other assets not so encumbered, in
its statement of financial position?
[FASB ASC 860-30-45-1]
2. Has the entity properly presented liabilities incurred by either
the secured party or the obligor in securities borrowing or
resale transactions separately?
[FASB ASC 860-30-45-2]
Disclosure
Additional Disclosure Information
FASB ASC 860-30-50 contains disclosures for both nonpublic and public companies. See the following “Public
Entity Disclosures” section for required disclosures specific to public entities.
Nonpublic Entities—Collateral
3A. Has the entity properly disclosed the following, regarding col-
lateral:
a. If the entity has entered into repurchase agreements or
securities lending transactions, its policy for requiring
collateral or other security?
b. If the entity has pledged any of its assets as collateral that
are not reclassified and separately reported in the state-
ment of financial position pursuant to FASB ASC 860-30-
25-5(a), the carrying amount and classification of those
assets as of the date of the latest statement of financial
position presented?
c. If the entity has accepted collateral that it is permitted by
contract or custom to sell or repledge, the fair value (as
of the date of each statement of financial position pre-
sented) of that collateral and of the portion of that collat-
eral that it has sold or repledged, and information about
the sources and uses of that collateral?
[FASB ASC 860-30-50-1A]
3B. (ASU No. 2009-16) Has the entity properly disclosed the follow-
ing, regarding collateral:
39 See footnote 36.
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a. If the entity has entered into repurchase agreements or
securities lending transactions, its policy for requiring
collateral or other security?
b. As of the date of the latest statement of financial position
presented, the carrying amount and classifications of any
assets pledged as collateral that are not reclassified and
separately reported in the statement of financial position
in accordance with FASB ASC 860-30-25-5(a) and asso-
ciated liabilities, and qualitative information about the
relationship(s) between those assets and associated lia-
bilities?
c. If the entity has accepted collateral that it is permitted by
contract or custom to sell or repledge, the fair value (as
of the date of each statement of financial position pre-
sented) of that collateral and of the portion of that collat-
eral that it has sold or repledged, and information about
the sources and uses of that collateral?
[“Pending Content” in FASB ASC 860-30-50-1A]
Nonpublic Entities—Restricted Assets
4A. Has the entity properly disclosed the description of the nature
of restrictions placed on any assets set aside solely for the pur-
pose of satisfying scheduled payments of a specific obligation?
[FASB ASC 860-30-50-2]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-30-50-2]
Public Entity Disclosures
Public Entities—Collateral
5A. Has the public entity properly disclosed the following, regard-
ing collateral:
a. The policy for requiring collateral or other security dis-
closed if the reporting entity has entered into repurchase
agreements or securities lending transactions?
b. If the entity has pledged any assets as collateral, the car-
rying amount, and classification of those assets and as-
sociated liabilities as of the date of the latest statement of
financial position presented, including qualitative infor-
mation about the relationship(s) between those assets
and associated liabilities?
c. If the entity has accepted collateral that is permitted by
contract or custom to sell or repledge, the following:
i. The fair value, as of the date of each statement of
financial position presented of that collateral?
ii. The fair value, as of the date of each statement of
financial position presented of the portion of that
collateral that it has sold or repledged?
iii. Information about the sources and uses of that col-
lateral?
[FASB ASC 860-30-50-4]
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Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-30-50-4]
Public Entities—Secured Borrowings
6A. Has the public entity properly disclosed, regarding a transfer
of financial assets accounted for as a secured borrowing, the
carrying amount and classification of assets and associated li-
abilities recognized in the transferor’s statement of financial
position at the end of each period presented, including quali-
tative information about the relationship(s) between those as-
sets and associated liabilities?
[FASB ASC 860-30-50-5]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-30-50-5]
II. Servicing Assets and Liabilities (FASB ASC 860-50)40
Presentation
1. Has the entity properly presented recognized servicing assets
and servicing liabilities that are subsequently measured using
the fair value measurement method in a manner that separates
those carrying amounts on the face of the statement of financial
position from the carrying amounts for separately recognized
servicing assets and servicing liabilities that are subsequently
measured using the amortization method?
[FASB ASC 860-50-45-1]
2. Has the entity properly presented the information, in order to
accomplish the separate reporting in FASB ASC 860-40-45-1,
either by (a) displaying separate line items for the amounts that
are subsequently measured using the fair value measurement
method and amounts that are subsequently measured using
the amortization method, or (b) presenting the aggregate of
those amounts that are subsequently measured at fair value
and those amounts that are subsequently measured using the
amortization method and by disclosing parenthetically the
amount that is subsequently measured at fair value is included
in the aggregate amount?
[FASB ASC 860-50-45-2]
Disclosure
Additional Disclosure Information
FASB ASC 860-50-50 contains disclosures for both nonpublic and public companies. See the following “Public
Entity Disclosures” section for required disclosures specific to public entities.
Nonpublic Entities—All Servicing Assets and Servicing Liabilities
3A. Has the public entity properly disclosed the following regard-
ing all servicing assets and servicing liabilities:
40 See footnote 36.
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a. Management’s basis for determining its classes of serv-
icing assets and servicing liabilities?
b. A description of the risks inherent in servicing assets and
servicing liabilities and, if applicable, the instruments
used to mitigate the income statement effect of changes
in fair value of the servicing assets and servicing liabili-
ties? (Disclosure of quantitative information about the
instruments used to manage the risks inherent in serv-
icing assets and servicing liabilities, including the fair
value of those instruments at the beginning and end of
the period, is encouraged but not required.)
c. The amount of contractually specified servicing fees (as de-
fined in the FASB ASC glossary), late fees, and ancillary
fees earned for each period for which results of opera-
tions are presented, including a description of where
each amount is reported in the statement of income?
[FASB ASC 860-50-50-2]
3B. (ASU No. 2009-16) Has the entity properly disclosed the follow-
ing regarding all servicing assets and servicing liabilities:
a. Management’s basis for determining its classes of serv-
icing assets and servicing liabilities?
b. A description of the risks inherent in servicing assets and
servicing liabilities and, if applicable, the instruments
used to mitigate the income statement effect of changes
in fair value of the servicing assets and servicing liabili-
ties?
c. The amount of contractually specified servicing fees (as de-
fined in the FASB ASC glossary), late fees, and ancillary
fees earned for each period for which results of opera-
tions are presented, including a description of where
each amount is reported in the statement of income?
d. Quantitative and qualitative information about the as-
sumptions used to estimate fair value?
e. Although not required, the entity is encouraged to dis-
close quantitative information about the instruments
used to manage the risks inherent in servicing assets and
servicing liabilities, including the fair value of those in-
struments at the beginning and the end of the period,
and quantitative and qualitative information about the
assumptions used to estimate the fair value of those in-
struments?
[“Pending Content” in FASB ASC 860-50-50-2]
Nonpublic Entities—Servicing Assets and Servicing Liabilities Sub-
sequently Measured at Fair Value
4A. Has the entity properly disclosed the following regarding all
servicing assets and servicing liabilities subsequently meas-
ured at fair value:
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a. For each class of servicing assets and servicing liabilities,
the activity in the balance of servicing assets and the
activity in the balance of servicing liabilities (including a
description of where changes in fair value are reported
in the statement of income for each period for which
results of operations are presented), including, but not
limited to, the following:
i. The beginning and ending balances?
ii. Additions (through purchases of servicing assets,
assumptions of servicing obligations, and servic-
ing obligations that result from transfers of finan-
cial assets)?
iii. Disposals?
iv. Changes in the fair value during the period result-
ing from changes in valuation inputs or assump-
tions used in the valuation model?
v. Changes in the fair value during the period result-
ing from other changes in fair value and a descrip-
tion of those changes?
vi. Other changes that affect the balance and a de-
scription of those changes?
b. A description of the valuation techniques or other meth-
ods used to estimate the fair value of servicing assets and
servicing liabilities? If a valuation model is used, the
description should include the methodology and model
validation procedures, as well as quantitative and qual-
itative information about the assumptions used in the
valuation model (for example, discount rates and pre-
payment speeds). (An entity that provides quantitative
information about the instruments used to manage the
risks inherent in the servicing assets and servicing liabil-
ities, is also encouraged, but not required, to disclose a
description of the valuation techniques, as well as quan-
titative and qualitative information about the assump-
tions used to estimate the fair value of those instruments.)
[FASB ASC 860-50-50-3]
4B. (ASU No. 2009-16) Has the entity properly disclosed the follow-
ing regarding all servicing assets and servicing liabilities sub-
sequently measured at fair value:
a. For each class of servicing assets and servicing liabilities,
the activity in the balance of servicing assets and the
activity in the balance of servicing liabilities (including a
description of where changes in fair value are reported
in the statement of income for each period for which
results of operations are presented), including, but not
limited to, the following:
i. The beginning and ending balances?
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ii. Additions (through purchases of servicing assets,
assumptions of servicing obligations, and recog-
nition of servicing obligations that result from
transfers of financial assets)?
iii. Disposals?
iv. Changes in the fair value during the period result-
ing from changes in valuation inputs or assump-
tions used in the valuation model?
v. Changes in the fair value during the period result-
ing from other changes in fair value and a descrip-
tion of those changes?
vi. Other changes that affect the balance and a de-
scription of those changes?
[“Pending Content” in FASB ASC 860-50-50-3]
Nonpublic Entities—Servicing Assets and Servicing Liabilities Sub-
sequently Amortized
5A. Has the entity properly disclosed the following regarding all
servicing assets and servicing liabilities measured subse-
quently under the amortization method:
a. For each class of servicing assets and servicing liabilities,
the activity in the balance of servicing assets and the
activity in the balance of servicing liabilities (including a
description of where changes in the carrying amount are
reported in the statement of income for each period for
which results of operations are presented), including, but
not limited to, the following:
i. The beginning and ending balances?
ii. Additions (through purchases of servicing assets,
assumption of servicing obligations, and servicing
obligations that result from transfers of financial
assets)?
iii. Disposals?
iv. Amortization?
v. Application of valuation allowance to adjust car-
rying value of servicing assets?
vi. Other-than-temporary impairments?
vii. Other changes that affect the balance and a de-
scription of those changes?
b. For each class of servicing assets and servicing liabilities,
the fair value of recognized servicing assets and servicing
liabilities at the beginning and end of the period if it is
practicable to estimate the value?
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c. A description of the valuation techniques or other meth-
ods used to estimate fair value of the servicing assets and
servicing liabilities? If a valuation model is used, the
description should include the methodology and model
validation procedures, as well as quantitative and qual-
itative information about the assumptions used in the
valuation model (for example, discount rates and pre-
payment speeds). (An entity that provides quantitative
information about the instrument used to manage the
risks inherent in the servicing assets and servicing liabil-
ities, is also encouraged, but not required, to disclose a
description of the valuation techniques as well as quan-
titative and qualitative information about the assump-
tions used to estimate the fair value of those instruments.)
d. The risk characteristics of the underlying financial assets
used to stratify recognized servicing assets for purposes
of measuring impairment in accordance with FASB ASC
860-50-35-9?
e. The activity by class in any valuation allowance for im-
pairment of recognized servicing assets—including be-
ginning and ending balances, aggregate additions
charged and recoveries credited to operations, and ag-
gregate write-downs charged against the allowance—for
each period for which results of operations are pre-
sented?
[FASB ASC 860-50-50-4]
5B. Has the entity properly disclosed the following regarding all
servicing assets and servicing liabilities subsequently meas-
ured under the amortization method:
a. For each class of servicing assets and servicing liabilities,
the activity in the balance of servicing assets and the
activity in the balance of servicing liabilities (including a
description of where changes in the carrying amount are
reported in the statement of income for each period for
which results of operations are presented), including, but
not limited to, the following:
i. The beginning and ending balances?
ii. Additions (through purchases of servicing assets,
assumption of servicing obligations, and recogni-
tion of servicing obligations that result from trans-
fers of financial assets)?
iii. Disposals?
iv. Amortization?
v. Application of valuation allowance to adjust car-
rying value of servicing assets?
vi. Other-than-temporary impairments?
vii. Other changes that affect the balance and a de-
scription of those changes?
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b. For each class of servicing assets and servicing liabilities,
the fair value of recognized servicing assets and servicing
liabilities at the beginning and end of the period?
c. The risk characteristics of the underlying financial assets
used to stratify recognized servicing assets for purposes
of measuring impairment in accordance with FASB ASC
860-50-35-9? (Note: If the predominant risk characteris-
tics and resulting stratums are changes, that fact and the
reasons for those changes should be included in the dis-
closures about the risk characteristics of the underlying
financial assets used to stratify the recognized servicing
assets in accordance with “Pending Content” in FASB
ASC 860-50-50-4.)
d. The activity by class in any valuation allowance for im-
pairment of recognized servicing assets—including be-
ginning and ending balances, aggregate additions
charged and recoveries credited to operations, and ag-
gregate write-downs charged against the allowance—for
each period for which results of operations are pre-
sented?
[“Pending Content” in FASB ASC 860-50-50-4]
All Entities Within the Scope of Subtopic—Servicing Assets and Serv-
icing Liabilities Which Subsequently Measurement at Fair Value Is
Elected as of the Beginning of the Fiscal Year
6. Has the entity properly disclosed separately, if it elected under
FASB ASC 860-50-35-3(d) to subsequently measure a class of
servicing assets and servicing liabilities at fair value at the
beginning of the fiscal year, the amount of the cumulative-effect
adjustment to retained earnings?
[FASB ASC 860-50-50-5]41
Public Entity Disclosures
Public Entities—All Servicing Assets and Servicing Liabilities
7A. Has the public entity properly disclosed the following for all
servicing assets and servicing liabilities:42
a. Management’s basis for determining its classes of serv-
icing assets and servicing liabilities?
b. A description of the risks inherent in servicing assets and
servicing liabilities?
c. If applicable, a description of the instruments used to
mitigate the income statement effect of changes in fair
value of the servicing assets and servicing liabilities?
41 Upon the effective date of ASU No. 2009-16, the requirements of FASB ASC 860-50-50-5 will not change; however, the heading will
be modified.
42 Per FASB ASC 860-50-50-7, disclosure of quantitative information about the instruments used to manage the risks inherent in
servicing assets and servicing liabilities, including the fair value of those instruments at the beginning and end of the period, is encour-
aged but not required. An entity that provides such quantitative information is also encouraged, but not required, to disclose quantitative
and qualitative information about the assumptions used to estimate the fair value of those instruments.
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d. The amount of contractually specified servicing fees, late
fees, and ancillary fees earned for each period for which
results of operations are presented, including a descrip-
tion of where each amount is reported in the statement
of income?
e. Quantitative and qualitative information about the as-
sumptions used to estimate the fair value?
[FASB ASC 860-50-50-7]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-50-50-7]
8A. Has the public entity properly disclosed the following for all
servicing assets and servicing liabilities subsequently meas-
ured at fair value:
a. For each class of servicing assets and servicing liabilities,
the activity in the balance of servicing assets and the
activity in the balance of servicing liabilities (including a
description of where changes in fair value are reported
in the statement of income for each period for which
results of operations are presented), including, but not
limited to, all of the following:
i. The beginning and ending balances?
ii. Additions (through purchases of servicing assets,
assumption of servicing obligations, and recogni-
tion of servicing obligations that result from trans-
fers of financial assets)?
iii. Disposals?
iv. Changes in fair value during the period resulting
from (1) changes in valuation inputs or assump-
tions used in the valuation model and (2) other
changes in fair value and a description of those
changes?
v. Other changes that affect the balance and a de-
scription of those changes?
[FASB ASC 860-50-50-8]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-50-50-8]
9A. Has the public entity properly disclosed the following for all
servicing assets and servicing liabilities subsequently amor-
tized in proportion to and over the period of estimated net
servicing income or loss and assessed for impairment or in-
creased obligation:
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a. For each class of servicing assets and servicing liabilities,
the activity in the balance of servicing assets and the
activity in the balance of servicing liabilities (including a
description of where changes in the carrying amount are
reported in the statement of income for each period for
which results of operations are presented), including, but
not limited to, the following:
i. The beginning and ending balances?
ii. Additions (through purchases of servicing assets,
assumption of servicing obligations, and servicing
obligations that result from transfers of financial
assets)?
iii. Disposals?
iv. Amortization?
v. Application of valuation allowance to adjust car-
rying value of servicing assets?
vi. Other-than-temporary impairments?
vii. Other changes that affect the balance and a de-
scription of those changes?
b. For each class of servicing assets and servicing liabilities,
the fair value of recognized servicing assets and servicing
liabilities at the beginning and end of the period if it is
practicable to estimate the value?
c. The risk characteristics of the underlying financial assets
used to stratify recognized servicing assets for purposes
of measuring impairment in accordance with the guid-
ance in paragraphs 9–14 of FASB ASC 860-50-35?
d. For each period for which results of operations are pre-
sented, the activity by class in any valuation allowance
for impairment of recognized servicing assets, including
(i) beginning and ending balances, (ii) aggregate addi-
tions charged and recoveries credited to operations, and
(iii) aggregate write-downs charged against the allow-
ance?
[FASB ASC 860-50-50-9]
Note (ASU No. 2009-16): This paragraph has been superseded
by ASU No. 2009-16.
[“Pending Content” in FASB ASC 860-50-50-9]
JJ. Financial Services—Insurance Activities (FASB ASC 944-20)
Presentation
General
1. Are payments to policyholders that represent a return of poli-
cyholders balances not reported as expenses in the statement
of earnings?
[FASB ASC 944-20-45-1]
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2. Do amounts reported as expenses include benefit claims in
excess of the related policyholder balances, expensesofcontract
administration, interest accrued to policyholders, and amorti-
zation of capitalized acquisition costs?
[FASB ASC 944-20-45-2]
Disclosure
Reinsurance Contracts
3. Are the following disclosed in relation to ceded insurance
transactions:
a. Nature of the transactiuons?
b. Purpose of the transactions?
c. Effect of the transactions?
d. The fact that the insurer is not relieved of its primary
obligation to the policyholder in a reinsurance transac-
tion?
[FASB ASC 944-20-50 par. 3–4]
KK. Financial Services—Acquisition Costs (FASB ASC 944-30)
Presentation
1. Has the entity properly classified acquisition costs as an asset?
2. Has the insurance entity recognized the amortization of a de-
ferred sales inducement as a component of benefit expense?
[FASB ASC 944-30-45-2]
Disclosure
General
3. Are the following disclosed relating to deferred acquisition
costs:
a. The nature and type of costs capitalized?
b. The method of amortizing these costs?
c. The amount of these costs amortized for the period?
d. The accounting policy applied to internal replacements,
including whether or not the entity has availed itself of
the alternative application guidance in paragraphs 44–45
of FASB ASC 944-30-35, and if so, for which kinds of
internal replacement transactions?
[FASB ASC 944-30-50 par. 1 and 4]
Sales Inducements
4. Has the entity disclosed its policy for sales inducements, in-
cluding all of the following:
a. The nature of the costs deferred?
b. The method of amortizing those deferred costs?
c. The amount of costs deferred and amortized for each of
the periods presented?
d. The unamortized balance of deferred costs as of each
balance sheet date?
[FASB ASC 944-30-50-3]
Participating Contracts
5. Are the following disclosed in the financial statements with
respect to participating contracts:
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a. The methods and assumptions used in estimating the
liability for future policy benefits?
b. The average rate of assumed investment yields use in
estimating expected gross margins?
c. The nature of acquisition costs capitalized, the method
of amortizing those costs, and the amount of those costs
amortized for the period?
[FASB ASC 944-30-50-2; FASB ASC 944-40-50-8]
LL. Financial Services—Claims Cost and Liabilities for Future Policy
Benefits (FASB ASC 944-40)
Presentation
General
1. For contracts with death or other insurance benefit features,
has a change in the additional liability been recognized as a
component of benefit expense in the statement of operations?
[FASB ASC 944-40-45-1]
2. For contracts that provide annuitization benefits, has the
change in the additional liability recognized under paragraphs
22–24 of FASB ASC 944-40-25 been reported as a component of
benefit expense in the statement of operations?
[FASB ASC 944-40-45-2]
Disclosure
3. Is the basis for estimating the liabilities for unpaid claims and
claim adjustment expenses disclosed?
[FASB ASC 944-40-50-1]
4. Are the methods and assumptions used in estimating the lia-
bility for future policy benefits disclosed?
[FASB ASC 944-40-50-6]
5. Has the entity disclosed the average rate of assumed invest-
ment yields in effect for the current year? (Encouraged, but not
required.)
[FASB ASC 944-40-50-7]
6. Is the carrying amount of liabilities for unpaid claims and claim
adjustment expenses relating to short-duration contracts that
are presented at present value in the financial statements, and
the range of interest rates used to discount those liabilities,
disclosed?
[FASB ASC 944-40-50-5]
7. For each fiscal year for which an income statement is presented,
is the following information about the liability for unpaid
claims and claim adjustment expenses disclosed:
a. The balance in the liability for unpaid claims and claim
adjustment expenses at the beginning and end of each
fiscal year presented and the related amount of reinsur-
ance recoverable?
b. Incurred claims and claim adjustment expenses withsep-
arate disclosure of the provision for insured events of the
current fiscal year and of increases or decreases in the
provision for insured events of prior fiscal years?
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c. Payments of claims and claim adjustment expenses with
separate disclosure of payments of claims and claim ad-
justment expenses attributable to insured events of the
current fiscal year and to insured events of prior fiscal
years?
[FASB ASC 944-40-50-3]
8. If changes in incurred claims and claim adjustment expenses
recognized in the income statement are attributable to insured
events of prior fiscal years, are the following disclosed in the
financial statements:
a. The reasons for the change?
b. Whether additional premiums or return premiums have
been accrued as a result of the prior-year effects?
[FASB ASC 944-40-50-3(d)]
9. Has the entity disclosed its policies and methodologies for es-
timating the liability for unpaid claims and claim adjustment
expenses for difficult-to-estimate liabilities, such as claims for
toxic waste cleanup, asbestos related illnesses, and other re-
mediation exposures?
[FASB ASC 944-40-50-4]
MM. Financial Services—Policyholder Dividends (FASB ASC 944-50)
General
Presentation
1. Are annual policyholder dividends reported separately as an
expense in the statement of income?
[FASB ASC 944-50-45-1]
Participating Insurance
Disclosure
2. For participating insurance, do disclosures include the follow-
ing:
a. The relative percentage?
b. The method of accounting for policyholders’ dividends?
c. The amount of dividends?
d. The amount of any additional income allocated to par-
ticipating policyholders?
[FASB ASC 944-50-50-1]
NN. Financial Services—Premium Deficiency and Loss Recognition
(FASB ASC 944-60)
Disclosure
1. If the entity considers anticipated investment income in deter-
mining if a premium deficiency relating to short-duration con-
tract exists, is it disclosed?
[FASB ASC 944-60-50-1]
OO. Financial Services—Separate Accounts (FASB ASC 944-80)
Presentation
1. Are separate account assets reported as summary totals in the
financial statements with an equivalent summary total re-
ported for liabilities?
[FASB ASC 944-80-45 par. 1–2]
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2. For separate account assets representing contract holder funds
for which the separate account arrangement meets all of the
criteria in FASB ASC 944-80-25-2, has the related investment
performance and corresponding amounts credited to the con-
tract holder been offset within the same statement of operations
line item netting to zero?
[FASB ASC 944-80-45-3]
Disclosure
3. Has the entity disclosed the following information regarding
separate accounts:
a. The general nature of the contracts reported in separate
accounts, including the extent and terms of minimum
guarantees?
b. The basis for presentation for separate account assets and
liabilities and related separate account activity?
c. The aggregate fair value of assets, by major investment
asset category, supporting separate accounts with addi-
tional insurance benefits and minimum investment re-
turn guarantees as of each date for which a statement of
financial position is presented?
d. The amount of gains and losses recognized on assets
transferred to separate accounts for the periods pre-
sented?
[FASB ASC 944-80-50-1]
4. Has the entity disclosed a description of the liability valuation
methods and assumptions used in estimating the liabilities for
additional insurance benefits and minimum guarantees?
5. Have the following been disclosed in relation to minimum
guarantees:
a. The separate account liability balances (if utilized) sub-
ject to various types of benefits (for example, guaranteed
minimum death benefit, guaranteed minimum income
benefit, or guaranteed minimum accumulation benefit)?
Note: Disclosures within these categories of benefits for
the types of guarantees provided may also be appropri-
ate (for example, return of net deposits, return of net
deposits accrued at a stated rate, and return of highest
anniversary value).
b. The amount of liability reported for additional insurance
benefits, annuitization benefits, and other minimum
guarantees, by type of benefit, for the most recent balance
sheet date and the incurred paid amounts related to
FASB ASC 944-80-50-1(d)(3) for all periods presented?
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c. For contracts for which an additional liability is disclosed
in item (b), net amount at risk and weighted average
attained age of contract holders?
[FASB ASC 944-80-50-1(d)]
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FSP Section 20,200
Auditors’ Reports Checklist
.01 This section of the checklist has been developed primarily to address the requirements most likely
to be encountered when reporting on financial statements of life and health insurance entities in accordance
with generally accepted auditing standards (GAAS) as issued by the Auditing Standards Board (ASB), a
senior technical committee of the AICPA. Certain key differences in reporting requirements between audits
conducted in accordance with GAAS and audits conducted in accordance with the rules and standards of
the Public Company Accounting Oversight Board (PCAOB) are identified in bold text throughout this sec-
tion of the checklist. However, the differences identified are not intended to be all inclusive, and readers
should seek appropriate guidance for a comprehensive source of reporting requirements associated with
audits conducted in accordance with the rules and standards of the PCAOB.
Yes No N/A
1. Is each financial statement audited specifically identified in the in-
troductory paragraph of the auditor’s report?
[AU 508.06]
2. Do the titles of the financial statements referred to in the introduc-
tory paragraph of the auditor’s report match the titles of the finan-
cial statements presented?
[Common Practice]
3. Do the dates of the financial statements referred to in the introduc-
tory paragraph of the auditor’s report match the dates of the finan-
cial statements presented?
[Common Practice]
4. Is the report appropriately addressed?
[AU 508.09]
Practice Tip
Interpretation No. 17, “Clarification in the Audit Report of the Extent of Testing of Internal Control Over
Financial Reporting in Accordance With Generally Accepted Auditing Standards,” of AU section 508, Re-
ports on Audited Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .85–.88), pro-
vides language that may be added to the auditor’s standard report on the financial statements of a nonissuer
to clarify differences between a GAAS audit and an audit conducted in accordance with the standards of
the PCAOB. Interpretation No. 18, “References to PCAOB Standards in an Audit Report on a Nonissuer,”
of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .89–.92) explains how the auditor
should report if engaged to also follow PCAOB auditing standards in the audit of a nonissuer.
5. Does the independent auditor’s report include the following ele-
ments:
a. A title that includes the word independent?
[AU 508.08a]
b. The titles of each financial statement in the introductory par-
agraph of the report?
[AU 508.06]
212 Life and Health Insurance Entities
FSP §20,200.01
(continued)
Yes No N/A
c. If the financial statements include a separate statement of
changes in stockholders’ equity accounts, it is identified in the
introductory paragraph of the report?
[AU 508.06]
d. A statement that the financial statements are the responsibil-
ity of management and that the auditor’s responsibility is to
express an opinion on the financial statements based on his
or her audit?
[AU 508.08c]
e. For audits conducted in accordance with GAAS in the United
States, a statement that the audit was conducted in accor-
dance with GAAS and an identification of the country of ori-
gin of those standards (for example, auditing standards gen-
erally accepted in the United States of America or U.S.
GAAS)?
[AU 508.08d]
f. (Audits of Issuers Only) A statement that the audit was con-
ducted in accordance with the standards of the PCAOB
(United States)?
[PCAOB Auditing Standard No. 1 par. 3 (AU-P app. A par.
3)]
g. A statement that those standards require that the auditor plan
and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstate-
ment?
[AU 508.08e]
h. A statement that an audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the fi-
nancial statements; assessing the accounting principles used
and significant estimates made by management; and evalu-
ating the overall financial statement presentation?
[AU 508.08f]
i. A statement that the auditor believes that his or her audit
provides a reasonable basis for his or her opinion?
[AU 508.08g]
j. When the auditor reports on financial statements presented
in conformity with U.S. generally accepted accounting prin-
ciples (GAAP), an opinion concerning whether the financial
statements present fairly, in all material respects, the financial
position of the reporting entity as of the balance sheet date
and the results of its operations and its cash flows for the pe-
riod then ended in conformity with GAAP? The opinion
should include an identification of the United States of Amer-
ica as the country of origin of those accounting principles.
[AU 508.08h]
Notes: Interpretation No. 19, “Financial Statements Prepared in Conformity
With International Financial Reporting Standards as Issued by the Inter-
national Accounting Standards Board,” of AU section 508 (AICPA, Profes-
sional Standards, vol. 1, AU sec. 9508 par. .93–.97) provides that, when the
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auditor of a nonissuer reports on financial statements prepared in conform-
ity with International Financial Reporting Standards (IFRSs), the auditor
would refer, in the auditor’s report, to the IFRSs rather than U.S. GAAP.
When an auditor of a nonissuer reports on financial statements presented
in conformity with both the IFRSs as issued by the International Account-
ing Standards Board (IASB) and a jurisdictional variation of the IFRSs, the
auditor would refer, in the auditor’s report, to both the IFRSs and the IFRSs
as endorsed by [insert name of endorsing country or economic union].
When an auditor of a nonissuer reports on financial statements presented
in conformity with a jurisdictional variation of the IFRSs such that the en-
tity’s financial statements do not contain an explicit and unreserved state-
ment of compliance with the IFRSs as issued by the IASB, paragraphs
.14–.15 of AU section 534, Reporting on Financial Statements Prepared for Use
in Other Countries (AICPA, Professional Standards, vol. 1), and paragraphs
.35–.60 of AU section 508 (AICPA, Professional Standards, vol. 1) apply to
financial statements prepared for more than limited distribution in the
United States.
k. When the auditor reports on financial statements presented
in conformity with the IFRSs, an opinion concerning whether
the financial statements present fairly, in all material respects,
the financial position of the reporting entity as of the balance
sheet date and the results of its operations and its cash flows
for the period then ended in conformity with the IFRSs as
issued by the IASB?
[AU 9508.93–.97]
l. When the auditor reports on financial statements presented
both in conformity with the IFRSs and a jurisdictional variant
of the IFRSs, an opinion concerning whether the financial
statements present fairly, in all material respects, the financial
position of the reporting entity as of the balance sheet date
and the results of its operations and its cash flows for the pe-
riod then ended in conformity with the IFRSs as issued by the
IASB and with the IFRSs as endorsed by [insert name of en-
dorsing country or economic union]?
[AU 9508.93–.97]
m. When the auditor reports on financial statements presented
in conformity with a jurisdictional variation of the IFRSs such
that the entity’s financial statements do not contain an explicit
and unreserved statement of compliance with the IFRSs as
issued by the IASB, a variation of the standard report that
reflects the guidance in paragraphs .14–.15 of AU section 534
and paragraphs .35–.60 of AU section 508 (AICPA, Profes-
sional Standards, vol. 1) for financial statements prepared for
more than limited distribution in the United States?
[AU 9508.93–.97]
n. The manual or printed signature of the auditor’s firm?
[AU 508.08i]
o. The date of the audit report?
[AU 508.08j; AU 530.05]
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Practice Tip
The independent auditor has 2 methods available for dating the report when a subsequent event disclosed
in the financial statements occurs after the original date of the auditor’s report but before the issuance of the
related financial statements. The auditor may use "dual dating" (for example, "February 16, 20pp, except for
Note pp, for which the date is March 1, 20pp,") or may date the report as of the later date. In the former
instance, the responsibility for events occurring subsequent to the original report date is limited to the spe-
cific event referred to in the note (or otherwise disclosed). In the latter instance, the independent auditor’s
responsibility for subsequent events extends to the date of the report, and, accordingly, the procedures out-
lined in paragraph .12 of AU section 560, Subsequent Events (AICPA, Professional Standards, vol. 1), generally
should be extended to that date.
6. Does the reporting language conform with the auditor’s standard
report on
a. financial statements of a single year or period?
b. comparative financial statements?
[AU 508.08]
7. Does the report include appropriate language for the following sit-
uations:
a. Only one basic financial statement is presented and there are
no scope limitations?
[AU 508.33–.34]
b. Audited and unaudited financial statements are presented in
comparative form?
[AU 504.15–.17]
c. Different opinions are expressed on comparative financial
statements?
[AU 508.05]
Note: Interpretation No. 14, “Reporting on Audits Conducted in Accor-
dance With Auditing Standards Generally Accepted in the United States of
America and in Accordance With International Standards on Auditing,” of
AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par.
.56–.59) provides that, when the audit of a nonissuer is conducted both in
accordance with standards generally accepted in the United States of
America and in accordance with the International Standards on Auditing
(ISAs), the auditor may so indicate in the auditor’s report. To determine
whether an audit was conducted in accordance with the ISAs, it is neces-
sary to consider the text of the ISAs in their entirety, including the basic
principles and essential procedures together with the related guidance in-
cluded in the ISAs.
Practice Tip
If the audit of financial statements to be used in the United States was conducted in accordance with audit-
ing standards generally accepted in the United States of America and ISAs as issued by the International
Auditing and Assurance Standards Board, in their entirety, although not required, has the auditor consid-
ered indicating in the auditor‘s report that the audit was also conducted in accordance with ISA as allowed.
[AU 9508.57–.59]
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8. Is the reporting form, content, and timing of paragraphs .20–.30 of
AU section 325, Communicating Internal Control Related Matters Iden-
tified in an Audit (AICPA, Professional Standards, vol. 1), followed
when communicating matters related to an organization’s internal
control over financial reporting identified in an audit of financial
statements?
[AU 325.20–.30]
Note: Auditors are required to communicate control deficiencies identified
during an audit that are significant deficiencies or material weaknesses as
defined by AU section 325, including significant deficiencies or material
weaknesses that were communicated in previous audits and have not yet
been remediated. Those control deficiencies must be communicated in
writing to management and those charged with governance.
9. If a subsequent event disclosed in the financial statements occurs
after the original date of the independent auditor’s report but be-
fore the issuance of the related financial statements, has the auditor
followed one of the following two methods available for dating the
report:
a. Dual dating, in which the independent auditor’s responsibil-
ity for events occurring subsequent to the original report date
is limited to the specific event referred to in an explanatory
note in the report (or otherwise disclosed)?
b. Dating the report as of the later date, in which the independ-
ent auditor’s responsibility for subsequent events extends to
the date of the report?
[AU 530.03–.05]
10. (Audits of Issuers Only) If the auditor obtains knowledge about a
subsequent event that
a. materially and adversely affects the effectiveness of the en-
tity’s internal control over financial reporting as of the date
specified in the assessment, has the auditor either
i. issued an adverse opinion on internal control over fi-
nancial reporting (and followed the direction in para-
graph .C2 of appendix C of PCAOB Auditing Standard
No. 5, An Audit of Internal Control Over Financial Report-
ing That is Integrated with an Audit of Financial Statements
(AICPA, PCAOB Standards and Related Rules, Standards,
AU-P sec. 320), if management’s assessment states that
internal control over financial reporting is effective)?
ii. disclaimed an opinion if the auditor is unable to deter-
mine the effect of the subsequent event on the effective-
ness of the entity’s internal control over financial re-
porting?
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b. relates to conditions that did not exist at the date specified in
the assessment but arose subsequent to that date and before
issuance of the auditor’s report, and the subsequent event has
a material effect on the entity’s internal control over financial
reporting, has the auditor included in his or her report an
explanatory paragraph describing the event and its effects or
directed the reader’s attention to the event and its effects as
disclosed in management’s report?
[PCAOB Auditing Standard No. 5 par. 96–97 (AU-P
320.96–.97)]
11. If the accountant is not independent, has he or she followed one of
the two reporting alternatives available:
a. Disclaiming the opinion with respect to the financial state-
ments and specifically stating that he or she is not independ-
ent?
b. Issuing a compilation report in accordance with Statements
on Standards for Accounting and Review Services (SSARS)
indicating the lack of independence (nonpublic entities only)?
[AU 504.05 and .09–.10]
Note: The Accounting and Review Services Committee issued SSARS
No. 19, Compilation and Review Engagements (AICPA, Professional Stan-
dards, vol. 2), that revises the standards for compilation and review
engagements including the following:
● The introduction of new terms, such as review evidence and
review risk, to the review literature to harmonize with inter-
national review standards
● A discussion of materiality in the context of a review engage-
ment.
● A requirement that an accountant document the establish-
ment of an understanding with management through a writ-
ten communication (that is, an engagement letter) regarding
the services to be performed.
● The establishment of enhanced documentation requirements
for compilation and review engagements.
● The ability for an accountant to include a general description
in the accountant’s compilation report regarding the reason(s)
for an independence impairment.
12. If the opinion is based in part on the report of another auditor,
a. does the introductory paragraph of the standard report dis-
close the fact that the opinion is based, in part, on the report
of other auditors?
b. does the opinion paragraph include a reference to the report
of the other auditor?
[AU 508.11a, .12, and .13]
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13. If, to prevent the financial statements from being misleading be-
cause of unusual circumstances, the financial statements contain a
departure from an accounting principle promulgated by a body
designated by the AICPA Council to establish such principles, does
the report include, in a separate paragraph or paragraphs, the in-
formation required by the rule?
[AU 508.11b and .15]
14. If the auditor uses the work of a specialist in performing an audit,
have they added an optional explanatory paragraph?
[AU 336.16]
Note: Reference to and identification of the specialist may be added if
the auditor believes such a reference will facilitate an understanding
of the reason for the explanatory paragraph.
[AU 336.16]
15. If there is substantial doubt about the entity’s ability to continue as
a going concern for a reasonable period of time, not to exceed one
year beyond the date of the financial statements being audited,
a. does the report include an explanatory paragraph, following
the opinion paragraph, to reflect that conclusion?
b. is that conclusion expressed through the use of the phrase
“substantial doubt about its (the entity’s) ability to continue
as a going concern” or similar wording that includes the
terms substantial doubt and going concern?
[AU 508.11c; AU 341.12]
Practice Tip
In evaluating whether there is substantial doubt about the entity’s ability to continue as a going concern, the
auditor’s evaluation is based on his or her knowledge of relevant conditions that exist at or have occurred
prior to the date of the auditor’s report. If, after considering identified conditions and events and management’s
plans, the auditor concludes that substantial doubt about the entity’s ability to continue as a going concern
for a reasonable period of time remains, the audit report should include an explanatory paragraph to reflect
that conclusion.
In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion
concerning the existence of substantial doubt about the entity’s ability to continue as a going concern. See
paragraph .13 of AU section 341, The Auditor’s Consideration of an Entity’s Ability to Continue as a Going Con-
cern (AICPA, Professional Standards, vol. 1), for an example.
16. Is the report dated no earlier than the date on which the auditor has
obtained sufficient appropriate audit evidence to support the audi-
tor’s opinion on the financial statements?
[AU 530.01]
17. (Audits of Issuers Only) Is the report dated no earlier than the date
on which the auditor has obtained sufficient competent evidence to
support the auditor‘s opinion on the financial statements?
[PCAOB Auditing Standard No. 5 par. 89 (AU-P 320.89)]
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18. (Audits of Issuers Only) When performing an integrated audit of
financial statements and internal control over financial reporting,
are the auditor’s reports on the entity’s financial statements and on
internal control over financial reporting dated the same?
[PCAOB Auditing Standard No. 5 par. 89 (AU-P 320.89)]
19. (Audits of Issuers Only) Prior to the report release date, among
other matters, has the auditor obtained sufficient evidence to sup-
port the representations in the auditor’s reports?
[PCAOB Auditing Standard No. 3 par. 15 (AU-P 339.15)]
Practice Tip
Changes in Accounting Estimates
Paragraph .15 of AU section 420, Consistency of Application of Generally Accepted Accounting Principles (AICPA,
Professional Standards, vol. 1), clarifies that the change in an accounting estimate that does not include a
change in accounting principle does not require an explanatory paragraph in the auditor’s report. However,
an accounting change of this type having a material effect on the financial statements may require disclosure
in a note to the financial statements.
Changes in Classification
Paragraph .17 of AU section 420 clarifies that changes in classification from the prior year’s financial state-
ments are usually not of sufficient importance to necessitate disclosure; however, material changes in clas-
sification should be indicated and explained in the financial statements or notes.
Error Corrections
Paragraph .16 of AU section 420 states that the correction of an error in previously issued financial state-
ments resulting from mathematical mistakes, oversight, or misuse of facts that existed at the time the finan-
cial statements were originally prepared does not involve the consistency standard if no element of account-
ing principles or their application is included. Accordingly, the independent auditor need not recognize the
correction in his report. However, if the independent auditor had previously reported on the financial state-
ments containing the error, the auditor has concluded, based on the considerations in paragraph .05 of AU
section 561, Subsequent Discovery of Facts Existing at the Date of the Auditor’s Report (AICPA, Professional Stan-
dards, vol. 1), that action should be taken to prevent future reliance on his report, and the issuance of finan-
cial statements accompanied by the auditor’s report for a subsequent period is imminent, the auditor should
disclose the revision in such statements instead of reissuing the earlier statements.
Notes: For audits of issuers, certain circumstances, although not affecting
the auditor’s unqualified opinion, may require that the auditor add explan-
atory language to the standard report as described in paragraphs .11–.19 of
AU-P section 508, Reports on Audited Financial Statements (AICPA, PCAOB
Standards and Related Rules, Standards).
Other circumstances may require a departure from an unqualified opinion,
either in the form of a qualified opinion, an adverse opinion, or a dis-
claimed opinion as described in paragraphs .20–.63 of AU-P section 508.
For special reporting situations relating to the auditor’s report on internal
control over financial reporting, refer to appendix C, “Special Reporting
Situations,” of Auditing Standard No. 5 (AU-P sec. 320).
******
PCAOB Auditing Standard No. 6, Evaluating Consistency of Financial State-
ments (AICPA, PCAOB Standards and Related Rules, Standards, AU-P sec.
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420), updated the auditor’s responsibilities to evaluate and report on the
consistency of an entity’s financial statements and align the auditor’s re-
sponsibilities with Financial Accounting Standards Board (FASB) State-
ment No. 154, Accounting Changes and Error Corrections.
One significant difference in terminology between FASB Statement No. 154
(which is codified in FASB Accounting Standards Codification (ASC) 250, Ac-
counting Changes and Error Corrections) and Auditing Standard No. 6 (AU-P
sec. 420) is the use of the term error in the FASB standard whereas the
PCAOB standard uses the term misstatement and specifically states that the
meaning is the same for purposes of the PCAOB Auditing Standards. Au-
diting Standard No. 6 (AU-P sec. 420) also establishes that the auditor’s
report should indicate whether an adjustment to previously issued finan-
cial statements results from a change in accounting principle or the correc-
tion of a misstatement.
Auditing Standard No. 6 (AU-P sec. 420) contains numerous amendments
to AU-P section 508 and other interim PCAOB Auditing Standards. If Au-
diting Standard No. 6 (AU-P sec. 420) is applicable to issuers’ financial
statements, answer questions 21–22; otherwise, skip questions 21–22. For
more information and for the full text of the auditing standard, refer to the
PCAOB website at www.pcaob.org. Also refer to the Securities and
Exchange Commission (SEC) website at www.sec.gov.
20. If there has been a material change between periods in accounting
principles or in the method of their application, including a change
from an accounting principle that is not generally accepted to one
that is generally accepted and a change in accounting principle that
is inseparable from the effect of a change in estimate, that has a
material effect on the comparability of the reporting entity’s finan-
cial statements,
a. does the report include an explanatory paragraph, following
the opinion paragraph that refers to the change?
b. does the explanatory paragraph identify the nature of the
change and refer the reader to the note to the financial state-
ments that discusses the change in detail?
[AU 508.05–.06 and .12–.13]
c. if the change in the accounting principle is a change in re-
porting entity that did not result from a transaction or an
event, is an explanatory paragraph included in the auditor’s
report? (Note: A change in the reporting entity resulting from
a transaction or event, such the creation, cessation, or com-
plete or partial purchase or disposition of a subsidiary or
other business unit, does not require that an explanatory par-
agraph about consistency be included in the auditor’s report.)
[AU 420.08]
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21. (Audits of Issuers Only) If there has been a change in accounting
principle that has a material effect on the financial statements, in-
cluding a change in the method of applying an accounting princi-
ple, a change in estimate effected by a change in accounting princi-
ple, and a change in classification that represents a change in
accounting principle, and meets the four criteria established in par-
agraph 7 of PCAOB Auditing Standard No. 6 (AU-P sec. 420 par.
.07),
a. does the report include an explanatory paragraph, following
the opinion paragraph, in the year of the change and in sub-
sequent years until the new accounting principle is applied in
all periods presented?
b. does the explanatory paragraph identify the nature of the
change and include a reference to the note disclosure describ-
ing the change?
c. if the change in the accounting principle is a change in re-
porting entity that did not result from a transaction or an
event, is an explanatory paragraph included in the auditor’s
report? (Note: A change in the reporting entity resulting from
a transaction or event, such the creation, cessation, or com-
plete or partial purchase or disposition of a subsidiary or
other business unit, does not require recognition in the audi-
tor’s report.)
[PCAOB Auditing Standard No. 6 par. 4–8 and 11 (AU-P
420.04–.08 and .11)]
22. (Audits of Issuers Only) If there has been a correction of a material
misstatement in previously issued financial statements, including a
change from an accounting principle that is not generally accepted
to one that is generally accepted and a change in classification that
represents the correction of a material misstatement, does the au-
ditor’s report contain an explanatory paragraph, following the
opinion paragraph, that includes
a. a statement that the previously issued financial statements
have been restated for the correction of a misstatement in the
respective period?
b. a reference to the entity’s disclosure of the correction of the
misstatement?
[PCAOB Auditing Standard No. 6 par. 5 and 9–11 (AU-P
420.05 and .09–.11)]
23. In an updated report on the individual financial statements of one
or more prior periods presented on a comparative basis with those
of the current period, if the opinion is different from the opinion
previously expressed on the financial statements of a prior period,
a. does the report include an explanatory paragraph, preceding
the opinion paragraph that discloses all of the substantive
reasons for the different opinion?
b. does the explanatory paragraph disclose
i. the date of the auditor’s previous report?
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ii. the type of opinion previously expressed?
iii. the circumstances or events that caused the auditor to
express a different opinion?
iv. that the auditor’s updated opinion on the financial
statements of the prior period is different from his or
her previous opinion on those statements?
[AU 508.11e and .69]
24. If financial statements of a prior period (presented for comparative
purposes) have been audited by a predecessor auditor whose report
is not presented,
a. does the introductory paragraph of the report indicate
i. that the financial statements of the prior period were
audited by another auditor?
ii. the date of the predecessor auditor’s report?
iii. the type of report issued by the predecessor auditor?
iv. if the report was other than a standard report, the sub-
stantive reasons therefore, including a description of
the nature of and reasons for the explanatory para-
graph added to the predecessor’s report or his or her
opinion qualification?
b. if the financial statements have been restated, does the intro-
ductory paragraph indicate that the predecessor auditor re-
ported on the financial statements of the prior period before
restatement?
[AU 508.11e and .74]
25. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor’s report if
a. the auditor wishes to clarify that an audit performed in accor-
dance with GAAS does not require the same level of testing
and reporting on internal control over financial reporting as
an audit of an issuer when Section 404(b) of the Sarbanes-
Oxley Act is applicable? (Note: Not required—Interpretation
No. 17 of AU section 508 [AICPA, Professional Standards, vol.
1] provides an example report.)
[AU 9508.85–.88]
b. the audit is conducted in accordance with both GAAS and the
PCAOB’s Auditing Standards as allowed by Interpretation
No. 18 of AU section 508 (AICPA, Professional Standards, vol.
1)? (Note: Not required—Interpretation No. 18 of AU section
508 [AICPA, Professional Standards, vol. 1] provides an exam-
ple report.)
[AU 9508.89–.92]
26. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor’s report if the prior period’s financial state-
ments are audited by a predecessor auditor who has ceased opera-
tions?
[AU 9508.60–.75]
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27. If selected quarterly financial data required by SEC Regulation S-K
has been omitted or has not been reviewed, does the report include
an additional paragraph stating that fact?
[AU 508.11f; AU 722.50]
Note: Statement on Auditing Standards (SAS) No. 116, Interim Financial In-
formation (AICPA, Professional Standards, vol. 1, AU sec. 722), amends AU
section 722 to accommodate reviews of interim financial information of
nonissuers, including companies offering securities pursuant to SEC Rule
144A or participating in private equity exchanges.
28. If other information in a document containing audited financial
statements is materially inconsistent with information appearing in
the financial statements, has it been determined whether the finan-
cial statements, the auditor’s report, or both require revision?
[AU 508.11h; AU 550.04]
Note: In February 2010, the ASB issued SAS No. 118, Other Information in
Documents Containing Audited Financial Statements; SAS No. 119, Supplemen-
tary Information in Relation to the Financial Statements as a Whole; and SAS
No. 120, Required Supplementary Information (AICPA, Professional Standards,
vol. 1). These standards amend or supersede AU section 550, Other Infor-
mation in Documents Containing Audited Financial Statements (AICPA, Profes-
sional Standards, vol. 1); AU section 551, Reporting on Information Accompa-
nying the Basic Financial Statements in Auditor-Submitted Documents; and AU
section 558, Required Supplementary Information (AICPA Professional Stan-
dards, vol. 1), respectively. Collectively, these statements address the audi-
tor’s responsibilities with respect to information that is required by a des-
ignated standard setter (for example, FASB, Governmental Accounting
Standards Board, Federal Accounting Standards Advisory Board, and the
IASB) to accompany an entity’s basic financial statements and supplemen-
tary information that is presented outside the basic financial statements.
The effective date of the SASs is for audits of financial statements for per-
iods beginning on or after December 15, 2010, and early application is per-
mitted.
29. If the auditor decides to emphasize a matter regarding the financial
statements in the report, is the matter being emphasized disclosed
in the financial statements’ and is the explanatory information pre-
sented in a separate paragraph that avoids use of phrases such as
“with the foregoing (following) explanation”?
[AU 508.11 and .19; AU 9410.18; AU 9342.03]
30. If it has not been possible to conduct the audit in accordance with
GAAS or to apply all of the procedures considered necessary in the
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion?
[AU 508.22]
31. If a qualified opinion is to be expressed because of a scope limita-
tion,
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a. are all of the substantive reasons for the qualification dis-
closed in one or more explanatory paragraphs preceding the
opinion paragraph?
b. does the qualified opinion include the word except or excep-
tion in a phrase such as except for or with the exception of?
c. is the situation described and referred to in both the scope
and opinion paragraphs?
d. does the wording in the opinion paragraph indicate that the
qualification pertains to the possible effects on the financial
statements and not to the scope limitation itself?
[AU 508.22–.32; AU 318.76]
Practice Tip
Scope limitations can be imposed by the client or by circumstances such as the timing of the auditor’s work,
the inability to obtain sufficient appropriate audit evidence, or an inadequacy in the accounting records.
Sufficient appropriate audit evidence includes, among other things, management having asserted responsi-
bility for the final financial statements. As provided in Technical Questions and Answers (TIS) section
9100.06, “The Effect of Obtaining the Management Representation Letter on Dating the Auditor’s Report”
(AICPA, Technical Practice Aids), the auditor will need to have the signed management representation letter
in hand prior to releasing the auditor’s report because management’s refusal to furnish written representa-
tions constitutes a limitation on the scope of the audit sufficient to preclude an unqualified opinion.
In circumstances in which the auditor is unable to obtain sufficient appropriate audit evidence to support
management’s assertions about the nature of a matter involving an uncertainty and its presentation or dis-
closure in the financial statements, the auditor should consider the need to express a qualified opinion or to
disclaim an opinion because of a scope limitation.
It also includes situations in which the auditor’s only evidence of the existence, valuation, or both, of (a)
investments without readily determinable fair value, or (b) interests held in trust by a third-party trustee, is
receiving confirmation from a third party for those assets.
In circumstances in which the auditor is unable to audit the existence or measurement of interests in invest-
ments in securities and interests in trusts, the auditor should consider whether that scope limitation requires
the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs .22–.26
of AU section 508 (AICPA, Professional Standards, vol. 1); Interpretation No. 1, “Auditing Interests in Trusts
Held by a Third-Party Trustee and Reported at Fair Value,” of AU section 328, Auditing Fair Value Measure-
ments and Disclosures (AICPA, Professional Standards, vol. 1, AU sec. 9328 par. .01–.04); and Interpretation No.
1, “Auditing Investments in Securities Where a Readily Determinable Fair Value Does Not Exist,” of AU
section 332, Auditing Derivative Instruments, Hedging Activities, and Investments in Securities (AICPA, Profes-
sional Standards, vol. 1, AU sec. 9332 par. .01–.04).
32. Is a qualified opinion or disclaimer of opinion expressed if the au-
ditor’s understanding of internal control raises doubts about the au-
ditability of an entity’s financial statements, such as
a. concerns about the integrity of an entity’s management cause
the auditor to conclude that the risk of management misrep-
resentation in the financial statements is such that an audit
cannot be conducted?
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b. concerns about the condition and reliability of an entity’s re-
cords cause the auditor to conclude that it is unlikely that suf-
ficient appropriate audit evidence will be available to support
an unqualified opinion on the financial statements?
[AU 314.109]
33. If, in the auditor’s judgment, the two-way communication between
the auditor and those charged with governance as described in AU
section 380, The Auditor’s Communication With Those Charged With
Governance (AICPA, Professional Standards, vol. 1), is not adequate
and the situation cannot be resolved, thereby prohibiting the audi-
tor from obtaining all the audit evidence required to form an opin-
ion on the financial statements, has the auditor considered the fol-
lowing:
a. Modifying the audit opinion on the basis of a scope limita-
tion?
b. Obtaining legal advice about the consequences of different
courses of action?
c. Communicating with an appropriate third party, (for exam-
ple, a regulator)
d. Withdrawing from the engagement?
[AU 380.63]
34. If, in the auditor’s judgment, significant difficulties in dealing with
management such as those described in AU section 380, have been
encountered, has the auditor considered modifying the audit opin-
ion on the basis of a scope limitation?
[AU 380.39]
35. If an opinion is disclaimed because of a scope limitation,
a. are all of the substantive reasons for the disclaimer stated in
a separate paragraph or paragraphs?
b. does the report state that the scope of the audit was not suf-
ficient to warrant the expression of an opinion?
c. does the report avoid identifying procedures that were per-
formed?
d. is the scope paragraph omitted?
e. if there are reservations about fair presentation of the finan-
cial statements in conformity with GAAP, are they described
in the report?
[AU 508.62–.63]
Note: Consult the Topical Index to AICPA Professional Standards under
“Scope of Audit—Limitations” for additional references to specific types of
scope limitations that could result in either a qualified or disclaimer of
opinion.
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36. If the financial statements are materially affected by a departure
from GAAP (including, for example, inadequate disclosure, inap-
propriate accounting principles, and unreasonable accounting esti-
mates), has the auditor issued a qualified opinion or an adverse
opinion?
[AU 508.35]
37. If a qualified opinion is to be expressed because of a GAAP depar-
ture,
a. are all of the substantive reasons that have led to the conclu-
sion that there is a departure from GAAP disclosed in one or
more separate explanatory paragraphs preceding the opinion
paragraph?
b. does the qualified opinion include the word except or excep-
tion in a phrase such as except for or with the exception of and a
reference to the explanatory paragraph?
c. does the explanatory paragraph disclose the principle effects
of the departure on financial position, results of operations,
and cash flows, if practicable, or state that the effects are not
reasonably determinable?
[AU 508.21 and AU 508.37–.39]
38. If an adverse opinion is to be expressed because of a GAAP depar-
ture,
a. are all of the substantive reasons for the adverse opinion dis-
closed in one or more separate explanatory paragraphs pre-
ceding the opinion paragraph?
b. does the explanatory paragraph disclose the principle effects
of the departure on financial position, results of operations,
and cash flows, if practicable, or state that the effects are not
reasonably determinable?
c. state that the financial statements do not present fairly the
financial position, or results of operations or cash flows in
conformity with GAAP?
[AU 508.58–.59]
39. If essential data concerning an impending change in GAAP and the
future resulting restatement are not disclosed, has the auditor is-
sued a qualified or adverse opinion?
[AU 9410.15]
40. If the auditor concludes that an illegal act has a material effect on
the financial statements and the act has not been properly ac-
counted for or disclosed, has the auditor issued a qualified or ad-
verse opinion (depending on the materiality effect on the financial
statements taken as a whole)?
[AU 317.18]
Note: Consult the Topical Index to AICPA Professional Standards under “De-
partures From Standard Report” for additional information.
Readers may also wish to refer to TIS section 1400.31, “GAAP Departure
for FASB ASC 810” (AICPA, Technical Practice Aids), for assistance in deter-
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mining the implications on the auditors report if the reporting entity does
not consolidate a variable interest entity.
Practice Tip
Reporting on financial statements prepared in conformity with an other comprehensive basis of accounting
(OCBOA) is addressed in AU section 623, Special Reports (AICPA, Professional Standards, vol. 1). For purposes
of that section, a comprehensive basis of accounting other than GAAP is one of the following:
a. A basis of accounting that the reporting entity uses to comply with the requirements or financial
reporting provisions of a governmental regulatory agency to whose jurisdiction the entity is subject.
An example is a basis of accounting insurance companies use pursuant to the rules of a state insur-
ance commission.
b. A basis of accounting that the reporting entity uses or expects to use to file its income tax return for
the period covered by the financial statements.
c. The cash receipts and disbursements basis of accounting, and modifications of the cash basis having
substantial support, such as recording depreciation on fixed assets or accruing income taxes.
d. A definite set of criteria having substantial support that is applied to all material items appearing in
financial statements, such as the price-level basis of accounting.
In considering whether the financial statements (including the accompanying notes) include all informative
disclosures that are appropriate for the basis of accounting used, paragraph .09 of AU section 623 states that
the auditor should apply essentially the same criteria to financial statements prepared on an OCBOA as he
or she does to financial statements prepared in conformity with GAAP.
41. When reporting on financial statements prepared in conformity
with a comprehensive basis of accounting other than GAAP, as de-
fined in paragraph .04 of AU section 623, does the independent au-
ditor’s report include the following elements (for audits prepared
in conformity with GAAS):
a. A title that includes the word independent?
[AU 623.05a]
b. A paragraph that states that
i. the financial statements identified in the report were
audited?
ii. the financial statements are the responsibility of the en-
tity’s management and that the auditor is responsible
for expressing an opinion on the financial statements
based on the audit?
[AU 623.05b]
c. A paragraph that states that
i. the audit was conducted in accordance with GAAS
with specific identification of the United States of
America as the country of origin of those standards?
ii. those standards require that the auditor plan and per-
form the audit to obtain reasonable assurance about
whether the financial statements are free of material
misstatement?
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iii. an audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial
statements; assessing the accounting principles used
and significant estimates made by management; and
evaluating the overall financial statement presentation?
iv. the auditor believes that his or her audit provides a rea-
sonable basis for the opinion?
[AU 623.05c]
d. A paragraph that states
i. the basis of presentation and refers to the note to the
financial statements that describes the basis?
ii. that the basis of presentation is a comprehensive basis
of accounting other than GAAP?
[AU 623.05d]
e. A paragraph that expresses the auditor’s opinion (or dis-
claims an opinion) on whether the financial statements are
presented fairly, in all material respects, in conformity with
the basis of accounting described?
[AU 623.05e]
f. If the financial statements are prepared in conformity with
the requirements or financial reporting provisions of a gov-
ernmental regulatory agency, a separate paragraph at the end
of the report stating that the report is intended solely for the
information and use of those within the entity and the regu-
latory agencies to whose jurisdiction the entity is subject, and
is not intended to be and should not be used by anyone other
than these specified parties?
[AU 623.05f]
g. The manual or printed signature of the auditor’s firm?
[AU 623.05g]
h. The date of the audit report?
[AU 623.05h]
42. When the financial statements are prepared in conformity with the
requirements or financial reporting provisions of a governmental
regulatory agency and the financial statements and reports will be
used by parties or distributed by the entity to parties other than the
regulatory agencies to whose jurisdiction the entity is subject, has
the standard form of report been modified as appropriate because
of the departures from GAAP and has an additional paragraph
been added to express an opinion on whether the financial state-
ments are presented in conformity with the regulatory basis of ac-
counting? (Note: Interpretation 15, “Auditor Reports on Regulatory
Accounting or Presentation When the Regulated Entity Distributes
the Financial Statements to Parties Other Than the Regulatory
Agency Either Voluntarily or Upon Specific Request,” of AU section
623 [AICPA, Professional Standards, vol. 1, AU sec. 9623 par. .96–.98]
provides an example report.)
[AU 544.04; AU 9623.96–.98]
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43. If certain other information, including supplementary information
required by GAAP, contained in annual reports and other client-
prepared documents described in paragraph .02 of AU section 550
that contain audited financial statements has been subjected to au-
diting procedures applied in the audit of the basic financial state-
ments, does the auditor express an opinion on whether the infor-
mation is fairly stated in all material respects in relation to those
financial statements taken as a whole in the auditor’s report and
does the report describe clearly the character of the auditor’s work
and the degree of responsibility the auditor is taking?
[AU 550.07; AU 558.09]
44. If other information contained in annual reports and other client-
prepared documents described in AU section 550 paragraph .02
that contain audited financial statements is materially inconsistent
with information appearing in the financial statements, has it been
determined whether the financial statements, the auditor’s report,
or both require revision?
[AU 508.11h; AU 550.04]
45. If other information contained in annual reports and other client-
prepared documents described in AU section 550 paragraph .02
that contain audited financial statements is materially inconsistent
with information appearing in the financial statements, and the au-
ditor has determined that neither the financial statements nor the
auditor’s report require revision, has the auditor either
a. requested that the client revise the other information to elim-
inate the material consistency?
b. considered other actions such as revising the audit report to
include an explanatory paragraph describing the material in-
consistency, withholding the use of the audit report in the
document, and withdrawing from the engagement?
[AU 550.04]
46. If information accompanies the basic financial statements and au-
ditor’s report in an auditor-submitted document, is it accompanied
by a report that
a. states that the audit was performed for the purpose of form-
ing an opinion on the basic financial statements taken as a
whole?
b. specifically identifies the accompanying information?
c. states that the accompanying information is presented for
purposes of additional analysis and is not a required part of
the basic financial statements?
d. includes either an opinion on whether the accompanying in-
formation is fairly stated in all material respects in relation to
the basic financial statements taken as a whole or a disclaimer
of opinion (depending on whether the information was sub-
jected to the auditing procedures applied in the audit of the
basic financial statements)?
[AU 551.05–.06]
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47. If information accompanying the basic financial statements and au-
ditor’s report in an auditor-submitted document is materially mis-
stated in relation to the basic financial statements taken as a whole,
has the auditor either
a. requested that the client revise the accompanying informa-
tion to eliminate the material misstatement?
b. considered other actions such as modifying the audit report
to describe the misstatement or refusing to include the ac-
companying information in the auditor-submitted document?
[AU 551.09]
48. When the basic financial statements are accompanied by supple-
mentary information required by GAAP and such supplementary
information has not been audited as part of the basic financial state-
ments, does the auditor’s report exclude any language that refers to
the supplementary information or the limited procedures applied
(except in the circumstances described in AU section 558 paragraph
.08)?
[AU 558.08]
49. When the basic financial statements are accompanied by supple-
mentary information required by GAAP and such supplementary
information has been audited as part of the basic financial state-
ments, has the audit report been expanded in accordance with AU
section 550 paragraph .07?
[AU 558.09]
50. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from pre-
scribed guidelines, the auditor is unable to complete prescribed
procedures with respect to such information, or the auditor is una-
ble to remove substantial doubt about whether the supplementary
information conforms to prescribed guidelines, does the report in-
clude an additional paragraph stating that fact?
[AU 558.08]
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Supplemental Information for Life
Insurance Entities That are Securities and
Exchange Commission Registrants
.01 Regulation S-X is the primary source of requirements for financial statements and related footnotes
required to be included in documents filed with the Securities and Exchange Commission (SEC). In addition
to Regulation S-X, preparers and auditors of financial statements should be familiar with the SEC’s Financial
Reporting Releases (FRRs) and Staff Accounting Bulletins (SABs). FRRs communicate the SEC’s position on
accounting and auditing principles and practices. SABs represent interpretations and practices followed by
the Division of Corporation Finance and the Office of the Chief Accountant of the SEC. Insurance companies
are subject to the requirements of Articles 1–4, 7, 10, and 12 of Regulation S-X.
.02 When determining compliance with SEC requirements, preparers and auditors should refer to the
appropriate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the follow-
ing documents should be consulted:
● Regulation S-X, Article 1, Application of Regulation S-X.
● Regulation S-X, Article 2, Qualifications and Reports of Accountants.
● Regulation S-X, Article 3, General Instructions as to Financial Statements.
● Regulation S-X, Article 3A, Consolidated and Combined Financial Statements.
● Regulation S-X, Article 4, Rules of General Application.
● Regulation S-X, Article 7, Insurance Companies.
● Regulation S-X, Article 10, Interim Financial Statements.
● Regulation S-X, Article 12, Form and Content of Schedules.
● SABs reflect the SEC staff’s views regarding accounting-related disclosure practices. They rep-
resent interpretations and policies followed by the Division of Corporation Finance and the Of-
fice of the Chief Accountant in administering the disclosure requirements of the federal securi-
ties laws.
● FRRs adopt, change, or interpret requirements relating to accounting, auditing, and disclosure
issues.
● The Sarbanes-Oxley Act of 2002.
● Rules and standards of the Public Company Accounting Oversight Board.
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Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted
accounting principles (U.S. GAAP). The financial statements are for illustrative purposes only, are not in-
tended to be comprehensive and are not intended to establish preference among alternative principles ac-
ceptable under U.S. GAAP. Decisions about the application of the U.S. GAAP discussed in the accounting
and financial reporting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities
(2010) should not be made by reference to the illustrative financial statements but by a careful reading to
the specified authoritative literature. The illustrative financial statements reflect many of the minimum dis-
closure requirements for a life and health insurance entity but do not include all of the amounts or transac-
tions discussed in other chapters of the guide or that might be found in practice. For example, the illustrative
notes indicate the subject matter generally required to be disclosed, but they should be expanded, reduced,
or otherwise modified to suit individual circumstances based on a careful reading of the specified authori-
tative literature.
.02 The illustrative financial statements do not include other transactions not unique to life and health
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertain-
ties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative
guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established account-
ing principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.
.04 The illustrative financial statements also do not reflect the impact of laws and regulations of the
insurance entity’s state of domicile. The impact on the financial statements of such laws and regulations
vary by state. Many states require conformity with the codification of statutory accounting practices in the
National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual to the
extent it does not conflict with its own state laws and regulations. Refer to the NAIC Accounting Practices
and Procedures Manual, NAIC Annual Statement Instructions, and specific state laws and regulations to deter-
mine the impact of codification and individual state laws and regulations.
.05 These illustrative statements are not intended to include items that should be accounted for under
the requirements of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC)
815, Derivatives and Hedging, and FASB ASC 820, Fair Value Measurements and Disclosures, and therefore do
not reflect the requirements of these Topics. Practitioners should refer to these Topics for guidance on re-
porting derivative instruments and hedging activities and fair value measurements.
.06 Life and health insurance entities generally present unclassified balance sheets.
Note: The illustrative financial statements and notes included in this checklist have been updated to
reflect FASB ASC. However, in FASB’s Notice to Constituents, it suggests the use of plain English in
financial statement footnotes to describe broad FASB ASC topic references. They suggest a reference
similar to “as required by the Derivatives and Hedging topic of FASB Accounting Standards Codifica-
tion.” Entities might consider revising their financial statement references to reflect this plain English
referencing, rather than the use of specific FASB ASC references. We have provided these detailed
references as a resource for our users.
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ABC LIFE INSURANCE COMPANY
Balance Sheet*
December 31, 20X1 and 20X0
(Amounts in thousands)
20X1 20X0
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost (estimated
fair value: $47,830 in 20X1 and $45,255 in 20X0) $ 44,864 $ 46,310
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X1 and $219,565 in 20X0) 255,893 214,563
Trading account securities, at estimated fair value (cost: $4,220
in 20X1 and $4,419 in 20X0) 3,950 4,190
Mortgage loans 79,258 106,692
Real estate 6,410 6,147
Policy loans 43,549 51,013
Short-term investments 7,515 6,321
Total investments 441,439 435,236
Cash and cash equivalents 5,285 3,343
Accrued investment income 6,660 8,026
Premiums due and other receivables,1 net of allowance of $4,500 and
$2,100 for doubtful accounts 1,647 1,092
Reinsurance receivable on paid and unpaid losses 596 407
Reinsurance receivable related to contract holder liabilities 5,714 3,048
Deferred policy acquisition costs 38,936 36,429
Property and equipment, net of accumulated depreciation 501 420
Other assets 152 158
Separate account assets 732 525
Total assets $501,662 $488,684
Liabilities
Future policy benefits $345,887 $341,207
Guaranteed interest contracts 21,342 23,555
Policyholders funds on deposit 49,408 46,202
Unpaid claims 5,418 4,737
(continued)
* Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 820, Fair Value Measurements and Disclosures,
establishes a framework for measuring fair value that applies broadly to financial and nonfinancial assets and liabilities and improves
the consistency, comparability, and reliability of the measurements. FASB ASC 820 codifies and simplifies existing guidance for devel-
oping measurements and improves disclosures about the measurements. Additionally, FASB ASC 825, Financial Instruments, improves
financial reporting by providing entities with the opportunity to mitigate volatility in reported earnings caused by measuring related
assets and liabilities differently without having to apply complex hedge accounting provisions. For additional information, see the FASB
website at www.fasb.org.
1 FASB ASC 310-10-50 requires, among other things, that the summary of significant accounting policies include the basis for account-
ing for trade receivables, and the classification and method of accounting for other receivables. It also requires that a description of the
accounting policies and methodology the entity used to estimate its allowance for doubtful accounts be included in the notes to the
financial statements. Such a description should identify the factors that influenced management’s judgment and may also include
discussion of risk elements relevant to particular categories of financial instruments. In addition, FASB ASC 310-10-50-6 requires that the
summary of significant accounting policies include the policy for charging off uncollectible trade receivables.
FASB ASC 310-10-45 contains other presentation and disclosure requirements that may apply to the financial statements of insurance
entities.
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20X1 20X0
Policyholders dividends 2,335 3,450
Amounts held in escrow and accrued expenses 4,977 4,562
Deferred federal income taxes 1,412 1,027
Other liabilities 253 4,465
Separate account liabilities 732 525
Total liabilities 431,764 429,730
Commitments and contingencies (Note 12)
Shareholders’ Equity
Capital stock: authorized—5,000,000 shares of $2 par value; 3,341,624
shares issued and outstanding 6,683 6,683
Retained earnings 57,776 55,522
Accumulated other comprehensive income 5,439 (3,251)
Total shareholders’ equity 69,898 58,954
Total liabilities and shareholders’ equity $501,662 $488,684
See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Statement of Income
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
20X1 20X0
Premiums and Other Revenues
Premiums:
Life and annuity premiums $24,833 $24,783
Accident and health premiums 10,141 9,153
Other premiums 20 43
Contract holder fees 1,961 1,844
Net investment income 32,998 35,141
Net realized gains (losses) on investments and other 4,222 (2,670)
Total premiums and other revenues 74,175 68,294
Benefits and Other Expenses
Policyholder benefits 39,158 30,815
Interest credited to policyholder accounts 4,363 4,156
General expenses 4,288 4,984
Amortization of deferred policy acquisition costs 1,276 1,305
Underwriting, acquisition, and insurance expenses 18,029 17,266
Policyholders’ dividends 4,665 6,898
Total benefits and expenses 71,779 65,424
Income before income taxes 2,396 2,870
Income taxes:
Current 1,547 601
Deferred (1,405) 540
Total income taxes 142 1,141
Net income 2,254 1,729
Net income per common share .67 .52
Dividends per common share — .98
See accompanying notes to financial statements.
237Illustrative Financial Statements
FSP §20,400.09
.09
ABC LIFE INSURANCE COMPANY
Statement of Comprehensive Income (Loss)
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
20X1 20X0
Net income $ 2,254 $ 1,729
Other comprehensive income (loss) 8,690 (1,730)
Total comprehensive income (loss) $10,944 $ (1)
See Note 5 to the financial statements for information about other
comprehensive income (loss).
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ABC LIFE INSURANCE COMPANY
Statement of Changes in Shareholders’ Equity
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
Capital Stock
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total
Shareholders’
Equity
Balance at January 1, 20X0 $6,683 $57,068 $(1,521) $62,230
Net income for 20X0 — 1,729 — 1,729
Shareholders’ dividends — (3,275) — (3,275)
Other comprehensive income
(loss) — — (1,730) (1,730)
Balance at December 31, 20X0 6,683 55,522 (3,251) 58,954
Net income for 20X1 — 2,254 — 2,254
Other comprehensive income — — 8,690 8,690
Balance at December 31, 20X1 $6,683 $57,776 $ 5,439 $69,898
See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Statements of Cash Flows
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
20X1 20X0
Cash flows from operating activities:
Net income $ 2,254 $ 1,729
Adjustments to reconcile net income to net cash provided by
operating activities:
Interest credited to universal life policies 7,927 10,445
Accrual of discount on investments, net (976) (1,328)
Net realized (gains) losses on investments (4,222) 2,670
Depreciation and amortization 3,041 3,534
Amortization of deferred policy acquisition costs 1,276 1,305
Deferred federal income taxes (2,538) 540
Change in operating assets and liabilities: Accrued investment
income 1,366 880
Capitalization of deferred policy acquisition costs (3,783) (6,645)
Policy liabilities (3,440) (16,234)
Other items, net (644) 3,269
Net cash provided by operating activities 261 165
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities (228,053) (122,495)
Mortgage loans and real estate (921) —
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities 206,051 95,177
Mortgage loans and real estate 27,970 18,621
Policy loans, net 2,320 6,468
Short-term investments, net 409 15,446
Net cash provided by investing activities 7,776 13,217
Cash flows from financing activities:
Dividends to shareholders — (3,275)
Receipts from universal life policies credited to contract holder
account balances 7,918 8,365
Return of contract holder account balances on universal life
policies (4,165) (3,718)
Withdrawals from interest-sensitive contracts (9,848) (13,046)
Cash used in financing activities (6,095) (11,674)
Net increase in cash and cash equivalents 1,942 1,708
Cash and cash equivalents, beginning of year 3,343 1,635
Cash and cash equivalents, end of year $ 5,285 $ 3,343
Supplemental cash flow information:
Income taxes paid $ 1,205 $ 785
See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Notes to Financial Statements
Years Ended December 31, 20X1 and 20X0
1. Organization and Significant Accounting Policies
Organization. ABC Life Insurance Company (ABC or the company) is a stock life insurance company incor-
porated in the state of ABC that offers individual life, disability income, long-term care, annuity, and in-
vestment products. ABC does business in the continental United States, with a concentration in New York,
New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect financial re-
porting are summarized as follows. The accompanying financial statements have been prepared in accor-
dance with GAAP that differ from statutory accounting practices (SAP) used for regulatory authorities. The
preparation of the financial statements in conformity with GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.
Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable and nonre-
deemable preferred stock not classified as either trading or held to maturity, and are reported at estimated
fair value. Unrealized holding gains and losses, net of tax, on available-for-sale securities are reported as a
net amount in other comprehensive income. Deferred policy acquisition cost offsets for universal life type
contracts and amounts attributable to certain participating contracts are recorded as a separate component
of accumulated other comprehensive income. Fixed maturity securities held to maturity consist of bonds,
notes, redeemable and nonredeemable preferred stock which the insurance company has the intent and
ability to hold to maturity, and are reported at amortized cost and adjusted for amortization of premium or
discount. Declines in fair value of individual held-to-maturity and available-for-sale securities below their
cost that are other then temporary have resulted in write-downs of the individual securities to their fair
value. The related write-downs have been included in earnings as realized losses. Trading account securities
consist of bonds, notes, and redeemable and nonredeemable preferred stock, and common stock held prin-
cipally for resale in the near term, and are recorded at their estimated fair values. Realized and unrealized
gains and losses on trading account securities are included in other income.
Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of premium
or discount, less allowance for losses. Real estate held for sale is carried at the lower of depreciated cost or
fair value less estimated selling costs. Real estate classified as held-for-sale is no longer depreciated. Real
estate, including real estate acquired in satisfaction of debt, is carried at depreciated cost. Impaired real
estate is written down to fair value with the impairment loss being included in net realized gains (losses) on
investments and other. Upon foreclosure (including in-substance foreclosure), the carrying value of the
property is recorded at the lower of cost or fair value (less selling costs if to be sold), which becomes its new
cost basis. The estimated fair value for real estate is determined based upon independent appraisals and
other available information about the property, which may take into consideration a number of factors,
including (i) discounted cash flows, (ii) sales of comparable properties, (iii) geographic location of property
and related market conditions, and (iv) disposition costs.
Foreclosed properties are actively managed by the company in order to maximize their value. Subsequent
to foreclosure, the carrying value of the property is periodically evaluated and a valuation allowance is
established, if necessary, to reflect any additional amounts considered unrecoverable upon sale. At the time
of the sale, the difference between the sales price and the carrying value is recorded as a realized gain or
loss. Policy loans are carried at unpaid balances. Short-term investments are stated at amortized cost, which
approximates fair value.
Provisions for impairments of securities classified as held to maturity are included in net realized gains
(losses) on investments and other. Realized gains and losses are determined by specific identification.
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Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Cash equiva-
lents are highly liquid financial instruments with an original maturity of three months or less.
Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insurance, universal
life insurance and investment products, and accident and health insurance, that vary with and are primarily
related to the production of new and renewal business, have been deferred. Traditional life insurance and
accident and health insurance acquisition costs are being amortized over the premium-paying period of the
related policies using assumptions consistent with those used in computing future policy benefit liabilities.
For universal life-type contracts and investment contracts that include significant surrender charges or that
yield significant revenues from sources other than the investment of contract holders’ funds, the deferred
contract acquisition cost amortization is matched to the recognition of gross profit.
Otherwise, deferred policy acquisition costs on investment contracts are amortized using an accounting
method that recognizes acquisition costs as expenses at a constant rate applied to net policy liabilities. The
effect on the deferred acquisition costs (DAC) asset that would result from realization of unrealized gains
(losses) is recognized with an offset to accumulated other comprehensive income in consolidated sharehold-
ers’ equity as of the balance sheet date.
FASB ASC 944-30 provides guidance on accounting by insurance enterprises for DAC on internal replace-
ments of insurance and investment contracts. The FASB ASC glossary defines internal replacement as a mod-
ification in product benefits, features, rights, or coverages that occurs by a contract exchange; by amend-
ment, endorsement, or rider to a contract; or by the election of a benefit, feature, right, or coverage within
the contract.
If an internal replacement modification substantially changes a contract, then the DAC is written off imme-
diately through income and any new deferrable costs associated with the new replacement are deferred. If
a contract modification does not substantially change the contract, the DAC amortization on the original
contract will continue and any acquisition costs associated with the related modification are immediately
expensed.
Adoption of FASB ASC 944-30 resulted in a reduction to DAC and value of business acquired on January 1,
2007, and an acceleration of the amortization period relating primarily to the company’s group life and
health insurance contracts that contain certain rate reset provisions. Prior to the adoption of FASB ASC 944-
30, DAC on such contracts was amortized over the expected renewable life of the contract. Upon adoption
of FASB ASC 944-30, DAC on such contracts is to be amortized over the rate reset period. The impact as of
January 1, 2007, was a cumulative effect adjustment of $XXX,XXX net of income tax of $XXX,XXX, which
was recorded as a reduction to retained earnings.
Deferred sales inducements. Costs related to sales inducements offered on sales to new customers, principally
on investment contracts and primarily in the form of additional credits to the customer’s account value or
enhancements to interest credited for a specified period, which are beyond amounts currently being credited
to existing contracts, are deferred and recorded as other assets. All other sales inducements are expensed as
incurred and included in interest credited to contract holders’ funds. Deferred sales inducements are amor-
tized to income using the same methodology and assumptions as DAC, and are included in interest credited
to contract holders’ funds. Deferred sales inducements are periodically reviewed for recoverability and writ-
ten down when necessary.
Property and equipment. Property and equipment are reported at cost, net of accumulated depreciation of
$501,000 and $420,000 in 20X1 and 20X0, respectively. Property and equipment are depreciated using the
straight line method over their estimated useful lives.
Future policy benefits and expenses. The liabilities for traditional life insurance and accident and health insur-
ance contract benefits and expenses are computed using a net level premium method including assumptions
about investment yields, mortality, withdrawals, and other assumptions based on ABC’s experience modi-
fied as necessary to reflect anticipated trends and to include provisions for possible unfavorable deviations.
Liability interest assumptions are graded and range from 3 percent to 10 percent. Benefit liabilities for tra-
ditional life insurance contracts include certain deferred profits on limited-payment policies that are being
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recognized in income over the contract term. Contract benefit claims are charged to expense in the period
that the claims are incurred.
The accrued account balance for nontraditional life insurance and investment contracts is computed as de-
posits net of withdrawals made by the contract holder, plus amounts credited based on contract specifica-
tions, less contract fees and charges assessed, plus any additional interest. Interest crediting rates for univer-
sal life and investment products range from 5.50 percent to 9.25 percent.
Included in contract holders’ account balances is a provision for contract holder dividends. Benefit liabilities
for contract holders’ account balances are computed under a retrospective deposit method and represent
contract account balances before applicable surrender charges. Contract benefits and claims that are charged
to expense include benefit claims incurred in the period in excess of related contract account balances. Inter-
est crediting rates for universal life and investment products range from 5.50 percent to 9.25 percent. Benefits
and expenses are charged against the account balance to recognize costs as incurred over the estimated lives
of the contracts. Expenses include interest credited to contract account balances and benefits paid in excess
of contract account balances.
Minimum guarantees. The company issues variable annuity contracts through separate accounts where the
company contractually guarantees to the contract holder total deposits made to the contract less any partial
withdrawals plus a minimum return. This guarantee includes benefits that are payable in the event of death,
annuitization, or at specified dates during the accumulation period.
Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the estimated
liability for benefit expenses both reported but not paid and incurred but not reported to ABC through
December 31. ABC does not discount its liabilities for unpaid claims. Liabilities for unpaid claims are esti-
mated using individual case-basis valuations and statistical analyses. Those estimates are subject to the ef-
fects of trends in claim severity and frequency. Although considerable variability is inherent in such esti-
mates, management believes that the liabilities for unpaid claims are adequate. The estimates are continually
reviewed and adjusted as necessary as experience develops or new information becomes known; such ad-
justments are included in current operations.
Income taxes. Federal income taxes are charged or credited to operations based upon amounts estimated to
be payable or recoverable as a result of taxable operations for the current year. Deferred income taxes have
been provided for temporary differences between the tax basis of assets and liabilities calculated using the
criteria of FASB ASC 740, Income Taxes, and their reported amounts in the financial statements using enacted
income tax rates and laws. The Company recognizes interest and penalties accrued on any unrecognized tax
benefits as a component of income tax expense. The Company did not have any accrued and recognized
interest or penalties associated with unrecognized tax benefits for the years ending December 31, 20X1 and
20X0.2
Reinsurance. In the normal course of business, the company seeks to limit its exposure to loss on any single
insured and to recover a portion of benefits paid by ceding reinsurance to other insurance entities or rein-
surers under excess coverage and coinsurance contracts. The company retains a maximum of $400,000 of
coverage per individual life. Amounts paid or deemed to have been paid for reinsurance contracts are re-
corded as reinsurance receivable.
Insurance premium revenues. Traditional life premiums, which include those products with fixed and guar-
anteed premiums and benefits and consist principally of whole life insurance contracts, limited-payment life
insurance contracts, and certain annuities with life contingencies, are generally recognized as revenue when
due. Revenues on universal life and investment-type contracts consist of contract charges against contract
holders’ funds for the cost of insurance, administration, surrender charges, actuarial margin, and other fees.
Accident and health insurance premiums are recognized as revenue pro rata over the terms of the contracts.
Separate accounts. Separate account assets and liabilities generally represent funds maintained in accounts to
meet specific investment objectives of contract holders who bear the investment risk. Investment income and
investment gains and losses accrue directly to such contract holders. The assets supporting the variable
2 Because these standards are not insurance industry specific, transition and adoption specifics are excluded.
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portion of both traditional variable annuities and variable contracts with guarantees are carried at fair value
and reported as summary total separate account assets with an equivalent summary total reported for lia-
bilities. Amounts assessed against the contract holders for mortality, administrative, and other services are
included in revenue and changes in liabilities for minimum guarantees are included in policyholder benefits
in the statement of operations. Separate account net investment income, net investment gains and losses,
and the related liability changes are offset within the same line item in the statement of operations.
Business risks and uncertainties. The development of liabilities for future policy benefits for the company’s
products requires management to make estimates and assumptions regarding mortality, morbidity, lapse,
expense, and investment experience. Such estimates are primarily based on historical experience and future
expectations of mortality, morbidity, expense, persistency, and investment assumptions. Actual results could
differ materially from those estimates. Management monitors actual experience and, if circumstances war-
rant, revises its assumptions and the related future policy benefit estimates.
The company’s investments are primarily comprised of fixed maturity securities, equity securities, real es-
tate, and mortgage loans. Significant changes in prevailing interest rates and geographic conditions may
adversely affect the timing and amount of cash flows on such investments and their related values. In ad-
dition, the value of these investments is often derived from an appraisal, an estimate or opinion of value. A
significant decline in the fair value of these investments could have an adverse effect on the company’s
balance sheet.
The company regularly invests in mortgaged backed securities (MBS) and other securities subject to prepay-
ment and call risk. Significant changes in prevailing interest rates may adversely affect the timing and
amount of cash flows on such securities. In addition, the amortization of market premium and accretion of
market discount for MBS is based on historical experience and estimates of future payment speeds on the
underlying mortgage loans. Actual prepayment speeds will differ from original estimates and may result in
material adjustments to amortization or accretion recorded in future periods.
Codification. The NAIC revised the Accounting Practices and Procedures Manual in a process referred to as
codification. Codification became effective on January 1, 2001. The company’s state of domicile has adopted
the provisions of the revised manual effective January 1, 2001. The revised manual has changed to some
extent, prescribed SAP, and has resulted in changes to the company’s statutory-basis financial statements.
The cumulative effect of changes in accounting principles adopted to conform to the revised Accounting
Practices and Procedures Manual of $XXX,XXX has been reported as an adjustment to increase (decrease) sur-
plus in the company’s statutory-basis financial statements as of January 1, 2001.
Guaranty funds. Guaranty fund (and other) assessments are accrued at the time the events occur on which
assessments are expected to be based.
2. Earnings Per Common Share
Basic and diluted earnings per common share are as follows.
(Thousands, except per common share data)
Income
(Numerator)
Shares
(Denominator)
Per Common
Share Amount
20X1
Net income 2,254
Income applicable to common ownership 2,254 3,342 .67
20X0
Net income 1,729
Income applicable to common ownership 1,729 3,342 .52
3. Investments
In reporting disclosures about investments in securities, entities should comply with the requirements of
FASB ASC 320, Investments—Debt and Equity Securities; FASB ASC 323, Investments—Equity Method and Joint
Ventures; and FASB ASC 325, Investments—Other.
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4. Fair Value of Financial Instruments
The following methods and assumptions were used to estimate the fair value of each class of financial
instruments for which it is practicable to estimate that value.
Short-term investments. For those short-term instruments amortized cost is a reasonable estimate of fair value.
Investment securities and trading account assets. For securities held for trading purposes and marketable equity
securities held for investment purposes, fair values are based on quoted market prices or dealer quotes. For
other securities held as investments, fair value equals quoted market price, if available. If a quoted market
price is not available, fair value is estimated using quoted market prices for similar securities.
Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is estimated using
discounted cash flows. The fair value of policy loans is estimated by discounting the future cash flows using
reasonable assumptions for mortality and repayments and using the current rates at which similar loans
would be made to contract holders with similar credit ratings and the same remaining maturities.
The estimated fair values of ABC’s mortgage loans on real estate and policy loans are as follows.
20X1 20X0
(Amounts in thousands)
Carrying
Amount Fair Value
Carrying
Amount Fair Value
Mortgage loans on real estate $79,258 $83,506 $106,692 $112,027
Policy loans 43,549 60,000 51,013 59,000
5. Accumulated Other Comprehensive Income
Accumulated other comprehensive income (loss) represents cumulative gains and losses on items that are
not reflected in earnings. The balances and activity for the years 20X1 and 20X0 are as follows.
20X1 20X0
(Amounts in thousands)
Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period $13,324 $(1,873)
Reclassification adjustment for gains (losses) included in net
earnings 46 (300)
Changes in net unrealized gains (losses) on investment securities 13,370 (2,173)
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred
federal income taxes (4,680) 443
Total other comprehensive income (loss) $ 8,690 $(1,730)
6. Income Taxes
Significant components for income tax expense attributable to continuing operations are as follows.
20X1 20X0
(Amounts in thousands)
Current income tax expense $1,547 $601
Deferred income tax (benefit) expense (1,405) 540
Total income tax expense $142 $1,141
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of
assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Signif-
icant components of the company’s deferred tax liabilities and assets are as follows.
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December 31,
20X1
December 31,
20X0
(Amounts in thousands)
Deferred tax liabilities:
Deferred policy acquisition costs $13,131 $12,297
Future policy benefits — 512
Accrual of discount on bonds 924 1,982
Other 3,641 1,024
Total deferred tax liabilities 17,696 15,815
Deferred tax assets:
Policyholder dividends 8,067 8,224
Future policy benefits 851 —
Deferred policy acquisition costs 2,078 1,561
Investment valuation allowance 1,087 1,651
Retirement plan accruals 1,917 497
Tax credits and loss carryforwards 1,820 1,945
Investment income differences 574 556
Other 406 354
Total deferred tax assets 16,800 14,788
Valuation allowance for deferred tax
assets (516) —
Net deferred tax assets 16,284 14,788
Net deferred tax liabilities $ 1,412 $ 1,027
A valuation allowance has been established due to the uncertainty of realized certain tax credits and loss
carryforwards, and a portion of other deferred tax assets.
A reconciliation of federal income tax expense as presented in the financial statements and income taxes
calculated using the statutory corporate tax rate follows.
20X1 20X0
(Amounts in thousands)
Income from operations $2,396 $2,870
Application of income tax rate 838 1,005
Small company deduction for life insurance
companies (556) (496)
Policyholders’ share of income (loss) in excess
of (less than) dividends paid (264) 752
Dividend received deduction (3) (50)
Other 127 (70)
Total tax expense $ 142 $1,141
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Reconciliation of Unrecognized Tax Benefits
20X1 20X0
(Amounts in thousands)
Beginning Balance $XXX $XXX
Prior period position increases XXX XXX
Prior period position decreases (XXX) (XXX)
Current period position increases XXX XXX
Current period position decreases (XXX) (XXX)
Decreases relating to settlements with
taxing authorities (XXX) (XXX)
Reductions due to a lapse of applicable
statue of limitations (XXX) (XXX)
Ending balance XXX XXX
None of the aforementioned unrecognized tax benefits, if recognized, would affect the effective tax rate.
Additionally, no tax positions exist for which it is reasonably possible that the total amounts of unrecognized
tax benefits will significantly increase or decrease within 12 months of December 31, 20X1. No interest or
penalties were recognized in the statement of operations or the statement of financial position for the years
ending December 31, 20X1 and 20X0. Tax years that remain subject to examination by major tax jurisdictions
include the years ending December 31, 19X8–20X1.
7. Financial Instruments With Off-Balance Sheet Risk and Concentration of Credit Risk
At December 31, 20X1, ABC held unrated or less-than-investment grade corporate debt securities of
$8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those holdings
amounted to 4 percent of ABC’s corporate debt securities investments and less than 2 percent of total assets.
The holdings of less-than-investment grade securities are widely diversified and of satisfactory quality based
on ABC’s investment policies and credit standards. ABC also invests in mortgage loans principally involving
commercial real estate. At December 31, 20X1, 3 percent of such mortgages ($2,000,000) involved properties
located in California and Arizona. Such investments consist of first mortgage liens on completed income-
producing properties, and mortgages on individual properties do not exceed $300,000.
8. Liability for Unpaid Claims
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount payable on
claims reported prior to the balance sheet date that have not yet been settled, claims reported subsequent to
the balance sheet date that have been incurred during the period then ended, and an estimate (based on
prior experience) of incurred but unreported claims relating to such period.
Activity in the liability for unpaid claims and claim adjustment expenses for the company’s health and
disability coverages is summarized as follows.
20X1 20X0
(Amounts in thousands)
Balance, beginning of year $ 4,737 $ 7,669
Less: reinsurance recoverables 296 1,018
Net balance, beginning of year 4,441 6,651
Amount incurred, related to prior years $ (297) $ 313
Current year 26,197 25,671
Total 25,900 25,984
Amount paid, related to prior years 6,923 8,937
Current year 18,303 19,257
Total 25,226 28,194
(continued)
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20X1 20X0
(Amounts in thousands)
Net balance, end of year 5,115 4,441
Plus: reinsurance recoverables 303 296
Balance, end of year $ 5,418 $ 4,737
As a result of changes in estimates of insured events in prior years, the provision of claims and claim ad-
justment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X1 and 20X0, respectively)
decreased by $297,000 in 20X1 reflecting lower-than-anticipated losses on pppppppppppppppp, and increased by
$313,000 in 20X0 reflecting higher-than-anticipated losses and related expenses for claims for ppppppppppppppp.
9. Minimum Guarantees
The following summarizes the liabilities for guarantees on variable contracts reflected in the general account.
Minimum
Guaranteed
Death Benefit
(MGDB)
Guaranteed
Minimum
Accumulation
Benefit (GMAB)
Guaranteed
Minimum
Income Benefit
(GMIB) Totals
Balance at January 1 $X,XXX,XXX $X,XXX,XXX $X,XXX,XXX $X,XXX,XXX
Incurred guarantee benefits3 X,XXX,XXX X,XXX,XXX X,XXX,XXX X,XXX,XXX
Paid guarantee benefits X,XXX,XXX X,XXX,XXX X,XXX,XXX X,XXX,XXX
Balance at December 31, 20XX4 $X,XXX,XX $X,XXX,XX $X,XXX,XX $X,XXX,XX
The minimum guaranteed death benefit (MGDB) liability is established equal to a benefit ratio multiplied
by the cumulative contract charges earned, plus accrued interest less contract benefit payments. The benefit
ratio is calculated as the estimated present value of all expected contract benefits divided by the present
value of all expected contract charges. The company regularly evaluates estimates used and adjusts the
additional liability balance, with a related charge or credit to benefit expense, if actual experience or other
evidence suggests that earlier assumptions should be revised.
The following assumptions and methodology were used to determine the MGDB liability at December 31,
20XX:
● Data used was 1,000 stochastically generated investment performance scenarios.
● Mean investment performance assumption was XX.
● Volatility assumption was XX.
● Mortality was assumed to be 90 percent of the Annuity 2000 table.
● Lapse rates vary by contract type and duration and range from 1 percent to 20 percent, with an
average of 3 percent.
● Discount rate was XX percent.
Guaranteed minimum accumulation benefits are considered to be derivatives under FASB ASC 944-815 and
are recognized at fair value through earnings.
The guaranteed minimum income benefit (GMIB) liability is established equal to a benefit ratio multiplied
by the cumulative contract charges earned, plus accrued interest less contract benefit payments. The benefit
3 For guaranteed minimum accumulation benefits, incurred guarantee benefits incorporates all changes in fair value other than
amounts resulting from paid guarantee benefits.
4 Included in the total reserve balance are reserves for variable annuity death benefits of $XXX,XXX, variable annuity income benefits
of $XXX,XXX and other guarantees of $XXX,XXX.
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ratio is calculated as the estimated present value of all expected contract benefits divided by the present
value of all expected contract charges. The company regularly evaluates estimates used and adjusts the
additional liability balance, with a related charge or credit to benefit expense, if actual experience or other
evidence suggests that earlier assumptions should be revised. The assumptions used for calculating the
GMIB liability at December 31, 20XX, are consistent with those used for calculating the MGDB liability.
Underlying assumptions for the liability related to income benefits include assumed future annuitization
elections based on factors such as the extent of benefit to the potential annuitant, eligibility conditions and
the annuitant’s attained age. In addition, the calculation of the GMIB liability assumes X percent of the
potential annuitizations that would be beneficial to the contract holder will be elected.
10. Reinsurance
The company utilizes indemnity reinsurance agreements to reduce its exposure to large losses in all aspects
of its insurance business. Such reinsurance permits recovery of a portion of losses from reinsurers, although
it does not discharge the primary liability of the company as direct insurer of the risks reinsured. The com-
pany evaluates the financial strength of potential reinsurers and continually monitors the financial condition
of reinsurers. The following tables include premium amounts ceded or assumed to or from other companies.
Direct Amount
Ceded to Other
Companies
Assumed from
Other
Companies Net Amount
(Amounts in thousands)
20X1
Premiums:
Life insurance $2,090 $560 $3,330 $4,860
Accident and health 1,440 1,290 — 150
Annuities 3,130 — 70 3,200
Total earned premiums $6,660 $1,850 $3,400 $8,210
20X0
Premiums:
Life insurance $2,080 $520 $3,680 $5,240
Accident and health 1,510 1,370 — 140
Annuities 1,840 — 30 1,870
Total earned premiums $5,430 $1,890 $3,710 $7,250
11. Separate Accounts
At December 31, 20X0 and 20X1, the company had the following variable contracts with guarantees. The
company’s variable annuity contracts may offer more than one type of guarantee in each contract; therefore,
the sum of amounts listed exceeds the total account balances of variable annuity contracts’ separate accounts
with guarantees.
Return of net deposits plus a minimum return:
In the event of death
Account value $XXX $XXX
Net amount at risk5 $XXX $XXX
Average attained age of contract
holders XX XX
Range of guaranteed minimum
return rates X–X% X–X%
(continued)
5 Defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
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Return of net deposits plus a minimum return:
At annuitization
Account value $XXX $XXX
Net amount at risk6 $XXX $XXX
Weighted average period
remaining until expected
annuitization XX XX
Range of guaranteed minimum
return rates X–X% X–X%
Accumulation at specified date
Account value $XXX $XXX
Net amount at risk7 $XXX $XXX
Range of guaranteed minimum
return rates X–X% X–X%
Account balances of contracts with guarantees were invested in variable separate accounts as follows:
Asset Type
December 31,
20X0
December 31,
20X1
U.S. Treasury securities and
obligations of U.S. government
corporations and agencies $ $
Obligations of states of the United
States and political subdivisions of
the states
Corporate debt securities:
—Investment grade
—Noninvestment grade
Foreign debt securities
Mortgage-backed securities
Equity securities (including mutual
funds)8
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents
Total $X,XXX,XXX $X,XXX,XXX
Assets transferred from the general account to the separate accounts are recognized at fair value to the extent
of third party contract holders’ proportionate interest in separate accounts when the arrangement meets
applicable criteria (FASB ASC 944-80-25-2). The gains recognized assets transferred to the separate accounts
during 20X1 and 20X0 were XX,XXX and XX,XXX, respectively.
6 Defined as the present value of the minimum guaranteed annuity payments determined in accordance with the terms of the contract
in excess of the current account balance.
7 Defined as the present value of the guaranteed minimum accumulation balance in excess of the current account balance.
8 The insurance enterprise may want to consider disclosing mutual funds by investment objective or other meaningful groupings that
are useful in understanding the nature of the guarantee risk.
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12. Guaranty Fund Assessments
At December 31, 20X1 and 20X0, ABC has recorded $45,000 and $67,000, respectively, in liabilities related to
guaranty fund (and other) assessments which are included in other liabilities in the balance sheet. At Decem-
ber 31, 20X1 and 20X0, the carried liability was reduced by recoverables for related premium tax offsets and
policy surcharges in the amount of $25,000 and $35,000, respectively. The period over which the assessments
are expected to be paid and the recorded premium tax offsets and policy surcharges are expected to be
realized is up to five and four years, respectively.
13. Statutory Financial Information
Under the law of ABC state, the state of incorporation, the maximum dividend that may be paid (without
prior approval of the ABC state insurance department), in any 12 month period is the greater of (a) net
investment income for the preceding calendar year or (b) 10 percent of contract holders’ surplus at the end
of the preceding calendar year. In general, net investment income for dividend purposes is interpreted by
the insurance department to be the statutory pretax net investment income including net realized capital
losses but excluding net realized capital gains. The maximum permissible amount of dividends for 20X3,
based on statutory net investment income for 20X1, is $20,000.
The company, which is domiciled in ABC state, prepares its statutory financial statements in accordance
with accounting principles and practices prescribed or permitted by the ABC state insurance department,
which (state of domicile) recognizes for determining solvency under the (state of domicile) insurance law.
The commissioner of the state of domicile insurance department has the right to permit other practices that
may deviate from prescribed practices. Prescribed SAP are those practices that are incorporated directly or
by reference in state laws, regulations, and general administrative rules applicable to all insurance enter-
prises domiciled in (state of domicile). Permitted SAP encompass all accounting practices that are not pre-
scribed; such practices differ from state to state, may differ from company to company within a state, and
may change in the future.
Note: Although the following reconciliation to statutory financial information is not required to be disclosed
in financial statements prepared in conformity with GAAP, insurance entities sometimes include such dis-
closures to facilitate use of those financial statements for purposes of filing with state regulatory authorities.
The second disclosure on variances from NAIC SAP (defined as follows) and permitted accounting practices
is required under FASB ASC 944-505-50.
The following reconciles ABC’s statutory net income and statutory surplus and capital stock determined in
accordance with accounting practices prescribed or permitted by the insurance department of Connecticut
with net earnings (loss) and equity on a GAAP basis.
20X1 20X0
(Amounts in thousands)
Statutory net income $ 3,572 $ 2,719
Adjustments:
Future policy benefits and policyholders’
account balances 572 894
Deferred policy acquisition costs 60 40
Deferred federal income tax (expense) benefit (1,405) 540
Valuation of investments 115 270
Postretirement benefits 272 354
Other, net (932) (3,088)
GAAP net income $ 2,254 $ 1,729
Statutory surplus and capital stock $65,388 $54,505
Adjustments:
Asset valuation reserves (1,054) (1,972)
(continued)
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20X1 20X0
(Amounts in thousands)
Statutory surplus, capital stock and asset
valuation reserves (875) (967)
Fixed income securities (29,472) (27,905)
Future policy benefits and policyholders’
account balances 115 270
Deferred federal income taxes (1,412) (1,027)
Valuation of investments 772 891
Deferred policy acquisition costs 38,936 36,429
Postretirement benefits (2,272) (2,354)
Other, net (228) 1,084
GAAP equity $69,898 $58,954
The company’s statutory financial statements are presented on the basis of accounting practices prescribed
or permitted by the [state of domicile] insurance department. [State of domicile] has adopted the NAIC Account-
ing Practices and Procedures Manual as the basis of its SAP, except that it has retained the prescribed practice
of writing off goodwill immediately to statutory surplus in the year of acquisition.
In addition, the commissioner of [state of domicile] insurance department has the right to permit other specific
practices that may deviate from prescribed practices. The commissioner has permitted the company to rec-
ord its home office property at estimated fair value instead of at depreciated cost, as required by NAIC SAP.
This accounting practice increased statutory capital and surplus by $X million and $X million at December
31, 20X1 and 20X0, respectively, over what it would have been had the permitted practice not been allowed.
The company’s statutory capital and surplus, including the effects of the permitted practice, was $X million
and $X million at December 31, 20X1 and 20X0, respectively.
Had the company amortized its goodwill over ten years and recorded its home office property at depreci-
ated cost, in accordance with NAIC SAP, the company’s capital and surplus would have been $X million
and $X million at December 31, 20X1 and 20X0, respectively.
14. Commitments and Contingencies
Future minimum rental payments, principally for administrative offices, under noncancellable operating
leases at December 31, 20X1, are as follows: 20X2, $1,113,000; 20X3, $1,064,000; 20X4, $1,011,000; 20X5,
$976,000; 20X6, $976,000; and $3,906,000 thereafter. Rental expense was $1,164,000 in 20X1 and $1,184,000 in
20X0.
ABC is named as defendant in a number of legal actions arising primarily from claims made under insur-
ance contracts or in connection with previous reinsurance agreements. These actions have been considered
in establishing its contract benefit liability. Management and its legal counsel are of the opinion that the
settlement of these actions will not have a material effect on ABC’s financial position or results of operations.

Your Opinion Matters
Thank you for selecting this publication for your accounting or auditing needs.
At the AICPA, we strive to provide the most useful publications available to the profession, which have been
produced with the highest quality. Responsiveness to our members and the profession as a whole is our
hallmark. We rely on feedback from our users to continually hone and improve our products.
Please take a few moments to let us know what you think of this edition. Does it meet your needs? Is it written
clearly? Is it comprehensive in its coverage? Is it easy to use? If not, how can we improve it?
Send your feedback by e-mail to A&APublications@aicpa.org.
Please note the name and edition of the publication, answers to the preceding questions, and anything else
you would like to share with us. Your feedback will help us improve subsequent editions and better serve
you.
Do you want to help even more?
Consider participating in a focus or advisory group related to this subject matter. If you are interested in, and
available for, participating in such a group, please be sure to include that information in your e-mail.
Thank you in advance for taking the time to write. We appreciate your feedback!
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